Hits from PDB |
Structure Title |
EC number |
4IX9 | CRYSTAL STRUCTURE OF SUBUNIT F OF V-ATPASE FROM S. CEREVISIAE | 3.6.3.14 |
4IXL | CRYSTAL STRUCTURE OF ENDO-BETA-1,4-XYLANASE FROM THE ALKALIPHILIC BACILLUS SP. SN5 | 3.2.1.8 |
4IXM | CRYSTAL STRUCTURE OF ZN(II)-BOUND YJIA GTPASE FROM E. COLI | 3.6 |
4IXN | CRYSTAL STRUCTURE OF ZN(II)-BOUND E37A,C66A,C67A TRIPLE MUTANT YJIA GTPASE | 3.6 |
4IXU | CRYSTAL STRUCTURE OF HUMAN ARGINASE-2 COMPLEXED WITH INHIBITOR 11D: {(5R)-5-AMINO-5-CARBOXY-5-[(3-ENDO)-8-(3,4-DICHLOROBENZYL)-8-AZABICYCLO[3.2.1]OCT-3-YL]PENTYL}(TRIHYDROXY)BORATE(1-) | 3.5.3.1 |
4IXV | CRYSTAL STRUCTURE OF HUMAN ARGINASE-2 COMPLEXED WITH INHIBITOR 2D: {(5R)-5-AMINO-5-CARBOXY-5-[1-(4-CHLOROBENZYL)PIPERIDIN-4-YL]PENTYL}(TRIHYDROXY)BORATE(1-) | 3.5.3.1 |
4IYR | CRYSTAL STRUCTURE OF FULL-LENGTH CASPASE-6 ZYMOGEN | 3.4.22.59 |
4IZ0 | CRYSTAL STRUCTURE OF HCV NS5B POLYMERASE IN COMPLEX WITH 2,4,5-TRICHLORO-N-(5-METHYL-1,2-OXAZOL-3-YL)BENZENESULFONAMIDE | 2.7.7.48 3.4.22 3.4.21.98 3.6.1.15 3.6.4.13 |
4IZ6 | STRUCTURE OF ENTE AND ENTB, AN NRPS ADENYLATION-PCP FUSION PROTEIN WITH PSEUDO TRANSLATIONAL SYMMETRY | 2.7.7.58 2.3.1 6.3.2.14 3.3.2.1 2.5.1 |
4IZ8 | CRYSTAL STRUCTURE OF STAPHYLOCOCCAL NUCLEASE VARIANT DELTA+PHS H8E AT CRYOGENIC TEMPERATURE | 3.1.31.1 |
4IZJ | CRYSTAL STRUCTURE OF YELLOWTAIL ASCITES VIRUS VP4 PROTEASE WITH A WILD-TYPE ACTIVE SITE REVEALS ACYL-ENZYME COMPLEXES AND PRODUCT COMPLEXES. | 3.4.21.115 3.4.21 |
4IZK | CRYSTAL STRUCTURE OF YELLOWTAIL ASCITES VIRUS VP4 PROTEASE ACTIVE SITE MUTANT (K674A) REVEALS BOTH AN ACYL-ENZYME COMPLEX AND AN EMPTY ACTIVE SITE | 3.4.21.115 3.4.21 |
4IZS | THE C145A MUTANT OF THE AMIDASE FROM NESTERENKONIA SP. AN1 IN COMPLEX WITH BUTYRAMIDE | 3.5.1.4 |
4IZT | THE E41Q MUTANT OF THE AMIDASE FROM NESTERENKONIA SP. AN1 SHOWING COVALENT ADDITION OF THE ACETAMIDE MOIETY OF FLUOROACETAMIDE AT THE ACTIVE SITE CYSTEINE | 3.5.1.4 |
4IZU | THE E41Q MUTANT OF THE AMIDASE FROM NESTERENKONIA SP. AN1 SHOWING THE RESULT OF MICHAEL ADDITION OF ACRYLAMIDE AT THE ACTIVE SITE CYSTEINE | 3.5.1.4 |
4IZV | THE E41Q/C145A DOUBLE MUTANT OF THE AMIDASE FROM NESTERENKONIA SP. AN1 IN COMPLEX WITH ACRYLAMIDE | 3.5.1.4 |
4IZW | THE E41L MUTANT OF THE AMIDASE FROM NESTERENKONIA SP. AN1 SHOWING COVALENT ADDITION OF THE ACETAMIDE MOIETY OF FLUOROACETAMIDE AT THE ACTIVE SITE CYSTEINE | 3.5.1.4 |
4J02 | CRYSTAL STRUCTURE OF HCV NS5B POLYMERASE IN COMPLEX WITH [(1R)-5,8-DICHLORO-1-PROPYL-1,3,4,9-TETRAHYDROPYRANO[3,4-B]INDOL-1-YL]ACETIC ACID | 3.4.22 3.4.21.98 3.6.1.15 3.6.4.13 2.7.7.48 |
4J03 | CRYSTAL STRUCTURE OF HUMAN SOLUBLE EPOXIDE HYDROLASE COMPLEXED WITH FULVESTRANT | 3.3.2.10 3.1.3.76 |
4J04 | CRYSTAL STRUCTURE OF HCV NS5B POLYMERASE IN COMPLEX WITH 4-CHLORO-2-{[(2,4,5-TRICHLOROPHENYL)SULFONYL]AMINO}BENZOIC ACID | 3.4.22 3.4.21.98 3.6.1.15 3.6.4.13 2.7.7.48 |
4J06 | CRYSTAL STRUCTURE OF HCV NS5B POLYMERASE IN COMPLEX WITH 2-{[(5-BROMOTHIOPHEN-2-YL)SULFONYL]AMINO}-4-CHLOROBENZOIC ACID | 3.4.22 3.4.21.98 3.6.1.15 3.6.4.13 2.7.7.48 |
4J08 | CRYSTAL STRUCTURE OF HCV NS5B POLYMERASE IN COMPLEX WITH 2-{[(4-METHYLPHENYL)SULFONYL]AMINO}-5-PHENOXYBENZOIC ACID | 3.4.22 3.4.21.98 3.6.1.15 3.6.4.13 2.7.7.48 |
4J0A | CRYSTAL STRUCTURE OF HCV NS5B POLYMERASE IN COMPLEX WITH 2-{[(4-METHYLPHENYL)SULFONYL]AMINO}-4-PHENOXYBENZOIC ACID | 3.4.22 3.4.21.98 3.6.1.15 3.6.4.13 2.7.7.48 |
4J0L | CRYSTAL STRUCTURE OF A FAMILY GH19 CHITINASE (W72A/E67Q MUTANT) FROM RYE SEEDS IN COMPLEX WITH TWO (GLCNAC)4 MOLECULES | 3.2.1.14 |
4J0N | CRYSTAL STRUCTURE OF A MANGANESE DEPENDENT ISATIN HYDROLASE | 3.5.2.20 |
4J0P | CRYSTAL STRUCTURE OF BACE-1 IN COMPLEX WITH 5-CYANO-PYRIDINE-2-CARBOXYLIC ACID [3-((S)-2-AMINO-4-METHYL-5,6-DIHYDRO-4H-[1,3]OXAZIN-4-YL)-4-FLUORO-PHENYL]-AMIDE | 3.4.23.46 |
4J0T | CRYSTAL STRUCTURE OF BACE-1 IN COMPLEX WITH 5-ETHOXY-PYRIDINE-2-CARBOXYLIC ACID [3-((R)-2-AMINO-5,5-DIFLUORO-4-METHYL-5,6-DIHYDRO-4H-[1,3]OXAZIN-4-YL)-4-FLUORO-PHENYL]-AMIDE | 3.4.23.46 |
4J0V | CRYSTAL STRUCTURE OF BACE-1 IN COMPLEX WITH 5-CYANO-PYRIDINE-2-CARBOXYLIC ACID [3-((4R,5R)-2-AMINO-5-FLUORO-4-METHYL-5,6-DIHYDRO-4H-[1,3]OXAZIN-4-YL)-4-FLUORO-PHENYL]-AMIDE | 3.4.23.46 |
4J0Y | CRYSTAL STRUCTURE OF BACE-1 IN COMPLEX WITH 5-CYANO-PYRIDINE-2-CARBOXYLIC ACID [3-((4R,5S)-2-AMINO-5-FLUORO-4-METHYL-5,6-DIHYDRO-4H-[1,3]OXAZIN-4-YL)-4-FLUORO-PHENYL]-AMIDE | 3.4.23.46 |
4J0Z | CRYSTAL STRUCTURE OF BACE-1 IN COMPLEX WITH 5-CYANO-PYRIDINE-2-CARBOXYLIC ACID [3-((4S,5R)-2-AMINO-5-FLUORO-4-FLUOROMETHYL-5,6-DIHYDRO-4H-[1,3]OXAZIN-4-YL)-4-FLUORO-PHENYL]-AMIDE | 3.4.23.46 |
4J17 | CRYSTAL STRUCTURE OF BACE-1 IN COMPLEX WITH 5-CYANO-PYRIDINE-2-CARBOXYLIC ACID [3-((S)-2-AMINO-4-DIFLUOROMETHYL-5,6-DIHYDRO-4H-[1,3]OXAZIN-4-YL)-4-FLUORO-PHENYL]-AMIDE | 3.4.23.46 |
4J1A | X-RAY STRUCTURE OF THE ADDUCT BETWEEN HEN EGG WHITE LYSOZYME AND AZIRU (GREEN CRYSTAL) | 3.2.1.17 |
4J1B | X-RAY STRUCTURE OF THE ADDUCT BETWEEN HEN EGG WHITE LYSOZYME AND AZIRU (BLACK CRYSTAL) | 3.2.1.17 |
4J1C | CRYSTAL STRUCTURE OF BACE-1 IN COMPLEX WITH 5-CYANO-PYRIDINE-2-CARBOXYLIC ACID [3-((S)-2-AMINO-5,5-DIFLUORO-4-FLUOROMETHYL-5,6-DIHYDRO-4H-[1,3]OXAZIN-4-YL)-4-FLUORO-PHENYL]-AMIDE | 3.4.23.46 |
4J1E | CRYSTAL STRUCTURE OF BACE-1 IN COMPLEX WITH 5-CYANO-PYRIDINE-2-CARBOXYLIC ACID [3-((4S,6S)-2-AMINO-4-FLUOROMETHYL-6-TRIFLUOROMETHYL-5,6-DIHYDRO-4H-[1,3]OXAZIN-4-YL)-4-FLUORO-PHENYL]-AMIDE | 3.4.23.46 |
4J1F | CRYSTAL STRUCTURE OF BACE-1 IN COMPLEX WITH 5-CYANO-PYRIDINE-2-CARBOXYLIC ACID [3-((4S,6S)-2-AMINO-4-METHYL-6-TRIFLUOROMETHYL-5,6-DIHYDRO-4H-[1,3]OXAZIN-4-YL)-4-FLUORO-PHENYL]-AMIDE | 3.4.23.46 |
4J1H | CRYSTAL STRUCTURE OF BACE-1 IN COMPLEX WITH 5-CYANO-PYRIDINE-2-CARBOXYLIC ACID [3-((4S,6R)-2-AMINO-4-METHYL-6-TRIFLUOROMETHYL-5,6-DIHYDRO-4H-[1,3]OXAZIN-4-YL)-4-FLUORO-PHENYL]-AMIDE | 3.4.23.46 |
4J1I | CRYSTAL STRUCTURE OF BACE-1 IN COMPLEX WITH 5-CYANO-PYRIDINE-2-CARBOXYLIC ACID [3-((4R,5R,6R)-2-AMINO-5-FLUORO-4-METHYL-6-TRIFLUOROMETHYL-5,6-DIHYDRO-4H-[1,3]OXAZIN-4-YL)-4-FLUORO-PHENYL]-AMIDE | 3.4.23.46 |
4J1K | CRYSTAL STRUCTURE OF BACE-1 IN COMPLEX WITH 5-CYANO-PYRIDINE-2-CARBOXYLIC ACID [3-((4R,5R,6S)-2-AMINO-5-FLUORO-4-METHYL-6-TRIFLUOROMETHYL-5,6-DIHYDRO-4H-[1,3]OXAZIN-4-YL)-4-FLUORO-PHENYL]-AMIDE | 3.4.23.46 |
4J1L | MUTANT ENDOTOXIN TENT | 3.4.24.68 |
4J1M | CRYSTAL STRUCTURE OF STAPHYLOCOCCAL NUCLEASE VARIANT DELTA+PHS R105E AT CRYOGENIC TEMPERATURE | 3.1.31.1 |
4J1Y | THE X-RAY CRYSTAL STRUCTURE OF HUMAN COMPLEMENT PROTEASE C1S ZYMOGEN | 3.4.21.42 |
4J2A | RB69 DNA POLYMERASE L415A TERNARY COMPLEX | 2.7.7.7 3.1.11 |
4J2B | RB69 DNA POLYMERASE L415G TERNARY COMPLEX | 2.7.7.7 3.1.11 |
4J2D | RB69 DNA POLYMERASE L415K TERNARY COMPLEX | 2.7.7.7 3.1.11 |
4J2E | RB69 DNA POLYMERASE L415M TERNARY COMPLEX | 2.7.7.7 3.1.11 |
4J3B | A NATURALLY VARIABLE RESIDUE IN THE S1 SUBSITE OF M1-FAMILY AMINOPEPTIDASES MODULATES CATALYTIC PROPERTIES AND PROMOTES FUNCTIONAL SPECIALIZATION | 3.4.11 |
4J3D | PSEUDOMONAS AERUGINOSA LPXC IN COMPLEX WITH A HYDROXAMATE INHIBITOR | 3.5.1 3.5.1.108 |
4J3J | CRYSTAL STRUCTURE OF DPP-IV WITH COMPOUND C3 | 3.4.14.5 |
4J3S | CRYSTAL STRUCTURE OF BARLEY LIMIT DEXTRINASE SOAKED WITH 300MM MALTOTETRAOSE | 3.2.1.41 |
4J3T | CRYSTAL STRUCTURE OF BARLEY LIMIT DEXTRINASE CO-CRYSTALLIZED WITH 25MM MALTOTETRAOSE | 3.2.1.41 |
4J3U | CRYSTAL STRUCTURE OF BARLEY LIMIT DEXTRINASE IN COMPLEX WITH MALTOSYL-S-BETACYCLODEXTRIN | 3.2.1.41 |
4J3V | CRYSTAL STRUCTURE OF BARLEY LIMIT DEXTRINASE IN COMPLEX WITH A BRANCHED THIO-LINKED HEXASACCHARIDE | 3.2.1.41 |
4J3W | CRYSTAL STRUCTURE OF BARLEY LIMIT DEXTRINASE (E510A MUTANT) IN COMPLEX WITH A BRANCHED MALTOHEXASACCHARIDE | 3.2.1.41 |
4J3X | CRYSTAL STRUCTURE OF BARLEY LIMIT DEXTRINASE (E510A MUTANT) IN COMPLEX WITH A BRANCHED MALTOHEPTASACCHARIDE | 3.2.1.41 |
4J40 | CRYSTAL STRUCTURE OF THE DUAL-DOMAIN GGDEF-EAL MODULE OF FIMX FROM PSEUDOMONAS AERUGINOSA | 3.1.4.52 |
4J4J | CRYSTAL STRUCTURE OF THE APOBEC3F VIF BINDING DOMAIN | 3.5.4.5 3.5.4.38 |
4J4M | CRYSTAL STRUCTURE OF TM-1, A TRIMERESURUS MUCROSQUAMATUS VENOM METALLOPROTEINASE | 3.4.24.53 3.4.24 |
4J51 | CYRSTAL STRUCTURE OF PROTEIN TYROSINE PHOSPHATASE LYP CATALYTIC DOMAIN COMPLEX WITH SMALL MOLECULAR INHIBITOR L75N04 | 3.1.3.48 |
4J54 | CRYSTAL STRUCTURE OF MULTIDRUG RESISTANT HIV-1 PROTEASE CLINICAL ISOLATE PR20 WITH THE POTENT ANTIVIRAL INHIBITOR GRL-0519A | 3.4.23.16 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1 |
4J55 | CRYSTAL STRUCTURE OF MULTIDRUG RESISTANT HIV-1 PROTEASE CLINICAL ISOLATE PR20 WITH THE POTENT ANTIVIRAL INHIBITOR GRL-02031 | 3.4.23.16 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1 |
4J5F | CRYSTAL STRUCTURE OF B. THURINGIENSIS AIIA MUTANT F107W | 3.1.1.81 |
4J5G | CRYSTAL STRUCTURE ANALYSIS OF STREPTOMYCES AUREOFACIENS RIBONUCLEASE SA T95A MUTANT | 3.1.27.3 4.6.1.24 |
4J5H | CRYSTAL STRUCTURE OF B. THURINGIENSIS AIIA MUTANT F107W WITH N-DECANOYL-L-HOMOSERINE BOUND AT THE ACTIVE SITE | 3.1.1.81 |
4J5J | CRYSTAL STRUCTURE OF MULTIDRUG RESISTANT HIV-1 PROTEASE CLINICAL ISOLATE PR20 IN COMPLEX WITH AMPRENAVIR | 3.4.23.16 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1 |
4J5K | CRYSTAL STRUCTURE ANALYSIS OF STREPTOMYCES AUREOFACIENS RIBONUCLEASE SA Y51F MUTANT | 3.1.27.3 4.6.1.24 |
4J5P | CRYSTAL STRUCTURE OF A COVALENTLY BOUND ALPHA-KETOHETEROCYCLE INHIBITOR (PHENHEXYL/OXADIAZOLE/PYRIDINE) TO A HUMANIZED VARIANT OF FATTY ACID AMIDE HYDROLASE | 3.5.1.99 3.1.1 |
4J5Q | TARG1 (C6ORF130), TERMINAL ADP-RIBOSE GLYCOHYDROLASE 1, APO STRUCTURE | 3.5.1 3.2.2 |
4J5R | TARG1 (C6ORF130), TERMINAL ADP-RIBOSE GLYCOHYDROLASE 1 BOUND TO ADP-HPD | 3.5.1 3.2.2 |
4J5S | TARG1 (C6ORF130), TERMINAL ADP-RIBOSE GLYCOHYDROLASE 1 ADP-RIBOSE COMPLEX | 3.5.1 3.2.2 |
4J5T | CRYSTAL STRUCTURE OF PROCESSING ALPHA-GLUCOSIDASE I | 3.2.1.106 |
4J5Z | CRYSTAL STRUCTURE OF RIBONUCLEASE A IN AQUEOUS SOLUTION: ONE OF TWELVE IN MSCS SET | 3.1.27.5 4.6.1.18 |
4J60 | CRYSTAL STRUCTURE OF RIBONUCLEASE A SOAKED IN 25% CYCLOPENTANOL: ONE OF TWELVE IN MSCS SET | 3.1.27.5 4.6.1.18 |
4J61 | CRYSTAL STRUCTURE OF RIBONUCLEASE A SOAKED IN 40% CYCLOPENTANONE: ONE OF TWELVE IN MSCS SET | 3.1.27.5 4.6.1.18 |
4J62 | CRYSTAL STRUCTURE OF RIBONUCLEASE A SOAKED IN 40% CYCLOHEXANOL: ONE OF TWELVE IN MSCS SET | 3.1.27.5 4.6.1.18 |
4J63 | CRYSTAL STRUCTURE OF RIBONUCLEASE A SOAKED IN 40% CYCLOHEXANONE: ONE OF TWELVE IN MSCS SET | 3.1.27.5 4.6.1.18 |
4J64 | CRYSTAL STRUCTURE OF RIBONUCLEASE A SOAKED IN 40% DIOXANE: ONE OF TWELVE IN MSCS SET | 3.1.27.5 4.6.1.18 |
4J65 | CRYSTAL STRUCTURE OF RIBONUCLEASE A SOAKED IN 40% DIMETHYLFORMAMIDE: ONE OF TWELVE IN MSCS SET | 3.1.27.5 4.6.1.18 |
4J66 | CRYSTAL STRUCTURE OF RIBONUCLEASE A SOAKED IN 25% DIMETHYL SULFOXIDE: ONE OF TWELVE IN MSCS SET | 3.1.27.5 4.6.1.18 |
4J67 | CRYSTAL STRUCTURE OF RIBONUCLEASE A SOAKED IN 50% 1,6-HEXANEDIOL: ONE OF TWELVE IN MSCS SET | 3.1.27.5 4.6.1.18 |
4J68 | CRYSTAL STRUCTURE OF RIBONUCLEASE A SOAKED IN 40% ISOPROPANOL: ONE OF TWELVE IN MSCS SET | 3.1.27.5 4.6.1.18 |
4J69 | CRYSTAL STRUCTURE OF RIBONUCLEASE A SOAKED IN 50% S,R,S-BISFURANOL: ONE OF TWELVE IN MSCS SET | 3.1.27.5 4.6.1.18 |
4J6A | CRYSTAL STRUCTURE OF RIBONUCLEASE A SOAKED IN 40% 2,2,2-TRIFLUOROETHANOL: ONE OF TWELVE IN MSCS SET | 3.1.27.5 4.6.1.18 |
4J6E | STRUCTURE OF LPXI D225A MUTANT | 3.6.1.54 |
4J6H | CRYSTAL STRUCTURE OF STAPHYLOCOCCAL NUCLEASE VARIANT DELTA+PHS H121Q AT CRYOGENIC TEMPERATURE | 3.1.31.1 |
4J6O | CRYSTAL STRUCTURE OF THE PHOSPHATASE DOMAIN OF C. THERMOCELLUM (BACTERIAL) PNKP | 3.1.3.16 |
4J7L | CRYSTAL STRUCTURE OF MOUSE DXO IN COMPLEX WITH PRODUCT RNA AND TWO MAGNESIUM IONS | 3.6.1 3.1.13 |
4J7M | CRYSTAL STRUCTURE OF MOUSE DXO IN COMPLEX WITH SUBSTRATE MIMIC RNA AND CALCIUM ION | 3.6.1 3.1.13 |
4J7N | CRYSTAL STRUCTURE OF MOUSE DXO IN COMPLEX WITH M7GPPPG CAP | 3.6.1 3.1.13 |
4J7R | CRYSTAL STRUCTURE OF CHLAMYDOMONAS REINHARDTII ISOAMYLASE 1 (ISA1) | 3.2.1.68 |
4J7V | CRYSTAL STRUCTURE OF CROSS-LINKED HEN EGG WHITE LYSOZYME SOAKED WITH 5MM [RU(BENZENE)CL2]2 | 3.2.1.17 |
4J94 | CRYSTAL STRUCTURE OF MYCP1 FROM THE ESX-1 TYPE VII SECRETION SYSTEM | 3.4.21.62 3.4.21 |
4J9T | CRYSTAL STRUCTURE OF A PUTATIVE, DE NOVO DESIGNED UNNATURAL AMINO ACID DEPENDENT METALLOPROTEIN, NORTHEAST STRUCTURAL GENOMICS CONSORTIUM TARGET OR61 | 3.2.1.18 |
4JA1 | STRUCTURE OF MMP3 COMPLEXED WITH A PLATINUM-BASED INHIBITOR | 3.4.24.17 |
4JA7 | RAT PP5 CO-CRYSTALLIZED WITH P5SA-2 | 3.1.3.16 |
4JA9 | RAT PP5 APO | 3.1.3.16 |
4JAW | CRYSTAL STRUCTURE OF LACTO-N-BIOSIDASE FROM BIFIDOBACTERIUM BIFIDUM COMPLEXED WITH LNB-THIAZOLINE | 3.2.1.140 3.2.1.52 |
4JB3 | CRYSTAL STRUCTURE OF BT_0970, A HAD FAMILY PHOSPHATASE FROM BACTEROIDES THETAIOTAOMICRON VPI-5482, TARGET EFI-501083, WITH BOUND SODIUM AND GLYCEROL, CLOSED LID, ORDERED LOOP | 3.1.3 3.1.3.104 |
4JB8 | CASPASE-7 IN COMPLEX WITH DARPIN C7_16 | 3.4.22.60 |
4JBS | CRYSTAL STRUCTURE OF THE HUMAN ENDOPLASMIC RETICULUM AMINOPEPTIDASE 2 IN COMPLEX WITH PHOSPHINIC PSEUDOTRIPEPTIDE INHIBITOR. | 3.4.11 |
4JC4 | CRYSTAL STRUCTURE OF PEPTIDYL-TRNA HYDROLASE FROM PSEUDOMONAS AERUGINOSA AT 2.25 ANGSTROM RESOLUTION | 3.1.1.29 |
4JCN | STRUCTURE OF ESP, SERINE PROTEASE FROM STAPHYLOCOCCUS EPIDERMIDIS | 3.4.21.19 |
4JCT | CLPP2 FROM LISTERIA MONOCYTOGENES | 3.4.21.92 |
4JCW | CRYSTAL STRUCTURE OF CLAVIBACTER MICHIGANENSIS EXPANSIN IN COMPLEX WITH CELLOPENTAOSE | 3.2.1.4 |
4JDG | STRUCTURE OF TOMATO BIFUNCTIONAL NUCLEASE TBN1, VARIANT N211D | 3.1.30 3.1.30.1 |
4JE4 | CRYSTAL STRUCTURE OF MONOBODY NSA1/SHP2 N-SH2 DOMAIN COMPLEX | 3.1.3.48 |
4JE6 | CRYSTAL STRUCTURE OF A HUMAN-LIKE MITOCHONDRIAL PEPTIDE DEFORMYLASE | 3.5.1.88 |
4JE7 | CRYSTAL STRUCTURE OF A HUMAN-LIKE MITOCHONDRIAL PEPTIDE DEFORMYLASE IN COMPLEX WITH ACTINONIN | 3.5.1.88 |
4JE8 | CRYSTAL STRUCTURE OF A HUMAN-LIKE MITOCHONDRIAL PEPTIDE DEFORMYLASE IN COMPLEX WITH MET-ALA-SER | 3.5.1.88 |
4JEC | JOINT NEUTRON AND X-RAY STRUCTURE OF PER-DEUTERATED HIV-1 PROTEASE IN COMPLEX WITH CLINICAL INHIBITOR AMPRENAVIR | 3.4.23.16 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1 |
4JEG | CRYSTAL STRUCTURE OF MONOBODY CS1/SHP2 C-SH2 DOMAIN COMPLEX | 3.1.3.48 |
4JEI | NONGLYCOSYLATED YARROWIA LIPOLYTICA LIP2 LIPASE | 3.1.1.3 |
4JF4 | OXA-23 MEROPENEM COMPLEX | 3.5.2.6 |
4JF5 | STRUCTURE OF OXA-23 AT PH 4.1 | 3.5.2.6 |
4JF6 | STRUCTURE OF OXA-23 AT PH 7.0 | 3.5.2.6 |
4JF7 | STRUCTURE OF THE PARAINFLUENZA VIRUS 5 (PIV5) HEMAGGLUTININ-NEURAMINIDASE (HN) ECTODOMAIN | 3.2.1.18 |
4JG3 | CRYSTAL STRUCTURE OF CATABOLITE REPRESSION CONTROL PROTEIN (CRC) FROM PSEUDOMONAS AERUGINOSA | 3.1.11.2 |
4JGC | HUMAN TDG N140A MUTANT IN A COMPLEX WITH 5-CARBOXYLCYTOSINE (5CAC) | 3.2.2.29 |
4JGG | CRYSTAL STRUCTURE OF TESA | 3.1.1.1 |
4JGU | CRYSTAL STRUCTURE OF CLOSTRIDIUM HISTOLYTICUM COLH COLLAGENASE POLYCYSTIC KIDNEY-DISEASE-LIKE DOMAIN 2B AT 1.4 ANGSTROM RESOLUTION IN THE PRESENCE OF CALCIUM | 3.4.24.3 |
4JGY | CRYSTAL STRUCTURE OF HUMAN COXSACKIEVIRUS A16 UNCOATING INTERMEDIATE (SPACE GROUP P4232) | 3.4.22.29 3.6.1.15 3.4.22.28 2.7.7.48 |
4JH0 | CRYSTAL STRUCTURE OF DIPEPTIDYL-PEPTIDASE 4 (CD26, ADENOSINE DEAMINASE COMPLEXING PROTEIN 2) (DPP-IV-WT) COMPLEX WITH BMS-767778 AKA 2-(3-(AMINOMETHYL)-4-(2,4- DICHLOROPHENYL)-2-METHYL-5-OXO-5,7-DIHYDRO-6H-PYRROLO[3,4- B]PYRIDIN-6-YL)-N,N-DIMETHYLACETAMIDE | 3.4.14.5 |
4JHC | CRYSTAL STRUCTURE OF THE UNCHARACTERIZED MAF PROTEIN YCEF FROM E. COLI | 3.6.1 |
4JHL | CRYSTAL STRUCTURE OF OF AXE2, AN ACETYLXYLAN ESTERASE FROM GEOBACILLUS STEAROTHERMOPHILUS | 3.1.1.72 |
4JHO | STRUCTURAL ANALYSIS AND INSIGHTS INTO GLYCON SPECIFICITY OF THE RICE GH1 OS7BGLU26 BETA-D-MANNOSIDASE | 3.2.1.25 |
4JHZ | STRUCTURE OF E. COLI BETA-GLUCURONIDASE BOUND WITH A NOVEL, POTENT INHIBITOR 2-[4-(1,3-BENZODIOXOL-5-YLMETHYL)PIPERAZIN-1-YL]-N-[(1S,2S,5S)-2,5-DIMETHOXYCYCLOHEXYL]ACETAMIDE | 3.2.1.31 |
4JIB | CRYSTAL STRUCTURE OF OF PDE2-INHIBITOR COMPLEX | 3.1.4.17 |
4JID | CRYSTAL STRUCTURE OF BALDCB / VANY-LIKE L,D-CARBOXYPEPTIDASE ZINC(II)-FREE | 3.4.16.4 |
4JIE | STRUCTURAL ANALYSIS AND INSIGHTS INTO GLYCON SPECIFICITY OF THE RICE GH1 OS7BGLU26 BETA-D-MANNOSIDASE | 3.2.1.25 |
4JIJ | CRYSTAL STRUCTURE OF AN INACTIVE MUTANT OF MMP-9 CATALYTIC DOMAIN IN COMPLEX WITH A FLUOROGENIC SYNTHETIC PEPTIDIC SUBSTRATE | 3.4.24.35 |
4JIW | C1882 PAAR-REPEAT PROTEIN FROM ESCHERICHIA COLI IN COMPLEX WITH A VGRG-LIKE BETA-HELIX THAT IS BASED ON A FRAGMENT OF T4 GP5 | 3.2.1.17 |
4JJ2 | HIGH RESOLUTION STRUCTURE OF A C-TERMINAL FRAGMENT OF THE T4 PHAGE GP5 BETA-HELIX | 3.2.1.17 |
4JJ4 | CRYSTAL STRUCTURE OF A CATALYTIC MUTANT OF AXE2 (AXE2-D191A), AN ACETYLXYLAN ESTERASE FROM GEOBACILLUS STEAROTHERMOPHILUS | 3.1.1.72 |
4JJ6 | CRYSTAL STRUCTURE OF A CATALYTIC MUTANT OF AXE2 (AXE2-H194A), AN ACETYLXYLAN ESTERASE FROM GEOBACILLUS STEAROTHERMOPHILUS | 3.1.1.72 |
4JJ7 | CASPASE-3 SPECIFIC UNNATURAL AMINO ACID-BASED PEPTIDES | 3.4.22.61 |
4JJ8 | CASPASE-3 SPECIFIC UNNATURAL AMINO ACID PEPTIDES | 3.4.22.60 |
4JJE | CASPASE-3 SPECIFIC UNNATURAL AMINO ACID PEPTIDES | 3.4.22.56 |
4JJJ | THE STRUCTURE OF T. FUSCA GH48 D224N MUTANT | 3.2.1.91 |
4JJO | CRYSTAL STRUCTURE OF APO-CLAVIBACTER MICHIGANENSIS EXPANSIN | 3.2.1.4 |
4JJQ | CRYSTAL STRUCTURE OF USP7-NTD WITH AN E2 ENZYME | 3.4.19.12 |
4JJS | CRYSTAL STRUCTURE OF HCV NS5B POLYMERASE IN COMPLEX WITH COMPOUND 2 | 3.4.22 3.4.21.98 3.6.1.15 3.6.4.13 2.7.7.48 |
4JJU | CRYSTAL STRUCTURE OF HCV NS5B POLYMERASE IN COMPLEX WITH COMPOUND 29 | 3.4.22 3.4.21.98 3.6.1.15 3.6.4.13 2.7.7.48 |
4JK5 | HUMAN UROKINASE-TYPE PLASMINOGEN ACTIVATOR (UPA) IN COMPLEX WITH A BICYCLIC PEPTIDE INHIBITOR (UK18-D-SER) | 3.4.21.73 |
4JK6 | HUMAN UROKINASE-TYPE PLASMINOGEN ACTIVATOR (UPA) IN COMPLEX WITH A BICYCLIC PEPTIDE INHIBITOR (UK18-D-ABA) | 3.4.21.73 |
4JKJ | CRYSTAL STRUCTURE OF THE S18Y VARIANT OF UBIQUITIN CARBOXY-TERMINAL HYDROLASE L1 | 3.4.19.12 |
4JKK | CRYSTAL STRUCTURE OF STREPTOCOCCUS AGALACTIAE BETA-GLUCURONIDASE IN SPACE GROUP I222 | 3.2.1.31 3.2.1.23 |
4JKL | CRYSTAL STRUCTURE OF STREPTOCOCCUS AGALACTIAE BETA-GLUCURONIDASE IN SPACE GROUP P21212 | 3.2.1.31 3.2.1.23 |
4JKM | CRYSTAL STRUCTURE OF CLOSTRIDIUM PERFRINGENS BETA-GLUCURONIDASE | 3.2.1.31 3.2.1.23 |
4JKO | CRYSTAL STRUCTURE OF A CATALYTIC MUTANT OF AXE2 (AXE2_S15A), AN ACETYLXYLAN ESTERASE FROM GEOBACILLUS STEAROTHERMOPHILUS | 3.1.1.72 |
4JKT | CRYSTAL STRUCTURE OF MOUSE GLUTAMINASE C, BPTES-BOUND FORM | 3.5.1.2 |
4JKX | CRYSTAL STRUCTURE MISTLETOE LECTIN I FROM VISCUM ALBUM IN COMPLEX WITH KINETIN AT 2.35 A RESOLUTION. | 3.2.2.22 |
4JLF | INHIBITOR RESISTANT (R220A) SUBSTITUTION IN THE MYCOBACTERIUM TUBERCULOSIS BETA-LACTAMASE | 3.5.2.6 |
4JLH | HIV-1 INTEGRASE CATALYTIC CORE DOMAIN A128T MUTANT COMPLEXED WITH ALLOSTERIC INHIBITOR | 3.4.23.16 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1 |
4JMJ | STRUCTURE OF DUSP11 | 3.1.3 |
4JMK | STRUCTURE OF DUSP8 | 3.1.3.16 3.1.3.48 |
4JMU | CRYSTAL STRUCTURE OF HIV MATRIX RESIDUES 1-111 IN COMPLEX WITH INHIBITOR | 3.4.23.16 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1 |
4JMY | CRYSTAL STRUCTURE OF HCV NS3/NS4A PROTEASE COMPLEXED WITH DDIVPC PEPTIDE | 3.4.21.98 2.7.7.48 3.6.1.15 3.6.4.13 |
4JNB | CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF HUMAN DUSP12 | 3.1.3.16 3.1.3.48 |
4JNC | SOLUBLE EPOXIDE HYDROLASE COMPLEXED WITH A CARBOXAMIDE INHIBITOR | 3.3.2.10 3.1.3.76 |
4JND | STRUCTURE OF A C.ELEGANS SEX DETERMINING PROTEIN | 3.1.3.16 |
4JOB | CRYSTAL STRUCTURE OF HUMAN LYSOPHOSPHATIDIC ACID PHOSPHATASE TYPE 6 COMPLEXED WITH L-(+)-TARTRATE | 3.1.3.2 |
4JOC | CRYSTAL STRUCTURE OF HUMAN LYSOPHOSPHATIDIC ACID PHOSPHATASE TYPE 6 COMPLEXED WITH MALONATE | 3.1.3.2 |
4JOD | CRYSTAL STRUCTURE OF HUMAN LYSOPHOSPHATIDIC ACID PHOSPHATASE TYPE 6 COMPLEXED WITH TRIS | 3.1.3.2 |
4JOO | SPIROCYCLIC BETA-SITE AMYLOID PRECURSOR PROTEIN CLEAVING ENZYME 1 (BACE1) INHIBITORS | 3.4.23.46 |
4JOS | CRYSTAL STRUCTURE OF A PUTATIVE 5'-METHYLTHIOADENOSINE/S-ADENOSYLHOMOCYSTEINE NUCLEOSIDASE FROM FRANCISELLA PHILOMIRAGIA ATCC 25017 (TARGET NYSGRC-029335) | 3.2.2.9 |
4JP4 | MMP13 IN COMPLEX WITH A REVERSE HYDROXAMATE ZN-BINDER | 3.4.24 |
4JP8 | CRYSTAL STRUCTURE OF PRO-F17H/S324A | 3.4.21 |
4JP9 | SPIROCYCLIC BETA-SITE AMYLOID PRECURSOR PROTEIN CLEAVING ENZYME 1 (BACE1) INHIBITORS | 3.4.23.46 |
4JPA | MMP13 IN COMPLEX WITH A PIPERAZINE HYDANTOIN LIGAND | 3.4.24 |
4JPC | SPIROCYCLIC BETA-SITE AMYLOID PRECURSOR PROTEIN CLEAVING ENZYME 1 (BACE1) INHIBITORS | 3.4.23.46 |
4JPE | SPIROCYCLIC BETA-SITE AMYLOID PRECURSOR PROTEIN CLEAVING ENZYME 1 (BACE1) INHIBITORS | 3.4.23.46 |
4JPM | STRUCTURE OF SHV-1 BETA-LACTAMASE IN COMPLEX WITH THE 7-ALKYLIDENECEPHALOSPORIN DCM-1-10 AT 1.14 ANG RESOLUTION | 3.5.2.6 |
4JQG | CRYSTAL STRUCTURE OF AN INACTIVE MUTANT OF MMP-9 CATALYTIC DOMAIN IN COMPLEX WITH A FLUOROGENIC SYNTHETIC PEPTIDIC SUBSTRATE WITH A FLUORINE ATOM. | 3.4.24.35 |
4JQY | HUMAN PROCASPASE-3, CRYSTAL FORM 1 | 3.4.22.56 |
4JQZ | HUMAN PROCASPASE-3, CRYSTAL FORM 2 | 3.4.22.56 |
4JR0 | HUMAN PROCASPASE-3 BOUND TO AC-DEVD-CMK | 3.4.22.56 |
4JR1 | HUMAN PROCASPASE-7 BOUND TO AC-DEVD-CMK | 3.4.22.60 |
4JR2 | HUMAN PROCASPASE-7/CASPASE-7 HETERODIMER BOUND TO AC-DEVD-CMK | 3.4.22.60 |
4JRA | CRYSTAL STRUCTURE OF THE BOTULINUM NEUROTOXIN A RECEPTOR-BINDING DOMAIN IN COMPLEX WITH THE LUMINAL DOMAIN OF SV2C | 3.4.24.69 |
4JRP | STRUCTURE OF E. COLI EXONUCLEASE I IN COMPLEX WITH A 5CY-DT13 OLIGONUCLEOTIDE | 3.1.11.1 |
4JRQ | CRYSTAL STRUCTURE OF E. COLI EXONUCLEASE I IN COMPLEX WITH A 5CY-DA13 OLIGONUCLEOTIDE | 3.1.11.1 |
4JRW | CRYSTAL STRUCTURE OF CLOSTRIDIUM HISTOLYTICUM COLG COLLAGENASE PKD DOMAIN 2 AT 1.6 ANGSTROM RESOLUTION | 3.4.24.3 |
4JS0 | COMPLEX OF CDC42 WITH THE CRIB-PR DOMAIN OF IRSP53 | 3.6.5.2 |
4JS4 | CRYSTAL STRUCTURE OF E. COLI EXONUCLEASE I IN COMPLEX WITH A DA16 OLIGONUCLEOTIDE | 3.1.11.1 |
4JS5 | CRYSTAL STRUCTURE OF E. COLI EXONUCLEASE I IN COMPLEX WITH A DT13 OLIGONUCLEOTIDE | 3.1.11.1 |
4JS7 | CRYSTAL STRUCTURE OF D78N MUTANT APO FORM OF CLAVIBACTER MICHIGANENSIS EXPANSIN | 3.2.1.4 |
4JSR | CRYSTAL STRUCTURE OF HUMAN SIRT3 WITH ELT INHIBITOR 11C [N-{2-[1-(6-CARBAMOYLTHIENO[3,2-D]PYRIMIDIN-4-YL)PIPERIDIN-4-YL]ETHYL}-N'-ETHYLTHIOPHENE-2,5-DICARBOXAMIDE] | 3.5.1 2.3.1.286 |
4JT8 | CRYSTAL STRUCTURE OF HUMAN SIRT3 WITH ELT INHIBITOR 28 [4-(4-{2-[(2,2-DIMETHYLPROPANOYL)AMINO]ETHYL}PIPERIDIN-1-YL)THIENO[3,2-D]PYRIMIDINE-6-CARBOXAMIDE[ | 3.5.1 2.3.1.286 |
4JT9 | CRYSTAL STRUCTURE OF HUMAN SIRT3 WITH ELT INHIBITOR 3 [14-(4-{2-[(METHYLSULFONYL)AMINO]ETHYL}PIPERIDIN-1-YL)THIENO[3,2-D]PYRIMIDINE-6-CARBOXAMIDE] | 3.5.1 2.3.1.286 |
4JTB | CRYSTAL STRUCTURE OF RIBOSOME INACTIVATING PROTEIN FROM MOMORDICA BALSAMINA COMPLEXED WITH PHOSPHATE ION AT 1.71 ANGSTROM RESOLUTION | 3.2.2.22 |
4JTP | CRYSTAL STRUCTURE OF RIBOSOME INACTIVATING PROTEIN FROM MOMORDICA BALSAMINA COMPLEXED WITH ASCORBIC ACID AT 1.85 ANGSTROM RESOLUTION | 3.2.2.22 |
4JTW | CRYSTAL STRUCTURE OF HCV NS5B POLYMERASE IN COMPLEX WITH COUPOUND 1 | 3.4.22 3.4.21.98 3.6.1.15 3.6.4.13 2.7.7.48 |
4JTY | CRYSTAL STRUCTURE OF HCV NS5B POLYMERASE WITH COMPOUND 2 | 3.4.22 3.4.21.98 3.6.1.15 3.6.4.13 2.7.7.48 |
4JTZ | CRYSTAL STRUCTURE OF HCV NS5B POLYMERASE IN COMPLEX WITH COMPOUND 4 | 3.4.22 3.4.21.98 3.6.1.15 3.6.4.13 2.7.7.48 |
4JU1 | CRYSTAL STRUCTURE OF HCV NS5B POLYMERASE IN COMPLEX WITH COMPOUND 6 | 3.4.22 3.4.21.98 3.6.1.15 3.6.4.13 2.7.7.48 |
4JU2 | CRYSTAL STRUCTURE OF HCV NS5B POLYMERASE IN COMPLEX WITH COMPOUND 12 | 3.4.22 3.4.21.98 3.6.1.15 3.6.4.13 2.7.7.48 |
4JU3 | CRYSTAL STRUCTURE OF HCV NS5B POLYMERASE IN COMPLEX WITH COMPOUND 8 | 3.4.22 3.4.21.98 3.6.1.15 3.6.4.13 2.7.7.48 |
4JU4 | CRYSTAL STRUCTURE OF HCV NS5B POLYMERASE IN COMPLEX WITH COMPOUND 22 | 3.4.22 3.4.21.98 3.6.1.15 3.6.4.13 2.7.7.48 |
4JU6 | CRYSTAL STRUCTURE OF HCV NS5B POLYMERASE IN COMPLEX WITH COMPOUND 24 | 3.4.22 3.4.21.98 3.6.1.15 3.6.4.13 2.7.7.48 |
4JU7 | CRYSTAL STRUCTURE OF HCV NS5B POLYMERASE IN COMPLEX WITH COMPOUND 24 | 3.4.22 3.4.21.98 3.6.1.15 3.6.4.13 2.7.7.48 |
4JUQ | PSEUDOMONAS AERUGINOSA METAP T2N MUTANT, IN MN FORM | 3.4.11.18 |
4JUR | CRYSTAL STRUCTURE OF THE EFFECTOR TAE4 FROM SALMONELLA TYPHIMURIUM IN COMPLEX WITH THE IMMUNITY TAI4 FROM ENTEROBACTER CLOACAE | 3.5.1.4 |
4JVQ | CRYSTAL STRUCTURE OF HCV NS5B POLYMERASE IN COMPLEX WITH COMPOUND 9 | 3.4.22 3.4.21.98 3.6.1.15 3.6.4.13 2.7.7.48 |
4JWK | CRYSTAL STRUCTURE OF THE COMPLEX OF PEPTIDYL-TRNA HYDROLASE FROM ACINETOBACTER BAUMANNII WITH CYTIDINE AT 1.87 A RESOLUTION | 3.1.1.29 |
4JWT | CRYSTAL STRUCTURE OF A PUTATIVE 5'-METHYLTHIOADENOSINE/S-ADENOSYLHOMOCYSTEINE NUCLEOSIDASE FROM SULFURIMONAS DENITRIFICANS DSM 1251 (TARGET NYSGRC-029304 ) | 3.2.2.16 3.2.2.9 |
4JX9 | CRYSTAL STRUCTURE OF THE COMPLEX OF PEPTIDYL T-RNA HYDROLASE FROM ACINETOBACTER BAUMANNII WITH URIDINE AT 1.4A RESOLUTION | 3.1.1.29 |
4JXE | CRYSTAL STRUCTURE OF SCHIZOSACCHAROMYCES POMBE SST2 CATALYTIC DOMAIN | 3.4.19 |
4JXG | CRYSTAL STRUCTURE OF AMPC BETA-LACTAMASE FROM E. COLI IN COMPLEX WITH OXACILLIN | 3.5.2.6 |
4JXS | X-RAY CRYSTAL STRUCTURE OF AMPC BETA-LACTAMASE FROM E. COLI IN COMPLEX WITH A NON-COVALENT INHIBITOR 3-[(4-CARBOXYBENZYL)SULFAMOYL]THIOPHENE-2-CARBOXYLIC ACID (COMPOUND 4) | 3.5.2.6 |
4JXV | X-RAY CRYSTAL STRUCTURE OF AMPC BETA-LACTAMASE FROM E. COLI IN COMPLEX WITH A NON-COVALENT INHIBITOR 3-{[2-(4-CARBOXYPHENYL)ETHYL]SULFAMOYL}THIOPHENE-2-CARBOXYLIC ACID (COMPOUND 5) | 3.5.2.6 |
4JXW | X-RAY CRYSTAL STRUCTURE OF AMPC BETA-LACTAMASE FROM E. COLI IN COMPLEX WITH A NON-COVALENT INHIBITOR 3-{[3-(4-CARBOXYPHENYL)PROPYL]SULFAMOYL}THIOPHENE-2-CARBOXYLIC ACID (COMPOUND 6) | 3.5.2.6 |
4JY0 | CRYSTAL STRUCTURE OF HCV NS5B POLYMERASE IN COMPLEX WITH COMPOUND 3 | 3.4.22 3.4.21.98 3.6.1.15 3.6.4.13 2.7.7.48 |
4JY1 | CRYSTAL STRUCTURE OF HCV NS5B POLYMERASE IN COMPLEX WITH COMPOUND 5 | 3.4.22 3.4.21.98 3.6.1.15 3.6.4.13 2.7.7.48 |
4JY7 | CRYSTAL STRUCTURE OF ACINETOBACTER BAUMANNII PEPTIDYL-TRNA HYDROLASE | 3.1.1.29 |
4JYT | CRYSTAL STRUCTURE OF MATRIPTASE IN COMPLEX WITH INHIBITOR | 3.4.21.109 |
4JYU | STRUCTURE OF FACTOR VIIA IN COMPLEX WITH THE INHIBITOR (2R)-2-[(1-AMINOISOQUINOLIN-6-YL)AMINO]-2-[3-ETHOXY-4-(PROPAN-2-YLOXY)PHENYL]-N-(PHENYLSULFONYL)ETHANAMIDE | 3.4.21.21 |
4JYV | STRUCTURE OF FACTOR VIIA IN COMPLEX WITH THE INHIBITOR (2R)-2-[3-ETHOXY-4-(PROPAN-2-YLOXY)PHENYL]-2-(ISOQUINOLIN-6-YLAMINO)-N-[(3-SULFAMOYLPHENYL)SULFONYL]ETHANAMIDE | 3.4.21.21 |
4JYW | X-RAY STRUCTURE OF HUMAN GLUTAMATE CARBOXYPEPTIDASE II (GCPII) IN COMPLEX WITH CTT1057 | 3.4.17.21 |
4JZ0 | X-RAY STRUCTURE OF HUMAN GLUTAMATE CARBOXYPEPTIDASE II (GCPII) IN COMPLEX WITH CTT1055 | 3.4.17.21 |
4JZ1 | CRYSTAL STRUCTURE OF MATRIPTASE IN COMPLEX WITH INHIBITOR | 3.4.21.109 |
4JZ5 | HIGH-RESOLUTION STRUCTURE OF CATALYTIC DOMAIN OF ENDOLYSIN PLY40 FROM BACTERIOPHAGE P40 OF LISTERIA MONOCYTOGENES | 3.2.1.17 |
4JZA | CRYSTAL STRUCTURE OF A LEGIONELLA PHOSPHOINOSITIDE PHOSPHATASE: INSIGHTS INTO LIPID METABOLISM IN PATHOGEN HOST INTERACTION | 3.1.3.64 |
4JZD | STRUCTURE OF FACTOR VIIA IN COMPLEX WITH THE INHIBITOR 2-{2-[(4-CARBAMIMIDOYLPHENYL)CARBAMOYL]-6-METHOXYPYRIDIN-3-YL}-5-{[(2S)-1-HYDROXY-3,3-DIMETHYLBUTAN-2-YL]CARBAMOYL}BENZOIC ACID | 3.4.21.21 |
4JZE | STRUCTURE OF FACTOR VIIA IN COMPLEX WITH THE INHIBITOR 2-{2-[(1-AMINOISOQUINOLIN-6-YL)CARBAMOYL]-6-METHOXYPYRIDIN-3-YL}-5-{[(2S)-1-HYDROXY-3,3-DIMETHYLBUTAN-2-YL]CARBAMOYL}BENZOIC ACID | 3.4.21.21 |
4JZF | STRUCTURE OF FACTOR VIIA IN COMPLEX WITH THE INHIBITOR 2-{2-[(3-CARBAMOYLPHENYL)CARBAMOYL]-6-METHOXYPYRIDIN-3-YL}-5-{[(2S)-1-HYDROXY-3,3-DIMETHYLBUTAN-2-YL]CARBAMOYL}BENZOIC ACID | 3.4.21.21 |
4JZI | CRYSTAL STRUCTURE OF MATRIPTASE IN COMPLEX WITH INHIBITOR." | 3.4.21.109 |
4JZS | CRYSTAL STRUCTURE OF THE BACILLUS SUBTILIS PYROPHOSPHOHYDROLASE BSRPPH (E68A MUTANT) | 3.6.1.55 |
4JZT | CRYSTAL STRUCTURE OF THE BACILLUS SUBTILIS PYROPHOSPHOHYDROLASE BSRPPH (E68A MUTANT) BOUND TO GTP | 3.6.1.55 |
4JZU | CRYSTAL STRUCTURE OF THE BACILLUS SUBTILIS PYROPHOSPHOHYDROLASE BSRPPH BOUND TO A NON-HYDROLYSABLE TRIPHOSPHORYLATED DINUCLEOTIDE RNA (PCP-PGPG) - FIRST GUANOSINE RESIDUE IN GUANOSINE BINDING POCKET | 3.6.1.55 |
4JZV | CRYSTAL STRUCTURE OF THE BACILLUS SUBTILIS PYROPHOSPHOHYDROLASE BSRPPH BOUND TO A NON-HYDROLYSABLE TRIPHOSPHORYLATED DINUCLEOTIDE RNA (PCP-PGPG) - SECOND GUANOSINE RESIDUE IN GUANOSINE BINDING POCKET | 3.6.1.55 |
4K00 | CRYSTAL STRUCTURE OF SLR0204, A 1,4-DIHYDROXY-2-NAPHTHOYL-COA THIOESTERASE FROM SYNECHOCYSTIS | 3.1.2.28 |
4K02 | CRYSTAL STRUCTURE OF ATDHNAT1, A 1,4-DIHYDROXY-2-NAPHTHOYL-COA THIOESTERASE FROM ARABIDOPSIS THALIANA | 3.1.2 |
4K0W | X-RAY CRYSTAL STRUCTURE OF OXA-23 A220 DUPLICATION CLINICAL VARIANT | 3.5.2.6 |
4K0X | X-RAY CRYSTAL STRUCTURE OF OXA-23 FROM ACINETOBACTER BAUMANNII | 3.5.2.6 |
4K14 | CRYSTAL STRUCTURE OF STAPHYLOCOCCAL NUCLEASE MUTANT V66I/V99L | 3.1.31.1 |
4K1E | ATOMIC RESOLUTION CRYSTAL STRUCTURES OF KALLIKREIN-RELATED PEPTIDASE 4 COMPLEXED WITH A MODIFIED SFTI INHIBITOR FCQR | 3.4.21 |
4K1G | STRUCTURE OF E. COLI NFO(ENDO IV)-H69A MUTANT BOUND TO A CLEAVED DNA DUPLEX CONTAINING A ALPHADA:T BASEPAIR | 3.1.21.2 |
4K1H | INDUCED OPENING OF INFLUENZA VIRUS NEURAMINIDASE N2 150-LOOP SUGGESTS AN IMPORTANT ROLE IN INHIBITOR BINDING | 3.2.1.18 |
4K1I | INDUCED OPENING OF INFLUENZA VIRUS NEURAMINIDASE N2 150-LOOP SUGGESTS AN IMPORTANT ROLE IN INHIBITOR BINDING | 3.2.1.18 |
4K1J | INDUCED OPENING OF INFLUENZA VIRUS NEURAMINIDASE N2 150-LOOP SUGGESTS AN IMPORTANT ROLE IN INHIBITOR BINDING | 3.2.1.18 |
4K1K | INDUCED OPENING OF INFLUENZA VIRUS NEURAMINIDASE N2 150-LOOP SUGGESTS AN IMPORTANT ROLE IN INHIBITOR BINDING | 3.2.1.18 |
4K1R | CRYSTAL STRUCTURE OF SCHIZOSACCHAROMYCES POMBE SST2 CATALYTIC DOMAIN AND UBIQUITIN | 3.4.19 |
4K1S | GLY-SER-SPLB PROTEASE FROM STAPHYLOCOCCUS AUREUS AT 1.96 A RESOLUTION | 3.4.21 |
4K1T | GLY-SER-SPLB PROTEASE FROM STAPHYLOCOCCUS AUREUS AT 1.60 A RESOLUTION | 3.4.21 |
4K24 | STRUCTURE OF ANTI-UPAR FAB ATN-658 IN COMPLEX WITH UPAR | 3.4.21.73 |
4K2A | CRYSTAL STRUCTURE OF HALOALKANE DEHALOGENASE DBEA FROM BRADYRHIZOBIUM ELKANI USDA94 | 3.8.1.5 |
4K2F | STRUCTURE OF PSEUDOMONAS AERUGINOSA PVDQ BOUND TO BRD-A08522488 | 3.5.1.97 |
4K2G | STRUCTURE OF PSEUDOMONAS AERUGINOSA PVDQ BOUND TO BRD-A33442372 | 3.5.1.97 |
4K2K | CRYSTAL STRUCTURE OF STAPHYLOCOCCAL NUCLEASE VARIANT DELTA+PHS L25A/L36A/I92A AT CRYOGENIC TEMPERATURE | 3.1.31.1 |
4K2L | CRYSTAL STRUCTURE OF STAPHYLOCOCCAL NUCLEASE VARIANT DELTA+PHS I92Q AT CRYOGENIC TEMPERATURE | 3.1.31.1 |
4K2Y | CRYSTAL STRUCTURE OF HUMAN CHYMASE IN COMPLEX WITH FRAGMENT INHIBITOR 6-CHLORO-1,3-DIHYDRO-2H-INDOL-2-ONE | 3.4.21.39 |
4K2Z | CRYSTAL STRUCTURE OF THE COMPLEX OF TYPE I RIBOSOME INACTIVATING PROTEIN FROM MOMORDICA BALSAMINA WITH METHYLETHYLAMINE AT 1.80 A RESOLUTION | 3.2.2.22 |
4K35 | THE STRUCTURE OF A GLYCOSIDE HYDROLASE FAMILY 81 ENDO-[BETA]-1,3-GLUCANASE | 3.2.1.39 3.2.1.6 |
4K3A | THE STRUCTURE OF A GLYCOSIDE HYDROLASE FAMILY 81 ENDO-[BETA]-1,3-GLUCANASE | 3.2.1.39 3.2.1.6 |
4K44 | AUTO-INHIBITION AND PHOSPHORYLATION-INDUCED ACTIVATION OF PLC-GAMMA ISOZYMES | 3.1.4.11 |
4K45 | AUTO-INHIBITION AND PHOSPHORYLATION-INDUCED ACTIVATION OF PLC-GAMMA ISOZYMES | 3.1.4.11 |
4K49 | X-RAY CRYSTAL STRUCTURE OF E. COLI YDII COMPLEXED WITH 2,4-DIHYDROXYPHENACYL COA | 3.1 3.1.2.28 |
4K4A | X-RAY CRYSTAL STRUCTURE OF E. COLI YDII COMPLEXED WITH PHENACYL-COA | 3.1 3.1.2.28 |
4K4B | X-RAY CRYSTAL STRUCTURE OF E. COLI YDII COMPLEXED WITH UNDECA-2-ONE-COA | 3.1 3.1.2.28 |
4K4C | X-RAY CRYSTAL STRUCTURE OF E. COLI YBDB COMPLEXED WITH PHENACYL-COA | 3.1.2 |
4K4D | X-RAY CRYSTAL STRUCTURE OF E. COLI YBDB COMPLEXED WITH 2,4-DIHYDROXYPHENACYL-COA | 3.1.2 |
4K4P | TL-3 INHIBITED TRP6ALA HIV PROTEASE | 3.4.23.16 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1 |
4K4Q | TL-3 INHIBITED TRP6ALA HIV PROTEASE WITH 3-BROMO-2,6-DIMETHOXYBENZOIC ACID BOUND IN FLAP SITE | 3.4.23.16 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1 |
4K4R | TL-3 INHIBITED TRP6ALA HIV PROTEASE WITH 1-BROMO-2-NAPTHOIC ACID BOUND IN EXOSITE | 3.4.23.16 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1 |
4K4S | POLIOVIRUS POLYMERASE ELONGATION COMPLEX (R3_FORM) | 2.7.7.48 3.4.22.29 3.6.1.15 3.4.22.28 |
4K4T | POLIOVIRUS POLYMERASE ELONGATION COMPLEX (R4_FORM) | 2.7.7.48 3.4.22.29 3.6.1.15 3.4.22.28 |
4K4U | POLIOVIRUS POLYMERASE ELONGATION COMPLEX (R5_FORM) | 2.7.7.48 3.4.22.29 3.6.1.15 3.4.22.28 |
4K4V | POLIOVIRUS POLYMERASE ELONGATION COMPLEX (R5+1_FORM) | 2.7.7.48 3.4.22.29 3.6.1.15 3.4.22.28 |
4K4W | POLIOVIRUS POLYMERASE ELONGATION COMPLEX (R5+2_FORM) | 2.7.7.48 3.4.22.29 3.6.1.15 3.4.22.28 |
4K4X | COXSACKIEVIRUS B3 POLYMERASE ELONGATION COMPLEX (R2_FORM), RNA | 2.7.7.48 3.4.22.29 3.6.1.15 3.4.22.28 |
4K4Y | COXSACKIEVIRUS B3 POLYMERASE ELONGATION COMPLEX (R2+1_FORM) | 3.4.22.29 3.6.1.15 3.4.22.28 2.7.7.48 |
4K4Z | COXSACKIEVIRUS B3 POLYMERASE ELONGATION COMPLEX (R2_MG_FORM) | 2.7.7.48 3.4.22.29 3.6.1.15 3.4.22.28 |
4K50 | RHINOVIRUS 16 POLYMERASE ELONGATION COMPLEX (R1_FORM) | 2.7.7.48 3.4.22.29 3.6.1.15 3.4.22.28 |
4K5L | PHOSPHONIC ARGININE MIMETICS AS INHIBITORS OF THE M1 AMINOPEPTIDASES FROM PLASMODIUM FALCIPARUM | 3.4.11 |
4K5M | PHOSPHONIC ARGININE MIMETICS AS INHIBITORS OF THE M1 AMINOPEPTIDASES FROM PLASMODIUM FALCIPARUM | 3.4.11 |
4K5N | PHOSPHONIC ARGININE MIMETICS AS INHIBITORS OF THE M1 AMINOPEPTIDASES FROM PLASMODIUM FALCIPARUM | 3.4.11 |
4K5O | PHOSPHONIC ARGININE MIMETICS AS INHIBITORS OF THE M1 AMINOPEPTIDASES FROM PLASMODIUM FALCIPARUM | 3.4.11 |
4K5P | PHOSPHONIC ARGININE MIMETICS AS INHIBITORS OF THE M1 AMINOPEPTIDASES FROM PLASMODIUM FALCIPARUM | 3.4.11 |
4K5Q | CRYSTAL STRUCTURE OF CALB MUTANT DGLM FROM CANDIDA ANTARCTICA | 3.1.1.3 |
4K5V | CRYSTAL STRUCTURE OF STAPHYLOCOCCAL NUCLEASE VARIANT DELTA+PHS V23T/L36A/V99T AT CRYOGENIC TEMPERATURE | 3.1.31.1 |
4K5W | CRYSTAL STRUCTURE OF STAPHYLOCOCCAL NUCLEASE VARIANT V23M/L25F/T62F AT CRYOGENIC TEMPERATURE | 3.1.31.1 |
4K5X | CRYSTAL STRUCTURE OF STAPHYLOCOCCAL NUCLEASE VARIANT V23M/L36F AT CRYOGENIC TEMPERATURE | 3.1.31.1 |
4K5Y | CRYSTAL STRUCTURE OF HUMAN CORTICOTROPIN-RELEASING FACTOR RECEPTOR 1 (CRF1R) IN COMPLEX WITH THE ANTAGONIST CP-376395 | 3.2.1.17 |
4K5Z | CRYSTAL STRUCTURE OF HUMAN CHYMASE IN COMPLEX WITH FRAGMENT INHIBITOR 6-CHLORO-2,3-DIHYDRO-1H-ISOINDOL-1-ONE | 3.4.21.39 |
4K60 | CRYSTAL STRUCTURE OF HUMAN CHYMASE IN COMPLEX WITH FRAGMENT 6-BROMO-1,3-DIHYDRO-2H-INDOL-2-ONE | 3.4.21.39 |
4K69 | CRYSTAL STRUCTURE OF HUMAN CHYMASE IN COMPLEX WITH FRAGMENT LINKED BENZIMIDAZOLONE INHIBITOR: (3S)-3-{3-[(6-BROMO-2-OXO-2,3-DIHYDRO-1H-INDOL-4-YL)METHYL]-2-OXO-2,3-DIHYDRO-1H-BENZIMIDAZOL-1-YL}HEXANOIC ACID | 3.4.21.39 |
4K6D | CRYSTAL STRUCTURE OF STAPHYLOCOCCAL NUCLEASE VARIANT V23M/T62F AT CRYOGENIC TEMPERATURE | 3.1.31.1 |
4K6E | CRYSTAL STRUCTURE OF SACCHAROMYCES CEREVISIAE DCP2 NUDIX DOMAIN IN COMPLEX WITH MG | 3 3.6.1.62 |
4K6G | CRYSTAL STRUCTURE OF CALB FROM CANDIDA ANTARCTICA | 3.1.1.3 |
4K6H | CRYSTAL STRUCTURE OF CALB MUTANT L278M FROM CANDIDA ANTARCTICA | 3.1.1.3 |
4K6K | CRYSTAL STRUCTURE OF CALB MUTANT D223G FROM CANDIDA ANTARCTICA | 3.1.1.3 |
4K6M | CRYSTAL STRUCTURE OF THE FULL-LENGTH JAPANESE ENCEPHALITIS VIRUS NS5 | 3.4.21.91 3.6.1.15 3.6.4.13 2.1.1.56 2.1.1.57 2.7.7.48 |
4K7C | CRYSTAL STRUCTURE OF PEPW FROM LACTOBACILLUS RHAMNOSIS HN001 (DR20) DETERMINED AS THE SELENOMET DERIVATIVE | 3.4.22 |
4K7E | CRYSTAL STRUCTURE OF JUNIN VIRUS NUCLEOPROTEIN | 3.1.13 |
4K7L | CRYSTAL STRUCTURE OF RNASE S VARIANT (K7C/Q11C) | 3.1.27.5 4.6.1.18 |
4K7M | CRYSTAL STRUCTURE OF RNASE S VARIANT (K7C/Q11C) WITH BOUND MERCURY IONS | 3.1.27.5 4.6.1.18 |
4K89 | CRYSTAL STRUCTURE OF PSEUDOMONAS AERUGINOSA STRAIN K SOLVENT TOLERANT ELASTASE | 3.4.24 |
4K8B | CRYSTAL STRUCTURE OF HCV NS3/4A PROTEASE COMPLEXED WITH INHIBITOR | 3.4.21.98 |
4K8I | CRYSTAL STRUCTURE OF STAPHYLOCOCCAL NUCLEASE MUTANT I92V/V99L | 3.1.31.1 |
4K8J | CRYSTAL STRUCTURE OF STAPHYLOCOCCAL NUCLEASE MUTANT V23L/V66I | 3.1.31.1 |
4K8S | HYDROXYETHYLAMINE-BASED INHIBITORS OF BACE1: P1-P3 MACROCYCLIZATION CAN IMPROVE POTENCY, SELECTIVITY, AND CELL ACTIVITY | 3.4.23.46 |
4K8W | AN ARM-SWAPPED DIMER OF THE S. PYOGENES PILIN SPECIFIC ASSEMBLY FACTOR SIPA | 3.4.21.89 |
4K8Y | ATOMIC RESOLUTION CRYSTAL STRUCTURES OF KALLIKREIN-RELATED PEPTIDASE 4 COMPLEXED WITH SUNFLOWER TRYPSIN INHIBITOR (SFTI-1) | 3.4.21 |
4K8Z | KOD POLYMERASE IN BINARY COMPLEX WITH DSDNA | 2.7.7.7 3.1 |
4K90 | EXTRACELLULAR METALLOPROTEINASE FROM ASPERGILLUS | 3.4.24 |
4K91 | CRYSTAL STRUCTURE OF PENICILLIN-BINDING PROTEIN 5 (PBP5) FROM PSEUDOMONAS AERUGINOSA IN APO STATE | 3.4.16.4 |
4K9H | BACE-1 INHIBITOR COMPLEX | 3.4.23.46 |
4KA7 | STRUCTURE OF ORGANELLAR OLIGOPEPTIDASE (E572Q) IN COMPLEX WITH AN ENDOGENOUS SUBSTRATE | 3.4.24.70 |
4KA8 | STRUCTURE OF ORGANELLAR OLIGOPEPTIDASE | 3.4.24.70 |
4KAA | CRYSTAL STRUCTURE OF THE HALOTAG2 PROTEIN AT THE RESOLUTION 2.3A, NORTHEAST STRUCTURAL GENOMICS CONSORTIUM (NESG) TARGET OR150 | 3.8.1.5 |
4KAC | X-RAY STRUCTURE OF THE COMPLEX HALOTAG2 WITH HALTS. NORTHEAST STRUCTURAL GENOMICS CONSORTIUM (NESG) TARGET OR150. | 3.8.1.5 |
4KAF | CRYSTAL STRUCTURE OF HALOALKANE DEHALOGENASE HALOTAG7 AT THE RESOLUTION 1.5A, NORTHEAST STRUCTURAL GENOMICS CONSORTIUM (NESG) TARGET OR151 | 3.8.1.5 |
4KAI | HCV NS5B GT1B N316 WITH GSK5852A | 2.7.7.48 3.4.22 3.4.21.98 3.6.1.15 3.6.4.13 |
4KAJ | X-RAY STRUCTURE OF THE COMPLEX OF HALOALKANE DEHALOGENASE HALOTAG7 WITH HALTS, NORTHEAST STRUCTURAL GENOMICS CONSORTIUM (NESG) TARGET OR151 | 3.8.1.5 |
4KAV | CRYSTAL STRUCTURE OF THE SOLUBLE DOMAIN OF LIPOOLIGOSACCHARIDE PHOSPHOETHANOLAMINE TRANSFERASE A FROM NEISSERIA MENINGITIDIS | 3.1.3.27 |
4KAY | STRUCTURE OF THE SOLUBLE DOMAIN OF LIPOOLIGOSACCHARIDE PHOSPHOETHANOLAMINE TRANSFERASE A FROM NEISSERIA MENINGITIDIS - COMPLEX WITH ZN | 3.1.3.27 |
4KAZ | CRYSTAL STRUCTURE OF RNASE T IN COMPLEX WITH A Y STRUCTURED DNA | 3.1.13 |
4KB0 | CRYSTAL STRUCTURE OF RNASE T IN COMPLEX WITH A BLUGE DNA (TWO NUCLEOTIDE INSERTION CC ) | 3.1.13 |
4KB1 | CRYSTAL STRUCTURE OF RNASE T IN COMPLEX WITH A BLUGE DNA (TWO NUCLEOTIDE INSERTION CT ) | 3.1.13 |
4KB5 | CRYSTAL STRUCTURE OF MYCP1 FROM MYCOBACTERIUM SMEGMATIS | 3.4.21 |
4KB7 | HCV NS5B GT1B N316Y WITH CMPD 32 | 2.7.7.48 3.4.22 3.4.21.98 3.6.1.15 3.6.4.13 |
4KB9 | CRYSTAL STRUCTURE OF WILD-TYPE HIV-1 PROTEASE WITH NOVEL TRICYCLIC P2-LIGANDS GRL-0739A | 3.4.23.16 |
4KBB | STRUCTURE OF BOTULINUM NEUROTOXIN B BINDING DOMAIN IN COMPLEX WITH BOTH SYNAPTOTAGMIN II AND GD1A | 3.4.24.69 |
4KBI | HCV NS5B GT1B N316Y WITH CMPD 4 | 2.7.7.48 3.4.22 3.4.21.98 3.6.1.15 3.6.4.13 |
4KBP | KIDNEY BEAN PURPLE ACID PHOSPHATASE | 3.1.3.2 |
4KC7 | CRYSTAL STRUCTURE OF ENDO-1,5-ALPHA-L-ARABINANASE FROM THERMOTOGA PETROPHILA RKU-1 | 3.2.1.99 |
4KC8 | CRYSTAL STRUCTURE OF ENDO-1,5-ALPHA-L-ARABINANASE FROM THERMOTOGA PETROPHILA RKU-1 IN COMPLEX WITH TRIS | 3.2.1.99 |
4KCA | CRYSTAL STRUCTURE OF ENDO-1,5-ALPHA-L-ARABINANASE FROM A BOVINE RUMINAL METAGENOMIC LIBRARY | 3.2.1.99 |
4KCB | CRYSTAL STRUCTURE OF EXO-1,5-ALPHA-L-ARABINANASE FROM BOVINE RUMINAL METAGENOMIC LIBRARY | 3.2.1.99 |
4KD3 | CRYSTAL STRUCTURE OF STAPHYLOCOCCAL NUCLEASE VARIANT DELTA+PHS L25A/V66A/I92A AT CRYOGENIC TEMPERATURE | 3.1.31.1 |
4KD4 | CRYSTAL STRUCTURE OF STAPHYLOCOCCAL NUCLEASE VARIANT V23L/L25V/V66I/I72V AT CRYOGENIC TEMPERATURE | 3.1.31.1 |
4KDI | CRYSTAL STRUCTURE OF P97/VCP N IN COMPLEX WITH OTU1 UBXL | 3.6.4.6 |
4KDL | CRYSTAL STRUCTURE OF P97/VCP N IN COMPLEX WITH OTU1 UBXL | 3.6.4.6 |
4KE0 | CRYSTAL STRUCTURE OF BACE1 IN COMPLEX WITH HYDROXYETHYLAMINE-MACROCYCLIC INHIBITOR 13 | 3.4.23.46 |
4KE1 | CRYSTAL STRUCTURE OF BACE1 IN COMPLEX WITH HYDROXYETHYLAMINE-MACROCYCLIC INHIBITOR 19 | 3.4.23.46 |
4KE5 | HCV NS5B GT1B N316Y WITH GSK5852 | 2.7.7.48 3.4.22 3.4.21.98 3.6.1.15 3.6.4.13 |
4KE6 | CRYSTAL STRUCTURE D196N MUTANT OF MONOGLYCERIDE LIPASE FROM BACILLUS SP. H257 IN COMPLEX WITH 1-RAC-LAUROYL GLYCEROL | 3.1.1.23 |
4KE7 | CRYSTAL STRUCTURE OF MONOGLYCERIDE LIPASE FROM BACILLUS SP. H257 IN COMPLEX WITH AN 1-MYRISTOYL GLYCEROL ANALOGUE | 3.1.1.23 |
4KE8 | CRYSTAL STRUCTURE OF MONOGLYCERIDE LIPASE FROM BACILLUS SP. H257 IN COMPLEX WITH MONOPALMITOYL GLYCEROL ANALOGUE | 3.1.1.23 |
4KE9 | CRYSTAL STRUCTURE OF MONOGLYCERIDE LIPASE FROM BACILLUS SP. H257 IN COMPLEX WITH AN 1-STEARYOL GLYCEROL ANALOGUE | 3.1.1.23 |
4KEA | CRYSTAL STRUCTURE OF D196N MUTANT OF MONOGLYCERIDE LIPASE FROM BACILLUS SP. H257 IN SPACE GROUP P212121 | 3.1.1.23 |
4KEL | ATOMIC RESOLUTION CRYSTAL STRUCTURE OF KALLIKREIN-RELATED PEPTIDASE 4 COMPLEXED WITH A MODIFIED SFTI INHIBITOR FCQR(N) | 3.4.21 |
4KEN | CRYSTAL STRUCTURE OF AMPC BETA-LACTAMASE N152G MUTANT IN COMPLEX WITH CEFOXITIN | 3.5.2.6 |
4KEP | CRYSTAL STRUCTURE OF 4-PYRIDOXOLACTONASE, WILD-TYPE | 3.1.1.27 |
4KEQ | CRYSTAL STRUCTURE OF 4-PYRIDOXOLACTONASE, 5-PYRIDOXOLACTONE BOUND | 3.1.1.27 |
4KER | CRYSTAL STRUCTURE OF SSOPOX W263V | 3.1.8.1 |
4KES | CRYSTAL STRUCTURE OF SSOPOX W263T | 3.1.8.1 |
4KEU | CRYSTAL STRUCTURE OF SSOPOX W263M | 3.1.8.1 |
4KEZ | CRYSTAL STRUCTURE OF SSOPOX W263F | 3.1.8.1 |
4KF1 | CRYSTAL STRUCTURE OF SSOPOX W263I IN COMPLEX WITH C10HTL | 3.1.8.1 |
4KFB | HIV-1 REVERSE TRANSCRIPTASE WITH BOUND FRAGMENT AT NNRTI ADJACENT SITE | 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 3.4.23.16 2.7.7 3.1 |
4KFR | STRUCTURE OF THE GENOME PACKAGING NTPASE B204 FROM SULFOLOBUS TURRETED ICOSAHEDRAL VIRUS 2 IN COMPLEX WITH SULFATE | 3 |
4KFS | STRUCTURE OF THE GENOME PACKAGING NTPASE B204 FROM SULFOLOBUS TURRETED ICOSAHEDRAL VIRUS 2 IN COMPLEX WITH AMP | 3 |
4KFT | STRUCTURE OF THE GENOME PACKAGING NTPASE B204 FROM SULFOLOBUS TURRETED ICOSAHEDRAL VIRUS 2 IN COMPLEX WITH ATP-GAMMAS | 3 |
4KFU | STRUCTURE OF THE GENOME PACKAGING NTPASE B204 FROM SULFOLOBUS TURRETED ICOSAHEDRAL VIRUS 2 IN COMPLEX WITH AMPPCP | 3 |
4KG2 | CRYSTAL STRUCTURE OF AMPC BETA-LACTAMASE FROM E. COLI IN COMPLEX WITH CEFOTAXIME | 3.5.2.6 |
4KG3 | CRYSTAL STRUCTURE OF SACCHAROMYCES CEREVISIAE DCP2 NUDIX DOMAIN IN COMPLEX WITH MG (E153Q MUTATION) | 3 3.6.1.62 |
4KG4 | CRYSTAL STRUCTURE OF SACCHAROMYCES CEREVISIAE DCP2 NUDIX DOMAIN (E198Q MUTATION) | 3 3.6.1.62 |
4KG5 | CRYSTAL STRUCTURE OF AMPC BETA-LACTAMASE N152G MUTANT IN COMPLEX WITH CEFOTAXIME | 3.5.2.6 |
4KG6 | CRYSTAL STRUCTURE OF AMPC BETA-LACTAMASE N152G MUTANT FROM E. COLI | 3.5.2.6 |
4KG9 | CRYSTAL STRUCTURE OF USP7-NTD WITH MCM-BP | 3.4.19.12 |
4KGA | CRYSTAL STRUCTURE OF KALLIKREIN-RELATED PEPTIDASE 4 | 3.4.21 |
4KGJ | CRYSTAL STRUCTURE OF HUMAN ALPHA-L-IDURONIDASE COMPLEX WITH 5-FLUORO-ALPHA-L-IDOPYRANOSYLURONIC ACID FLUORIDE | 3.2.1.76 |
4KGL | CRYSTAL STRUCTURE OF HUMAN ALPHA-L-IDURONIDASE COMPLEX WITH [2R,3R,4R,5S]-2-CARBOXY-3,4,5-TRIHYDROXY-PIPERIDINE | 3.2.1.76 |
4KHM | HCV NS5B GT1A WITH GSK5852 | 2.7.7.48 3.4.21.98 3.6.1.15 3.6.4.13 |
4KHQ | TERNARY COMPLEX OF RB69 MUTANT L415F WIT DUMPNPP | 2.7.7.7 3.1.11 |
4KHR | HCV NS5B GT1A C316Y WITH GSK5852 | 2.7.7.48 3.4.21.98 3.6.1.15 3.6.4.13 |
4KHS | TERNARY COMPLEX OF RB69 MUTANT L415F WITH A RIBONUCLEOTIDE AT 0 POSITION | 2.7.7.7 3.1.11 |
4KHU | TERNARY COMPLEX OF RB69 MUTANT L415F WITH A RIBONUCLEOTIDE AT -1 POSITION | 2.7.7.7 3.1.11 |
4KHV | CRYSTAL STRUCTURE OF STAPHYLOCOCCAL NUCLEASE VARIANT DELTA+PHS V23S AT CRYOGENIC TEMPERATURE | 3.1.31.1 |
4KHW | TERNARY COMPLEX OF RB69 MUTANT L415F WITH RIBONUCLEOTIDE AT -2 POSITION | 2.7.7.7 3.1.11 |
4KHY | TERNARY COMPLEX OF RB69 MUTANT L415F WITH RIBONUCLEOTIDE AT -3 POSITION | 2.7.7.7 3.1.11 |
4KI4 | TERNARY COMPLEX OF RB69 MUTANT L415F WITH RIBONUCLEOTIDES AT 0 AND -1 POSITION | 2.7.7.7 3.1.11 |
4KI6 | TERNARY COMPLEX OF RB69 MUTANT L415F WITH RIBONUCLEOTIDES AT -1 AND -2 POSITION | 2.7.7.7 3.1.11 |
4KI9 | CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF HUMAN DUSP12 AT 2.0 A RESOLUTION | 3.1.3.16 3.1.3.48 |
4KIE | CRYSTAL STRUCTURE OF THE EAL DOMAIN OF C-DI-GMP SPECIFIC PHOSPHODIESTERASE YAHA | 3.1.4 3.1.4.52 |
4KIR | CRYSTAL STRUCTURE OF D-HYDANTOINASE FROM BACILLUS SP. AR9 IN C2221 SPACE GROUP | 3.5.2.2 |
4KIT | CRYSTAL STRUCTURE OF HUMAN BRR2 IN COMPLEX WITH THE PRP8 JAB1/MPN DOMAIN | 3.6.4.13 |
4KIV | RECOMBINANT KRINGLE IV-10/W72R MUTANT OF HUMAN APOLIPOPROTEIN(A) | 3.4.21 |
4KJD | RATINTESTINAL AP EXPRESSED IN E. COLI | 3.1.3.1 |
4KJG | STRUCTURE OF RAT INTESTINAL ALKALINE PHOSPHATASE EXPRESSED IN INSECT CELL | 3.1.3.1 |
4KJN | CRYSTAL STRUCTURE OF STAPHYLOCOCCAL NUCLEASE VARIANT DELTA+PHS V23T/V66A/V99T AT CRYOGENIC TEMPERATURE | 3.1.31.1 |
4KJO | CRYSTAL STRUCTURE OF STAPHYLOCOCCAL NUCLEASE VARIANT DELTA+PHS L36A/V66T/V99T AT CRYOGENIC TEMPERATURE | 3.1.31.1 |
4KJX | CRYSTAL STRUCTURE OF THE COMPLEX OF THREE PHASE PARTITION TREATED LIPASE FROM THERMOMYCES LANUGINOSA WITH LAURIC ACID AND P-NITROBENZALDEHYDE (PNB) AT 2.1 RESOLUTION | 3.1.1.3 |
4KK3 | YWLE ARGININE PHOSPHATASE - WILDTYPE | 3.1.3.48 3.9.1.2 |
4KK4 | YWLE ARGININE PHOSPHATASE - C7S MUTANT WITH PHOSPHORYLATED ACTIVE SITE SERINE | 3.1.3.48 3.9.1.2 |
4KKO | CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH 4-((4-METHOXY-6-(2-MORPHOLINOETHOXY)-1,3,5-TRIAZIN-2-YL)AMINO)-2-((3-METHYLBUT-2-EN-1-YL)OXY)BENZONITRILE (JLJ513), A NON-NUCLEOSIDE INHIBITOR | 2.7.7.49 3.4.23.16 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1 |
4KL4 | CRYSTAL STRUCTURE OF RIBOSOME INACTIVATING PROTEIN FROM MOMORDICA BALSAMINA COMPLEXED WITH POLYETHYLENE GLYCOL AT 1.90 ANGSTROM RESOLUTION | 3.2.2.22 |
4KL7 | CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF RPFB FROM MYCOBACTERIUM TUBERCULOSIS | 3 |
4KLB | CRYSTAL STRUCTURE OF CRUZAIN IN COMPLEX WITH THE NON-COVALENT INHIBITOR NEQUIMED176 | 3.4.22.51 |
4KLN | STRUCTURE OF P97 N-D1 A232E MUTANT IN COMPLEX WITH ATPGS | 3.6.4.6 |
4KLZ | INHIBITION OF SMALL GTPASES BY STABILIZATION OF THE GDP COMPLEX, A NOVEL APPROACH APPLIED TO RIT1, A TARGET FOR RHEUMATOID ARTHRITIS | 3.6.5.2 |
4KM3 | DISCOVERY OF A NOVEL STRUCTURAL MOTIF IN METHIONINE AMINOPEPTIDASE FROM STREPTOCOCCI WITH POSSIBLE POST-TRANSLATIONAL MODIFICATION | 3.4.11.18 |
4KM4 | E. COLI ALKALINE PHOSPHATASE MUTANT S102G/R166S IN COMPLEX WITH INORGANIC PHOSPHATE | 3.1.3.1 |
4KMK | CRYSTAL STRUCTURE OF RIBOSOME INACTIVATING PROTEIN FROM MOMORDICA BALSAMINA AT 1.65 A RESOLUTION | 3.2.2.22 |
4KN5 | CRYSTAL STRUCTURE OF A PUTATIVE METHYLTHIOADENOSINE NUCLEOSIDASE FROM WEISSELLA PARAMESENTEROIDES ATCC 33313 (TARGET NYSGRC-029342 ) | 3.2.2.16 3.2.2.9 |
4KNK | CRYSTAL STRUCTURE OF STAPHYLOCOCCUS AUREUS HYDROLASE AMIA | 3.5.1.28 3.2.1.96 |
4KNL | CRYSTAL STRUCTURE OF STAPHYLOCOCCUS AUREUS HYDROLASE AMIA IN COMPLEX WITH ITS LIGAND | 3.5.1.28 3.2.1.96 |
4KNV | THE CRYSTAL STRUCTURE OF APO HUMAN HDHD4 FROM SE-MAD | 3.1.3.29 |
4KNW | THE CRYSTAL STRUCTURE OF HUMAN HDHD4 IN COMPLEX WITH MAGNESIUM AND THE PHOSPHATE MIMETIC VANADATE | 3.1.3.29 |
4KO0 | CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE (RT) IN COMPLEX WITH AN ANILINYLPYRIMIDINE DERIVATIVE (JLJ-135) | 2.7.7.49 3.4.23.16 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1 |
4KO8 | STRUCTURE OF P97 N-D1 R155H MUTANT IN COMPLEX WITH ATPGS | 3.6.4.6 |
4KP0 | CRYSTAL STRUCTURE OF THE HUMAN CHYMASE WITH TJK002 | 3.4.21.39 |
4KP6 | CRYSTAL STRUCTURE OF HUMAN PHOSPHODIESTERASE 4B (PDE4B) IN COMPLEX WITH A [1,3,5]TRIAZINE DERIVATIVE | 3.1.4.17 3.1.4.53 |
4KPG | CRYSTAL STRUCTURE OF MYCP1 FROM THE ESX-1 TYPE VII SECRETION SYSTEM | 3.4.21.62 3.4.21 |
4KPM | CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF RPFB FROM MYCOBACTERIUM TUBERCULOSIS IN COMPLEX WITH TRINAG | 3 |
4KPO | PLANT NUCLEOSIDE HYDROLASE - ZMNRH3 ENZYME | 3.2.2 |
4KPV | CRYSTAL STRUCTURE OF THE COMPLEX OF RIBOSOME INACTIVATING PROTEIN FROM MOMORDICA BALSAMINA WITH PYRIMIDINE-2,4(1H,3H)-DIONE AT 2.57 A RESOLUTION | 3.2.2.22 |
4KQN | 2.8 ANGSTROM RESOLUTION CRYSTAL STRUCTURE OF D-HYDANTOINASE FROM BACILLUS SP. AR9 IN C2221 SPACE GROUP | 3.5.2.2 |
4KQO | CRYSTAL STRUCTURE OF PENICILLIN-BINDING PROTEIN 3 FROM PSEUDOMONAS AERUGINOSA IN COMPLEX WITH PIPERACILLIN | 3.4.16.4 |
4KQQ | CRYSTAL STRUCTURE OF PENICILLIN-BINDING PROTEIN 3 FROM PSEUDOMONAS AERUGINOSA IN COMPLEX WITH (5S)-PENICILLOIC ACID | 3.4.16.4 |
4KQR | CRYSTAL STRUCTURE OF PENICILLIN-BINDING PROTEIN 3 FROM PSEUDOMONAS AERUGINOSA IN COMPLEX WITH (5S)-PENICILLOIC ACID | 3.4.16.4 |
4KR0 | COMPLEX STRUCTURE OF MERS-COV SPIKE RBD BOUND TO CD26 | 3.4.14.5 |
4KRT | X-RAY STRUCTURE OF ENDOLYSIN FROM CLOSTRIDIUM PERFRINGENS PHAGE PHISM101 | 3.2.1.17 |
4KRU | X-RAY STRUCTURE OF CATALYTIC DOMAIN OF ENDOLYSIN FROM CLOSTRIDIUM PERFRINGENS PHAGE PHISM101 | 3.2.1.17 |
4KRY | STRUCTURE OF AES FROM E. COLI IN COVALENT COMPLEX WITH PMS | 3.1.1 |
4KS1 | INFLUENZA NEURAMINIDASE IN COMPLEX WITH ANTIVIRAL COMPOUND (3S,4R,5R)-4-(ACETYLAMINO)-3-AMINO-5-(PENTAN-3-YLOXY)CYCLOHEX-1-ENE-1-CARBOXYLIC ACID | 3.2.1.18 |
4KS2 | INFLUENZA NEURAMINIDASE IN COMPLEX WITH ANTIVIRAL COMPOUND (3S,4R,5R)-4-(ACETYLAMINO)-3-CARBAMIMIDAMIDO-5-(PENTAN-3-YLOXY)CYCLOHEX-1-ENE-1-CARBOXYLIC ACID | 3.2.1.18 |
4KS3 | INFLUENZA NEURAMINIDASE IN COMPLEX WITH ANTIVIRAL COMPOUND (3S,4R,5R)-4-(ACETYLAMINO)-3-[4-(3-HYDROXYPROPYL)-1H-1,2,3-TRIAZOL-1-YL]-5-(PENTAN-3-YLOXY)CYCLOHEX-1-ENE-1-CARBOXYLIC ACID | 3.2.1.18 |
4KS5 | INFLUENZA NEURAMINIDASE IN COMPLEX WITH ANTIVIRAL COMPOUND (3S,4R,5R)-4-(ACETYLAMINO)-3-[4-(2-HYDROXYPROPAN-2-YL)-1H-1,2,3-TRIAZOL-1-YL]-5-(PENTAN-3-YLOXY)CYCLOHEX-1-ENE-1-CARBOXYLIC ACID | 3.2.1.18 |
4KS6 | CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF BOTULINUM NEUROTOXIN BONT/A C134S MUTANT WITH COVALENT INHIBITOR THAT MODIFIES CYS-165 CAUSING DISORDER IN 166-174 STRETCH | 3.4.24.69 |
4KSB | STRUCTURES OF P-GLYCOPROTEIN REVEAL ITS CONFORMATIONAL FLEXIBILITY AND AN EPITOPE ON THE NUCLEOTIDE-BINDING DOMAIN | 3.6.3.44 7.6.2.2 7.6.2.1 |
4KSC | STRUCTURES OF P-GLYCOPROTEIN REVEAL ITS CONFORMATIONAL FLEXIBILITY AND AN EPITOPE ON THE NUCLEOTIDE-BINDING DOMAIN | 3.6.3.44 7.6.2.2 7.6.2.1 |
4KSD | STRUCTURES OF P-GLYCOPROTEIN REVEAL ITS CONFORMATIONAL FLEXIBILITY AND AN EPITOPE ON THE NUCLEOTIDE-BINDING DOMAIN | 3.6.3.44 7.6.2.2 7.6.2.1 |
4KSE | CRYSTAL STRUCTURE OF A HIV P51 (219-230) DELETION MUTANT | 2.7.7.49 3.4.23.16 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1 |
4KSI | CRYSTAL STRUCTURE ANALYSIS OF THE ACIDIC LEUCINE AMINOPEPTIDASE OF TOMATO | 3.4.11.1 3.4.11.5 |
4KSJ | CRYSTAL STRUCTURE OF THE OTU DOMAIN OF GUMBY/FAM105B AT 1.6 ANGSTROM | 3.4.19.12 |
4KSK | GUMBY/FAM105B IN COMPLEX WITH UBIQUITIN | 3.4.19.12 |
4KT8 | THE COMPLEX STRUCTURE OF RV3378C-Y51FY90F WITH SUBSTRATE, TPP | 3.1.7.9 3.1.7.8 2.5.1 |
4KTA | CRYSTAL STRUCTURE OF STAPHYLOCOCCAL NUCLEASE VARIANT DELTA+PHS R105Q AT CRYOGENIC TEMPERATURES | 3.1.31.1 |
4KTC | NS3/NS4A PROTEASE WITH INHIBITOR | 3.4.21.98 3.6.1.15 3.6.4.13 3.4.22 2.7.7.48 |
4KTS | BOVINE TRYPSIN IN COMPLEX WITH MICROVIRIDIN J AT PH 8.5 | 3.4.21.4 |
4KTU | BOVINE TRYPSIN IN COMPLEX WITH MICROVIRIDIN J AT PH 6.5 | 3.4.21.4 |
4KTX | CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF BOTULINUM NEUROTOXIN BONT/A C134S MUTANT WITH COVALENT INHIBITOR THAT MODIFIES CYS-165 CAUSING DISORDER IN 167-174 STRETCH | 3.4.24.69 |
4KU0 | ENTEROBACTERIA PHAGE T4 GP5.4 PAAR REPEAT PROTEIN IN COMPLEX WITH T4 GP5 BETA-HELIX FRAGMENT | 3.2.1.17 |
4KUC | CRYSTAL STRUCTURE OF RICIN-A CHAIN IN COMPLEX WITH THE ANTIBODY 6C2 | 3.2.2.22 |
4KUF | CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF BOTULINUM NEUROTOXIN BONT/A C134 MUTANT WITH MTSEA MODIFIED CYS-165 CAUSING STRETCH DISORDER | 3.4.24.69 |
4KUP | ENDOTHIAPEPSIN IN COMPLEX WITH 20MM ACYLHYDRAZONE INHIBITOR | 3.4.23.22 |
4KV6 | CRYSTAL STRUCTURE OF STAPHYLOCOCCAL NUCLEASE VARIANT DELTA+PHS R126Q AT CRYOGENIC TEMPERATURE | 3.1.31.1 |
4KV8 | CRYSTAL STRUCTURE OF HIV RT IN COMPLEX WITH BILR0355BS | 3.1.13.2 3.4.23.16 2.7.7.49 2.7.7.7 3.1.26.13 2.7.7 3.1 |
4KVG | CRYSTAL STRUCTURE OF RIAM RA-PH DOMAINS IN COMPLEX WITH GTP BOUND RAP1 | 3.6.5.2 |
4KW3 | CRYSTAL STRUCTURE OF THE NON-STRUCTURAL PROTEIN 1 N-TERMINAL ORIGIN-RECOGNITION/NICKASE DOMAIN FROM THE EMERGING HUMAN BOCAVIRUS | 3.1.21 3.6.4.12 |
4KWB | STRUCTURE OF SIGNAL PEPTIDE PEPTIDASE A WITH C-TERMINI BOUND IN THE ACTIVE SITES: INSIGHTS INTO SPECIFICITY, SELF-PROCESSING AND REGULATION | 3.4.21 |
4KWN | A NEW STABILIZING WATER STRUCTURE AT THE SUBSTRATE BINDING SITE IN RIBOSOME INACTIVATING PROTEIN FROM MOMORDICA BALSAMINA AT 1.80 A RESOLUTION | 3.2.2.22 |
4KX3 | STRUCTURE OF MURINE CYTOSOLIC 5'-NUCLEOTIDASE III COMPLEXED WITH THYMIDINE MONOPHOSPHATE | 3.1.3.5 3.1.3.91 |
4KX5 | CYTOSOLIC 5'-NUCLEOTIDASE III COMPLEXED WITH CYTIDINE 5'-MONOPHOSPHATE | 3.1.3.5 3.1.3.91 |
4KX7 | CRYSTAL STRUCTURE OF HUMAN AMINOPEPTIDASE A | 3.4.11.7 |
4KX8 | CRYSTAL STRUCTURE OF HUMAN AMINOPEPTIDASE A COMPLEXED WITH AMASTATIN | 3.4.11.7 |
4KX9 | CRYSTAL STRUCTURE OF HUMAN AMINOPEPTIDASE A COMPLEXED WITH ARGININE | 3.4.11.7 |
4KXA | CRYSTAL STRUCTURE OF HUMAN AMINOPEPTIDASE A COMPLEXED WITH ASPARTATE AND CALCIUM | 3.4.11.7 |
4KXB | CRYSTAL STRUCTURE OF HUMAN AMINOPEPTIDASE A COMPLEXED WITH BESTATIN | 3.4.11.7 |
4KXC | CRYSTAL STRUCTURE OF HUMAN AMINOPEPTIDASE A COMPLEXED WITH GLUTAMATE | 3.4.11.7 |
4KXD | CRYSTAL STRUCTURE OF HUMAN AMINOPEPTIDASE A COMPLEXED WITH GLUTAMATE AND CALCIUM | 3.4.11.7 |
4KXH | THE X-RAY CRYSTAL STRUCTURE OF A DIMERIC VARIANT OF HUMAN PANCREATIC RIBONUCLEASE | 3.1.27.5 4.6.1.18 |
4KXI | CRYSTALLOGRAPHIC STUDY OF THE COMPLEX OF NI(II) SCHIFF BASE COMPLEX AND HEW LYSOZYME | 3.2.1.17 |
4KXL | CRYSTAL STRUCTURE OF DNPH1 (RCL) WITH 6-CYCLOPENTYL-AMP | 3.2.2 |
4KXM | CRYSTAL STRUCTURE OF DNPH1 (RCL) WITH N6-ISOPENTENYL-AMP | 3.2.2 |
4KXN | CRYSTAL STRUCTURE OF DNPH1 (RCL) WITH KINETINE RIBOSIDE MONOPHOSPHATE | 3.2.2 |
4KXP | CRYSTAL STRUCTURE OF AMP COMPLEXES OF PORCINE LIVER FRUCTOSE-1,6-BISPHOSPHATASE MUTANT I10D IN T-STATE | 3.1.3.11 |
4KXQ | STRUCTURE OF NAD-DEPENDENT PROTEIN DEACETYLASE SIRTUIN-1 (CLOSED STATE, 1.85 A) | 3.5.1 2.3.1.286 2.3.1 |
4KY5 | CRYSTAL STRUCTURE OF STAPHYLOCOCCAL NUCLEASE VARIANT DELTA+PHS V23D AT PH 7 AND CRYOGENIC TEMPERATURE | 3.1.31.1 |
4KY6 | CRYSTAL STRUCTURE OF STAPHYLOCOCCAL NUCLEASE VARIANT DELTA+PHS L25D AT PH 6 AND CRYOGENIC TEMPERATURE | 3.1.31.1 |
4KY7 | CRYSTAL STRUCTURE OF STAPHYLOCOCCAL NUCLEASE VARIANT DELTA+PHS V74D AT CRYOGENIC TEMPERATURE | 3.1.31.1 |
4KYQ | STRUCTURE OF A PRODUCT BOUND PLANT PHOSPHATASE | 3.1.3 |
4KYR | STRUCTURE OF A PRODUCT BOUND PLANT PHOSPHATASE | 3.1.3 |
4KYW | RESTRICTION ENDONUCLEASE DPNI IN COMPLEX WITH TWO DNA MOLECULES | 3.1.21.4 |
4KYX | CRYSTAL STRUCTURE OF ADP-RIBOSE PYROPHOSPHATASE MUTT FROM RICKETTSIA FELIS | 3.6.1 |
4KZ3 | CRYSTAL STRUCTURE OF AMPC BETA-LACTAMASE IN COMPLEX WITH FRAGMENT 44 (5-CHLORO-3-SULFAMOYLTHIOPHENE-2-CARBOXYLIC ACID) | 3.5.2.6 |
4KZ4 | CRYSTAL STRUCTURE OF AMPC BETA-LACTAMASE IN COMPLEX WITH FRAGMENT 60 (2-[(PROPYLSULFONYL)AMINO]BENZOIC ACID) | 3.5.2.6 |
4KZ5 | CRYSTAL STRUCTURE OF AMPC BETA-LACTAMASE IN COMPLEX WITH FRAGMENT 5 (N-{[3-(2-CHLOROPHENYL)-5-METHYL-1,2-OXAZOL-4-YL]CARBONYL}GLYCINE) | 3.5.2.6 |
4KZ6 | CRYSTAL STRUCTURE OF AMPC BETA-LACTAMASE IN COMPLEX WITH FRAGMENT 13 ((2R,6R)-6-METHYL-1-(3-SULFANYLPROPANOYL)PIPERIDINE-2-CARBOXYLIC ACID) | 3.5.2.6 |
4KZ7 | CRYSTAL STRUCTURE OF AMPC BETA-LACTAMASE IN COMPLEX WITH FRAGMENT 16 ((1R,4S)-4,7,7-TRIMETHYL-3-OXO-2-OXABICYCLO[2.2.1]HEPTANE-1-CARBOXYLIC ACID) | 3.5.2.6 |
4KZ8 | CRYSTAL STRUCTURE OF AMPC BETA-LACTAMASE IN COMPLEX WITH FRAGMENT 20 (1,3-DIETHYL-2-THIOXODIHYDROPYRIMIDINE-4,6(1H,5H)-DIONE) | 3.5.2.6 |
4KZ9 | CRYSTAL STRUCTURE OF AMPC BETA-LACTAMASE IN COMPLEX WITH FRAGMENT 41 ((4R,4AS,8AS)-4-PHENYLDECAHYDROQUINOLIN-4-OL) | 3.5.2.6 |
4KZA | CRYSTAL STRUCTURE OF AMPC BETA-LACTAMASE IN COMPLEX WITH FRAGMENT 48 (3-(CYCLOPROPYLSULFAMOYL)THIOPHENE-2-CARBOXYLIC ACID) | 3.5.2.6 |
4KZB | CRYSTAL STRUCTURE OF AMPC BETA-LACTAMASE IN COMPLEX WITH FRAGMENT 50 (N-(METHYLSULFONYL)-N-PHENYL-ALANINE) | 3.5.2.6 |
4KZF | THE MECHANISM OF THE AMIDASES: THE EFFECT OF THE MUTATION E142L IN THE AMIDASE FROM GEOBACILLUS PALLIDUS | 3.5.1.4 |
4L0G | CRYSTAL STRUCTURE OF A GH48 CELLOBIOHYDROLASE FROM CALDICELLULOSIRUPTOR BESCII | 3.2.1.4 |
4L0J | STRUCTURE OF A TRANSLOCATION SIGNAL DOMAIN MEDIATING CONJUGATIVE TRANSFER BY TYPE IV SECRETION SYSTEMS | 3.6.1 |
4L0L | CRYSTAL STRUCTURE OF P.AERUGINOSA PBP3 IN COMPLEX WITH COMPOUND 4 | 3.4.16.4 |
4L0M | CRYSTAL STRUCTURE OF A PUTATIVE 5'-METHYLTHIOADENOSINE/S-ADENOSYLHOMOCYSTEINE NUCLEOSIDASE FROM BORRELIA BURGDORFERI B31 BOUND TO ADENINE (TARGET NYSGRC-029268 ) | 3.2.2.16 3.2.2.9 |
4L15 | CRYSTAL STRUCTURE OF FIGL-1 AAA DOMAIN | 3.6.4 |
4L16 | CRYSTAL STRUCTURE OF FIGL-1 AAA DOMAIN IN COMPLEX WITH ADP | 3.6.4 |
4L19 | MATRIX METALLOPROTEINASE-13 COMPLEXED WITH SELECTIVE INHIBITOR COMPOUND Q1 | 3.4.24 |
4L1A | CRYSTALLOGRAPHIC STUDY OF MULTI-DRUG RESISTANT HIV-1 PROTEASE LOPINAVIR COMPLEX: MECHANISM OF DRUG RECOGNITION AND RESISTANCE | 2.7.7.49 3.1.26.13 |
4L1G | CRYSTAL STRUCTURE OF THE BC1960 PEPTIDOGLYCAN N-ACETYLGLUCOSAMINE DEACETYLASE FROM BACILLUS CEREUS | 3.5.1 3.5.1.104 |
4L1J | THREE DIMENSIONAL STRUCTURE OF MUTANT D143A OF HUMAN HD DOMAIN-CONTAINING PROTEIN 2, NORTHEAST STRUCTURAL GENOMICS CONSORTIUM (NESG) TARGET HR6723 | 3.1.3.89 |
4L2H | STRUCTURE OF A CATALYTICALLY INACTIVE PARG IN COMPLEX WITH A POLY-ADP-RIBOSE FRAGMENT | 3.2.1.143 |
4L2L | HUMAN LEUKOTRIENE A4 HYDROLASE COMPLEXED WITH LIGAND 4-(4-BENZYLPHENYL)THIAZOL-2-AMINE | 3.3.2.6 3.4.11.4 |
4L3O | CRYSTAL STRUCTURE OF SIRT2 IN COMPLEX WITH THE MACROCYCLIC PEPTIDE S2IL5 | 3.5.1 2.3.1.286 |
4L48 | CRYSTAL STRUCTURE OF D78N MUTANT CLAVIBACTER MICHIGANENSIS EXPANSIN IN COMPLEX WITH CELLOHEXAOSE | 3.2.1.4 |
4L4O | THE CRYSTAL STRUCTURE OF CBXYN10B IN NATIVE FORM | 3.2.1.8 |
4L4P | THE MUTANT(E139A) STRUCTURE IN COMPLEX WITH XYLOTRIOSE | 3.2.1.8 |
4L55 | X-RAY STRUCTURE OF THE ADDUCT BETWEEN BOVINE PANCREATIC RIBONUCLEASE AND AZIRU | 3.1.27.5 4.6.1.18 |
4L57 | HIGH RESOLUTIN STRUCTURE OF HUMAN CYTOSOLIC 5'(3')-DEOXYRIBONUCLEOTIDASE | 3.1.3 |
4L5N | CRYSTALLOGRAPHIC STRUCTURE OF HHV-1 URACIL-DNA GLYCOSYLASE COMPLEXED WITH THE BACILLUS PHAGE PZA INHIBITOR PROTEIN P56 | 3.2.2.27 |
4L63 | APO FORM OF AB5 HOLOTOXIN | 3.4.24 |
4L66 | CRYSTAL STRUCTURE OF RIBOSOME INACTIVATING PROTEIN FROM MOMORDICA BALSAMINA WITH HIGHLY ORDERED WATER STRUCTURE IN THE SUBSTRATE BINDING SITE | 3.2.2.22 |
4L6A | STRUCTURE OF HUMAN MITOCHONDRIAL 5'(3')-DEOXYRIBONUCLEOTIDASE | 3.1.3 |
4L6B | ENDOTHIAPEPSIN IN COMPLEX WITH THIOPHEN-BASED INHIBITOR SAP128 | 3.4.23.22 |
4L6C | CRYSTAL STRUCTURE OF HUMAN MITOCHONDRIAL DEOXYRIBONUCLEOTIDASE IN COMPLEX WITH THE INHIBITOR PIB-T | 3.1.3 |
4L6T | GM1 BOUND FORM OF THE ECX AB5 HOLOTOXIN | 3.4.24 |
4L6X | CRYSTAL STRUCTURE OF A GH48 CELLOBIOHYDROLASE FROM CALDICELLULOSIRUPTOR BESCII | 3.2.1.4 |
4L72 | CRYSTAL STRUCTURE OF MERS-COV COMPLEXED WITH HUMAN DPP4 | 3.4.14.5 |
4L7E | THREE DIMENSIONAL STRUCTURE OF MUTANT D78A OF HUMAN HD DOMAIN-CONTAINING PROTEIN 2, GENOMICS CONSORTIUM (NESG) TARGET HR6723 | 3.1.3.89 |
4L7G | DIETHYLAMINOSULFUR TRIFLUORIDE-MEDIATED INTRAMOLECULAR CYCLIZATION OF 2-HYDROXY-BENZYLUREAS TO FUSED BICYCLIC AMINOOXAZOLINE COMPOUNDS AND EVALUATION OF THEIR BIOCHEMICAL ACTIVITY AGAINST BETA-SECRETASE-1 (BACE1) | 3.4.23.46 |
4L7H | DIETHYLAMINOSULFUR TRIFLUORIDE-MEDIATED INTRAMOLECULAR CYCLIZATION OF 2-HYDROXY-BENZYLUREAS TO FUSED BICYCLIC AMINOOXAZOLINE COMPOUNDS AND EVALUATION OF THEIR BIOCHEMICAL ACTIVITY AGAINST BETA-SECRETASE-1 (BACE-1) | 3.4.23.46 |
4L7J | DIETHYLAMINOSULFUR TRIFLUORIDE-MEDIATED INTRAMOLECULAR CYCLIZATION OF 2-HYDROXY-BENZYLUREAS TO FUSED BICYCLIC AMINOOXAZOLINE COMPOUNDS AND EVALUATION OF THEIR BIOCHEMICAL ACTIVITY AGAINST BETA-SECRETASE-1 (BACE-1) | 3.4.23.46 |
4L7Q | CRYSTAL STRUCTURE OF GAMMA GLUTAMYL HYDROLASE (WILD-TYPE) FROM ZEBRAFISH | 3.4.19.9 |
4L7W | CRYSTAL STRUCTURE MUTANT H77A OF HUMAN HD DOMAIN-CONTAINING PROTEIN 2, GENOMICS CONSORTIUM (NESG) TARGET HR6723 | 3.1.3.89 |
4L8F | CRYSTAL STRUCTURE OF GAMMA-GLUTAMYL HYDROLASE (C108A) COMPLEX WITH MTX | 3.4.19.9 |
4L8G | CRYSTAL STRUCTURE OF K-RAS G12C, GDP-BOUND | 3.6.5.2 |
4L8W | CRYSTAL STRUCTURE OF GAMMA GLUTAMYL HYDROLASE (H218N) FROM ZEBRAFISH COMPLEX WITH MTX POLYGLUTAMATE | 3.4.19.9 |
4L8Y | CRYSTAL STRUCTURE OF GAMMA-GLUTAMYL HYDROLASE (C108A) FROM ZEBRAFISH | 3.4.19.9 |
4L95 | CRYSTAL STRUCTURE OF GAMMA GLUTAMYL HYDROLASE (H218N) FROM ZEBRAFISH | 3.4.19.9 |
4L9D | CRYSTAL STRUCTURE OF THE PKD1 DOMAIN FROM VIBRIO CHOLERAE METALLOPROTEASE PRTV | 3.4.24 |
4L9S | CRYSTAL STRUCTURE OF H-RAS G12C, GDP-BOUND | 3.6.5.2 |
4L9W | CRYSTAL STRUCTURE OF H-RAS G12C, GMPPNP-BOUND | 3.6.5.2 |
4L9X | TRIAZINE HYDROLASE FROM ARTHOBACTER AURESCENS MODIFIED FOR MAXIMUM EXPRESSION IN E.COLI | 3.8.1.8 |
4LAA | CRYSTAL STRUCTURE OF STAPHYLOCOCCAL NUCLEASE VARIANT DELTA+PHS L36H AT CRYOGENIC TEMPERATURE | 3.1.31.1 |
4LAP | ENDOTHIAPEPSIN IN COMPLEX WITH THIOPHEN-BASED INHIBITOR SAP114 | 3.4.23.22 |
4LBT | ENDOTHIAPEPSIN IN COMPLEX WITH 100MM ACYLHYDRAZONE INHIBITOR | 3.4.23.22 |
4LC5 | STRUCTURAL BASIS OF SUBSTRATE SPECIFICITY OF CDA SUPERFAMILY GUANINE DEAMINASE | 3.5 |
4LC7 | AMINOOXAZOLINE INHIBITOR OF BACE-1 | 3.4.23.46 |
4LCF | CRYSTAL STRUCTURE OF THE PSEUDOMONAS AERUGINOSA LPXC/LPC-014 COMPLEX | 3.5.1 3.5.1.108 |
4LCG | CRYSTAL STRUCTURE OF THE PSEUDOMONAS AERUGINOSA LPXC/LPC-050 COMPLEX | 3.5.1 3.5.1.108 |
4LCH | CRYSTAL STRUCTURE OF THE PSEUDOMONAS AERUGINOSA LPXC/LPC-051 COMPLEX | 3.5.1 3.5.1.108 |
4LCN | CRYTSAL STRUCTURE OF NE0047 IN COMPLEX WITH 2'-DEOXY-GUANOSINE | 3.5 |
4LCO | CRYSTAL STRUCTURE OF NE0047 WITH COMPLEX WITH SUBSTRATE AMMELINE | 3.5 |
4LCP | CRYTSAL STRUCTURE OF NE0047 IN COMPLEX WITH 2,6-DIAMINOPURINE | 3.5 |
4LD0 | T. THERMOPHILUS RUVC IN COMPLEX WITH HOLLIDAY JUNCTION SUBSTRATE | 3.1.22.4 |
4LD2 | CRYSTAL STRUCTURE OF NE0047 IN COMPLEX WITH CYTIDINE | 3.5 |
4LD4 | CRYSTAL STRUCTURE OF NE0047 IN COMPLEX WITH CYTOSINE | 3.5 |
4LDE | STRUCTURE OF BETA2 ADRENOCEPTOR BOUND TO BI167107 AND AN ENGINEERED NANOBODY | 3.2.1.17 |
4LDJ | CRYSTAL STRUCTURE OF A GDP-BOUND G12C ONCOGENIC MUTANT OF HUMAN GTPASE KRAS | 3.6.5.2 |
4LDL | STRUCTURE OF BETA2 ADRENOCEPTOR BOUND TO HYDROXYBENZYLISOPROTERENOL AND AN ENGINEERED NANOBODY | 3.2.1.17 |
4LDO | STRUCTURE OF BETA2 ADRENOCEPTOR BOUND TO ADRENALINE AND AN ENGINEERED NANOBODY | 3.2.1.17 |
4LDT | THE STRUCTURE OF H/CEOTUB1-UBIQUITIN ALDEHYDE-UBCH5B~UB | 3.4.19.12 |
4LEN | CTX-M-9 IN COMPLEX WITH THE BROAD SPECTRUM INHIBITOR 3-(2- CARBOXYVINYL)BENZO(B)THIOPHENE-2-BORONIC ACID | 3.5.2.6 |
4LF0 | THE E142D MUTANT OF THE AMIDASE FROM GEOBACILLUS PALLIDUS | 3.5.1.4 |
4LFD | STAPHYLOCOCCUS AUREUS SORTASE B-SUBSTRATE COMPLEX | 3.4.22.71 |
4LFP | X-RAY STRUCTURE OF THE ADDUCT BETWEEN HEN EGG WHITE LYSOZYME AND A HOMOLEPTIC GOLD(I) COMPLEX WITH THE SACCHARYNATE LIGAND | 3.2.1.17 |
4LFX | X-RAY STRUCTURE OF THE ADDUCT BETWEEN HEN EGG WHITE LYSOZYME AND AUOXO6, A DINUCLEAR GOLD(III) COMPLEX WITH -DIOXO BRIDGES LINKING THE TWO METAL CENTERS | 3.2.1.17 |
4LFY | CRYSTAL STRUCTURE OF A DIHYDROOROTASE FROM BURKHOLDERIA CENOCEPACIA J2315 | 3.5.2.3 |
4LG7 | CRYSTAL STRUCTURE MBD4 MBD DOMAIN IN COMPLEX WITH METHYLATED CPG DNA | 3.2.2 |
4LGK | X-RAY STRUCTURE OF THE ADDUCT BETWEEN HEN EGG WHITE LYSOZYME AND AU2PHEN, A DINUCLEAR GOLD(III) COMPLEX WITH -DIOXO BRIDGES LINKING THE TWO METAL CENTERS | 3.2.1.17 |
4LGM | CRYSTAL STRUCTURE OF SULFOLOBUS SOLFATARICUS VPS4 | 3.6.4.6 |
4LGP | RICIN A CHAIN BOUND TO CAMELID NANOBODY (VHH1) | 3.2.2.22 |
4LGR | RICIN A CHAIN BOUND TO CAMELID NANOBODY (VHH3) | 3.2.2.22 |
4LGS | RICIN A CHAIN BOUND TO CAMELID NANOBODY (VHH4) | 3.2.2.22 |
4LGX | STRUCTURE OF CHITINASE D FROM SERRATIA PROTEAMACULANS REVEALED AN UNUSUALLY CONSTRAINED SUBSTRATE BINDING SITE | 3.2.1.14 |
4LH4 | DUAL INHIBITION OF HIV-1 REPLICATION BY INTEGRASE-LEDGF ALLOSTERIC INHIBITORS IS PREDOMINANT AT POST-INTEGRATION STAGE DURING VIRUS PRODUCTION RATHER THAN AT INTEGRATION | 3.4.23.16 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1 |
4LH5 | DUAL INHIBITION OF HIV-1 REPLICATION BY INTEGRASE-LEDGF ALLOSTERIC INHIBITORS IS PREDOMINANT AT POST-INTEGRATION STAGE DURING VIRUS PRODUCTION RATHER THAN AT INTEGRATION | 3.4.23.16 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1 |
4LH8 | TRIAZINE HYDROLASE FROM ARTHOBACTER AURESCENS MODIFIED FOR MAXIMUM EXPRESSION IN E.COLI | 3.8.1.8 |
4LH9 | CRYSTAL STRUCTURE OF THE REFOLDED HOOD DOMAIN (ASP256-GLY295) OF HETR | 3.4.21 |
4LHE | CRYSTAL STRUCTURE OF CLOSED FORM OF MONOACYLGLYCEROL LIPASE | 3.1.1.23 |
4LHH | ENDOTHIAPEPSIN IN COMPLEX WITH 2MM ACYLHYDRAZONE INHIBITOR | 3.4.23.22 |
4LHJ | RICIN A CHAIN BOUND TO CAMELID NANOBODY (VHH5) | 3.2.2.22 |
4LHQ | RICIN A CHAIN BOUND TO CAMELID NANOBODY (VHH8) | 3.2.2.22 |
4LHR | CRYSTAL STRUCTURE OF A DEOXYURIDINE 5'-TRIPHOSPHATE NUCLEOTIDOHYDROLASE FROM BURKHOLDERIA THAILANDENSIS | 3.6.1.23 |
4LIF | CRYSTAL STRUCTURE OF THE JCV LARGE T-ANTIGEN ORIGIN BINDING DOMAIN | 3.6.4 |
4LIP | PSEUDOMONAS LIPASE COMPLEXED WITH RC-(RP, SP)-DIBUTYLCARBAMOYLGLYCERO-3-O-BUTYLPHOSPHONATE | 3.1.1.3 |
4LJ3 | CRYSTAL STRUCTURE OF THE EAL DOMAIN OF C-DI-GMP SPECIFIC PHOSPHODIESTERASE YAHA IN COMPLEX WITH SUBSTRATE C-DI-GMP AND CA++ | 3.1.4 3.1.4.52 |
4LJY | CRYSTAL STRUCTURE OF RNA SPLICING EFFECTOR PRP5 IN COMPLEX WITH ADP | 3.6.4.13 |
4LK2 | CRYSTAL STRUCTURE OF RNA SPLICING EFFECTOR PRP5 | 3.6.4.13 |
4LK4 | STRUCTURE OF VIBRIO CHOLERAE VESB PROTEASE | 3 |
4LKO | CRYSTAL STRUCTURE OF HUMAN DPP-IV IN COMPLEX WITH BMS-744891 | 3.4.14.5 |
4LKQ | CRYSTAL STRUCTURE OF PDE10A2 WITH FRAGMENT ZT017 | 3.1.4.17 3.1.4.35 |
4LLJ | CRYSTAL STRUCTURE OF PDE10A2 WITH FRAGMENT ZT214 | 3.1.4.17 3.1.4.35 |
4LLK | CRYSTAL STRUCTURE OF PDE10A2 WITH FRAGMENT ZT217 | 3.1.4.17 3.1.4.35 |
4LLP | CRYSTAL STRUCTURE OF PDE10A2 WITH FRAGMENT ZT401 | 3.1.4.17 3.1.4.35 |
4LLX | CRYSTAL STRUCTURE OF PDE10A2 WITH FRAGMENT ZT434 | 3.1.4.17 3.1.4.35 |
4LM0 | CRYSTAL STRUCTURE OF PDE10A2 WITH FRAGMENT ZT448 | 3.1.4.17 3.1.4.35 |
4LM1 | CRYSTAL STRUCTURE OF PDE10A2 WITH FRAGMENT ZT450 | 3.1.4.17 3.1.4.35 |
4LM2 | CRYSTAL STRUCTURE OF PDE10A2 WITH FRAGMENT ZT462 | 3.1.4.17 3.1.4.35 |
4LM3 | CRYSTAL STRUCTURE OF PDE10A2 WITH FRAGMENT ZT464 | 3.1.4.17 3.1.4.35 |
4LM4 | CRYSTAL STRUCTURE OF PDE10A2 WITH FRAGMENT ZT902 | 3.1.4.17 3.1.4.35 |
4LMD | CRYSTAL STRUCTURE OF THE JCV LARGE T-ANTIGEN ORIGIN BINDING DOMAIN | 3.6.4 |
4LND | CRYSTAL STRUCTURE OF HUMAN APURINIC/APYRIMIDINIC ENDONUCLEASE 1 WITH ESSENTIAL MG2+ COFACTOR | 4.2.99.18 3.1 |
4LOR | C1S CUB1-EGF-CUB2 IN COMPLEX WITH A COLLAGEN-LIKE PEPTIDE FROM C1Q | 3.4.21.42 |
4LOS | C1S CUB2-CCP1 | 3.4.21.42 |
4LOT | C1S CUB2-CCP1-CCP2 | 3.4.21.42 |
4LOY | CRYSTAL STRUCTURE ANALYSIS OF THROMBIN IN COMPLEX WITH COMPOUND D57, 5-CHLOROTHIOPHENE-2-CARBOXYLIC ACID [(S)-2-[2-METHYL-3-(2- OXOPYRROLIDIN-1-YL)BENZENESULFONYLAMINO]-3-(4-METHYLPIPERAZIN-1- YL)-3-OXOPROPYL]AMIDE (SAR107375) | 3.4.21.5 |
4LP9 | ENDOTHIAPEPSIN COMPLEXED WITH PHE-REDUCED-TYR PEPTIDE. | 3.4.23.22 |
4LPK | CRYSTAL STRUCTURE OF K-RAS WT, GDP-BOUND | 3.6.5.2 |
4LQ3 | CRYSTAL STRUCTURE OF HUMAN NOROVIRUS RNA-DEPENDENT RNA-POLYMERASE BOUND TO THE INHIBITOR PPNDS | 3.4.22.66 |
4LQ9 | CRYSTAL STRUCTURE OF HUMAN NOROVIRUS RNA-DEPENDENT RNA-POLYMERASE IN COMPLEX WITH NAF2 | 3.4.22.66 |
4LQG | X-RAY STRUCTURE OF HUMAN GLUTAMATE CARBOXYPEPTIDASE II (GCPII) IN COMPLEX WITH A PHOSPHORAMIDATE INHIBITOR CTT1056 | 3.4.17.21 |
4LQY | CRYSTAL STRUCTURE OF HUMAN ENPP4 WITH AMP | 3.6.1.29 |
4LR2 | CRYSTAL STRUCTURE OF HUMAN ENPP4 (APO) | 3.6.1.29 |
4LRO | CRYSTAL STRUCTURE OF SPERMIDINE INHIBITED RIBOSOME INACTIVATING PROTEIN FROM MOMORDICA BALSAMINA | 3.2.2.22 |
4LRQ | CRYSTAL STRUCTURE OF A LOW MOLECULAR WEIGHT PHOSPHOTYROSINE PHOSPHATASE FROM VIBRIO CHOLERAEO395 | 3.1.3.48 |
4LRW | CRYSTAL STRUCTURE OF K-RAS G12C (CYSTEINE-LIGHT), GDP-BOUND | 3.6.5.2 |
4LSG | STRUCTURE OF MOUSE P-GLYCOPROTEIN | 3.6.3.44 7.6.2.2 7.6.2.1 |
4LSL | CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH (E)-3-(3-(4-CHLORO-2-(2-(2,4-DIOXO-3,4-DIHYDROPYRIMIDIN-1(2H)-YL)ETHOXY)PHENOXY)PHENYL)ACRYLONITRILE (JLJ476), A NON-NUCLEOSIDE INHIBITOR | 2.7.7.49 3.4.23.16 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1 |
4LSN | CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH (E)-3-(3-BROMO-5-(4-CHLORO-2-(2-(2,4-DIOXO-3,4-DIHYDROPYRIMIDIN-1(2H)-YL)ETHOXY)PHENOXY)PHENYL)ACRYLONITRILE (JLJ518), A NON-NUCLEOSIDE INHIBITOR | 2.7.7.49 3.4.23.16 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1 |
4LSZ | CASPASE-7 IN COMPLEX WITH DARPIN D7.18 | 3.4.22.60 |
4LT0 | HEWL CO-CRYSTALLIZED WITH CARBOPLATIN IN NON-NACL CONDITIONS: CRYSTAL 1 PROCESSED USING THE EVAL SOFTWARE PACKAGE | 3.2.1.17 |
4LT1 | HEWL CO-CRYSTALLISED WITH CARBOPLATIN IN NON-NACL CONDITIONS: CRYSTAL 1 PROCESSED USING THE XDS SOFTWARE PACKAGE | 3.2.1.17 |
4LT2 | HEWL CO-CRYSTALLIZED WITH CARBOPLATIN IN NON-NACL CONDITIONS: CRYSTAL 2 PROCESSED USING THE EVAL SOFTWARE PACKAGE | 3.2.1.17 |
4LT3 | HEWL CO-CRYSTALLIZED WITH CARBOPLATIN IN NON-NACL CONDITIONS: CRYSTAL 2 PROCESSED USING THE XDS SOFTWARE PACKAGE | 3.2.1.17 |
4LT4 | CRYSTAL STRUCTURE OF ARGININE INHIBITED RIBOSOME INACTIVATING PROTEIN FROM MOMORDICA BALSAMINA AT 1.69 A RESOLUTION | 3.2.2.22 |
4LUC | CRYSTAL STRUCTURE OF SMALL MOLECULE DISULFIDE 6 BOUND TO K-RAS G12C | 3.6.5.2 |
4LUG | CRYSTAL STRUCTURE OF INORGANIC PYROPHOSPHATASE PPA1 FROM ARABIDOPSIS THALIANA | 3.6.1.1 |
4LUQ | CRYSTAL STRUCTURE OF VIRULENCE EFFECTOR TSE3 IN COMPLEX WITH NEUTRALIZER TSI3 | 3.2.1.17 |
4LV0 | AMPC BETA-LACTAMASE IN COMPLEX WITH M-AMINOPHENYL BORONIC ACID | 3.5.2.6 |
4LV1 | AMPC BETA-LACTAMASE IN COMPLEX WITH [1-(3-CHLOROPHENYL)-1H-PYRAZOL-4-YL] BORONIC ACID | 3.5.2.6 |
4LV2 | AMPC BETA-LACTAMASE IN COMPLEX WITH [1-(6-CHLOROPYRIMIDIN-4-YL)-1H-PYRAZOL-4-YL] BORONIC ACID | 3.5.2.6 |
4LV3 | AMPC BETA-LACTAMASE IN COMPLEX WITH (3,5-DI-TERT-BUTYLPHENYL) BORONIC ACID | 3.5.2.6 |
4LV6 | CRYSTAL STRUCTURE OF SMALL MOLECULE DISULFIDE 4 COVALENTLY BOUND TO K-RAS G12C | 3.6.5.2 |
4LVC | CRYSTAL STRUCTURE OF S-ADENOSYL-L-HOMOCYSTEINE HYDROLASE FROM BRADYRHIZOBIUM ELKANII IN COMPLEX WITH ADENOSINE | 3.3.1.1 |
4LVN | CRYSTAL STRUCTURE OF PFSUB1-PRODOMAIN-NIMP.M7 FAB COMPLEX | 3.4.21.61 3.4.21.62 |
4LVO | CRYSTAL STRUCTURE OF PFSUB1-PRODOMAIN-NIMP.M7 FAB COMPLEX WITH ADDED CACL2 | 3.4.21.61 3.4.21.62 |
4LWQ | CRYSTAL STRUCTURE OF NATIVE PEPTIDYL T-RNA HYDROLASE FROM ACINETOBACTER BAUMANNII AT 1.38A RESOLUTION | 3.1.1.29 |
4LWX | CRYSTAL STRUCTURE OF THE COMPLEX OF RIBOSOME INACTIVATING PROTEIN FROM MOMORDICA BALSAMINA WITH PEPTIDOGLYCAN FRAGMENT AT 1.78 A RESOLUTION | 3.2.2.22 |
4LX4 | CRYSTAL STRUCTURE DETERMINATION OF PSEUDOMONAS STUTZERI ENDOGLUCANASE CEL5A USING A TWINNED DATA SET | 3.2.1.4 |
4LXA | CRYSTAL STRUCTURE OF HUMAN BETA SECRETASE IN COMPLEX WITH COMPOUND 11A | 3.4.23.46 |
4LXB | CRYSTAL STRUCTURE ANALYSIS OF THROMBIN IN COMPLEX WITH COMPOUND D58 | 3.4.21.5 |
4LXC | THE ANTIMICROBIAL PEPTIDASE LYSOSTAPHIN FROM STAPHYLOCOCCUS SIMULANS | 3.4.24.75 |
4LXG | CRYSTAL STRUCTURE OF DXNB2, A CARBON - CARBON BOND HYDROLASE FROM SPHINGOMONAS WITTICHII RW1 | 3.7.1.8 |
4LXH | CRYSTAL STRUCTURE OF THE S105A MUTANT OF A CARBON-CARBON BOND HYDROLASE, DXNB2 FROM SPHINGOMONAS WITTICHII RW1, IN COMPLEX WITH 3-CL HOPDA | 3.7.1.8 |
4LXI | CRYSTAL STRUCTURE OF THE S105A MUTANT OF A CARBON-CARBON BOND HYDROLASE, DXNB2 FROM SPHINGOMONAS WITTICHII RW1, IN COMPLEX WITH 5,8-DIF HOPDA | 3.7.1.8 |
4LXK | CRYSTAL STRUCTURE OF HUMAN BETA SECRETASE IN COMPLEX WITH COMPOUND 11D | 3.4.23.46 |
4LXM | CRYSTAL STRUCTURE OF HUMAN BETA SECRETASE IN COMPLEX WITH COMPOUND 12A | 3.4.23.46 |
4LXR | STRUCTURE OF THE TOLL - SPATZLE COMPLEX, A MOLECULAR HUB IN DROSOPHILA DEVELOPMENT AND INNATE IMMUNITY | 3.2.2.6 |
4LXS | STRUCTURE OF THE TOLL - SPATZLE COMPLEX, A MOLECULAR HUB IN DROSOPHILA DEVELOPMENT AND INNATE IMMUNITY (GLYCOSYLATED FORM) | 3.2.2.6 |
4LXZ | STRUCTURE OF HUMAN HDAC2 IN COMPLEX WITH SAHA (VORINOSTAT) | 3.5.1.98 |
4LY1 | STRUCTURE OF HUMAN HDAC2 IN COMPLEX WITH INHIBITOR 4-(ACETYLAMINO)-N-[2-AMINO-5-(THIOPHEN-2-YL)PHENYL]BENZAMIDE | 3.5.1.98 |
4LY4 | CRYSTAL STRUCTURE OF PEPTIDOGLYCAN DEACETYLASE (HP0310) WITH ZINC FROM HELICOBACTER PYLORI | 3.5.1 3.1.1.72 |
4LYB | CDS WITHIN A LYSOYZME SINGLE CRYSTAL | 3.2.1.17 |
4LYC | CD IONS WITHIN A LYSOYZME SINGLE CRYSTAL | 3.2.1.17 |
4LYD | CRYSTAL STRUCTURE OF THE S105A MUTANT OF A C-C HYDROLASE, DXNB2 FROM SPHINGOMONAS WITTICHII RW1 | 3.7.1.8 |
4LYE | CRYSTAL STRUCTURE OF THE S105A MUTANT OF A C-C HYDROLASE, DXNB2 FROM SPHINGOMONAS WITTICHII RW1, IN COMPLEX WITH SUBSTRATE HOPDA | 3.7.1.8 |
4LYF | CRYSTAL STRUCTURE OF SMALL MOLECULE VINYLSULFONAMIDE 8 COVALENTLY BOUND TO K-RAS G12C | 3.6.5.2 |
4LYH | CRYSTAL STRUCTURE OF SMALL MOLECULE VINYLSULFONAMIDE 9 COVALENTLY BOUND TO K-RAS G12C | 3.6.5.2 |
4LYJ | CRYSTAL STRUCTURE OF SMALL MOLECULE VINYLSULFONAMIDE 9 COVALENTLY BOUND TO K-RAS G12C, ALTERNATIVE SPACE GROUP | 3.6.5.2 |
4LYK | CRYSTAL STRUCTURE OF THE EAL DOMAIN OF C-DI-GMP SPECIFIC PHOSPHODIESTERASE YAHA IN COMPLEX WITH ACTIVATING COFACTOR MG++ | 3.1.4 3.1.4.52 |
4LYM | CRYSTAL STRUCTURE OF LOW HUMIDITY TETRAGONAL LYSOZYME AT 2.1-ANGSTROMS RESOLUTION. VARIABILITY IN HYDRATION SHELL AND ITS STRUCTURAL CONSEQUENCES | 3.2.1.17 |
4LYO | CROSS-LINKED CHICKEN LYSOZYME CRYSTAL IN NEAT ACETONITRILE, THEN BACK-SOAKED IN WATER | 3.2.1.17 |
4LYP | CRYSTAL STRUCTURE OF GLYCOSIDE HYDROLASE FAMILY 5 MANNOSIDASE FROM RHIZOMUCOR MIEHEI | 3.2.1.25 |
4LYQ | CRYSTAL STRUCTURE OF GLYCOSIDE HYDROLASE FAMILY 5 MANNOSIDASE FROM RHIZOMUCOR MIEHEI, E202A MUTANT | 3.2.1.25 |
4LYR | GLYCOSIDE HYDROLASE FAMILY 5 MANNOSIDASE FROM RHIZOMUCOR MIEHEI, E301A MUTANT | 3.2.1.25 |
4LYT | COMPARISON OF RADIATION-INDUCED DECAY AND STRUCTURE REFINEMENT FROM X-RAY DATA COLLECTED FROM LYSOZYME CRYSTALS AT LOW AND AMBIENT TEMPERATURES | 3.2.1.17 |
4LYZ | REAL-SPACE REFINEMENT OF THE STRUCTURE OF HEN EGG-WHITE LYSOZYME | 3.2.1.17 |
4LZ4 | X-RAY STRUCTURE OF THE COMPLEX BETWEEN HUMAN THROMBIN AND THE TBA DELETION MUTANT LACKING THYMINE 3 NUCLEOBASE | 3.4.21.5 |
4LZB | URACIL BINDING POCKET IN VACCINIA VIRUS URACIL DNA GLYCOSYLASE | 3.2.2.27 |
4LZM | COMPARISON OF THE CRYSTAL STRUCTURE OF BACTERIOPHAGE T4 LYSOZYME AT LOW, MEDIUM, AND HIGH IONIC STRENGTHS | 3.2.1.17 |
4LZP | STRUCTURE OF THE TIR DOMAIN OF THE IMMUNOSUPPRESSOR BTPA FROM BRUCELLA | 3.2.2.6 |
4LZT | ATOMIC RESOLUTION REFINEMENT OF TRICLINIC HEW LYSOZYME AT 295K | 3.2.1.17 |
4M0E | STRUCTURE OF HUMAN ACETYLCHOLINESTERASE IN COMPLEX WITH DIHYDROTANSHINONE I | 3.1.1.7 |
4M0F | STRUCTURE OF HUMAN ACETYLCHOLINESTERASE IN COMPLEX WITH TERRITREM B | 3.1.1.7 |
4M0L | GAMMA SUBUNIT OF THE TRANSLATION INITIATION FACTOR 2 FROM SULFOLOBUS SOLFATARICUS COMPLEXED WITH GDP | 3.6.5.3 |
4M0W | CRYSTAL STRUCTURE OF SARS-COV PAPAIN-LIKE PROTEASE C112S MUTANT IN COMPLEX WITH UBIQUITIN | 3.4.19.12 3.4.22.69 3.4.22 |
4M1J | CRYSTAL STRUCTURE OF PSEUDOMONAS AERUGINOSA PVDQ IN COMPLEX WITH A TRANSITION STATE ANALOGUE | 3.5.1.97 |
4M1M | CORRECTED STRUCTURE OF MOUSE P-GLYCOPROTEIN | 3.6.3.44 7.6.2.2 7.6.2.1 |
4M1O | CRYSTAL STRUCTURE OF SMALL MOLECULE VINYLSULFONAMIDE 7 COVALENTLY BOUND TO K-RAS G12C | 3.6.5.2 |
4M1R | STRUCTURE OF A NOVEL CELLULASE 5 FROM A SUGARCANE SOIL METAGENOMIC LIBRARY | 3.2.1.4 |
4M1S | CRYSTAL STRUCTURE OF SMALL MOLECULE VINYLSULFONAMIDE 13 COVALENTLY BOUND TO K-RAS G12C | 3.6.5.2 |
4M1T | CRYSTAL STRUCTURE OF SMALL MOLECULE VINYLSULFONAMIDE 14 COVALENTLY BOUND TO K-RAS G12C | 3.6.5.2 |
4M1U | THE CRYSTAL STRUCTURE OF STX2 AND A DISACCHARIDE LIGAND | 3.2.2.22 |
4M1W | CRYSTAL STRUCTURE OF SMALL MOLECULE VINYLSULFONAMIDE COVALENTLY BOUND TO K-RAS G12C | 3.6.5.2 |
4M1Y | CRYSTAL STRUCTURE OF SMALL MOLECULE VINYLSULFONAMIDE 15 COVALENTLY BOUND TO K-RAS G12C | 3.6.5.2 |
4M1Z | CRYSTAL STRUCTURE OF MYCP1 WITH THE N-TERMINAL PROPEPTIDE REMOVED | 3.4.21.62 3.4.21 |
4M21 | CRYSTAL STRUCTURE OF SMALL MOLECULE ACRYLAMIDE 11 COVALENTLY BOUND TO K-RAS G12C | 3.6.5.2 |
4M22 | CRYSTAL STRUCTURE OF SMALL MOLECULE ACRYLAMIDE 16 COVALENTLY BOUND TO K-RAS G12C | 3.6.5.2 |
4M24 | CRYSTAL STRUCTURE OF THE ENDO-1,4-GLUCANASE, RBCEL1, IN COMPLEX WITH CELLOBIOSE | 3.2.1.4 |
4M2L | GAMMA SUBUNIT OF THE TRANSLATION INITIATION FACTOR 2 FROM SULFOLOBUS SOLFATARICUS IN NUCLEOTIDE-FREE FORM | 3.6.5.3 |
4M2S | CORRECTED STRUCTURE OF MOUSE P-GLYCOPROTEIN BOUND TO QZ59-RRR | 3.6.3.44 7.6.2.2 7.6.2.1 |
4M2T | CORRECTED STRUCTURE OF MOUSE P-GLYCOPROTEIN BOUND TO QZ59-SSS | 3.6.3.44 7.6.2.2 7.6.2.1 |
4M2Z | CRYSTAL STRUCTURE OF RNASE III COMPLEXED WITH DOUBLE-STRANDED RNA AND CMP (TYPE II CLEAVAGE) | 3.1.26.3 |
4M30 | CRYSTAL STRUCTURE OF RNASE III COMPLEXED WITH DOUBLE-STRANDED RNA AND AMP (TYPE II CLEAVAGE) | 3.1.26.3 |
4M3K | STRUCTURE OF A SINGLE DOMAIN CAMELID ANTIBODY FRAGMENT CAB-H7S IN COMPLEX WITH THE BLAP BETA-LACTAMASE FROM BACILLUS LICHENIFORMIS | 3.5.2.6 |
4M3M | INFLUENZA NEURAMINIDASE IN COMPLEX WITH A STEREOMUTATED ANALOGUE OF OSELTAMIVIR CARBOXYLATE | 3.2.1.18 |
4M3O | CRYSTAL STRUCTURE OF K.LACTIS RTR1 NTD | 3.1.3.16 |
4M3R | RB69 DNA POLYMERASE TERNARY COMPLEX WITH DT/DG AT POSITION N-1 OF PRIMER/TEMPLATE DUPLEX | 2.7.7.7 3.1.11 |
4M3T | RB69 DNA POLYMERASE TERNARY COMPLEX WITH DT/DG AT POSITION N-2 OF PRIMER/TEMPLATE DUPLEX | 2.7.7.7 3.1.11 |
4M3U | RB69 DNA POLYMERASE TERNARY COMPLEX WITH DT/DG AT POSITION N-3 OF PRIMER/TEMPLATE DUPLEX | 2.7.7.7 3.1.11 |
4M3W | RB69 DNA POLYMERASE TERNARY COMPLEX WITH DT/DG AT POSITION N-4 OF PRIMER/TEMPLATE DUPLEX | 2.7.7.7 3.1.11 |
4M3X | RB69 DNA POLYMERASE TERNARY COMPLEX WITH DT/DG AT POSITION N-5 OF PRIMER/TEMPLATE DUPLEX | 2.7.7.7 3.1.11 |
4M3Y | RB69 DNA POLYMERASE TERNARY COMPLEX WITH DG/DT AT POSITION N-1 OF PRIMER/TEMPLATE DUPLEX | 2.7.7.7 3.1.11 |
4M3Z | RB69 DNA POLYMERASE TERNARY COMPLEX WITH DG/DT AT POSITION N-2 OF PRIMER/TEMPLATE DUPLEX | 2.7.7.7 3.1.11 |
4M41 | RB69 DNA POLYMERASE TERNARY COMPLEX WITH DG/DT AT POSITION N-3 OF PRIMER/TEMPLATE DUPLEX | 2.7.7.7 3.1.11 |
4M42 | RB69 DNA POLYMERASE TERNARY COMPLEX WITH DG/DT AT POSITION N-4 OF PRIMER/TEMPLATE DUPLEX | 2.7.7.7 3.1.11 |
4M45 | RB69 DNA POLYMERASE TERNARY COMPLEX WITH DG/DT AT POSITION N-5 OF PRIMER/TEMPLATE DUPLEX | 2.7.7.7 3.1.11 |
4M4C | CRYSTAL STRUCTURE OF RHODOSTOMIN ARGDP MUTANT | 3.4.24 |
4M4N | STRUCTURAL EVALUATION THE Y358H MUTANT OF THE ASPERGILLUS FUMIGATUS KDNASE (SIALIDASE) | 3.2.1.18 |
4M4O | CRYSTAL STRUCTURE OF THE APTAMER MINE-LYSOZYME COMPLEX | 3.2.1.17 |
4M4S | GAMMA SUBUNIT OF THE TRANSLATION INITIATION FACTOR 2 FROM SULFOLOBUS SOLFATARICUS IN COMPLEX WITH GDP AND FORMATE ION MIMIC AIF2GAMMA*GDP*PI COMPLEX (A FORMATE ION SUBSTITUTES FOR PI) | 3.6.5.3 |
4M4U | STRUCTURAL EVALUATION D84A MUTANT OF THE ASPERGILLUS FUMIGATUS KDNASE (SIALIDASE) | 3.2.1.18 |
4M4V | STRUCTURAL EVALUATION R171L MUTANT OF THE ASPERGILLUS FUMIGATUS KDNASE (SIALIDASE) | 3.2.1.18 |
4M51 | CRYSTAL STRUCTURE OF AMIDOHYDROLASE NIS_0429 (SER145ALA MUTANT) FROM NITRATIRUPTOR SP. SB155-2 | 3.5.4.40 |
4M53 | GAMMA SUBUNIT OF THE TRANSLATION INITIATION FACTOR 2 FROM SULFOLOBUS SOLFATARICUS IN COMPLEX WITH GDPCP | 3.6.5.3 |
4M56 | THE STRUCTURE OF WILD-TYPE MALL FROM BACILLUS SUBTILIS | 3.2.1.10 |
4M5A | CRYSTAL STRUCTURE OF THE COMPLEX OF RIBOSOME INACTIVATING PROTEIN FROM MOMORDICA BALSAMINA INHIBITED BY ASYMMETRIC DIMETHYL ARGININE AT 1.70 A RESOLUTION | 3.2.2.22 |
4M5E | TSE3 STRUCTURE | 3.2.1.17 |
4M5F | COMPLEX STRUCTURE OF TSE3-TSI3 | 3.2.1.17 |
4M5W | CRYSTAL STRUCTURE OF THE USP7/HAUSP CATALYTIC DOMAIN | 3.4.19.12 |
4M5X | CRYSTAL STRUCTURE OF THE USP7/HAUSP CATALYTIC DOMAIN | 3.4.19.12 |
4M65 | IN SITU THERMOLYSIN CRYSTALLIZED ON A MITEGEN MICROMESH WITH ASPARAGINE LIGAND | 3.4.24 |
4M6D | CRYSTAL STRUCTURE OF THE APTAMER MINF-LYSOZYME COMPLEX. | 3.2.1.17 |
4M6F | DIMER OF THE G-SEGMENT INVERTASE BOUND TO A DNA SUBSTRATE | 3.1.22 6.5.1 |
4M6G | STRUCTURE OF THE MYCOBACTERIUM TUBERCULOSIS PEPTIDOGLYCAN AMIDASE RV3717 IN COMPLEX WITH L-ALANINE-ISO-D-GLUTAMINE REACTION PRODUCT | 3.5.1.28 |
4M6H | STRUCTURE OF THE REDUCED, METAL-FREE FORM OF MYCOBACTERIUM TUBERCULOSIS PEPTIDOGLYCAN AMIDASE RV3717 | 3.5 |
4M6I | STRUCTURE OF THE REDUCED, ZN-BOUND FORM OF MYCOBACTERIUM TUBERCULOSIS PEPTIDOGLYCAN AMIDASE RV3717 | 3.5 |
4M6W | CRYSTAL STRUCTURE OF THE C-TERMINAL SEGMENT OF FANCM IN COMPLEX WITH FAAP24 | 3.6.4.13 |
4M7G | STREPTOMYCES ERYTHRAEUS TRYPSIN | 3.4.21.4 |
4M80 | THE STRUCTURE OF E292S GLYCOSYNTHASE VARIANT OF EXO-1,3-BETA-GLUCANASE FROM CANDIDA ALBICANS AT 1.85A RESOLUTION | 3.2.1.58 2.4.1 |
4M81 | THE STRUCTURE OF E292S GLYCOSYNTHASE VARIANT OF EXO-1,3-BETA-GLUCANASE FROM CANDIDA ALBICANS COMPLEXED WITH 1-FLUORO-ALPHA-D-GLUCOPYRANOSIDE (DONOR) AND P-NITROPHENYL BETA-D-GLUCOPYRANOSIDE (ACCEPTOR) AT 1.86A RESOLUTION | 3.2.1.58 2.4.1 |
4M82 | THE STRUCTURE OF E292S GLYCOSYNTHASE VARIANT OF EXO-1,3-BETA-GLUCANASE FROM CANDIDA ALBICANS COMPLEXED WITH P-NITROPHENYL-GENTIOBIOSIDE (PRODUCT) AT 1.6A RESOLUTION | 3.2.1.58 2.4.1 |
4M8A | CRYSTAL STRUCTURE OF THERMOTOGA MARITIMA FTSH PERIPLASMIC DOMAIN | 3.4.24 |
4M8O | TERNARY COMPLEX OF DNA POLYMERASE EPSILON WITH AN INCOMING DATP | 2.7.7.7 3.1.11 |
4M8U | THE STRUCTURE OF MALL MUTANT ENZYME V200A FROM BACILLUS SUBTILUS | 3.2.1.10 |
4M8X | GS-8374, A NOVEL PHOSPHONATE-CONTAINING INHIBITOR OF HIV-1 PROTEASE, EFFECTIVELY INHIBITS HIV PR MUTANTS WITH AMINO ACID INSERTIONS | 3.4.23.16 2.7.7.49 3.1.26.13 |
4M8Y | GS-8374, A NOVEL PHOSPHONATE-CONTAINING INHIBITOR OF HIV-1 PROTEASE, EFFECTIVELY INHIBITS HIV PR MUTANTS WITH AMINO ACID INSERTIONS | 3.4.23.16 2.7.7.49 3.1.26.13 |
4M94 | D(ATCCGTTATAACGGAT) COMPLEXED WITH MOLONEY MURINE LEUKEMIA VIRUS REVERSE TRANSCRIPTASE CATALYTIC FRAGMENT | 3.4.23 2.7.7.49 2.7.7.7 3.1.26.4 2.7.7 3.1 |
4M95 | D(ATCCGTTATAACGGAT)COMPLEXED WITH MOLONEY MURINE LEUKEMIA VIRUS REVERSE TRANSCRIPTASE CATALYTIC FRAGMENT | 3.4.23 2.7.7.49 2.7.7.7 3.1.26.4 2.7.7 3.1 |
4M9F | DENGUE VIRUS NS2B-NS3 PROTEASE A125C VARIANT AT PH 8.5 | 3.4.21.91 3.6.1.15 3.6.4.13 2.1.1.56 2.1.1.57 2.7.7.48 |
4M9I | A125C NS2B-NS3 PROTEASE FROM DENGUE VIRUS AT PH 5.5 | 3.4.21.91 3.6.1.15 3.6.4.13 2.1.1.56 2.1.1.57 2.7.7.48 |
4M9K | NS2B-NS3 PROTEASE FROM DENGUE VIRUS AT PH 5.5 | 3.4.21.91 3.6.1.15 3.6.4.13 2.1.1.56 2.1.1.57 2.7.7.48 |
4M9M | NS2B-NS3 PROTEASE FROM DENGUE VIRUS AT PH 8.5 | 3.4.21.91 3.6.1.15 3.6.4.13 2.1.1.56 2.1.1.57 2.7.7.48 |
4M9Q | CRYSTAL STRUCTURE OF C-TERMINALLY TRUNCATED ARL13B FROM CHLAMYDOMONAS RHEINHARDTII BOUND TO GPPNHP | 3.6.5.2 |
4M9R | CRYSTAL STRUCTURE OF CED-3 | 3.4.22 3.4.22.60 |
4M9T | NS2B-NS3 PROTEASE FROM DENGUE VIRUS IN THE PRESENCE OF DTNB, A COVALENT ALLOSTERIC INHIBITOR | 3.4.21.91 3.6.1.15 3.6.4.13 2.1.1.56 2.1.1.57 2.7.7.48 |
4MA4 | S-GLUTATHIONYLATED PFKFB3 | 2.7.1.105 3.1.3.46 |
4MAD | CRYSTAL STRUCTURE OF BETA-GALACTOSIDASE C (BGAC) FROM BACILLUS CIRCULANS ATCC 31382 | 3.2.1.35 |
4MAK | CRYSTAL STRUCTURE OF A PUTATIVE SSRNA ENDONUCLEASE CAS2, CRISPR ADAPTATION PROTEIN FROM E.COLI | 3.1 |
4MAT | E.COLI METHIONINE AMINOPEPTIDASE HIS79ALA MUTANT | 3.4.11.18 |
4MAZ | THE STRUCTURE OF MALL MUTANT ENZYME V200S FROM BACILLUS SUBTILUS | 3.2.1.10 |
4MB1 | THE STRUCTURE OF MALL MUTANT ENZYME G202P FROM BACILLUS SUBTILUS | 3.2.1.10 |
4MB3 | CRYSTAL STRUCTURE OF E153Q MUTANT OF COLD-ADAPTED CHITINASE FROM MORITELLA MARINA | 3.2.1.14 |
4MB4 | CRYSTAL STRUCTURE OF E153Q MUTANT OF COLD-ADAPTED CHITINASE FROM MORITELLA COMPLEX WITH NAG4 | 3.2.1.14 |
4MB5 | CRYSTAL STRUCTURE OF E153Q MUTANT OF COLD-ADAPTED CHITINASE FROM MORITELLA COMPLEX WITH NAG5 | 3.2.1.14 |
4MB7 | CRYSTAL STRUCTURE OF A VIRAL DNA GLYCOSYLASE | 4.2.99.18 3.2.2.23 |
4MBB | CUBIC CRYSTAL FORM OF PIR1 DUAL SPECIFICITY PHOSPHATASE CORE | 3.1.3 |
4MBF | CRYSTAL STRUCTURE OF PENAM SULFONE PSR-4-157 BOUND TO SHV-1 BETA-LACTAMASE | 3.5.2.6 |
4MBH | PENAM SULFONE PSR-3-226 BOUND TO E166A VARIANT OF SHV-1 BETA-LACTAMASE | 3.5.2.6 |
4MBK | CRYSTAL STRUCTURE OF K234R INHIBITOR-RESISTANT VARIANT OF SHV BETA-LACTAMASE IN COMPLEX WITH SA2-13 | 3.5.2.6 |
4MC1 | HIV PROTEASE IN COMPLEX WITH SA526P | 3.4.23.16 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1 |
4MC2 | HIV PROTEASE IN COMPLEX WITH SA525P | 3.4.23.16 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1 |
4MC6 | HIV PROTEASE IN COMPLEX WITH SA499 | 3.4.23.16 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1 |
4MC9 | HIV PROTEASE IN COMPLEX WITH AA74 | 3.4.23.16 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1 |
4MCK | CRYSTAL STRUCTURE OF FAMILY GH19, CLASS IV CHITINASE FROM ZEA MAYS | 3.2.1.14 |
4MCP | A HIGH RESOLUTION STRUCTURE OF HUMAN GLUTAMATE CARBOXYPEPTIDASE II (GCPII) IN COMPLEX WITH FOLYL-GAMMA-L-GLUTAMIC ACID (PTEROYLDI-GAMMA-L-GLUTAMIC ACID) | 3.4.17.21 |
4MCQ | A HIGH RESOLUTION STRUCTURE OF HUMAN GLUTAMATE CARBOXYPEPTIDASE II (GCPII) IN COMPLEX WITH FOLYLDI-GAMMA-L-GLUTAMIC ACID (PTEROYLTRI-GAMMA-L-GLUTAMIC ACID) | 3.4.17.21 |
4MCR | A HIGH RESOLUTION STRUCTURE OF HUMAN GLUTAMATE CARBOXYPEPTIDASE II (GCPII) IN COMPLEX WITH FOLYLTRI-GAMMA-L-GLUTAMIC ACID (PTEROYLTETRA-GAMMA-L-GLUTAMIC ACID) | 3.4.17.21 |
4MCS | A HIGH RESOLUTION STRUCTURE OF HUMAN GLUTAMATE CARBOXYPEPTIDASE II (GCPII) HIS475TYR VARIANT IN COMPLEX WITH GLUTAMIC ACID | 3.4.17.21 |
4MCW | METALLO-ENZYME FROM P. MARINA | 3.1.4.1 |
4MD6 | CRYSTAL STRUCTURE OF PDE5 IN COMPLEX WITH INHIBITOR 5R | 3.1.4.35 |
4MDA | STRUCTURE OF MOS1 TRANSPOSASE CATALYTIC DOMAIN AND RALTEGRAVIR WITH MN | 3.1 |
4MDB | STRUCTURE OF MOS1 TRANSPOSASE CATALYTIC DOMAIN AND RALTEGRAVIR WITH MG | 3.1 |
4MDS | DISCOVERY OF N-(BENZO[1,2,3]TRIAZOL-1-YL)-N-(BENZYL)ACETAMIDO)PHENYL) CARBOXAMIDES AS SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS (SARS-COV) 3CLPRO INHIBITORS: IDENTIFICATION OF ML300 AND NON-COVALENT NANOMOLAR INHIBITORS WITH AN INDUCED-FIT BINDING | 3.4.22 3.4.19.12 3.4.22.69 |
4MDX | CRYSTAL STRUCTURE OF BACILLUS SUBTILIS MAZF IN COMPLEX WITH RNA | 3.1 3.1.27 |
4ME5 | CRYSTAL STRUCTURE OF STAPHYLOCOCCAL NUCLEASE VARIANT DELTA+PHS V23S/V66A AT CRYOGENIC TEMPERATURE | 3.1.31.1 |
4ME7 | CRYSTAL STRUCTURE OF BACILLUS SUBTILIS TOXIN MAZF IN COMPLEX WITH COGNATE ANTITOXIN MAZE | 3.1 3.1.27 |
4ME8 | CRYSTAL STRUCTURE OF A SIGNAL PEPTIDASE I (EF3073) FROM ENTEROCOCCUS FAECALIS V583 AT 2.27 A RESOLUTION | 3.4.21.89 |
4MEL | CRYSTAL STRUCTURE OF THE HUMAN USP11 DUSP-UBL DOMAINS | 3.4.19.12 |
4MEM | CRYSTAL STRUCTURE OF THE RAT USP11 DUSP-UBL DOMAINS | 3.4.19.12 |
4MEZ | CRYSTAL STRUCTURE OF M68L/M69T DOUBLE MUTANT TEM-1 | 3.5.2.6 |
4MFB | CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH 8-(2-(2-(2,4-DIOXO-3,4-DIHYDROPYRIMIDIN-1(2H)-YL)ETHOXY)PHENOXY)INDOLIZINE-2-CARBONITRILE (JLJ555), A NON-NUCLEOSIDE INHIBITOR | 2.7.7.49 3.4.23.16 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1 |
4MG3 | CRYSTAL STRUCTURAL ANALYSIS OF 2A PROTEASE FROM COXSACKIEVIRUS A16 | 3.4.22.29 3.6.1.15 3.4.22.28 2.7.7.48 |
4MGQ | PBXYN10C CBM APO | 3.2.1.8 |
4MH8 | THE CRYSTAL STRUCTURE OF THE MONOMERIC REVERSE TRANSCRIPTASE FROM MOLONEY MURINE LEUKEMIA VIRUS | 2.7.7.49 2.7.7.7 3.1.26.4 3.4.23 2.7.7 3.1 |
4MHX | CRYSTAL STRUCTURE OF SULFAMIDASE | 3.10.1.1 |
4MIA | HEPATITIS C VIRUS POLYMERASE NS5B GENOTYPE 1B (BK) IN COMPLEX WITH RG7109 (N-{4-[6-TERT-BUTYL-5-METHOXY-8-(6-METHOXY-2-OXO-2,5-DIHYDROPYRIDIN-3-YL)QUINOLIN-3-YL]PHENYL}METHANESULFONAMIDE) | 2.7.7.48 3.4.22 3.4.21.98 3.6.1.15 3.6.4.13 |
4MIB | HEPATITIS C VIRUS POLYMERASE NS5B GENOTYPE 1B (BK) IN COMPLEX WITH COMPOUND 48 (N-({(3S)-1-[6-TERT-BUTYL-5-METHOXY-8-(2-OXO-1,2-DIHYDROPYRIDIN-3-YL)QUINOLIN-3-YL]PYRROLIDIN-3-YL}METHYL)METHANESULFONAMIDE) | 2.7.7.48 3.4.22 3.4.21.98 3.6.1.15 3.6.4.13 |
4MIU | CRYSTAL STRUCTURE OF STAPHYLOCOCCAL NUCLEASE VARIANT DELTA+PHS V23T/V99T AT CRYOGENIC TEMPERATURE | 3.1.31.1 |
4MIW | HIGH-RESOLUTION STRUCTURE OF THE N-TERMINAL ENDONUCLEASE DOMAIN OF THE LASSA VIRUS L POLYMERASE | 2.7.7.48 3.1 |
4MIX | PATOXG GLYCOSYLTRANSFERASE | 2.4.1 3.5.1.44 |
4MJ2 | CRYSTAL STRUCTURE OF APO-IDURONIDASE IN THE R3 FORM | 3.2.1.76 |
4MJ3 | HALOALKANE DEHALOGENASE DMRA FROM MYCOBACTERIUM RHODESIAE JS60 | 3.8.1.5 |
4MJ4 | HUMAN IDURONIDASE APO STRUCTURE P21 FORM | 3.2.1.76 |
4MJN | STRUCTURE OF THE C RING OF THE CF1FO ATP SYNTHASES. | 3.6.3.14 |
4MJO | HUMAN LIVER FRUCTOSE-1,6-BISPHOSPHATASE(D-FRUCTOSE-1,6-BISPHOSPHATE, 1-PHOSPHOHYDROLASE) (E.C.3.1.3.11) COMPLEXED WITH THE ALLOSTERIC INHIBITOR 3 | 3.1.3.11 |
4MJU | INFLUENZA NEURAMINIDASE IN COMPLEX WITH A NOVEL ANTIVIRAL COMPOUND | 3.2.1.18 |
4MJV | INFLUENZA NEURAMINIDASE IN COMPLEX WITH A NOVEL ANTIVIRAL COMPOUND | 3.2.1.18 |
4MK1 | 5-BROMOPYRIDINE-2,3-DIOL BOUND TO INFLUENZA 2009 PH1N1 ENDONUCLEASE | 3.1 |
4MK2 | 3-(5-HYDROXY-6-OXO-1,6-DIHYDROPYRIDIN-3-YL)BENZONITRILE BOUND TO INFLUENZA 2009 PH1N1 ENDONUCLEASE | 3.1 |
4MK5 | 6-(3-METHOXYPHENYL)PYRIDINE-2,3-DIOL BOUND TO INFLUENZA 2009 PH1N1 ENDONUCLEASE | 3.1 |
4MK7 | HEPATITIS C VIRUS POLYMERASE NS5B GENOTYPE 1B (BK) IN COMPLEX WITH INHIBITOR 2 (3-(3-TERT-BUTYL-4-METHOXYPHENYL)PYRIDIN-2(1H)-ONE) | 2.7.7.48 3.4.22 3.4.21.98 3.6.1.15 3.6.4.13 |
4MK8 | HEPATITIS C VIRUS POLYMERASE NS5B GENOTYPE 1B (BK) IN COMPLEX WITH INHIBITOR 4 (N-(4-{2-[3-TERT-BUTYL-2-METHOXY-5-(2-OXO-1,2-DIHYDROPYRIDIN-3-YL)PHENYL]ETHYL}PHENYL)METHANESULFONAMIDE) | 2.7.7.48 3.4.22 3.4.21.98 3.6.1.15 3.6.4.13 |
4MK9 | HEPATITIS C VIRUS POLYMERASE NS5B GENOTYPE 1B (BK) IN COMPLEX WITH INHIBITOR 12 (N-{2-[3-TERT-BUTYL-2-METHOXY-5-(2-OXO-1,2-DIHYDROPYRIDIN-3-YL)PHENYL]-1,3-BENZOXAZOL-5-YL}METHANESULFONAMIDE) | 2.7.7.48 3.4.22 3.4.21.98 3.6.1.15 3.6.4.13 |
4MKA | HEPATITIS C VIRUS POLYMERASE NS5B GENOTYPE 1B (BK) IN COMPLEX WITH INHIBITOR 13 (N-{2-[3-TERT-BUTYL-2-METHOXY-5-(2-OXO-1,2-DIHYDROPYRIDIN-3-YL)PHENYL]-1,3-BENZOXAZOL-5-YL}METHANESULFONAMIDE) | 2.7.7.48 3.4.22 3.4.21.98 3.6.1.15 3.6.4.13 |
4MKB | HEPATITIS C VIRUS POLYMERASE NS5B GENOTYPE 1B (BK) IN COMPLEX WITH INHIBITOR 14 (N-(4-{(E)-2-[3-TERT-BUTYL-2-METHOXY-5-(3-OXO-2,3-DIHYDROPYRIDAZIN-4-YL)PHENYL]ETHENYL}PHENYL)METHANESULFONAMIDE) | 2.7.7.48 3.4.22 3.4.21.98 3.6.1.15 3.6.4.13 |
4MKI | COBALT TRANSPORTER ATP-BINDING SUBUNIT | 3.6.3 |
4MKT | HUMAN LEUKOTRIENE A4 HYDROLASE IN COMPLEX WITH PRO-GLY-PRO ANALOGUE AND 4-(4-BENZYLPHENYL)THIAZOL-2-AMINE | 3.3.2.6 3.4.11.4 |
4ML2 | CRYSTAL STRUCTURE OF WILD-TYPE YAFQ | 3.1 |
4ML7 | CRYSTAL STRUCTURE OF BRUCELLA ABORTUS PLIC IN COMPLEX WITH HUMAN LYSOZYME | 3.2.1.17 |
4MLF | CRYSTAL STRUCTURE FOR THE COMPLEX OF THROMBIN MUTANT D102N AND HIRUDIN | 3.4.21.5 |
4MLL | THE 1.4 A STRUCTURE OF THE CLASS D BETA-LACTAMASE OXA-1 K70D COMPLEXED WITH OXACILLIN | 3.5.2.6 |
4MMG | CRYSTAL STRUCTURE OF YAFQ MUTANT H87Q FROM E.COLI | 3.1 |
4MMJ | CRYSTAL STRUCTURE OF YAFQ FROM E.COLI STRAIN BL21(DE3) | 3.1 |
4MNJ | CRYSTAL STRUCTURE OF GH18 CHITINASE FROM CYCAD, CYCAS REVOLUTA | 3.2.1.14 |
4MNK | CRYSTAL STRUCTURE OF GH18 CHITINASE FROM CYCAS REVOLUTA IN COMPLEX WITH (GLCNAC)3 | 3.2.1.14 |
4MNL | CRYSTAL STRUCTURE OF GH18 CHITINASE (G77W/E119Q MUTANT) FROM CYCAS REVOLUTA IN COMPLEX WITH (GLCNAC)4 | 3.2.1.14 |
4MNM | CRYSTAL STRUCTURE OF GH18 CHITINASE (G77W/E119Q MUTANT) FROM CYCAS REVOLUTA IN COMPLEX WITH (GLCNAC)4 | 3.2.1.14 |
4MNT | CRYSTAL STRUCTURE OF HUMAN DJ-1 IN COMPLEX WITH CU | 3.4 3.1.2 3.5.1 3.5.1.124 |
4MNV | CRYSTAL STRUCTURE OF BICYCLIC PEPTIDE UK729 BOUND AS AN ACYL-ENZYME INTERMEDIATE TO UROKINASE-TYPE PLASMINOGEN ACTIVATOR (UPA) | 3.4.21.73 |
4MNW | CRYSTAL STRUCTURE OF UROKINASE-TYPE PLASMINOGEN ACTIVATOR (UPA) COMPLEXED WITH BICYCLIC PEPTIDE UK749 | 3.4.21.73 |
4MNX | CRYSTAL STRUCTURE OF UROKINASE-TYPE PLASMINOGEN ACTIVATOR (UPA) COMPLEXED WITH BICYCLIC PEPTIDE UK811 | 3.4.21.73 |
4MNY | CRYSTAL STRUCTURE OF UROKINASE-TYPE PLASMINOGEN ACTIVATOR (UPA) COMPLEXED WITH BICYCLIC PEPTIDE UK903 | 3.4.21.73 |
4MOB | ACYL-COENZYME A THIOESTERASE 12 IN COMPLEX WITH ADP | 3.1.2.1 |
4MOC | HUMAN ACYL-COENZYME A THIOESTERASE 12 | 3.1.2.1 |
4MOV | 1.45 A RESOLUTION CRYSTAL STRUCTURE OF PROTEIN PHOSPHATASE 1 | 3.1.3.16 |
4MOY | STRUCTURE OF A SECOND NUCLEAR PP1 HOLOENZYME, CRYSTAL FORM 1 | 3.1.3.16 |
4MP0 | STRUCTURE OF A SECOND NUCLEAR PP1 HOLOENZYME, CRYSTAL FORM 2 | 3.1.3.16 |
4MPQ | CRYSTAL STRUCTURE OF1-PYRROLINE-4-HYDROXY-2-CARBOXYLATE DEAMINASE FROM BRUCELLA MELITENSIS ATCC 23457 | 3.5.4.22 |
4MPU | HUMAN BETA-TRYPTASE CO-CRYSTAL STRUCTURE WITH (6S,8R)-N,N'-BIS[3-({4-[3-(AMINOMETHYL)PHENYL]PIPERIDIN-1-YL}CARBONYL)PHENYL]-8-HYDROXY-6-(1-HYDROXYCYCLOBUTYL)-5,7-DIOXASPIRO[3.4]OCTANE-6,8-DICARBOXAMIDE | 3.4.21.59 |
4MPV | HUMAN BETA-TRYPTASE CO-CRYSTAL STRUCTURE WITH (2R,4S)-N,N'-BIS[3-({4-[3-(AMINOMETHYL)PHENYL]PIPERIDIN-1-YL}CARBONYL)PHENYL]-4-HYDROXY-2-(2-HYDROXYPROPAN-2-YL)-5,5-DIMETHYL-1,3-DIOXOLANE-2,4-DICARBOXAMIDE | 3.4.21.59 |
4MPW | HUMAN BETA-TRYPTASE CO-CRYSTAL STRUCTURE WITH [(1,1,3,3-TETRAMETHYLDISILOXANE-1,3-DIYL)DI-1-BENZOFURAN-3,5-DIYL]BIS({4-[3-(AMINOMETHYL)PHENYL]PIPERIDIN-1-YL}METHANONE) | 3.4.21.59 |
4MPX | HUMAN BETA-TRYPTASE CO-CRYSTAL STRUCTURE WITH [(1,1,3,3-TETRAMETHYLDISILOXANE-1,3-DIYL)DI-1-BENZOTHIENE-4,2-DIYL]BIS({4-[3-(AMINOMETHYL)PHENYL]PIPERIDIN-1-YL}METHANONE) | 3.4.21.59 |
4MQ3 | THE 1.1 ANGSTROM STRUCTURE OF CATALYTIC CORE DOMAIN OF FIV INTEGRASE | 3.4.23 2.7.7.49 3.1.26.13 3.1.13.2 3.6.1.23 2.7.7 3.1 |
4MQA | HUMAN BETA-TRYPTASE CO-CRYSTAL STRUCTURE WITH {(1,1,3,3-TETRAMETHYLDISILOXANE-1,3-DIYL)BIS[5-(METHYLSULFANYL)BENZENE-3,1-DIYL]}BIS({4-[3-(AMINOMETHYL)PHENYL]PIPERIDIN-1-YL}METHANONE) | 3.4.21.59 |
4MQY | CRYSTAL STRUCTURE OF THE ESCHERICHIA COLI LPXC/LPC-138 COMPLEX | 3.5.1 3.5.1.108 |
4MR1 | X-RAY STRUCTURE OF THE ADDUCT BETWEEN HEN EGG WHITE LYSOZYME AND CIS-DIAMMINEDIIODOPLATINUM(II) | 3.2.1.17 |
4MRI | HUMAN BRAIN ASPARTOACYLASE MUTANT F295S COMPLEX WITH INTERMEDIATE ANALOG (N-PHOSPHONOMETHYL-L-ASPARTATE) | 3.5.1.15 |
4MRW | CRYSTAL STRUCTURE OF PDE10A2 WITH FRAGMENT ZT0120 (7-CHLOROQUINOLIN-4-OL) | 3.1.4.17 3.1.4.35 |
4MRZ | CRYSTAL STRUCTURE OF PDE10A2 WITH FRAGMENT ZT0429 (4-METHYL-3-NITROPYRIDIN-2-AMINE) | 3.1.4.17 3.1.4.35 |
4MS0 | CRYSTAL STRUCTURE OF PDE10A2 WITH FRAGMENT ZT0443 (6-CHLOROPYRIMIDINE-2,4-DIAMINE) | 3.1.4.17 3.1.4.35 |
4MS6 | HUMAN LEUKOTRIENE A4 HYDROLASE IN COMPLEX WITH PRO-GLY-PRO ANALOGUE | 3.3.2.6 3.4.11.4 |
4MS7 | CRYSTAL STRUCTURE OF SCHIZOSACCHAROMYCES POMBE SST2 CATALYTIC DOMAIN | 3.4.19 |
4MSA | CRYSTAL STRUCTURE OF PDE10A2 WITH FRAGMENT ZT0449 (5-NITRO-1H-BENZIMIDAZOLE) | 3.1.4.17 3.1.4.35 |
4MSC | CRYSTAL STRUCTURE OF PDE10A2 WITH FRAGMENT ZT1595 (2-[(QUINOLIN-7-YLOXY)METHYL]QUINOLINE) | 3.1.4.17 3.1.4.35 |
4MSD | CRYSTAL STRUCTURE OF SCHIZOSACCHAROMYCES POMBE AMSH-LIKE PROTEIN SST2 T319I MUTANT | 3.4.19 |
4MSE | CRYSTAL STRUCTURE OF PDE10A2 WITH FRAGMENT ZT1597 (2-({[(2S)-2-METHYL-2,3-DIHYDRO-1,3-BENZOTHIAZOL-5-YL]OXY}METHYL)QUINOLINE) | 3.1.4.17 3.1.4.35 |
4MSH | CRYSTAL STRUCTURE OF PDE10A2 WITH FRAGMENT ZT0143 ((2S)-4-CHLORO-2,3-DIHYDRO-1,3-BENZOTHIAZOL-2-AMINE) | 3.1.4.17 3.1.4.35 |
4MSJ | CRYSTAL STRUCTURE OF S. POMBE AMSH-LIKE PROTEASE SST2 CATALYTIC DOMAIN FROM P212121 SPACE GROUP | 3.4.19 |
4MSM | CRYSTAL STRUCTURE OF SCHIZOSACCHAROMYCES POMBE AMSH-LIKE PROTEASE SST2 E286A MUTANT BOUND TO UBIQUITIN | 3.4.19 |
4MSN | CRYSTAL STRUCTURE OF PDE10A2 WITH FRAGMENT ZT0451 (8-NITROQUINOLINE) | 3.1.4.17 3.1.4.35 |
4MSQ | CRYSTAL STRUCTURE OF SCHIZOSACCHAROMYCES POMBE AMSH-LIKE PROTEASE SST2 CATALYTIC DOMAIN BOUND TO UBIQUITIN | 3.4.19 |
4MSS | CRYSTAL STRUCTURE OF BURKHOLDERIA CENOCEPACIA FAMILY 3 GLYCOSIDE HYDROLASE (NAGZ) BOUND TO (3S,4R,5R,6S)-3-ACETAMIDO-4,5,6-TRIHYDROXYAZEPANE | 3.2.1.52 |
4MST | CRYSTAL STRUCTURE OF A PUTATIVE CATALYTIC DOMAIN OF A CHITINASE-LIKE PROTEIN (HBCLP1) FROM HEVEA BRASILIENSIS | 3.2.1.14 |
4MTB | BOVINE TRYPSIN IN COMPLEX WITH SMALL MOLECULE INHIBITOR | 3.4.21.4 |
4MTC | CRYSTAL STRUCTURE OF HUMAN C53A DJ-1 | 3.4 3.1.2 3.5.1 3.5.1.124 |
4MTW | THERMOLYSIN IN COMPLEX WITH UBTLN36 | 3.4.24.27 |
4MUM | CRYSTAL STRUCTURE OF MITOCHONDRIAL 5'(3')-DEOXY RIBONUCLEOTIDASE ALTERNATIVE SPLICED VARIANT | 3.1.3 |
4MUW | CRYSTAL STRUCTURE OF PDE10A WITH NOVEL KETO-BENZIMIDAZOLE INHIBITOR | 3.1.4.17 3.1.4.35 |
4MVH | CRYSTAL STRUCTURE OF PDE10A WITH NOVEL KETO-BENZIMIDAZOLE INHIBITOR | 3.1.4.17 3.1.4.35 |
4MVN | CRYSTAL STRUCTURE OF THE STAPHYLOCOCCAL SERINE PROTEASE SPLA IN COMPLEX WITH A SPECIFIC PHOSPHONATE INHIBITOR | 3.4.21 |
4MWJ | ANHUI N9 | 3.2.1.18 |
4MWL | SHANGHAI N9 | 3.2.1.18 |
4MWO | CRYSTAL STRUCTURE OF HUMAN MITOCHONDRIAL 5'(3')-DEOXYRIBONUCLEOTIDASE IN COMPLEX WITH THE INHIBITOR CPB-T | 3.1.3 |
4MWP | THERMOLYSIN IN COMPLEX WITH UBTLN46 | 3.4.24.27 |
4MWQ | ANHUI N9-OSELTAMIVIR CARBOXYLATE | 3.2.1.18 |
4MWR | ANHUI N9-ZANAMIVIR | 3.2.1.18 |
4MWS | CRYSTAL STRUCTURE OF HUMAN PPCA (TRIGONAL CRYSTAL FORM 1) | 3.4.16.5 |
4MWT | CRYSTAL STRUCTURE OF HUMAN PPCA (TRIGONAL CRYSTAL FORM 2) | 3.4.16.5 |
4MWU | ANHUI N9-LANINAMIVIR | 3.2.1.18 |
4MWV | ANHUI N9-PERAMIVIR | 3.2.1.18 |
4MWW | SHANGHAI N9-OSELTAMIVIR CARBOXYLATE | 3.2.1.18 |
4MWX | SHANGHAI N9-ZANAMIVIR | 3.2.1.18 |
4MWY | SHANGHAI N9-LANINAMIVIR | 3.2.1.18 |
4MX0 | SHANGHAI N9-PERAMIVIR | 3.2.1.18 |
4MX1 | STRUCTURE OF RICIN A CHAIN BOUND WITH 2-AMINO-4-OXO-N-(2-(3-PHENYLUREIDO)ETHYL)-3,4-DIHYDROPTERIDINE-7-CARBOXAMIDE | 3.2.2.22 |
4MX5 | STRUCTURE OF RICIN A CHAIN BOUND WITH BENZYL-(2-(2-AMINO-4-OXO-3,4-DIHYDROPTERIDINE-7-CARBOXAMIDO)ETHYL)CARBAMATE | 3.2.2.22 |
4MXF | X-RAY STRUCTURE OF THE ADDUCT BETWEEN BOVINE PANCREATIC RIBONUCLEASE AND AUOXO6, A DINUCLEAR GOLD(III) COMPLEX WITH -DIOXO BRIDGES LINKING THE TWO METAL CENTERS | 3.1.27.5 4.6.1.18 |
4MXI | CLPP SER98DHA | 3.4.21.92 |
4MXJ | THERMOLYSIN IN COMPLEX WITH UBTLN35 | 3.4.24.27 |
4MXR | CRYSTAL STRUCTURE OF TRYPANOSOMA CRUZI FORMIMINOGLUTAMASE WITH MN2+2 | 3.5.3.8 |
4MXU | HUMAN BRAIN ASPARTOACYLASE MUTANT K213E COMPLEX WITH INTERMEDIATE ANALOG (N-PHOSPHONOMETHYL-L-ASPARTATE) | 3.5.1.15 |
4MYF | CRYSTAL STRUCTURE OF TRYPANOSOMA CRUZI FORMIMINOGLUTAMASE(OXIDIZED) WITH MN2+2 AT PH 6.0 | 3.5.3.8 |
4MYK | CRYSTAL STRUCTURE OF TRYPANOSOMA CRUZI FORMIMINOGLUTAMASE (OXIDIZED) WITH MN2+2 AT PH 8.5 | 3.5.3.8 |
4MYL | CRYSTAL STRUCTURE OF TRYPANOSOMA CRUZI FORMIMINOGLUTAMASE (OXIDIZED) AT PH 4.6 | 3.5.3.8 |
4MYN | CRYSTAL STRUCTURE OF TRYPANOSOMA CRUZI FORMIMINOGLUTAMASE N114H VARIANT WITH MN2+2 | 3.5.3.8 |
4MYQ | SELECTIVE INHIBITION OF THE CATALYTIC DOMAIN OF HUMAN PHOSPHODIESTERASE 4B WITH A-33 | 3.1.4.17 3.1.4.53 |
4MZ4 | DISCOVERY OF AN IRREVERSIBLE HCV NS5B POLYMERASE INHIBITOR | 2.7.7.48 3.4.22 3.4.21.98 3.6.1.15 3.6.4.13 |
4MZ5 | STRUCTURE OF IMPORTIN-ALPHA: DUTPASE NLS COMPLEX | 3.6.1.23 |
4MZ6 | STRUCTURE OF IMPORTIN-ALPHA: DUTPASE S11E NLS MUTANT COMPLEX | 3.6.1.23 |
4MZ7 | STRUCTURAL INSIGHT INTO DGTP-DEPENDENT ACTIVATION OF TETRAMERIC SAMHD1 DEOXYNUCLEOSIDE TRIPHOSPHATE TRIPHOSPHOHYDROLASE | 3.1.5 |
4MZA | CRYSTAL STRUCTURE OF HPIV3 HEMAGGLUTININ-NEURAMINIDASE | 3.2.1.18 |
4MZD | HIGH RESOLUTION CRYSTAL STRUCTURE OF THE NISIN LEADER PEPTIDASE NISP FROM LACTOCOCCUS LACTIS | 3.4.21 |
4MZE | CRYSTAL STRUCTURE OF HPIV3 HEMAGGLUTININ-NEURAMINIDASE, H552Q/Q559R MUTANT | 3.2.1.18 |
4MZM | MAZF FROM S. AUREUS CRYSTAL FORM I, P212121, 2.1 A | 3.1 |
4MZN | THERMOLYSIN IN COMPLEX WITH UBTLN59 | 3.4.24.27 |
4MZP | MAZF FROM S. AUREUS CRYSTAL FORM III, C2221, 2.7 A | 3.1 |
4MZS | MOUSE CATHEPSIN S WITH COVALENT LIGAND (3S,4S)-1-[(2-CHLOROPHENYL)SULFONYL]-N-[(2E)-2-IMINOETHYL]-4-(MORPHOLIN-4-YLCARBONYL)PYRROLIDINE-3-CARBOXAMIDE | 3.4.22.27 |
4MZT | MAZF FROM S. AUREUS CRYSTAL FORM II, C2221, 2.3 A | 3.1 |
4N00 | DISCOVERY OF 7-THP CHROMANS: BACE1 INHIBITORS THAT REDUCE A-BETA IN THE CNS | 3.4.23.46 |
4N06 | CRYSTAL STRUCTURE OF CAS1 FROM ARCHAEOGLOBUS FULGIDUS AND ITS NUCLEOLYTIC ACTIVITY | 3.1 |
4N0D | CRYSTAL STRUCTURE OF THE K345L VARIANT OF THE GI ALPHA1 SUBUNIT BOUND TO GTPGAMMAS | 3.6.5.1 |
4N0E | CRYSTAL STRUCTURE OF THE K345L VARIANT OF THE GI ALPHA1 SUBUNIT BOUND TO GDP | 3.6.5.1 |
4N0G | CRYSTAL STRUCTURE OF PYL13-PP2CA COMPLEX | 3.1.3.16 |
4N0J | CRYSTAL STRUCTURE OF DIMETHYLLYSINE HEN EGG-WHITE LYSOZYME IN COMPLEX WITH SCLX4 AT 1.9 A RESOLUTION | 3.2.1.17 |
4N0M | CRYSTAL STRUCTURE OF HUMAN C53A DJ-1 IN COMPLEX WITH CU | 3.4 3.1.2 3.5.1 3.5.1.124 |
4N0N | CRYSTAL STRUCTURE OF ARTERIVIRUS NONSTRUCTURAL PROTEIN 10 (HELICASE) | 3.4.22 3.4.19.12 3.4.21 2.7.7.48 3.6.4.12 3.6.4.13 |
4N0O | COMPLEX STRUCTURE OF ARTERIVIRUS NONSTRUCTURAL PROTEIN 10 (HELICASE) WITH DNA | 3.4.22 3.4.19.12 3.4.21 2.7.7.48 3.6.4.12 3.6.4.13 |
4N0Y | STRUCTURE OF THE HEPATITIS C ENVELOPE GLYCOPROTEIN E1 ANTIGENIC REGION 314-324 BOUND TO THE CROSS-NEUTRALIZING ANTIBODY IGH526 | 3.4.22 3.4.21.98 3.6.1.15 3.6.4.13 2.7.7.48 |
4N12 | CRYSTAL STRUCTURE OF HUMAN E18D DJ-1 IN COMPLEX WITH CU | 3.4 3.1.2 3.5.1 3.5.1.124 |
4N1H | STRUCTURE OF A SINGLE-DOMAIN CAMELID ANTIBODY FRAGMENT CAB-F11N IN COMPLEX WITH THE BLAP BETA-LACTAMASE FROM BACILLUS LICHENIFORMIS | 3.5.2.6 |
4N1I | CRYSTAL STRUCTURE OF THE ALPHA-L-ARABINOFURANOSIDASE UMABF62A FROM USTILAGO MAIDYS | 3.2.1.55 |
4N1T | STRUCTURE OF HUMAN MTH1 IN COMPLEX WITH TH287 | 3.6.1.55 3.6.1.56 |
4N1U | STRUCTURE OF HUMAN MTH1 IN COMPLEX WITH TH588 | 3.6.1.55 3.6.1.56 |
4N20 | CRYSTAL STRUCTURE OF PROTEIN ARGININE DEIMINASE 2 (0 MM CA2+) | 3.5.3.15 |
4N22 | CRYSTAL STRUCTURE OF PROTEIN ARGININE DEIMINASE 2 (50 UM CA2+) | 3.5.3.15 |
4N24 | CRYSTAL STRUCTURE OF PROTEIN ARGININE DEIMINASE 2 (100 UM CA2+) | 3.5.3.15 |
4N25 | CRYSTAL STRUCTURE OF PROTEIN ARGININE DEIMINASE 2 (250 UM CA2+) | 3.5.3.15 |
4N26 | CRYSTAL STRUCTURE OF PROTEIN ARGININE DEIMINASE 2 (500 UM CA2+) | 3.5.3.15 |
4N28 | CRYSTAL STRUCTURE OF PROTEIN ARGININE DEIMINASE 2 (1 MM CA2+) | 3.5.3.15 |
4N2A | CRYSTAL STRUCTURE OF PROTEIN ARGININE DEIMINASE 2 (5 MM CA2+) | 3.5.3.15 |
4N2B | CRYSTAL STRUCTURE OF PROTEIN ARGININE DEIMINASE 2 (10 MM CA2+) | 3.5.3.15 |
4N2C | CRYSTAL STRUCTURE OF PROTEIN ARGININE DEIMINASE 2 (F221/222A, 10 MM CA2+) | 3.5.3.15 |
4N2D | CRYSTAL STRUCTURE OF PROTEIN ARGININE DEIMINASE 2 (D123N, 0 MM CA2+) | 3.5.3.15 |
4N2E | CRYSTAL STRUCTURE OF PROTEIN ARGININE DEIMINASE 2 (D123N, 10 MM CA2+) | 3.5.3.15 |
4N2F | CRYSTAL STRUCTURE OF PROTEIN ARGININE DEIMINASE 2 (D169A, 0 MM CA2+) | 3.5.3.15 |
4N2G | CRYSTAL STRUCTURE OF PROTEIN ARGININE DEIMINASE 2 (D169A, 10 MM CA2+) | 3.5.3.15 |
4N2H | CRYSTAL STRUCTURE OF PROTEIN ARGININE DEIMINASE 2 (D177A, 0 MM CA2+) | 3.5.3.15 |
4N2I | CRYSTAL STRUCTURE OF PROTEIN ARGININE DEIMINASE 2 (D177A, 10 MM CA2+) | 3.5.3.15 |
4N2K | CRYSTAL STRUCTURE OF PROTEIN ARGININE DEIMINASE 2 (Q350A, 0 MM CA2+) | 3.5.3.15 |
4N2L | CRYSTAL STRUCTURE OF PROTEIN ARGININE DEIMINASE 2 (Q350A, 10 MM CA2+) | 3.5.3.15 |
4N2M | CRYSTAL STRUCTURE OF PROTEIN ARGININE DEIMINASE 2 (E354A, 0 MM CA2+) | 3.5.3.15 |
4N2N | CRYSTAL STRUCTURE OF PROTEIN ARGININE DEIMINASE 2 (E354A, 10 MM CA2+) | 3.5.3.15 |
4N2R | CRYSTAL STRUCTURE OF THE ALPHA-L-ARABINOFURANOSIDASE UMABF62A FROM USTILAGO MAYDIS IN COMPLEX WITH L-ARABINOFURANOSE | 3.2.1.55 |
4N2X | CRYSTAL STRUCTURE OF DL-2-HALOACID DEHALOGENASE | 3.8.1.10 |
4N2Z | CRYSTAL STRUCTURE OF THE ALPHA-L-ARABINOFURANOSIDASE PAABF62A FROM PODOSPORA ANSERINA IN COMPLEX WITH CELLOTRIOSE | 3.2.1.55 |
4N31 | STRUCTURE AND ACTIVITY OF STREPTOCOCCUS PYOGENES SIPA: A SIGNAL PEPTIDASE HOMOLOGUE ESSENTIAL FOR PILUS POLYMERISATION | 3.4.21.89 |
4N3G | CRYSTAL STRUCTURE OF EUKARYOTIC TRANSLATION INITIATION FACTOR EIF5B (870-1116) FROM CHAETOMIUM THERMOPHILUM, DOMAINS III AND IV | 3.6.5.3 |
4N3N | CRYSTAL STRUCTURE OF EUKARYOTIC TRANSLATION INITIATION FACTOR EIF5B (517-1116) FROM CHAETOMIUM THERMOPHILUM, APO FORM | 3.6.5.3 |
4N3S | CRYSTAL STRUCTURE OF EUKARYOTIC TRANSLATION INITIATION FACTOR EIF5B (399-852) FROM SACCHAROMYCES CEREVISIAE, APO FORM | 3.6.5.3 |
4N43 | HUMAN ENTEROVIRUS 71 UNCOATING INTERMEDIATE CAPTURED AT ATOMIC RESOLUTION | 3.4.22.29 3.6.1.15 3.4.22.28 2.7.7.48 |
4N4B | CRYSTAL STRUCTURE OF THE ALPHA-L-ARABINOFURANOSIDASE PAABF62A FROM PODOSPORA ANSERINA | 3.2.1.55 |
4N4C | CRYSTAL STRUCTURE OF THE C-TERMINAL SWAPPED DIMER OF A BOVINE SEMINAL RIBONUCLEASE MUTANT | 3.1.27.5 4.6.1.18 |
4N4E | THERMOLYSIN IN COMPLEX WITH UBTLN58 | 3.4.24.27 |
4N4Z | TRYPANOSOMA BRUCEI PROCATHEPSIN B STRUCTURE SOLVED BY SERIAL MICROCRYSTALLOGRAPHY USING SYNCHROTRON RADIATION | 3.4.22 |
4N5D | TAILORING SMALL MOLECULES FOR AN ALLOSTERIC SITE ON PROCASPASE-6: CPD1 | 3.4.22.59 |
4N5P | THERMOLYSIN IN COMPLEX WITH UBTLN20 | 3.4.24.27 |
4N5R | HEN EGG-WHITE LYSOZYME PHASED USING FREE-ELECTRON LASER DATA | 3.2.1.17 |
4N5U | CRYSTAL STRUCTURE OF THE 4TH FN3 DOMAIN OF HUMAN PROTEIN TYROSINE PHOSPHATASE, RECEPTOR TYPE F [PSI-NYSGRC-006240] | 3.1.3.48 |
4N66 | THERMOLYSIN IN COMPLEX WITH UBTLN37 | 3.4.24.27 |
4N6G | TAILORING SMALL MOLECULES FOR AN ALLOSTERIC SITE ON PROCASPASE-6 | 3.4.22.59 |
4N6N | CRYSTAL STRUCTURE OF OXIDIZED LEGUMAIN IN COMPLEX WITH CYSTATIN E/M | 3.4.22.34 |
4N6O | CRYSTAL STRUCTURE OF REDUCED LEGUMAIN IN COMPLEX WITH CYSTATIN E/M | 3.4.22.34 |
4N6P | CRYSTAL STRUCTURE OF C-LOBE OF BOVINE LACTOFERRIN COMPLEXED WITH MECLOFENAMIC ACID AT 1.4 A RESOLUTION | 3.4.21 |
4N79 | STRUCTURE OF CATHEPSIN K-DERMATAN SULFATE COMPLEX | 3.4.22.38 |
4N7J | TAILORING SMALL MOLECULES FOR AN ALLOSTERIC SITE ON PROCASPASE-6 | 3.4.22.59 |
4N7M | TAILORING SMALL MOLECULES FOR AN ALLOSTERIC SITE ON PROCASPASE-6 | 3.4.22.59 |
4N7S | CRYSTAL STRUCTURE OF TSE3-TSI3 COMPLEX WITH ZINC ION | 3.2.1.17 |
4N80 | CRYSTAL STRUCTURE OF TSE3-TSI3 COMPLEX | 3.2.1.17 |
4N81 | ANOTHER FLEXIBLE REGION AT THE ACTIVE SITE OF AN INOSITOL MONOPHOSPHATASE FROM ZYMOMONAS MOBILIS | 3.1.3.25 |
4N88 | CRYSTAL STRUCTURE OF TSE3-TSI3 COMPLEX WITH CALCIUM ION | 3.2.1.17 |
4N8D | DPP4 COMPLEXED WITH SYN-7AA | 3.4.14.5 |
4N8E | DPP4 COMPLEXED WITH COMPOUND 12A | 3.4.14.5 |
4N8S | CRYSTAL STRUCTURE OF THE TERNARY COMPLEX OF LIPASE FROM THERMOMYCES LANUGINOSA WITH ETHYLACETOACETATE AND P-NITROBENZALDEHYDE AT 2.3 A RESOLUTION | 3.1.1.3 |
4N8W | CATHEPSIN K - CHONDROITIN SULFATE COMPLEX | 3.4.22.38 |
4N8Z | IN SITU LYSOZYME CRYSTALLIZED ON A MITEGEN MICROMESH WITH BENZAMIDINE LIGAND | 3.2.1.17 |
4N92 | CRYSTAL STRUCTURE OF BETA-LACTAMSE PENP_E166S | 3.5.2.6 |
4N9K | CRYSTAL STRUCTURE OF BETA-LACTAMSE PENP_E166S IN COMPLEX WITH CEPHALORIDINE | 3.5.2.6 |
4N9L | CRYSTAL STRUCTURE OF BETA-LACTAMSE PENP_E166S IN COMPLEX WITH MEROPENEM | 3.5.2.6 |
4N9N | CRYSTAL STRUCTURE OF SACCHAROMYCES CEREVISIAE UPC2 TRANSCRIPTION FACTOR FUSED WITH T4 LYSOZYME | 3.2.1.17 |
4N9P | CRYSTAL STRUCTURE OF STAPHYLOCOCCAL NUCLEASE VARIANT DELTA+PHS V23T/L25A/V99T AT CRYOGENIC TEMPERATURE | 3.1.31.1 |
4N9R | X-RAY STRUCTURE OF THE COMPLEX BETWEEN HEN EGG WHITE LYSOZYME AND PENTACHOLROCARBONYLIRIDATE(III) (1 DAY) | 3.2.1.17 |
4N9T | CRYSTAL STRUCTURE OF STAPHYLOCOCCAL NUCLEASE VARIANT DELTA+PHS V66A/I92S AT CRYOGENIC TEMPERATURE | 3.1.31.1 |
4N9Y | CRYSTAL STRUCTURE OF MOUSE POLY(ADP-RIBOSE) GLYCOHYDROLASE (PARG) CATALYTIC DOMAIN MUTANT E748Q | 3.2.1.143 |
4NA0 | CRYSTAL STRUCTURE OF MOUSE POLY(ADP-RIBOSE) GLYCOHYDROLASE (PARG) CATALYTIC DOMAIN WITH ADPRIBOSE | 3.2.1.143 |
4NA4 | CRYSTAL STRUCTURE OF MOUSE POLY(ADP-RIBOSE) GLYCOHYDROLASE (PARG) CATALYTIC DOMAIN WITH ADP-HPD | 3.2.1.143 |
4NA5 | CRYSTAL STRUCTURE OF MOUSE POLY(ADP-RIBOSE) GLYCOHYDROLASE (PARG) CATALYTIC DOMAIN MUTANT E748N | 3.2.1.143 |
4NA6 | CRYSTAL STRUCTURE OF MOUSE POLY(ADP-RIBOSE) GLYCOHYDROLASE (PARG) CATALYTIC DOMAIN MUTANT E749N | 3.2.1.143 |
4NA7 | FACTOR XIA IN COMPLEX WITH THE INHIBITOR 3'-[(2S,4R)-6-CARBAMIMIDOYL-4-METHYL-4-PHENYL-1,2,3,4-TETRAHYDROQUINOLIN-2-YL]-4-CARBAMOYL-5'-[(3-METHYLBUTANOYL)AMINO]BIPHENYL-2-CARBOXYLIC ACID | 3.4.21.27 |
4NA8 | FACTOR XIA IN COMPLEX WITH THE INHIBITOR 5-AMINOCARBONYL-2-[3-[(2S,4R)-6-CARBAMIMIDOYL-4-METHYL-4-PHENYL-2,3-DIHYDRO-1H-QUINOLIN-2-YL]PHENYL]BENZOIC ACID | 3.4.21.27 |
4NA9 | FACTOR VIIA IN COMPLEX WITH THE INHIBITOR 3'-AMINO-5'-[(2S,4R)-6-CARBAMIMIDOYL-4-PHENYL-1,2,3,4-TETRAHYDROQUINOLIN-2-YL]BIPHENYL-2-CARBOXYLIC ACID | 3.4.21.21 |
4NAB | STRUCTURE OF THE (SR)CA2+-ATPASE MUTANT E309Q IN THE CA2-E1-MGAMPPCP FORM | 3.6.3.8 7.2.2.10 |
4NAQ | CRYSTAL STRUCTURE OF PORCINE AMINOPEPTIDASE-N COMPLEXED WITH POLY-ALANINE | 3.4.11.2 |
4NAV | CRYSTAL STRUCTURE OF HYPOTHETICAL PROTEIN XCC2798 FROM XANTHOMONAS CAMPESTRIS, TARGET EFI-508608 | 3.1.3.45 |
4NBI | D-AMINOACYL-TRNA DEACYLASE (DTD) FROM PLASMODIUM FALCIPARUM IN COMPLEX WITH D-TYROSYL-3'-AMINOADENOSINE AT 1.86 ANGSTROM RESOLUTION | 3.1 3.1.1.96 |
4NBJ | D-AMINOACYL-TRNA DEACYLASE (DTD) FROM PLASMODIUM FALCIPARUM IN COMPLEX WITH D-TYROSYL-3'-AMINOADENOSINE AT 2.20 ANGSTROM RESOLUTION | 3.1 3.1.1.96 |
4NBK | TAILORING SMALL MOLECULES FOR AN ALLOSTERIC SITE ON PROCASPASE-6 | 3.4.22.59 |
4NBL | TAILORING SMALL MOLECULES FOR AN ALLOSTERIC SITE ON PROCASPASE-6 | 3.4.22.59 |
4NBN | TAILORING SMALL MOLECULES FOR AN ALLOSTERIC SITE ON PROCASPASE-6 | 3.4.22.59 |
4NBP | CRYSTAL STRUCTURE OF THE JCV LARGE T-ANTIGEN ORIGIN BINDING DOMAIN | 3.6.4 |
4NBS | THE STRUCTURE OF AIF2GAMMA SUBUNIT H20F FROM ARCHAEON SULFOLOBUS SOLFATARICUS COMPLEXED WITH GDPCP | 3.6.5.3 |
4NC2 | CRYSTAL STRUCTURE OF TCDB-B1 BOUND TO B39 VHH | 3.4.22 2.4.1 |
4NC5 | HUMAN SIALIDASE 2 IN COMPLEX WITH 2,3-DIFLUOROSIALIC ACID (COVALENT INTERMEDIATE) | 3.2.1.18 |
4NCF | CRYSTAL STRUCTURE OF EUKARYOTIC TRANSLATION INITIATION FACTOR EIF5B (399-852) FROM SACCHAROMYCES CEREVISIAE IN COMPLEX WITH GDP | 3.6.5.3 |
4NCG | DISCOVERY OF DORAVIRINE, AN ORALLY BIOAVAILABLE NON-NUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITOR POTENT AGAINST A WIDE RANGE OF RESISTANT MUTANT HIV VIRUSES | 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 3.4.23.16 2.7.7 3.1 |
4NCL | CRYSTAL STRUCTURE OF EUKARYOTIC TRANSLATION INITIATION FACTOR EIF5B (517-970) FROM CHAETOMIUM THERMOPHILUM IN COMPLEX WITH GDP | 3.6.5.3 |
4NCN | CRYSTAL STRUCTURE OF EUKARYOTIC TRANSLATION INITIATION FACTOR EIF5B (517-858) FROM CHAETOMIUM THERMOPHILUM IN COMPLEX WITH GTP | 3.6.5.3 |
4NCS | HUMAN SIALIDASE 2 IN COMPLEX WITH 2,3-DIFLUOROSIALIC ACID (COVALENT INTERMEDIATE) | 3.2.1.18 |
4NCY | IN SITU TRYPSIN CRYSTALLIZED ON A MITEGEN MICROMESH WITH IMIDAZOLE LIGAND | 3.4.21.4 |
4NDF | HUMAN APRATAXIN (APTX) BOUND TO RNA-DNA, AMP, AND ZN - PRODUCT COMPLEX | 3.6.1.71 3.6.1.72 |
4NDG | HUMAN APRATAXIN (APTX) BOUND TO RNA-DNA AND ZN - ADENOSINE VANADATE TRANSITION STATE MIMIC COMPLEX | 3.6.1.71 3.6.1.72 |
4NDH | HUMAN APRATAXIN (APTX) BOUND TO DNA, AMP, AND ZN - PRODUCT COMPLEX | 3.6.1.71 3.6.1.72 |
4NDI | HUMAN APRATAXIN (APTX) AOA1 VARIANT K197Q BOUND TO RNA-DNA, AMP, AND ZN - PRODUCT COMPLEX | 3.6.1.71 3.6.1.72 |
4NDX | CRYSTAL STRUCTURE OF STAPHYLOCOCCAL NUCLEASE VARIANT DELTA+PHS I92N AT CRYOGENIC TEMPERATURE | 3.1.31.1 |
4NE9 | PCSK9 IN COMPLEX WITH LDLR PEPTIDE | 3.4.21 |
4NEB | PREVIOUSLY DE-IONIZED HEW LYSOZYME BATCH CRYSTALLIZED IN 0.5 M MNCL2 | 3.2.1.17 |
4NED | CRYSTAL STRUCTURE OF C-LOBE OF BOVINE LACTOFERRIN COMPLEXED WITH FENOPROFEN AT 2.1 ANGSTROM RESOLUTION | 3.4.21 |
4NET | CRYSTAL STRUCTURE OF ADC-1 BETA-LACTAMASE | 3.5.2.6 |
4NF7 | CRYSTAL STRUCTURE OF THE GH5 FAMILY CATALYTIC DOMAIN OF ENDO-1,4-BETA-GLUCANASE CEL5C FROM BUTYRIVIBRIO PROTEOCLASTICUS. | 3.2.1.4 |
4NFE | HUMAN KALLIKREIN-RELATED PEPTIDASE 2 IN COMPLEX WITH BENZAMIDINE | 3.4.21.35 |
4NFF | HUMAN KALLIKREIN-RELATED PEPTIDASE 2 IN COMPLEX WITH PPACK | 3.4.21.35 |
4NFL | CRYSTAL STRUCTURE OF HUMAN MITOCHONDRIAL 5'(3')-DEOXYRIBONUCLEOTIDASE IN COMPLEX WITH THE INHIBITOR NPB-T | 3.1.3 |
4NFR | HUMAN BRAIN ASPARTOACYLASE MUTANT E285A COMPLEX WITH INTERMEDIATE ANALOG (N-PHOSPHONOMETHYL-L-ASPARTATE) | 3.5.1.15 |
4NFU | STRUCTURE OF THE CENTRAL PLANT IMMUNITY SIGNALING NODE EDS1 IN COMPLEX WITH ITS INTERACTION PARTNER SAG101 | 3 |
4NFV | PREVIOUSLY DE-IONIZED HEW LYSOZYME BATCH CRYSTALLIZED IN 1.1 M MNCL2 | 3.2.1.17 |
4NG1 | PREVIOUSLY DE-IONIZED HEW LYSOZYME BATCH CRYSTALLIZED IN 1.9 M CSCL | 3.2.1.17 |
4NG8 | DIALYZED HEW LYSOZYME BATCH CRYSTALLIZED IN 1.9 M CSCL AND COLLECTED AT 100 K. | 3.2.1.17 |
4NG9 | FACTOR VIIA IN COMPLEX WITH THE INHIBITOR (2R)-2-[(1-AMINOISOQUINOLIN-6-YL)AMINO]-2-[3-ETHOXY-4-(PROPAN-2-YLOXY)PHENYL]-N-(3-SULFAMOYLBENZYL)ETHANAMIDE | 3.4.21.21 |
4NGA | FACTOR VIIA IN COMPLEX WITH THE INHIBITOR (2R)-2-[(1-AMINOISOQUINOLIN-6-YL)AMINO]-2-[3-ETHOXY-4-(PROPAN-2-YLOXY)PHENYL]-N-[2-(PROPAN-2-YLSULFONYL)BENZYL]ETHANAMIDE | 3.4.21.21 |
4NGB | STRUCTURE OF HUMAN DICER PLATFORM-PAZ-CONNECTOR HELIX CASSETTE IN COMPLEX WITH 12-MER SIRNA HAVING UU-3' ENDS (2.25 ANGSTROM RESOLUTION) | 3.1.26 3.1.26.3 |
4NGC | STRUCTURE OF HUMAN DICER PLATFORM-PAZ-CONNECTOR HELIX CASSETTE IN COMPLEX WITH 12-MER SIRNA HAVING UA-3' ENDS (2.1 ANGSTROM RESOLUTION) | 3.1.26 3.1.26.3 |
4NGD | STRUCTURE OF HUMAN DICER PLATFORM-PAZ-CONNECTOR HELIX CASSETTE IN COMPLEX WITH 12-MER SIRNA HAVING 5'-P AND UU-3' ENDS (1.95 ANGSTROM RESOLUTION) | 3.1.26 3.1.26.3 |
4NGE | CRYSTAL STRUCTURE OF HUMAN PRESEQUENCE PROTEASE IN COMPLEX WITH AMYLOID-BETA (1-40) | 3.4.24 |
4NGG | STRUCTURE OF HUMAN DICER PLATFORM-PAZ-CONNECTOR HELIX CASSETTE IN COMPLEX WITH 13-MER SIRNA HAVING 5'-A AND UU-3' ENDS (2.6 ANGSTROM RESOLUTION) | 3.1.26 3.1.26.3 |
4NGI | PREVIOUSLY DE-IONIZED HEW LYSOZYME CRYSTALLIZED IN 1.0 M RBCL AND COLLECTED AT 125K | 3.2.1.17 |
4NGJ | DIALYZED HEW LYSOZYME BATCH CRYSTALLIZED IN 1.0 M RBCL AND COLLECTED AT 100 K | 3.2.1.17 |
4NGK | PREVIOUSLY DE-IONIZED HEW LYSOZYME BATCH CRYSTALLIZED IN 0.2 M COCL2 | 3.2.1.17 |
4NGL | PREVIOUSLY DE-IONIZED HEW LYSOZYME BATCH CRYSTALLIZED IN 0.6 M COCL2 | 3.2.1.17 |
4NGM | CRYSTAL STRUCTURE OF GLUTAMATE CARBOXYPEPTIDASE II IN A COMPLEX WITH UREA-BASED INHIBITOR | 3.4.17.21 |
4NGN | CRYSTAL STRUCTURE OF GLUTAMATE CARBOXYPEPTIDASE II IN A COMPLEX WITH UREA-BASED INHIBITOR | 3.4.17.21 |
4NGO | PREVIOUSLY DE-IONIZED HEW LYSOZYME BATCH CRYSTALLIZED IN 1.0 M COCL2 | 3.2.1.17 |
4NGP | CRYSTAL STRUCTURE OF GLUTAMATE CARBOXYPEPTIDASE II IN A COMPLEX WITH UREA-BASED INHIBITOR | 3.4.17.21 |
4NGQ | CRYSTAL STRUCTURE OF GLUTAMATE CARBOXYPEPTIDASE II IN A COMPLEX WITH UREA-BASED INHIBITOR | 3.4.17.21 |
4NGR | CRYSTAL STRUCTURE OF GLUTAMATE CARBOXYPEPTIDASE II IN A COMPLEX WITH UREA-BASED INHIBITOR | 3.4.17.21 |
4NGS | CRYSTAL STRUCTURE OF GLUTAMATE CARBOXYPEPTIDASE II IN A COMPLEX WITH UREA-BASED INHIBITOR | 3.4.17.21 |
4NGT | CRYSTAL STRUCTURE OF GLUTAMATE CARBOXYPEPTIDASE II IN A COMPLEX WITH UREA-BASED INHIBITOR | 3.4.17.21 |
4NGV | PREVIOUSLY DE-IONIZED HEW LYSOZYME BATCH CRYSTALLIZED IN 0.5 M YBCL3 | 3.2.1.17 |
4NGW | DIALYZED HEW LYSOZYME BATCH CRYSTALLIZED IN 0.5 M YBCL3 AND COLLECTED AT 100 K | 3.2.1.17 |
4NGY | DIALYZED HEW LYSOZYME BATCH CRYSTALLIZED IN 0.75 M YBCL3 AND COLLECTED AT 100 K | 3.2.1.17 |
4NGZ | PREVIOUSLY DE-IONIZED HEW LYSOZYME CRYSTALLIZED IN 0.5 M YBCL3/30% (V/V) GLYCEROL AND COLLECTED AT 125K | 3.2.1.17 |
4NH3 | STRUCTURE OF HUMAN DICER PLATFORM-PAZ-CONNECTOR HELIX CASSETTE IN COMPLEX WITH 13-MER SIRNA HAVING 5'-PU AND UU-3' ENDS (2.6 ANGSTROM RESOLUTION) | 3.1.26 3.1.26.3 |
4NH5 | STRUCTURE OF HUMAN DICER PLATFORM-PAZ-CONNECTOR HELIX CASSETTE IN COMPLEX WITH 14-MER SIRNA HAVING 5'-PUU AND UU-3' ENDS (2.55 ANGSTROM RESOLUTION) | 3.1.26 3.1.26.3 |
4NH6 | STRUCTURE OF HUMAN DICER PLATFORM-PAZ-CONNECTOR HELIX CASSETTE IN COMPLEX WITH 15-MER SIRNA HAVING 5'-PUUU AND UU-3' ENDS (2.55 ANGSTROM RESOLUTION) | 3.1.26 3.1.26.3 |
4NHA | STRUCTURE OF HUMAN DICER PLATFORM-PAZ-CONNECTOR HELIX CASSETTE IN COMPLEX WITH 16-MER SIRNA HAVING 5'-P AND UU-3' ENDS (3.4 ANGSTROM RESOLUTION) | 3.1.26 3.1.26.3 |
4NHI | CRYSTAL STRUCTURE OF HEN EGG-WHITE LYSOZYME IN TRIS BUFFER AT PH 7.5 WITH MAGNESIUM FORMATE | 3.2.1.17 |
4NHO | STRUCTURE OF THE SPLICEOSOMAL DEAD-BOX PROTEIN PRP28 | 3.6.4.13 |
4NHP | X-RAY STRUCTURE OF THE COMPLEX BETWEEN THE HEN EGG WHITE LYSOZYME AND PENTACHLOROCARBONYLIRIDATE (III) (4 DAYS) | 3.2.1.17 |
4NHQ | X-RAY STRUCTURE OF THE COMPLEX BETWEEN HEN EGG WHITE LYSOZYME AND PENTACHLOROCARBONYLIRIDATE(III) (5 DAYS) | 3.2.1.17 |
4NHS | X-RAY STRUCTURE OF THE COMPLEX BETWEEN HEN EGG WHITE LYSOZYME AND PENTACHLOROCARBONYLIRIDATE(III) (9 DAYS) | 3.2.1.17 |
4NHT | X-RAY STRUCTURE OF THE COMPLEX BETWEEN HEN EGG WHITE LYSOZYME AND PENTACHLOROCARBONYLIRIDATE(III) (6 DAYS) | 3.2.1.17 |
4NI3 | CRYSTAL STRUCTURE OF GH29 FAMILY ALPHA-L-FUCOSIDASE FROM FUSARIUM GRAMINEARUM IN THE CLOSED FORM | 3.2.1.51 |
4NIJ | X-RAY STRUCTURE OF THE COMPLEX BETWEEN HEN EGG WHITE LYSOZYME AND PENTACHLOROCARBONYLIRIDATE(III) (30 DAYS) | 3.2.1.17 |
4NIV | CRYSTAL STRUCTURE OF TRYPSILIGASE (K60E/N143H/Y151H/D189K TRYPSIN) TRIGONAL FORM | 3.4.21.4 |
4NIW | CRYSTAL STRUCTURE OF TRYPSILIGASE (K60E/N143H/Y151H/D189K TRYPSIN) ORTHORHOMBIC FORM | 3.4.21.4 |
4NIX | CRYSTAL STRUCTURE OF TRYPSILIGASE (K60E/N143H/Y151H/D189K TRYPSIN) ORTHORHOMBIC FORM, ZINC-BOUND | 3.4.21.4 |
4NIY | CRYSTAL STRUCTURE OF TRYPSILIGASE (K60E/N143H/Y151H/D189K TRYPSIN) COMPLEXED TO YRH-ECOTIN (M84Y/M85R/A86H ECOTIN) | 3.4.21.4 |
4NJE | CRYSTAL STRUCTURE OF PYROCOCCUS FURIOSUS L-ASPARAGINASE WITH LIGAND | 3.5.1.1 |
4NJN | CRYSTAL STRUCTURE OF E.COLI GLPG AT PH 4.5 | 3.4.21.105 |
4NJP | PROTEOLYSIS INSIDE THE MEMBRANE IS A RATE-GOVERNED REACTION NOT DRIVEN BY SUBSTRATE AFFINITY | 3.4.21.105 |
4NJQ | STRUCTURAL AND KINETIC BASES FOR THE METAL PREFERENCE OF THE M18 AMINOPEPTIDASE FROM PSEUDOMONAS AERUGINOSA | 3.4.11 |
4NJR | STRUCTURAL AND KINETIC BASES FOR THE METAL PREFERENCE OF THE M18 AMINOPEPTIDASE FROM PSEUDOMONAS AERUGINOSA | 3.4.11 |
4NK3 | AMP-C BETA-LACTAMASE (PSEUDOMONAS AERUGINOSA) IN COMPLEX WITH MK-7655 | 3.5.2.6 |
4NKK | CRYSTAL STRUCTURE OF A MULTI-DRUG RESISTANT CLINICAL ISOLATE-769 HIV-1 PROTEASE VARIANT THAT IS RESISTANT TO THE DIMERIZATION INHIBITORY ACTIVITY OF TLF-PAFF | 2.7.7.49 3.1.26.13 |
4NKL | CRYSTAL STRUCTURE OF STAPHYLOCOCCAL NUCLEASE VARIANT DELTA+PHS V66A/I92Q AT CRYOGENIC TEMPERATURE | 3.1.31.1 |
4NL4 | PRIA HELICASE BOUND TO ADP | 3.6.4 |
4NL8 | PRIA HELICASE BOUND TO SSB C-TERMINAL TAIL PEPTIDE | 3.6.4 |
4NLD | CRYSTAL STRUCTURE OF THE HEPATITIS C VIRUS NS5B RNA-DEPENDENT RNA POLYMERASE COMPLEX WITH BMS-791325 ALSO KNOWN AS (1AR,12BS)-8-CYCLOHEXYL-N-(DIMETHYLSULFAMOYL)-11-METHOXY-1A-{[(1R,5S)-3-METHYL-3,8-DIAZABICYCLO[3.2.1]OCT-8-YL]CARBONYL}-1,1A,2,12B-TETRAHYDROCYCLOPROPA[D]INDOLO[2,1-A][2]BENZAZEPINE-5-CARBOXAMIDE AND 2-(4-FLUOROPHENYL)-N-METHYL-6-[(METHYLSULFONYL)AMINO]-5-(PROPAN-2-YLOXY)-1-BENZOFURAN-3-CARBOXAMIDE | 2.7.7.48 3.4.22 3.4.21.98 3.6.1.15 3.6.4.13 |
4NLO | POLIOVIRUS POLYMERASE - C290I LOOP MUTANT | 2.7.7.48 3.4.22.29 3.6.1.15 3.4.22.28 |
4NLP | POLIOVIRUS POLYMERASE - C290V LOOP MUTANT | 2.7.7.48 3.4.22.29 3.6.1.15 3.4.22.28 |
4NLQ | POLIOVIRUS POLYMERASE - C290F LOOP MUTANT | 2.7.7.48 3.4.22.29 3.6.1.15 3.4.22.28 |
4NLR | POLIOVIRUS POLYMERASE - C290S LOOP MUTANT | 2.7.7.48 3.4.22.29 3.6.1.15 3.4.22.28 |
4NLS | POLIOVIRUS POLYMERASE - S288A LOOP MUTANT | 2.7.7.48 3.4.22.29 3.6.1.15 3.4.22.28 |
4NLT | POLIOVIRUS POLYMERASE - S291P LOOP MUTANT | 2.7.7.48 3.4.22.29 3.6.1.15 3.4.22.28 |
4NLU | POLIOVIRUS POLYMERASE - G289A LOOP MUTANT | 2.7.7.48 3.4.22.29 3.6.1.15 3.4.22.28 |
4NLV | POLIOVIRUS POLYMERASE - G289A/C290F LOOP MUTANT | 2.7.7.48 3.4.22.29 3.6.1.15 3.4.22.28 |
4NLW | POLIOVIRUS POLYMERASE - G289A/C290I LOOP MUTANT | 2.7.7.48 3.4.22.29 3.6.1.15 3.4.22.28 |
4NLX | POLIOVIRUS POLYMERASE - G289A/C290V LOOP MUTANT | 2.7.7.48 3.4.22.29 3.6.1.15 3.4.22.28 |
4NLY | POLIOVIRUS POLYMERASE - C290E LOOP MUTANT | 2.7.7.48 3.4.22.29 3.6.1.15 3.4.22.28 |
4NMM | CRYSTAL STRUCTURE OF A G12C ONCOGENIC VARIANT OF HUMAN KRAS BOUND TO A NOVEL GDP COMPETITIVE COVALENT INHIBITOR | 3.6.5.2 |
4NMN | AQUIFEX AEOLICUS REPLICATIVE HELICASE (DNAB) COMPLEXED WITH ADP, AT 3.3 RESOLUTION | 3.6.4.12 |
4NMW | CRYSTAL STRUCTURE OF CARBOXYLESTERASE BIOH FROM SALMONELLA ENTERICA | 3.1.1.85 |
4NMX | PCSK9(DELTACRD) IN COMPLEX WITH PHAGE-DERIVED INHIBITORY PEPTIDE 2-8 | 3.4.21 |
4NMZ | CRYSTAL STRUCTURE OF STAPHYLOCOCCAL NUCLEASE VARIANT DELTA+PHS V23Q/V66A AT CRYOGENIC TEMPERATURE | 3.1.31.1 |
4NN9 | REFINED ATOMIC STRUCTURES OF N9 SUBTYPE INFLUENZA VIRUS NEURAMINIDASE AND ESCAPE MUTANTS | 3.2.1.18 |
4NND | STRUCTURAL BASIS OF PTPN18 FINGERPRINT ON DISTINCT HER2 TYROSINE PHOSPHORYLATION SITES | 3.1.3.48 |
4NOJ | CRYSTAL STRUCTURE OF THE MATURE FORM OF ASPARAGINYL ENDOPEPTIDASE (AEP)/LEGUMAIN ACTIVATED AT PH 3.5 | 3.4.22.34 |
4NOK | CRYSTAL STRUCTURE OF PROENZYME ASPARAGINYL ENDOPEPTIDASE (AEP)/LEGUMAIN AT PH 7.5 | 3.4.22.34 |
4NOL | CRYSTAL STRUCTURE OF PROENZYME ASPARAGINYL ENDOPEPTIDASE (AEP)/LEGUMAIN MUTANT D233A AT PH 7.5 | 3.4.22.34 |
4NOM | CRYSTAL STRUCTURE OF ASPARAGINYL ENDOPEPTIDASE (AEP)/LEGUMAIN ACTIVATED AT PH 4.5 | 3.4.22.34 |
4NOO | MOLECULAR MECHANISM FOR SELF-PROTECTION AGAINST TYPE VI SECRETION SYSTEM IN VIBRIO CHOLERAE | 3.2.1 |
4NOV | XSA43E, A GH43 FAMILY ENZYME FROM BUTYRIVIBRIO PROTEOCLASTICUS | 3.2.1.37 |
4NP4 | CLOSTRIDIUM DIFFICILE TOXIN B CROP DOMAIN IN COMPLEX WITH FAB DOMAINS OF NEUTRALIZING ANTIBODY BEZLOTOXUMAB | 3.4.22 2.4.1 |
4NP5 | CRYSTAL STRUCTURE OF STAPHYLOCOCCAL NUCLEASE VARIANT DELTA+PHS V66A/I92N AT CRYOGENIC TEMPERATURE | 3.1.31.1 |
4NP7 | STRUCTURE OF PHOSPHOTRIESTERASE MUTANT (S308L/Y309A) FROM AGROBACTERIUM RADIOBACTER WITH DIETHYL THIOPHOSPHATE BOUND IN THE ACTIVE SITE | 3.1.8.1 |
4NPA | SCRYSTAL STRUCTURE OF PROTEIN WITH UNKNOWN FUNCTION FROM VIBRIO CHOLERAE AT P22121 SPACEGROUP | 3.2.2.4 |
4NPH | CRYSTAL STRUCTURE OF SSAN FROM SALMONELLA ENTERICA | 3.6.3.14 7.1.2.2 |
4NPR | CRYSTAL STRUCTURE OF THE FAMILY 12 XYLOGLUCANASE FROM ASPERGILLUS NIVEUS | 3.2.1.151 |
4NPV | CRYSTAL STRUCTURE OF HUMAN PDE1B BOUND TO INHIBITOR 7A (6,7,8-TRIMETHOXY-N-(PENTAN-3-YL)QUINAZOLIN-4-AMINE) | 3.1.4.17 |
4NPW | CRYSTAL STRUCTURE OF HUMAN PDE1B BOUND TO INHIBITOR 19A (7,8-DIMETHOXY-N-[(2S)-1-(3-METHYL-1H-PYRAZOL-5-YL)PROPAN-2-YL]QUINAZOLIN-4-AMINE) | 3.1.4.17 |
4NQ2 | STRUCTURE OF ZN(II)-BOUND METALLO-BETA-LACTAMSE VIM-2 FROM PSEUDOMONAS AERUGINOSA | 3.5.2.6 |
4NQ3 | CRYSTAL STRUCTURE OF CYANUIC ACID HYDROLASE FROM A. CAULINODANS | 3.5.2.15 |
4NQ4 | BACILLUS CEREUS ZN-DEPENDENT METALLO-BETA-LACTAMASE AT PH 7 | 3.5.2.6 |
4NQ5 | BACILLUS CEREUS ZN-DEPENDENT METALLO-BETA-LACTAMASE AT PH 7 COMPLEXED WITH COMPOUND CS319 | 3.5.2.6 |
4NQ6 | BACILLUS CEREUS ZN-DEPENDENT METALLO-BETA-LACTAMASE AT PH 7 COMPLEXED WITH COMPOUND L-CS319 | 3.5.2.6 |
4NQK | STRUCTURE OF AN UBIQUITIN COMPLEX | 3.6.4.13 |
4NQL | THE CRYSTAL STRUCTURE OF THE DUB DOMAIN OF AMSH ORTHOLOGUE, SST2 FROM S. POMBE, IN COMPLEX WITH LYSINE 63-LINKED DIUBIQUITIN | 3.4.19 |
4NRR | CRYSTAL STRUCTURE OF GLYCOSIDE HYDROLASE FAMILY 5 MANNOSIDASE (E202A MUTANT) FROM RHIZOMUCOR MIEHEI IN COMPLEX WITH MANNOSYL-FRUCTOSE | 3.2.1.25 |
4NRS | CRYSTAL STRUCTURE OF GLYCOSIDE HYDROLASE FAMILY 5 MANNOSIDASE (E202A MUTANT) FROM RHIZOMUCOR MIEHEI IN COMPLEX WITH MANNOBIOSE | 3.2.1.25 |
4NRT | HUMAN NOROVIRUS POLYMERASE BOUND TO COMPOUND 6 (SURAMIN DERIVATIVE) | 2.7.7.48 3.4.22.66 3.6.1.15 |
4NRV | CRYSTAL STRUCTURE OF NON-EDITED HUMAN NEIL1 | 3.2.2 4.2.99.18 |
4NRW | MVNEI1-G86D | 3.2.2.23 4.2.99.18 |
4NS4 | CRYSTAL STRUCTURE OF COLD-ACTIVE ESTARASE FROM PSYCHROBACTER CRYOHALOLENTIS K5T | 3.1.1.6 |
4NSG | CARBOPLATIN BINDING TO HEWL IN NABR CRYSTALLISATION CONDITIONS STUDIED AT AN X-RAY WAVELENGTH OF 1.5418A | 3.2.1.17 |
4NSH | CARBOPLATIN BINDING TO HEWL IN 0.2M NH4SO4, 0.1M NAAC IN 25% PEG 4000 AT PH 4.6 | 3.2.1.17 |
4NSI | CARBOPLATIN BINDING TO HEWL IN 20% PROPANOL, 20% PEG 4000 AT PH5.6 | 3.2.1.17 |
4NSJ | CARBOPLATIN BINDING TO HEWL IN 2M NH4FORMATE, 0.1M HEPES AT PH 7.5 | 3.2.1.17 |
4NSO | CRYSTAL STRUCTURE OF THE EFFECTOR-IMMUNITY PROTEIN COMPLEX | 3.2.1 |
4NSP | CRYSTAL STRUCTURE OF HUMAN ENDOV | 3.1.26 |
4NSV | LYSOBACTER ENZYMOGENES LYSC ENDOPROTEINASE K30R MUTANT COVALENTLY INHIBITED BY TLCK | 3.4.21.50 |
4NSY | WILD-TYPE LYSOBACTER ENZYMOGENES LYSC ENDOPROTEINASE COVALENTLY INHIBITED BY TLCK | 3.4.21.50 |
4NT8 | FORMYL-METHIONINE-ALANINE COMPLEX STRUCTURE OF PEPTIDE DEFORMYLASE FROM XANTHOMOONAS ORYZAE PV. ORYZAE | 3.5.1.88 |
4NTQ | CDIA-CT/CDII TOXIN AND IMMUNITY COMPLEX FROM ENTEROBACTER CLOACAE | 3.1 |
4NUY | CRYSTAL STRUCTURE OF ENDOS, AN ENDO-BETA-N-ACETYL-GLUCOSAMINIDASE FROM STREPTOCOCCUS PYOGENES | 3.2.1.96 |
4NUZ | CRYSTAL STRUCTURE OF A GLYCOSYNTHASE MUTANT (D233Q) OF ENDOS, AN ENDO-BETA-N-ACETYL-GLUCOSAMINIDASE FROM STREPTOCOCCUS PYOGENES | 3.2.1.96 |
4NV0 | CRYSTAL STRUCTURE OF CYTOSOLIC 5'-NUCLEOTIDASE IIIB (CN-IIIB) BOUND TO 7-METHYLGUANOSINE | 3.1.3.5 3.1.3.91 |
4NV4 | 1.8 ANGSTROM CRYSTAL STRUCTURE OF SIGNAL PEPTIDASE I FROM BACILLUS ANTHRACIS. | 3.4.21.89 |
4NW2 | TANDEM CHROMODOMAINS OF HUMAN CHD1 IN COMPLEX WITH INFLUENZA VIRUS NS1 C-TERMINAL TAIL TRIMETHYLATED AT K229 | 3.6.4.12 |
4NW7 | PDE4 CATALYTIC DOMAIN | 3.1.4.17 3.1.4.53 |
4NWE | LYSOZYME UNDER 30 BAR PRESSURE OF NITROUS OXIDE | 3.2.1.17 |
4NWF | CRYSTAL STRUCTURE OF THE TYROSINE PHOSPHATASE SHP-2 WITH N308D MUTATION | 3.1.3.48 |
4NWG | CRYSTAL STRUCTURE OF THE TYROSINE PHOSPHATASE SHP-2 WITH E139D MUTATION | 3.1.3.48 |
4NWH | LYSOZYME UNDER 30 BAR PRESSURE OF XENON | 3.2.1.17 |
4NWI | CRYSTAL STRUCTURE OF CYTOSOLIC 5'-NUCLEOTIDASE IIIB (CN-IIIB) BOUND TO CYTIDINE | 3.1.3.5 3.1.3.91 |
4NWK | CRYSTAL STRUCTURE OF HEPATIS C VIRUS PROTEASE (NS3) COMPLEXED WITH BMS-605339 AKA N-(TERT-BUTOXYCARBONYL)-3-ME THYL-L-VALYL-(4R)-N-((1R,2S)-1-((CYCLOPROPYLSULFONYL)CARBA MOYL)-2-VINYLCYCLOPROPYL)-4-((6-METHOXY-1-ISOQUINOLINYL)OX Y)-L-PROLINAMIDE | 2.7.7.48 3.4.21.98 3.6.1.15 3.6.4.13 |
4NWL | CRYSTAL STRUCTURE OF HEPATIS C VIRUS PROTEASE (NS3) COMPLEXED WITH BMS-650032 AKA N-(TERT-BUTOXYCARBONYL)-3-ME THYL-L-VALYL-(4R)-4-((7-CHLORO-4-METHOXY-1-ISOQUINOLINYL)O XY)-N-((1R,2S)-1-((CYCLOPROPYLSULFONYL)CARBAMOYL)-2-VINYLC YCLOPROPYL)-L-PROLINAMIDE | 2.7.7.48 3.4.21.98 3.6.1.15 3.6.4.13 |
4NX4 | RE-REFINEMENT OF CAP-1 HIV-CA COMPLEX | 3.4.23.16 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1 |
4NX8 | STRUCTURE OF A PTP-LIKE PHYTASE FROM BDELLOVIBRIO BACTERIOVORUS | 3.1.3.48 |
4NXS | CRYSTAL STRUCTURE OF HUMAN ALPHA-GALACTOSIDASE A IN COMPLEX WITH 1-DEOXYGALACTONOJIRIMYCIN-PFPHT | 3.2.1.22 3.2.1.47 |
4NY2 | STRUCTURE OF VIBRIO CHOLERAE CHITIN DE-N-ACETYLASE IN COMPLEX WITH ACETATE ION (ACT) IN P 21 | 3.5.1.41 |
4NY5 | X-RAY STRUCTURE OF THE ADDUCT FORMED BETWEEN HEN EGG WHITE LYSOZYME AND NAMI-A | 3.2.1.17 |
4NYF | HIV INTEGRASE IN COMPLEX WITH INHIBITOR | 2.7.7 3.4.23.16 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 3.1 |
4NYH | ORTHORHOMBIC CRYSTAL FORM OF PIR1 DUAL SPECIFICITY PHOSPHATASE CORE | 3.1.3 |
4NYI | APPROACH FOR TARGETING RAS WITH SMALL MOLECULES THAT ACTIVATE SOS-MEDIATED NUCLEOTIDE EXCHANGE | 3.6.5.2 |
4NYJ | APPROACH FOR TARGETING RAS WITH SMALL MOLECULES THAT ACTIVATE SOS-MEDIATED NUCLEOTIDE EXCHANGE | 3.6.5.2 |
4NYM | APPROACH FOR TARGETING RAS WITH SMALL MOLECULES THAT ACTIVATE SOS-MEDIATED NUCLEOTIDE EXCHANGE | 3.6.5.2 |
4NYN | CRYSTAL STRUCTURE OF RNASE H1 FROM HALOPHILIC ARCHAEON HALOBACTERIUM SALINARUM NRC-1 | 3.1.26.4 |
4NYU | STRUCTURE OF VIBRIO CHOLERAE CHITIN DE-N-ACETYLASE IN COMPLEX WITH ACETATE ION (ACT) IN C 2 2 21 | 3.5.1.41 |
4NYY | STRUCTURE OF VIBRIO CHOLERAE CHITIN DE-N-ACETYLASE IN COMPLEX WITH ACETATE ION (ACT) IN P 2 21 21 | 3.5.1.41 |
4NYZ | THE EMCV 3DPOL STRUCTURE WITH ALTERED MOTIF A CONFORMATION AT 2.15A RESOLUTION | 3.6.1.15 3.4.22.28 2.7.7.48 3.6.4.13 |
4NZ0 | THE EMCV 3DPOL STRUCTURE AT 2.8A RESOLUTION | 2.7.7.48 3.6.4.13 3.4.22.28 |
4NZ1 | STRUCTURE OF VIBRIO CHOLERAE CHITIN DE-N-ACETYLASE IN COMPLEX WITH DI(N-ACETYL-D-GLUCOSAMINE) (CBS) IN P 21 | 3.5.1.41 |
4NZ3 | STRUCTURE OF VIBRIO CHOLERAE CHITIN DE-N-ACETYLASE IN COMPLEX WITH DI(N-ACETYL-D-GLUCOSAMINE) (CBS) IN P 21 21 21 | 3.5.1.41 |
4NZ4 | STRUCTURE OF VIBRIO CHOLERAE CHITIN DE-N-ACETYLASE IN COMPLEX WITH 2-(ACETYLAMINO)-2-DEOXY-A-D-GLUCOPYRANOSE (NDG) AND ZINC ION | 3.5.1.41 |
4NZ5 | STRUCTURE OF VIBRIO CHOLERAE CHITIN DE-N-ACETYLASE IN COMPLEX WITH 2-(ACETYLAMINO)-2-DEOXY-A-D-GLUCOPYRANOSE (NDG) AND CADMIUM ION | 3.5.1.41 |
4NZ8 | CRYSTAL STRUCTURE OF PORCINE AMINOPEPTIDASE-N COMPLEXED WITH CLEAVED POLY-ALANINE | 3.4.11.2 |
4NZC | CRYSTAL STRUCTURE OF CHITINASE D FROM SERRATIA PROTEAMACULANS AT 1.45 ANGSTROM RESOLUTION | 3.2.1.14 |
4NZG | CRYSTAL STRUCTURE OF THE N-TERMINAL DOMAIN OF MOLONEY MURINE LEUKEMIA VIRUS INTEGRASE, NORTHEAST STRUCTURAL GENOMICS CONSORTIUM TARGET OR3 | 3.4.23 2.7.7.49 2.7.7.7 3.1.26.4 2.7.7 3.1 |
4NZJ | CRYSTAL STRUCTURE OF A PUTATIVE ALPHA-GALACTOSIDASE (BF1418) FROM BACTEROIDES FRAGILIS NCTC 9343 AT 1.57 A RESOLUTION | 3.2.1.22 |
4NZL | EXTRACELLULAR PROTEINS OF STAPHYLOCOCCUS AUREUS INHIBIT THE NEUTROPHIL SERINE PROTEASES | 3.4.21.37 |
4NZQ | CRYSTAL STRUCTURE OF CA2+-FREE PROTHROMBIN DELETION MUTANT RESIDUES 146-167 | 3.4.21.5 |
4NZZ | CRYSTAL STRUCTURE OF EPOXIDE HYDROLASE FROM BACILLUS MEGATERIUM | 3.2.2.10 |
4O03 | CRYSTAL STRUCTURE OF CA2+ BOUND PROTHROMBIN DELETION MUTANT RESIDUES 146-167 | 3.4.21.5 |
4O08 | CRYSTAL STRUCTURE OF BACILLUS MEGATERIUM EPOXIDE HYDROLASE IN COMPLEX WITH AN INHIBITOR | 3.2.2.10 |
4O0C | HIGH RESOLUTION CRYSTAL STRUCTURE OF UNCLEAVED HUMAN L-ASPARAGINASE PROTEIN | 3.4.19.5 3.5.1.1 |
4O0D | CRYSTAL STRUCTURE OF THE HUMAN L-ASPARAGINASE PROTEIN T168S MUTANT | 3.4.19.5 3.5.1.1 |
4O0E | CRYSTAL STRUCTURE OF THE HUMAN L-ASPARAGINASE PROTEIN T186V MUTANT | 3.4.19.5 3.5.1.1 |
4O0F | CRYSTAL STRUCTURE OF THE HUMAN L-ASPARAGINASE PROTEIN T219A MUTANT | 3.4.19.5 3.5.1.1 |
4O0G | CRYSTAL STRUCTURE OF THE HUMAN L-ASPARAGINASE PROTEIN T219V MUTANT | 3.4.19.5 3.5.1.1 |
4O0H | CRYSTAL STRUCTURE OF HUMAN L-ASPARAGINASE PROTEIN WITH COVALENTLY LINKED SUBSTRATE L-ASPARAGINE | 3.4.19.5 3.5.1.1 |
4O0J | HIV-1 INTEGRASE CATALYTIC CORE DOMAIN COMPLEXED WITH ALLOSTERIC INHIBITOR (2S)-TERT-BUTOXY[4-(4-CHLOROPHENYL)-6-(3,4-DIMETHYLPHENYL)-2,5-DIMETHYLPYRIDIN-3-YL]ETHANOIC ACID | 3.4.23.16 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1 |
4O0K | CRYSTAL STRUCTURE OF 1-PYRROLINE-4-HYDROXY-2-CARBOXYLATE DEAMINASE FROM BRUCELLA MELITENSIS WITH COVALENTLY BOUND SUBSTRATE | 3.5.4.22 |
4O0O | CRYSTAL STRUCTURE OF THE COMPLEX OF TYPE 1 RIBOSOME INACTIVATING PROTEIN FROM MOMORDICA BALSAMINA WITH 5-FLUOROURACIL AT 2.59 A RESOLUTION | 3.2.2.22 |
4O1N | CRYSTAL STRUCTURE OF STAPHYLOCOCCAL SUPERANTIGEN-LIKE PROTEIN SAOUHSC_00383 | 3.4.21 |
4O1R | CRYSTAL STRUCTURE OF NPUDNAB INTEIN | 3.6.4.12 |
4O1S | CRYSTAL STRUCTURE OF TVOVMA INTEIN | 3.6.3.14 7.1.2.2 |
4O1Y | CRYSTAL STRUCTURE OF PORCINE PANCREATIC PHOSPHOLIPASE A2 IN COMPLEX WITH 1-NAPHTHALENEACETIC ACID | 3.1.1.4 |
4O23 | CRYSTAL STRUCTURE OF MONO-ZINC FORM OF SUCCINYL DIAMINOPIMELATE DESUCCINYLASE FROM NEISSERIA MENINGITIDIS MC58 | 3.5.1.18 |
4O2X | STRUCTURE OF A MALARIAL PROTEIN | 3.4.21.92 |
4O34 | ROOM TEMPERATURE MACROMOLECULAR SERIAL CRYSTALLOGRAPHY USING SYNCHROTRON RADIATION | 3.2.1.17 |
4O36 | SEMISYNTHETIC RNASE S1-15-H7/11-Q10 | 3.1.27.5 4.6.1.18 |
4O37 | SEMINSYNTHETIC RNASE S1-15-3PL-7/11 | 3.1.27.5 4.6.1.18 |
4O3M | TERNARY COMPLEX OF BLOOM'S SYNDROME HELICASE | 3.6.4.12 |
4O42 | TANDEM CHROMODOMAINS OF HUMAN CHD1 IN COMPLEX WITH INFLUENZA NS1 C-TERMINAL TAIL DIMETHYLATED AT K229 | 3.6.4.12 |
4O44 | CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH 4-((4-(MESITYLAMINO)-6-(3-MORPHOLINOPROPOXY)-1,3,5-TRIAZIN-2-YL)AMINO)BENZONITRILE (JLJ529), A NON-NUCLEOSIDE INHIBITOR | 2.7.7.49 3.4.23.16 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1 |
4O47 | CRYSTAL STRUCTURE OF UNCLEAVED GUINEA PIG L-ASPARAGINASE TYPE III | 3.5.1.1 |
4O48 | CRYSTAL STRUCTURE OF CLEAVED GUINEA PIG L-ASPARAGINASE TYPE III IN COMPLEX WITH L-ASPARTATE | 3.5.1.1 |
4O4G | CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH 4-((4-(MESITYLAMINO)-1,3,5-TRIAZIN-2-YL)AMINO)BENZONITRILE (JLJ527), A NON-NUCLEOSIDE INHIBITOR | 2.7.7.49 3.4.23.16 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1 |
4O4Q | CRYSTAL STRUCTURE OF THE COMPLEX FORMED BETWEEN TYPE 1 RIBOSOME INACTIVATING PROTEIN AND URIDINE DIPHOSPHATE AT 1.81 A RESOLUTION | 3.2.2.22 |
4O4R | MURINE NOROVIRUS RDRP IN COMPLEX WITH PPNDS | 2.7.7.48 3.4.22.66 3.6.1.15 |
4O55 | HIV-1 INTEGRASE CATALYTIC CORE DOMAIN COMPLEXED WITH ALLOSTERIC INHIBITOR (2S)-TERT-BUTOXY[6-(5-CHLORO-1H-BENZIMIDAZOL-2-YL)-2,5-DIMETHYL-4-PHENYLPYRIDIN-3-YL]ETHANOIC ACID | 3.4.23.16 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1 |
4O5B | HIV-1 INTEGRASE CATALYTIC CORE DOMAIN COMPLEXED WITH ALLOSTERIC INHIBITOR (2S)-TERT-BUTOXY[6-(5-CHLORO-1H-BENZIMIDAZOL-2-YL)-2,5-DIMETHYL-4-PHENYLPYRIDIN-3-YL]ETHANOIC ACID | 3.4.23.16 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1 |
4O5S | CRYSTAL STRUCTURE OF DIELS-ALDERASE CE11 | 3.1.8.2 |
4O5T | CRYSTAL STRUCTURE OF DIELS-ALDERASE CE20 IN COMPLEX WITH A PRODUCT ANALOG | 3.1.8.2 |
4O66 | CRYSTAL STRUCTURE OF SMARCAL1 HARP SUBSTRATE RECOGNITION DOMAIN | 3.6.4 |
4O6B | DENGUE TYPE2 VIRUS NON-STRUCTURAL PROTEIN 1 (NS1) FORM 1 CRYSTAL | 3.4.21.91 3.6.1.15 3.6.4.13 2.1.1.56 2.1.1.57 2.7.7.48 |
4O6D | WEST NILE VIRUS NON-STRUCTURAL PROTEIN 1 (NS1) FORM 1 CRYSTAL | 3.4.21.91 3.6.1.15 3.6.4.13 2.1.1.56 2.1.1.57 2.7.7.48 |
4O6H | 2.8A CRYSTAL STRUCTURE OF LYMPHOCYTIC CHORIOMENINGITIS VIRUS NUCLEOPROTEIN C-TERMINAL DOMAIN | 3.1.13 |
4O6I | 2.0A CRYSTAL STRUCTURE OF LYMPHOCYTIC CHORIOMENINGITIS VIRUS NUCLEOPROTEIN C-TERMINAL DOMAIN | 3.1.13 |
4O7D | CRYSTAL STRUCTURE OF HUMAN GLUTAMINASE IN COMPLEX DON | 3.5.1.2 |
4O7I | STRUCTURAL AND FUNCTIONAL CHARACTERIZATION OF 3'(2'),5'-BISPHOSPHATE NUCLEOTIDASE1 FROM ENTAMOEBA HISTOLYTICA | 3.1.3.7 |
4O8C | STRUCTURE OF THE H170Y MUTANT OF THERMOSTABLE P-NITROPHENYLPHOSPHATASE FROM BACILLUS STEAROTHERMOPHILUS | 3.1.3.1 |
4O8E | CRYSTAL STRUCTURE OF THE COMPLEX OF TYPE I RIBOSOME INACTIVATING PROTEIN FROM MOMORDICA BALSAMINA WITH URIDINE TRIPHOSPHATE AT 2.0 A RESOLUTION | 3.2.2.22 |
4O8L | STRUCTURE OF SORTASE A FROM STREPTOCOCCUS PNEUMONIAE | 3.4.22.70 |
4O8N | CRYSTAL STRUCTURE OF STHARAF62A, A GH62 FAMILY ALPHA-L-ARABINOFURANOSIDASE FROM STREPTOMYCES THERMOVIOLACEUS, IN THE APOPROTEIN FORM | 3.2.1.55 |
4O8O | CRYSTAL STRUCTURE OF STHARAF62A, A GH62 FAMILY ALPHA-L-ARABINOFURANOSIDASE FROM STREPTOMYCES THERMOVIOLACEUS, BOUND TO ALPHA-L-ARABINOSE | 3.2.1.55 |
4O8P | CRYSTAL STRUCTURE OF STHARAF62A, A GH62 FAMILY ALPHA-L-ARABINOFURANOSIDASE FROM STREPTOMYCES THERMOVIOLACEUS, BOUND TO XYLOTETRAOSE | 3.2.1.55 |
4O8T | STRUCTURE OF SORTASE A C207A MUTANT FROM STREPTOCOCCUS PNEUMONIAE | 3.4.22.70 |
4O8Z | CRYSTAL STRUCTURE OF HUMAN SIRT3 IN COMPLEX WITH COMPOUND (2-BUTYLBENZOFURAN-3-YL)(4-(2-(DIETHYLAMINO)ETHOXY)-3,5-DIIODOPHENYL)METHANONE | 3.5.1 2.3.1.286 |
4O97 | CRYSTAL STRUCTURE OF MATRIPTASE IN COMPLEX WITH INHIBITOR | 3.4.21.109 |
4O9I | STRUCTURE OF CHD4 DOUBLE CHROMODOMAINS DEPICTS COOPERATIVE FOLDING FOR DNA BINDING | 3.6.4.12 |
4O9V | CRYSTAL STRUCTURE OF MATRIPTASE IN COMPLEX WITH INHIBITOR | 3.4.21.109 |
4OAO | A MUTANT OF AXE2 (R55A), AND ACETYL-XYLOOLIGOSACCHARIDE ESTERASE FROM GEOBACILLUS STEARMOPHILUS | 3.1.1.72 |
4OAP | AN AXE2 MUTANT (W190I), AN ACETYL-XYLOOLIGOSACCHARIDE ESTERASE FROM GEOBACILLUS STEARMOPHILUS | 3.1.1.72 |
4OB6 | COMPLEX STRUCTURE OF ESTERASE RPPE S159A/W187H AND SUBSTRATE (S)-AC-CPA | 3.1.1 |
4OB7 | CRYSTAL STRUCTURE OF ESTERASE RPPE MUTANT W187H | 3.1.1 |
4OB8 | CRYSTAL STRUCTURE OF A NOVEL THERMOSTABLE ESTERASE FROM PSEUDOMONAS PUTIDA ECU1011 | 3.1.1 |
4OBC | CRYSTAL STRUCTURE OF HCV POLYMERASE NS5B GENOTYPE 2A JFH-1 ISOLATE WITH THE S15G, C223H, V321I RESISTANCE MUTATIONS AGAINST THE GUANOSINE ANALOG GS-0938 (PSI-3529238) | 2.7.7.48 3.4.22 3.4.21.98 3.6.1.15 3.6.4.13 |
4OBD | CRYSTAL STRUCTURE OF NELFINAVIR-RESISTANT, INACTIVE HIV-1 PROTEASE (D30N/N88D) IN COMPLEX WITH THE P1-P6 SUBSTRATE VARIANT (L449F/S451N) | 3.4.23.16 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1 |
4OBE | CRYSTAL STRUCTURE OF GDP-BOUND HUMAN KRAS | 3.6.5.2 |
4OBF | CRYSTAL STRUCTURE OF NELFINAVIR-RESISTANT, INACTIVE HIV-1 PROTEASE VARIANT (D30N/N88D) IN COMPLEX WITH THE P1-P6 SUBSTRATE VARIANT (S451N) | 3.4.23.16 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1 |
4OBG | CRYSTAL STRUCTURE OF NELFINAVIR-RESISTANT, INACTIVE HIV-1 PROTEASE (D30N/N88D) IN COMPLEX WITH THE P1-P6 SUBSTRATE. | 3.4.23.16 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1 |
4OBH | CRYSTAL STRUCTURE OF INACTIVE HIV-1 PROTEASE IN COMPLEX WITH THE P1-P6 SUBSTRATE VARIANT (L449F) | 3.4.23.16 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1 |
4OBJ | CRYSTAL STRUCTURE OF INACTIVE HIV-1 PROTEASE IN COMPLEX WITH THE P1-P6 SUBSTRATE VARIANT (S451N) | 3.4.23.16 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1 |
4OBK | CRYSTAL STRUCTURE OF INACTIVE HIV-1 PROTEASE IN COMPLEX WITH THE P1-P6 SUBSTRATE VARIANT (L449F/S451N) | 3.4.23.16 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1 |
4OBR | CRYSTAL STRUCTURE OF HUMAN ALPHA-L-IDURONIDASE COMPLEX WITH ALPHA-L-IDURONIC ACID | 3.2.1.76 |
4OBS | CRYSTAL STRUCTURE OF HUMAN ALPHA-L-IDURONIDASE IN THE P212121 FORM | 3.2.1.76 |
4OBZ | STRUCTURE OF CATHEPSIN D WITH INHIBITOR 2-(3,4-DIMETHOXYPHENYL)-N-[N-(4-METHYLBENZYL)CARBAMIMIDOYL]ACETAMIDE | 3.4.23.5 |
4OC0 | X-RAY STRUCTURE OF OF HUMAN GLUTAMATE CARBOXYPEPTIDASE II (GCPII) IN A COMPLEX WITH CCIBZL, A UREA-BASED INHIBITOR N~2~-[(1-CARBOXYCYCLOPROPYL)CARBAMOYL]-N~6~-(4-IODOBENZOYL)-L-LYSINE | 3.4.17.21 |
4OC1 | X-RAY STRUCTURE OF OF HUMAN GLUTAMATE CARBOXYPEPTIDASE II (GCPII) IN A COMPLEX WITH COIBZL, A UREA-BASED INHIBITOR (2S)-2-[({(1S)-1-CARBOXY-2-[(2S)-OXIRAN-2-YL]ETHYL}CARBAMOYL)AMINO]-6-[(4-IODOBENZOYL)AMINO]HEXANOIC ACID | 3.4.17.21 |
4OC2 | X-RAY STRUCTURE OF OF HUMAN GLUTAMATE CARBOXYPEPTIDASE II (GCPII) IN A COMPLEX WITH CEIBZL, A UREA-BASED INHIBITOR N~2~-{[(1S)-1-CARBOXYBUT-3-YN-1-YL]CARBAMOYL}-N~6~-(4-IODOBENZOYL)-L-LYSINE | 3.4.17.21 |
4OC3 | X-RAY STRUCTURE OF OF HUMAN GLUTAMATE CARBOXYPEPTIDASE II (GCPII) IN A COMPLEX WITH CFIBZL, A UREA-BASED INHIBITOR N~2~-{[(1S)-1-CARBOXY-2-(FURAN-2-YL)ETHYL]CARBAMOYL}-N~6~-(4-IODOBENZOYL)-L-LYSINE | 3.4.17.21 |
4OC4 | X-RAY STRUCTURE OF OF HUMAN GLUTAMATE CARBOXYPEPTIDASE II (GCPII) IN A COMPLEX WITH CPIBZL, A UREA-BASED INHIBITOR N~2~-{[(1S)-1-CARBOXY-2-(PYRIDIN-4-YL)ETHYL]CARBAMOYL}-N~6~-(4-IODOBENZOYL)-L-LYSINE | 3.4.17.21 |
4OC5 | X-RAY STRUCTURE OF OF HUMAN GLUTAMATE CARBOXYPEPTIDASE II (GCPII) IN A COMPLEX WITH CHIBZL, A UREA-BASED INHIBITOR N~2~-{[(S)-CARBOXY(4-HYDROXYPHENYL)METHYL]CARBAMOYL}-N~6~-(4-IODOBENZOYL)-L-LYSINE | 3.4.17.21 |
4OC6 | STRUCTURE OF CATHEPSIN D WITH INHIBITOR 2-BROMO-N-[(2S,3S)-4-{[2-(2,4-DICHLOROPHENYL)ETHYL][3-(1,3-DIOXO-1,3-DIHYDRO-2H-ISOINDOL-2-YL)PROPANOYL]AMINO}-3-HYDROXY-1-(3-PHENOXYPHENYL)BUTAN-2-YL]-4,5-DIMETHOXYBENZAMIDE | 3.4.23.5 |
4OCH | APO STRUCTURE OF SMR DOMAIN OF MUTS2 FROM DEINOCOCCUS RADIODURANS | 3.1 |
4OCZ | CRYSTAL STRUCTURE OF HUMAN SOLUBLE EPOXIDE HYDROLASE COMPLEXED WITH 1-(1-ISOBUTYRYLPIPERIDIN-4-YL)-3-(4-(TRIFLUOROMETHYL)PHENYL)UREA | 3.3.2.10 3.1.3.76 |
4OD0 | CRYSTAL STRUCTURE OF HUMAN SOLUBLE EPOXIDE HYDROLASE COMPLEXED WITH 1-(1-PROPANOYLPIPERIDIN-4-YL)-3-[4-(TRIFLUOROMETHOXY)PHENYL]UREA | 3.3.2.10 3.1.3.76 |
4OD6 | STRUCTURE OF SMR DOMAIN OF MUTS2 FROM DEINOCOCCUS RADIODURANS, MN2+ SOAKED | 3.1 |
4OD8 | CRYSTAL STRUCTURE OF THE VACCINIA VIRUS DNA POLYMERASE HOLOENZYME SUBUNIT D4 IN COMPLEX WITH THE A20 N-TERMINUS | 3.2.2.27 |
4OD9 | STRUCTURE OF CATHEPSIN D WITH INHIBITOR N-(3,4-DIMETHOXYBENZYL)-NALPHA-{N-[(3,4-DIMETHOXYPHENYL)ACETYL]CARBAMIMIDOYL}-D-PHENYLALANINAMIDE | 3.4.23.5 |
4ODA | CRYSTAL STRUCTURE OF THE VACCINIA VIRUS DNA POLYMERASE HOLOENZYME SUBUNIT D4 IN COMPLEX WITH THE A20 N-TERMINUS | 3.2.2.27 |
4ODG | CRYSTAL STRUCTURE OF STAPHYLOCOCCAL NUCLEASE VARIANT V23I/V66I/V74I/V99I AT CRYOGENIC TEMPERATURE | 3.1.31.1 |
4OEC | CRYSTAL STRUCTURE OF GLYCEROPHOSPHODIESTER PHOSPHODIESTERASE FROM THERMOCOCCUS KODAKARENSIS KOD1 | 3.1.4.46 |
4OEL | CRYSTAL STRUCTURE OF CATHEPSIN C IN COMPLEX WITH DIPEPTIDE SUBSTRATES | 3.4.14.1 |
4OEM | CRYSTAL STRUCTURE OF CATHEPSIN C IN COMPLEX WITH DIPEPTIDE SUBSTRATES | 3.4.14.1 |
4OEW | CRYSTAL STRUCTURE OF THE PDE5A1 CATALYTIC DOMAIN IN COMPLEX WITH NOVEL INHIBITORS | 3.1.4.35 |
4OEX | CRYSTAL STRUCTURE OF THE PDE5A1 CATALYTIC DOMAIN IN COMPLEX WITH NOVEL INHIBITORS | 3.1.4.35 |
4OF1 | CRYSTAL STRUCTURE OF TOXIN FROM STAPHYLOCOCCUS AUREUS MU50 | 3.1 |
4OFA | STRUCTURAL BASIS FOR THYMINE GLYCOSYLASE ACTIVITY ON T:O6-METHYLG MISMATCH BY METHYL-CPG BINDING DOMAIN PROTEIN 4: IMPLICATIONS FOR ROLES OF ARG468 IN MISMATCH RECOGNITION AND CATALYSIS | 3.2.2 |
4OFE | STRUCTURAL BASIS FOR THYMINE GLYCOSYLASE ACTIVITY ON T:O6-METHYLG MISMATCH BY METHYL-CPG BINDING DOMAIN PROTEIN 4: IMPLICATIONS FOR ROLES OF ARG468 IN MISMATCH RECOGNITION AND CATALYSIS | 3.2.2 |
4OFH | STRUCTURAL BASIS FOR THYMINE GLYCOSYLASE ACTIVITY ON T:O6-METHYLG MISMATCH BY METHYL-CPG BINDING DOMAIN PROTEIN 4: IMPLICATIONS FOR ROLES OF ARG468 IN MISMATCH RECOGNITION AND CATALYSIS | 3.2.2 |
4OFZ | STRUCTURE OF UNLIGANDED TREHALOSE-6-PHOSPHATE PHOSPHATASE FROM BRUGIA MALAYI | 3.1.3.12 |
4OGB | CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF PDE4D2 WITH COMPOUND 2 | 3.1.4.53 |
4OGC | CRYSTAL STRUCTURE OF THE TYPE II-C CAS9 ENZYME FROM ACTINOMYCES NAESLUNDII | 3.1 |
4OGE | CRYSTAL STRUCTURE OF THE TYPE II-C CAS9 ENZYME FROM ACTINOMYCES NAESLUNDII | 3.1 |
4OGF | CRYSTAL STRUCTURE OF HUMAN DJ-1 WITH GLYOXYLATE AS SUBSTRATE ANALOG | 4.2.1.130 3.1.2 3.5.1 3.5.1.124 |
4OGW | STRUCTURE OF A HUMAN CD38 MUTANT COMPLEXED WITH NMN | 3.2.2.5 3.2.2.6 2.4.99.20 |
4OGX | CRYSTAL STRUCTURE OF FAB DX-2930 IN COMPLEX WITH HUMAN PLASMA KALLIKREIN AT 2.4 ANGSTROM RESOLUTION | 3.4.21.34 |
4OGY | CRYSTAL STRUCTURE OF FAB DX-2930 IN COMPLEX WITH HUMAN PLASMA KALLIKREIN AT 2.1 ANGSTROM RESOLUTION | 3.4.21.34 |
4OGZ | CRYSTAL STRUCTURE OF A PUTATIVE ALPHA-GALACTOSIDASE/MELIBIASE (BF4189) FROM BACTEROIDES FRAGILIS NCTC 9343 AT 2.00 A RESOLUTION | 3.2.1.22 |
4OH0 | CRYSTAL STRUCTURE OF OXA-58 CARBAPENEMASE | 3.5.2.6 |
4OHD | LEOPARD SYNDROME-ASSOCIATED SHP2/A461T MUTANT | 3.1.3.48 |
4OHE | LEOPARD SYNDROME-ASSOCIATED SHP2/G464A MUTANT | 3.1.3.48 |
4OHH | LEOPARD SYNDROME-ASSOCIATED SHP2/Q506P MUTANT | 3.1.3.48 |
4OHI | LEOPARD SYNDROME-ASSOCIATED SHP2/Q510E MUTANT | 3.1.3.48 |
4OHL | LEOPARD SYNDROME-ASSOCIATED SHP2/T468M MUTANT | 3.1.3.48 |
4OI5 | GLYCEROL-FREE STRUCTURE OF THERMOLYSIN IN COMPLEX WITH UBTLN58 | 3.4.24.27 |
4OID | STRUCTURAL AND KINETIC BASES FOR THE METAL PREFERENCE OF THE M18 AMINOPEPTIDASE FROM PSEUDOMONAS AERUGINOSA | 3.4.11 |
4OIE | WEST NILE VIRUS NON-STRUCTURAL PROTEIN NS1 | 3.4.21.91 3.6.1.15 3.6.4.13 2.1.1.56 2.1.1.57 2.7.7.48 |
4OIF | 3D STRUCTURE OF GAN42B, A GH42 BETA-GALACTOSIDASE FROM G. | 3.2.1.23 |
4OIG | DENGUE VIRUS NON-STRUCTURAL PROTEIN NS1 | 3.4.21.91 3.6.1.15 3.6.4.13 2.1.1.56 2.1.1.57 2.7.7.48 |
4OII | WEST NILE VIRUS NS1 IN COMPLEX WITH NEUTRALIZING 22NS1 ANTIBODY FAB | 3.4.21.91 3.6.1.15 3.6.4.13 2.1.1.56 2.1.1.57 2.7.7.48 |
4OIX | CRYSTAL STRUCTURE OF TRUNCATED ACYLPHOSPHATASE FROM S. SULFATARICUS | 3.6.1.7 |
4OJ1 | CRYSTAL STRUCTURE OF TRUNCATED ACYLPHOSPHATASE FROM S. SULFATARICUS | 3.6.1.7 |
4OJ3 | THE CRYSTAL STRUCTURE OF V84P MUTANT OF S. SOLFATARICUS ACYLPHOSPHATASE | 3.6.1.7 |
4OJG | THE CRYSTAL STRUCTURE OF V84D MUTANT OF S. SOLFATARICUS ACYLPHOSPHATASE | 3.6.1.7 |
4OJH | THE CRYSTAL STRUCTURE OF TRUNCATED, Y86E MUTANT OF S. SOLFATARICUS ACYLPHOSPHATASE | 3.6.1.7 |
4OJK | STRUCTURE OF THE CGMP DEPENDENT PROTEIN KINASE II AND RAB11B COMPLEX | 3.6.5.2 |
4OJQ | CRYSTAL STRUCTURE OF HEPATITIS C VIRUS NS3 HELICASE INHIBITOR CO-COMPLEX WITH FRAGMENT 1 [(5-BROMO-1H-INDOL-3-YL)ACETIC ACID] | 2.7.7.48 3.4.21.98 3.6.1.15 3.6.4.13 |
4OJR | CRYSTAL STRUCTURE OF THE HIV-1 INTEGRASE CATALYTIC DOMAIN WITH GSK1264 | 3.4.23.16 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1 |
4OJT | HELICOBACTER PYLORI MTAN COMPLEXED WITH S-RIBOSYLHOMOCYSTEINE AND ADENINE | 3.2.2.9 3.2.2.30 |
4OJV | CRYSTAL STRUCTURE OF UNLIGANDED YEAST PDE1 | 3.1.4.17 |
4OJX | CRYSTAL STRUCTURE OF YEAST PHOSPHODIESTERASE-1 IN COMPLEX WITH GMP | 3.1.4.17 |
4OJY | 3D STRUCTURE OF THE E323A CATALYTIC MUTANT OF GAN42B, A GH42 BETA-GALACTOSIDASE FROM G. STEAROTHERMOPHILUS | 3.2.1.23 |
4OK3 | CRYSTAL STRUCTURE OF HEPATITIS C VIRUS NS3 HELICASE INHIBITOR CO-COMPLEX WITH COMPOUND 7 [[1-(3-CHLOROBENZYL)-1H-INDOL-3-YL]ACETIC ACID] | 2.7.7.48 3.4.21.98 3.6.1.15 3.6.4.13 |
4OK5 | CRYSTAL STRUCTURE OF HEPATITIS C VIRUS NS3 HELICASE INHIBITOR CO-COMPLEX WITH COMPOUND 9 [1-(3-ETHYNYLBENZYL)-1H-INDOL-3-YL]ACETIC ACID] | 2.7.7.48 3.4.21.98 3.6.1.15 3.6.4.13 |
4OK6 | CRYSTAL STRUCTURE OF HEPATITIS C VIRUS NS3 HELICASE INHIBITOR CO-COMPLEX WITH COMPOUND 13 [[1-(2-METHOXY-5-NITROBENZYL)-1H-INDOL-3-YL]ACETIC ACID] | 2.7.7.48 3.4.21.98 3.6.1.15 3.6.4.13 |
4OKD | CRYSTAL STRUCTURE OF CHLAMYDOMONAS REINHARDTII ISOAMYLASE 1 (ISA1) IN COMPLEX WITH MALTOHEPTAOSE | 3.2.1.68 |
4OKE | STRUCTURE OF RNASE AS, A POLYADENYLATE-SPECIFIC EXORIBONUCLEASE AFFECTING MYCOBACTERIAL VIRULENCE IN VIVO | 3.1.13 |
4OKF | RNASE S IN COMPLEX WITH AN ARTIFICIAL PEPTIDE | 3.1.27.5 4.6.1.18 |
4OKG | LPXC FROM P.AERUGINOSA WITH THE INHIBITOR 6-(BENZIMIDAZOL-1-YL)-5-[4-[2-[6-[(4-METHYLPIPERAZIN-1-YL)METHYL]-3-PYRIDYL]ETHYNYL]PHENYL]PYRIDINE-3-CARBOHYDROXAMIC ACID | 3.5.1 3.5.1.108 |
4OKH | CRYSTAL STRUCTURE OF CALPAIN-3 PENTA-EF-HAND DOMAIN | 3.4.22.54 |
4OKJ | CRYSTAL STRUCTURE OF RNASE AS FROM M TUBERCULOSIS | 3.1.13 |
4OKK | CRYSTAL STRUCTURE OF RNASE AS FROM M TUBERCULOSIS IN COMPLEX WITH UMP | 3.1.13 |
4OKO | CRYSTAL STRUCTURE OF FRANCISELLA TULARENSIS REP34 (RAPID ENCYSTMENT PHENOTYPE PROTEIN 34 KDA) | 3.4 |
4OKP | CRYSTAL STRUCTURE OF AMPC BETA-LACTAMASE IN COMPLEX WITH THE PRODUCT FORM OF 7-AMINO-DESACETOXYCEPHALOSPORANIC ACID | 3.5.2.6 |
4OKS | CRYSTAL STRUCTURE OF HEPATITIS C VIRUS NS3 HELICASE INHIBITOR CO-COMPLEX WITH COMPOUND 19 [[6-(3,5-DIAMINOPHENYL)-1-(2-METHOXY-5-NITROBENZYL)-1H-INDOL-3-YL]ACETIC ACID] | 2.7.7.48 3.4.21.98 3.6.1.15 3.6.4.13 |
4OL7 | CRYSTAL STRUCTURE OF STAPHYLOCOCCAL NUCLEASE VARIANT DELTA+PHS V66E A109E AT CRYOGENIC TEMPERATURE | 3.1.31.1 |
4OL8 | TY3 REVERSE TRANSCRIPTASE BOUND TO DNA/RNA | 2.7.7.49 2.7.7.7 3.1.26.4 3.4.23 |
4OLA | CRYSTAL STRUCTURE OF HUMAN ARGONAUTE2 | 3.1.26 |
4OLB | CRYSTAL STRUCTURE OF HUMAN ARGONAUTE2 BOUND TO TRYPTOPHAN | 3.1.26 |
4OLD | CRYSTAL STRUCTURE OF AMPC BETA-LACTAMASE IN COMPLEX WITH THE PRODUCT FORM OF (6R,7R)-7-AMINO-8-OXO-5-THIA-1-AZABICYCLO[4.2.0]OCT-2-ENE-2-CARBOXYLIC ACID | 3.5.2.6 |
4OLG | CRYSTAL STRUCTURE OF AMPC BETA-LACTAMASE IN COMPLEX WITH COVALENTLY BOUND N-FORMYL 7-AMINOCEPHALOSPORANIC ACID | 3.5.2.6 |
4OLJ | CRYSTAL STRUCTURE OF ARG119GLN MUTANT OF PEPTIDYL-TRNA HYDROLASE FROM ACINETOBACTER BAUMANNII AT 1.49 A RESOLUTION | 3.1.1.29 |
4OLT | CHITOSANASE COMPLEX STRUCTURE | 3.2.1.132 |
4OM7 | CRYSTAL STRUCTURE OF TIR DOMAIN OF TLR6 | 3.2.2.6 |
4OM9 | X-RAY CRYSTAL STRUCTURE OF THE PASSENGER DOMAIN OF PLASMID ENCODED TOXIN, AN AUTROTANSPORTER ENTEROTOXIN FROM ENTEROAGGREGATIVE ESCHERICHIA COLI (EAEC) | 3.4.21 |
4OMC | X-RAY STRUCTURE OF HUMAN FURIN IN COMPLEX WITH THE COMPETITIVE INHIBITOR META-GUANIDINOMETHYL-PHAC-RVR-AMBA | 3.4.21.75 |
4OME | X-RAY STRUCTURE OF HUMAN GLUTAMATE CARBOXYPEPTIDASE II IN COMPLEX WITH DCCBL, A UREA BASED INHIBITOR WITH DISTAL CARBORANE MOIETY | 3.4.17.21 |
4ON9 | DECH BOX HELICASE DOMAIN | 3.6.4.13 |
4ONW | CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF DAPE PROTEIN FROM V.CHOLEREA | 3.5.1.18 |
4OO0 | CRYSTAL STRUCTURE OF MAF-LIKE PROTEIN BCEJ2315_23540 FROM BURKHOLDERIA CENOCEPACIA | 3.6.1.9 |
4OO8 | CRYSTAL STRUCTURE OF STREPTOCOCCUS PYOGENES CAS9 IN COMPLEX WITH GUIDE RNA AND TARGET DNA | 3.1 |
4OO9 | STRUCTURE OF THE HUMAN CLASS C GPCR METABOTROPIC GLUTAMATE RECEPTOR 5 TRANSMEMBRANE DOMAIN IN COMPLEX WITH THE NEGATIVE ALLOSTERIC MODULATOR MAVOGLURANT | 3.2.1.17 |
4OOG | CRYSTAL STRUCTURE OF YEAST RNASE III (RNT1P) COMPLEXED WITH THE PRODUCT OF DSRNA PROCESSING | 3.1.26.3 |
4OOH | STRUCTURE OF RIBONUCLEASE A AT 40C | 3.1.27.5 4.6.1.18 |
4OOK | THIRD METAL BOUND M.TUBERCULOSIS METHIONINE AMINOPEPTIDASE | 3.4.11.18 |
4OON | CRYSTAL STRUCTURE OF PBP1A IN COMPLEX WITH COMPOUND 17 ((4Z,8S,11E,14S)-5-(2-AMINO-1,3-THIAZOL-4-YL)-14-(5,6-DIHYDROXY-1,3-DIOXO-1,3-DIHYDRO-2H-ISOINDOL-2-YL)-8-FORMYL-2-METHYL-6-OXO-3,10-DIOXA-4,7,11-TRIAZATETRADECA-4,11-DIENE-2,12,14-TRICARBOXYLIC ACID) | 2.4.2 3.4 2.4.1.129 3.4.16.4 |
4OOO | X-RAY STRUCTURE OF THE LYSOZYME DERIVATIVE OF TETRAKIS(ACETATO)CHLORIDO DIRUTHENIUM(II,III) COMPLEX | 3.2.1.17 |
4OOP | ARABIDOPSIS THALIANA DUTPASE WITH WITH MAGNESIUM AND ALPHA,BETA-IMIDO-DUTP | 3.6.1.23 |
4OOQ | APO-DUTPASE FROM ARABIDOPSIS THALIANA | 3.6.1.23 |
4OOT | X-RAY STRUCTURE OF THE PROTEIN-GOLD ADDUCT FORMED UPON REACTION OF AUBIPIC WITH HEN EGG WHITE LYSOZYME | 3.2.1.17 |
4OOU | CRYSTAL STRUCTURE OF BETA-1,4-D-MANNANASE FROM CRYPTOPYGUS ANTARCTICUS | 3.2.1.78 |
4OOW | HCV NS5B POLYMERASE WITH A FRAGMENT OF QUERCETAGETIN | 2.7.7.48 3.4.22 3.4.21.98 3.6.1.15 3.6.4.13 |
4OOY | AVIBACTAM AND CLASS C BETA-LACTAMASES: MECHANISM OF INHIBITION, CONSERVATION OF BINDING POCKET AND IMPLICATIONS FOR RESISTANCE | 3.5.2.6 |
4OOZ | CRYSTAL STRUCTURE OF BETA-1,4-D-MANNANASE FROM CRYPTOPYGUS ANTARCTICUS IN COMPLEX WITH MANNOPENTAOSE | 3.2.1.78 |
4OP4 | CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF DAPE PROTEIN FROM V.CHOLEREA IN THE ZN BOUND FORM | 3.5.1.18 |
4OP5 | CRYSTAL STRUCTURE OF STABILIZED TEM-1 BETA-LACTAMASE VARIANT V.13 CARRYING R164S MUTATION | 3.5.2.6 |
4OP8 | ROOM TEMPERATURE CRYSTAL STRUCTURE OF STABILIZED TEM-1 BETA-LACTAMASE VARIANT V.13 CARRYING G238S MUTATION | 3.5.2.6 |
4OPJ | BH-RNASEH:TCDA-DNA COMPLEX | 3.1.26.4 |
4OPK | BH-RNASEH:2'-SME-DNA COMPLEX | 3.1.26.4 |
4OPM | CRYSTAL STRUCTURE OF A PUTATIVE LIPASE (LIP1) FROM ACINETOBACTER BAUMANNII AYE AT 1.70 A RESOLUTION | 3.1.1.3 |
4OPQ | ROOM TEMPERATURE CRYSTAL STRUCTURE OF STABILIZED TEM-1 BETA-LACTAMASE VARIANT V.13 CARRYING R164S/G238S MUTATIONS | 3.5.2.6 |
4OPR | CRYSTAL STRUCTURE OF STABILIZED TEM-1 BETA-LACTAMASE VARIANT V.13 CARRYING G238S MUTATION | 3.5.2.6 |
4OPY | ROOM TEMPERATURE CRYSTAL STRUCTURE OF STABILIZED TEM-1 BETA-LACTAMASE VARIANT V.13 CARRYING R164S MUTATION | 3.5.2.6 |
4OPZ | CRYSTAL STRUCTURE OF STABILIZED TEM-1 BETA-LACTAMASE VARIANT V.13 CARRYING G238S MUTATION IN COMPLEX WITH BORON-BASED INHIBITOR EC25 | 3.5.2.6 |
4OQ0 | CRYSTAL STRUCTURE OF STABILIZED TEM-1 BETA-LACTAMASE VARIANT V.13 CARRYING R164S/G238S MUTATION IN COMPLEX WITH BORON-BASED INHIBITOR EC25 | 3.5.2.6 |
4OQ2 | 5HMC SPECIFIC RESTRICTION ENDONUCLEASE PVURTS1I | 3.1.21 |
4OQ4 | CRYSTAL STRUCTURE OF E18A HUMAN DJ-1 | 3.4 3.1.2 3.5.1 3.5.1.124 |
4OQF | MYCOBACTERIUM TUBERCULOSIS RECA GLYCEROL BOUND LOW TEMPERATURE STRUCTURE IIB-SR | 3.1 |
4OQG | CRYSTAL STRUCTURE OF TEM-1 BETA-LACTAMASE IN COMPLEX WITH BORON-BASED INHIBITOR EC25 | 3.5.2.6 |
4OQH | CRYSTAL STRUCTURE OF STABILIZED TEM-1 BETA-LACTAMASE VARIANT V.13 CARRYING R164S MUTATION IN COMPLEX WITH BORON-BASED INHIBITOR EC25 | 3.5.2.6 |
4OQI | CRYSTAL STRUCTURE OF STABILIZED TEM-1 BETA-LACTAMASE VARIANT V.13 CARRYING R164S/G238S MUTATIONS | 3.5.2.6 |
4OQO | CRYSTAL STRUCTURE OF THE TRYPTIC GENERATED IRON-FREE C-LOBE OF BOVINE LACTOFERRIN AT 2.42 ANGSTROM RESOLUTION | 3.4.21 |
4OR9 | CRYSTAL STRUCTURE OF HUMAN CALCINEURIN | 3.1.3.16 |
4ORA | CRYSTAL STRUCTURE OF A HUMAN CALCINEURIN MUTANT | 3.1.3.16 |
4ORB | CRYSTAL STRUCTURE OF MOUSE CALCINEURIN | 3.1.3.16 |
4ORC | CRYSTAL STRUCTURE OF MAMMALIAN CALCINEURIN | 3.1.3.16 |
4ORD | CRYSTAL STRUCTURE OF ZEBRA FISH THIOESTERASE SUPERFAMILY MEMBER 2 | 3.1.2 |
4OS1 | CRYSTAL STRUCTURE OF UROKINASE-TYPE PLASMINOGEN ACTIVATOR (UPA) COMPLEXED WITH BICYCLIC PEPTIDE UK601 (BICYCLIC 1) | 3.4.21.73 |
4OS2 | CRYSTAL STRUCTURE OF UROKINASE-TYPE PLASMINOGEN ACTIVATOR (UPA) COMPLEXED WITH BICYCLIC PEPTIDE UK602 (BICYCLIC 1) | 3.4.21.73 |
4OS4 | CRYSTAL STRUCTURE OF UROKINASE-TYPE PLASMINOGEN ACTIVATOR (UPA) COMPLEXED WITH BICYCLIC PEPTIDE UK603 (BICYCLIC 1) | 3.4.21.73 |
4OS5 | CRYSTAL STRUCTURE OF UROKINASE-TYPE PLASMINOGEN ACTIVATOR (UPA) COMPLEXED WITH BICYCLIC PEPTIDE UK603 (BICYCLIC 2) | 3.4.21.73 |
4OS6 | CRYSTAL STRUCTURE OF UROKINASE-TYPE PLASMINOGEN ACTIVATOR (UPA) COMPLEXED WITH BICYCLIC PEPTIDE UK604 (BICYCLIC 2) | 3.4.21.73 |
4OS7 | CRYSTAL STRUCTURE OF UROKINASE-TYPE PLASMINOGEN ACTIVATOR (UPA) COMPLEXED WITH BICYCLIC PEPTIDE UK607 (BICYCLIC) | 3.4.21.73 |
4OSD | DIMER OF A C-TERMINAL FRAGMENT OF PHAGE T4 GP5 BETA-HELIX | 3.2.1.17 |
4OSX | STRUCTURE OF UNCLEAVED GLYCINE-BOUND HUMAN L-ASPARAGINASE PROTEIN | 3.4.19.5 3.5.1.1 |
4OSY | STRUCTURE OF FULLY-CLEAVED GLYCINE-BOUND HUMAN L-ASPARAGINASE PROTEIN | 3.4.19.5 3.5.1.1 |
4OT4 | X-RAY STRUCTURE OF THE ADDUCT FORMED BETWEEN CISPLATIN AND RIBONUCLEASE A | 3.1.27.5 4.6.1.18 |
4OTP | CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF THE HUMAN RIOK1 ATYPICAL PROTEIN KINASE IN COMPLEX WITH ADP/MG2+ | 2.7.11.1 3.6.3 |
4OU3 | CRYSTAL STRUCTURE OF PORCINE AMINOPEPTIDASE N COMPLEXED WITH CNGRCG TUMOR-HOMING PEPTIDE | 3.4.11.2 |
4OU4 | CRYSTAL STRUCTURE OF ESTERASE RPPE MUTANT S159A COMPLEXED WITH (S)-AC-CPA | 3.1.1.1 |
4OU5 | CRYSTAL STRUCTURE OF ESTERASE RPPE MUTANT S159A/W187H | 3.1.1.1 |
4OUE | CRYSTAL STRUCTURE OF AN A-L-FUCOSIDASE GH29 FROM BACTEROIDES THETAIOTAOMICRON (BT2192) IN COMPLEX WITH IPTG | 3.2.1.111 |
4OUI | STRUCTURE OF VIBRIO CHOLERAE CHITIN DE-N-ACETYLASE IN COMPLEX WITH TRIACETYLCHITOTRIOSE (CTO) | 3.5.1.41 |
4OUN | CRYSTAL STRUCTURE OF MINI-RIBONUCLEASE 3 FROM BACILLUS SUBTILIS | 3.1.26 |
4OV6 | CRYSTAL STRUCTURE OF PCSK9(53-451) WITH ADNECTIN | 3.4.21 |
4OVL | INTERROGATING HIV INTEGRASE FOR COMPOUNDS THAT BIND- A SAMPL CHALLENGE | 2.7.7.1 3.4.23.16 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1 |
4OVW | ENDOGLUCANASE I COMPLEXED WITH EPOXYBUTYL CELLOBIOSE | 3.2.1.4 |
4OVZ | X-RAY STRUCTURAL AND BIOLOGICAL EVALUATION OF A SERIES OF POTENT AND HIGHLY SELECTIVE INHIBITORS OF HUMAN CORONAVIRUS PAPAIN-LIKE PROTEASES | 3.4.19.12 3.4.22.69 3.4.22 |
4OW0 | X-RAY STRUCTURAL AND BIOLOGICAL EVALUATION OF A SERIES OF POTENT AND HIGHLY SELECTIVE INHIBITORS OF HUMAN CORONAVIRUS PAPAIN-LIKE PROTEASES | 3.4.19.12 3.4.22.69 3.4.22 |
4OW1 | CRYSTAL STRUCTURE OF RESUSCITATION PROMOTING FACTOR C | 3 |
4OW3 | THERMOLYSIN STRUCTURE DETERMINED BY FREE-ELECTRON LASER | 3.4.24.27 |
4OWA | CARBOPLATIN BINDING TO HEWL UNDER SODIUM IODIDE CRYSTALLISATION CONDITIONS | 3.2.1.17 |
4OWB | CISPLATIN BINDING TO HEWL UNDER SODIUM BROMIDE CRYSTALLISATION CONDITIONS | 3.2.1.17 |
4OWC | PTI6 BINDING TO HEWL | 3.2.1.17 |
4OWE | PTCL6 BINDING TO HEWL | 3.2.1.17 |
4OWH | PTBR6 BINDING TO HEWL | 3.2.1.17 |
4OWZ | STRUCTURE OF ECP/H15A MUTANT. | 3.1.27 |
4OX3 | STRUCTURE OF THE LDCB LD-CARBOXYPEPTIDASE REVEALS THE MOLECULAR BASIS OF PEPTIDOGLYCAN RECOGNITION | 3.4 |
4OXB | STRUCTURE OF ECP WITH SULPHATE ANIONS AT 1.50 ANGSTROMS | 3.1.27 |
4OXF | STRUCTURE OF ECP IN COMPLEX WITH CITRATE IONS AT 1.50 ANGSTROMS | 3.1.27 |
4OXP | X-RAY CRYSTAL STRUCTURE OF THE S1 AND 5'-SENSOR DOMAINS OF RNASE E FROM CAULOBACTER CRESCENTUS | 3.1.26.12 |
4OY3 | CRYSTAL STRUCTURE OF THE HELICOBACTER PYLORI MTAN-D198N MUTANT WITH S-ADENOSYLHOMOCYSTEINE IN THE ACTIVE SITE | 3.2.2.30 3.2.2.9 |
4OYL | HUMICOLA INSOLENS CUTINASE IN COMPLEX WITH MONO-ETHYLPHOSPHATE | 3.1.1.74 |
4OYY | HUMICOLA INSOLENS CUTINASE | 3.1.1.74 |
4OZE | A.AOLICUS LPXC IN COMPLEX WITH NATIVE PRODUCT | 3.5.1 3.5.1.108 |
4OZO | CRYSTAL STRUCTURE OF AN A-L-FUCOSIDASE GH29 FROM BACTEROIDES THETAIOTAOMICRON (BT2192) IN COMPLEX WITH ONPTG | 3.2.1.111 |
4P08 | ENGINEERED THERMOSTABLE DIMERIC COCAINE ESTERASE | 3.1.1.84 |
4P0E | YHDE E33A (P212121 SPACE GROUP) | 3.6.1.9 |
4P0M | CRYSTAL STRUCTURE OF AN EVOLVED PUTATIVE PENICILLIN-BINDING PROTEIN HOMOLOG, RV2911, FROM MYCOBACTERIUM TUBERCULOSIS | 3.4.16.4 |
4P0N | CRYSTAL STRUCTURE OF PDE10A WITH A NOVEL IMIDAZO[4,5-B]PYRIDINE INHIBITOR | 3.1.4.17 3.1.4.35 |
4P0P | CRYSTAL STRUCTURE OF HUMAN MUS81-EME1 IN COMPLEX WITH 5'-FLAP DNA, AND MG2+ | 3.1.22 |
4P0Q | CRYSTAL STRUCTURE OF HUMAN MUS81-EME1 IN COMPLEX WITH 5'-FLAP DNA | 3.1.22 |
4P0R | HUMAN MUS81-EME1-3'FLAP DNA COMPLEX | 3.1.22 |
4P10 | PRO-CARBOXYPEPTIDASE U IN COMPLEX WITH 5-(3-AMINOPROPYL)-1-PROPYL-6,7-DIHYDRO-4H-BENZIMIDAZOLE-5-CARBOXYLIC ACID | 3.4.17.20 |
4P16 | CRYSTAL STRUCTURE OF THE PAPAIN-LIKE PROTEASE OF MIDDLE-EAST RESPIRATORY SYNDROME CORONAVIRUS | 2.7.7.48 3.4.19.12 3.4.22.69 3.6.4.12 3.6.4.13 |
4P1H | CRYSTAL STRUCTURE OF WILD TYPE HYPOCREA JECORINA CEL7A IN A MONOCLINIC CRYSTAL FORM | 3.2.1.91 |
4P1J | CRYSTAL STRUCTURE OF WILD TYPE HYPOCREA JECORINA CEL7A IN A HEXAGONAL CRYSTAL FORM | 3.2.1.91 |
4P1R | CRYSTAL STRUCTURE OF PDE10A WITH IMIDAZO[4,5-B]PYRIDINES AS POTENT AND SELECTIVE INHIBITORS | 3.1.4.17 3.1.4.35 |
4P1Z | STRUCTURE OF THE MID DOMAIN FROM MIWI | 3.1.26 |
4P2C | COMPLEX OF SHIGA TOXIN 2E WITH A NEUTRALIZING SINGLE-DOMAIN ANTIBODY | 3.2.2.22 |
4P2E | ACOUSTIC TRANSFER OF PROTEIN CRYSTALS FROM AGAR PEDESTALS TO MICROMESHES FOR HIGH THROUGHPUT SCREENING OF HEAVY ATOM DERIVATIVES | 3.2.1.17 |
4P2G | CRYSTAL STRUCTURE OF DJ-1 IN SULFINIC ACID FORM (AGED CRYSTAL) | 3.4 3.1.2 3.5.1 3.5.1.124 |
4P2P | AN INDEPENDENT CRYSTALLOGRAPHIC REFINEMENT OF PORCINE PHOSPHOLIPASE A2 AT 2.4 ANGSTROMS RESOLUTION | 3.1.1.4 |
4P2T | CRYSTAL STRUCTURE OF KAPOSI'S SARCOMA-ASSOCIATED HERPESVIRUS (KSHV) PROTEASE IN COMPLEX WITH A DIMER DISRUPTOR | 3.4.21.97 |
4P31 | CRYSTAL STRUCTURE OF A SELENOMETHIONINE DERIVATIVE OF E. COLI LPTB IN COMPLEX WITH ADP-MAGENSIUM | 3.6.3 7.5.2 |
4P32 | CRYSTAL STRUCTURE OF E. COLI LPTB IN COMPLEX WITH ADP-MAGNESIUM | 3.6.3 7.5.2 |
4P33 | CRYSTAL STRUCTURE OF E. COLI LPTB-E163Q IN COMPLEX WITH ATP-SODIUM | 3.6.3 7.5.2 |
4P34 | CRYSTAL STRUCTURE OF DJ-1 IN SULFENIC ACID FORM (FRESH CRYSTAL) | 3.4 3.1.2 3.5.1 3.5.1.124 |
4P35 | CRYSTAL STRUCTURE OF DJ-1 WITH ZINC(II) BOUND (CRYSTAL I) | 3.4 3.1.2 3.5.1 3.5.1.124 |
4P36 | CRYSTAL STRUCTURE OF DJ-1 WITH ZN(II) BOUND (CRYSTAL 2) | 3.4 3.1.2 3.5.1 3.5.1.124 |
4P44 | X-RAY STRUCTURE OF HUMAN GLUTAMATE CARBOXYPEPTIDASE II (GCPII) IN COMPLEX WITH A PHOSPHORAMIDATE INHIBITOR JRB-4-81 | 3.4.17.21 |
4P45 | X-RAY STRUCTURE OF HUMAN GLUTAMATE CARBOXYPEPTIDASE II (GCPII) IN COMPLEX WITH A PHOSPHORAMIDATE INHIBITOR JRB-4-73 | 3.4.17.21 |
4P4B | X-RAY STRUCTURE OF HUMAN GLUTAMATE CARBOXYPEPTIDASE II (GCPII) IN COMPLEX WITH A PHOSPHORAMIDATE INHIBITOR CTT54 | 3.4.17.21 |
4P4D | X-RAY STRUCTURE OF HUMAN GLUTAMATE CARBOXYPEPTIDASE II (GCPII) IN COMPLEX WITH A PHOSPHORAMIDATE INHIBITOR MP1C | 3.4.17.21 |
4P4E | X-RAY STRUCTURE OF HUMAN GLUTAMATE CARBOXYPEPTIDASE II (GCPII) IN COMPLEX WITH A PHOSPHORAMIDATE INHIBITOR MP1D | 3.4.17.21 |
4P4F | X-RAY STRUCTURE OF HUMAN GLUTAMATE CARBOXYPEPTIDASE II (GCPII) IN COMPLEX WITH A PHOSPHORAMIDATE INHIBITOR NC-2-40 | 3.4.17.21 |
4P4I | X-RAY STRUCTURE OF HUMAN GLUTAMATE CARBOXYPEPTIDASE II (GCPII) IN COMPLEX WITH A PHOSPHORAMIDATE INHIBITOR T33 | 3.4.17.21 |
4P4J | X-RAY STRUCTURE OF HUMAN GLUTAMATE CARBOXYPEPTIDASE II (GCPII) IN COMPLEX WITH A PHOSPHORAMIDATE INHIBITOR T33D | 3.4.17.21 |
4P54 | CRYSTAL STRUCTURE OF THE HELICOBACTER PYLORI MTAN-D198N MUTANT WITH 5'-METHYLTHIOADENOSINE IN THE ACTIVE SITE. | 3.2.2.9 3.2.2.30 |
4P5D | CRYSTAL STRUCTURE OF RAT DNPH1 (RCL) WITH 6-NAPHTHYL-PURINE-RIBOSIDE-MONOPHOSPHATE | 3.2.2 |
4P5E | CRYSTAL STRUCTURE OF HUMAN DNPH1 (RCL) WITH 6-NAPHTHYL-PURINE-RIBOSIDE-MONOPHOSPHATE | 3.2.2 |
4P5U | CRYSTAL STRUCTURE OF TATD | 3.1.15 3.1.11 3.1.13 |
4P69 | ACEK (D477A) ICDH COMPLEX | 2.7.11.5 3.1.3 |
4P6E | CRYSTAL STRUCTURE OF HUMAN CATHEPSIN S BOUND TO A NON-COVALENT INHIBITOR | 3.4.22.27 |
4P6G | CRYSTAL STRUCTURE OF HUMAN CATHEPSIN S BOUND TO A NON-COVALENT INHIBITOR. | 3.4.22.27 |
4P6I | CRYSTAL STRUCTURE OF THE CAS1-CAS2 COMPLEX FROM ESCHERICHIA COLI | 3.1 |
4P7B | CRYSTAL STRUCTURE OF S. TYPHIMURIUM PEPTIDYL-TRNA HYDROLASE | 3.1.1.29 |
4P7L | STRUCTURE OF ESCHERICHIA COLI PGAB C-TERMINAL DOMAIN, P212121 CRYSTAL FORM | 3.5.1 |
4P7N | STRUCTURE OF ESCHERICHIA COLI PGAB C-TERMINAL DOMAIN IN COMPLEX WITH GLUCOSAMINE | 3.5.1 |
4P7O | STRUCTURE OF ESCHERICHIA COLI PGAB C-TERMINAL DOMAIN, P1 CRYSTAL FORM | 3.5.1 |
4P7Q | STRUCTURE OF ESCHERICHIA COLI PGAB C-TERMINAL DOMAIN IN COMPLEX WITH N-ACETYLGLUCOSAMINE | 3.5.1 |
4P7R | STRUCTURE OF ESCHERICHIA COLI PGAB C-TERMINAL DOMAIN IN COMPLEX WITH A POLY-BETA-1,6-N-ACETYL-D-GLUCOSAMINE (PNAG) HEXAMER | 3.5.1 |
4P92 | CRYSTAL STRUCTURE OF DIENELACTONE HYDROLASE C123S MUTANT AT 1.65 A RESOLUTION | 3.1.1.45 |
4P93 | STRUCTURE OF DIENELACTONE HYDROLASE AT 1.85 A RESOLUTION CRYSTALLISED IN THE C2 SPACE GROUP | 3.1.1.45 |
4PA1 | CRYSTAL STRUCTURE OF CATALYTIC CORE DOMAIN OF FIV INTEGRASE | 3.4.23 2.7.7.49 3.1.26.13 3.1.13.2 3.6.1.23 2.7.7 3.1 |
4PAD | BINDING OF CHLOROMETHYL KETONE SUBSTRATE ANALOGUES TO CRYSTALLINE PAPAIN | 3.4.22.2 |
4PBE | PHOSPHOTRIESTERASE VARIANT REV6 | 3.1.8.1 |
4PBG | 6-PHOSPHO-BETA-GALACTOSIDASE FORM-CST | 3.2.1.85 |
4PBX | CRYSTAL STRUCTURE OF THE SIX N-TERMINAL DOMAINS OF HUMAN RECEPTOR PROTEIN TYROSINE PHOSPHATASE SIGMA | 3.1.3.48 |
4PCP | CRYSTAL STRUCTURE OF PHOSPHOTRIESTERASE VARIANT R0 | 3.1.8.1 |
4PCT | CRYSTAL STRUCTURE OF A BACTERIAL FUCOSIDASE WITH IMINOCYCLITOL (2S,3S,4R,5S)-3,4-DIHYDROXY-2-ETHYNYL-5-METHYLPYRROLIDINE | 3.2.1.51 |
4PCZ | CRYSTAL STRUCTURE OF A COMPLEX BETWEEN R247G LLFPG MUTANT AND A THF CONTAINING DNA | 3.2.2.23 4.2.99.18 |
4PD2 | CRYSTAL STRUCTURE OF A COMPLEX BETWEEN A C248GH LLFPG MUTANT AND A THF CONTAINING DNA | 3.2.2.23 4.2.99.18 |
4PDG | CRYSTAL STRUCTURE OF A COMPLEX BETWEEN AN INHIBITED LLFPG AND A THF CONTAINING DNA | 3.2.2.23 4.2.99.18 |
4PDI | CRYSTAL STRUCTURE OF A COMPLEX BETWEEN AN INHIBITED LLFPG AND A N7-BENZYL-FAPY-DG CONTAINING DNA | 3.2.2.23 4.2.99.18 |
4PDW | A BENZONITRILE ANALOGUE INHIBITS RHINOVIRUS REPLICATION | 3.4.22.29 3.6.1.15 3.4.22.28 2.7.7.48 |
4PDX | CRYSTAL STRUCTURE OF ESCHERCHIA COLI UNCHARACTERIZED PROTEIN YJCS | 3.1.6 |
4PE8 | CRYSTAL STRUCTURE OF TATD IN COMPLEX WITH TRINUCLEOTIDE DNA | 3.1.15 3.1.11 3.1.13 |
4PEL | S1C MUTANT OF PENICILLIN G ACYLASE FROM KLUYVERA CITROPHILA | 3.5.1.11 |
4PEP | THE MOLECULAR AND CRYSTAL STRUCTURES OF MONOCLINIC PORCINE PEPSIN REFINED AT 1.8 ANGSTROMS RESOLUTION | 3.4.23.1 |
4PEQ | STRUCTURE OF BOVINE RIBONUCLEASE INHIBITOR COMPLEXED WITH BOVINE RIBONUCLEASE I | 3.1.27.5 4.6.1.18 |
4PES | CRYSTAL STRUCTURE OF INSULIN DEGRADING ENZYME COMPLEXED WITH INHIBITOR TERT-BUTYL [(2S)-2-(2,5-DIFLUOROPHENYL)-3-(QUINOLIN-3-YL)PROPYL]CARBAMATE | 3.4.24.56 |
4PEW | STRUCTURE OF SACTELAM55A FROM STREPTOMYCES SP. SIREXAA-E | 3.2.1.58 |
4PEX | STRUCTURE OF THE E502A VARIANT OF SACTELAM55A FROM STREPTOMYCES SP. SIREXAA-E IN COMPLEX WITH GLUCOSE | 3.2.1.58 |
4PEY | STRUCTURE OF THE E502A VARIANT OF SACTELAM55A FROM STREPTOMYCES SP. SIREXAA-E IN COMPLEX WITH LAMINARITRIOSE | 3.2.1.58 |
4PEZ | STRUCTURE OF THE E502A VARIANT OF SACTELAM55A FROM STREPTOMYCES SP. SIREXAA-E IN COMPLEX WITH LAMINARITETRAOSE | 3.2.1.58 |
4PF0 | STRUCTURE OF THE E502A VARIANT OF SACTELAM55A FROM STREPTOMYCES SP. SIREXAA-E IN COMPLEX WITH LAMINARIHEXAOSE | 3.2.1.58 |
4PF7 | CRYSTAL STRUCTURE OF INSULIN DEGRADING ENZYME COMPLEXED WITH INHIBITOR | 3.4.24.56 |
4PF9 | CRYSTAL STRUCTURE OF INSULIN DEGRADING ENZYME COMPLEXED WITH INHIBITOR | 3.4.24.56 |
4PFC | CRYSTAL STRUCTURE OF INSULIN DEGRADING ENZYME COMPLEXED WITH INHIBITOR | 3.4.24.56 |
4PFJ | THE STRUCTURE OF BI-ACETYLATED SAHH | 3.3.1.1 |
4PGA | GLUTAMINASE-ASPARAGINASE FROM PSEUDOMONAS 7A | 3.5.1.38 |
4PGF | THE STRUCTURE OF MONO-ACETYLATED SAHH | 3.3.1.1 |
4PHI | CRYSTAL STRUCTURE OF HEWL WITH HEXATUNGSTOTELLURATE(VI) | 3.2.1.17 |
4PHL | TBRPDEB1-INHIBITOR COMPLEX | 3.1.4 |
4PHU | CRYSTAL STRUCTURE OF HUMAN GPR40 BOUND TO ALLOSTERIC AGONIST TAK-875 | 3.2.1.17 |
4PHV | X-RAY CRYSTAL STRUCTURE OF THE HIV PROTEASE COMPLEX WITH L-700,417, AN INHIBITOR WITH PSEUDO C2 SYMMETRY | 3.4.23.16 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1 |
4PHW | CRYSTAL STRUCTURE OF PDE10A WITH 1H-BENZIMIDAZOL-2-YL(4-((3-(TETRAHYDRO-2H-PYRAN-4-YL)-2-PYRIDINYL)OXY)PHENYL)METHANONE | 3.1.4.17 3.1.4.35 |
4PI3 | CRYSTAL STRUCTURE ANALYSIS OF CRUZAIN BOUND TO VINYL SULFONE ANALOG OF WRR-483 (WRR-666) | 3.4.22.51 |
4PIC | YWLE ARGININE PHOSPHATASE FROM GEOBACILLUS STEAROTHERMOPHILUS | 3.9.1.2 |
4PID | CRYSTAL STRUCTURE OF HUMAN ADENOVIRUS 2 PROTEASE WITH A WEAK PYRIMIDINE NITRILE INHIBITOR | 3.4.22.39 |
4PIE | CRYSTAL STRUCTURE OF HUMAN ADENOVIRUS 2 PROTEASE A SUBSTRATE BASED NITRILE INHIBITOR | 3.4.22.39 |
4PII | CRYSTAL STRUCTURE OF HYPOTHETICAL PROTEIN PF0907 FROM PYROCOCCUS FURIOSUS SOLVED BY SULFUR SAD USING SWISS LIGHT SOURCE DATA | 3.2.2 4.2.99.18 |
4PIQ | CRYSTAL STRUCTURE OF HUMAN ADENOVIRUS 8 PROTEASE WITH A NITRILE INHIBITOR | 3.4.22.39 |
4PIS | CRYSTAL STRUCTURE OF HUMAN ADENOVIRUS 8 PROTEASE IN COMPLEX WITH A NITRILE INHIBITOR | 3.4.22.39 |
4PIV | HUMAN FATTY ACID SYNTHASE PSI/KR TRI-DOMAIN WITH NADPH AND GSK2194069 | 2.3.1.85 2.3.1.38 2.3.1.39 2.3.1.41 1.1.1.100 4.2.1.59 1.3.1.39 3.1.2.14 |
4PJ3 | STRUCTURAL INSIGHT INTO THE FUNCTION AND EVOLUTION OF THE SPLICEOSOMAL HELICASE AQUARIUS, STRUCTURE OF AQUARIUS IN COMPLEX WITH AMPPNP | 3.6.4.13 |
4PJK | DICTY MYOSIN II R238E.E459R MUTANT (WITH ADP.PI) IN THE PI RELEASE STATE | 3.6.4.1 |
4PJZ | CRYSTAL STRUCTURE OF T4 LYSOZYME-GSS-PEPTIDE IN COMPLEX WITH TEICOPLANIN-A2-2 | 3.2.1.17 |
4PK0 | CRYSTAL STRUCTURE OF T4 LYSOZYME-PEPTIDE IN COMPLEX WITH TEICOPLANIN-A2-2 | 3.2.1.17 |
4PK9 | THE CRYSTAL STRUCTURE OF NATIVE PATATIN | 3.1.1 |
4PKA | CRYSTAL STRUCTURE OF PATATIN AGED WITH DIISOPROPYLPHOSPHOROFLUORIDATE | 3.1.1 |
4PKB | CRYSTAL STRUCTURE OF PATATIN-17 COMPLEXED WITH METHYL ARACHIDONYL FLUOROPHOSPHONATE (MAFP) | 3.1.1 |
4PKQ | ANTHRAX TOXIN LETHAL FACTOR WITH BOUND ZINC | 3.4.24.83 |
4PKR | ANTHRAX TOXIN LETHAL FACTOR WITH BOUND SMALL MOLECULE INHIBITOR 10 | 3.4.24.83 |
4PKS | ANTHRAX TOXIN LETHAL FACTOR WITH BOUND SMALL MOLECULE INHIBITOR 11 | 3.4.24.83 |
4PKT | ANTHRAX TOXIN LETHAL FACTOR WITH BOUND SMALL MOLECULE INHIBITOR 13 | 3.4.24.83 |
4PKU | ANTHRAX TOXIN LETHAL FACTOR WITH BOUND SMALL MOLECULE INHIBITOR 15 | 3.4.24.83 |
4PKV | ANTHRAX TOXIN LETHAL FACTOR WITH BOUND SMALL MOLECULE INHIBITOR 16 | 3.4.24.83 |
4PKW | ANTHRAX TOXIN LETHAL FACTOR WITH BOUND SMALL MOLECULE INHIBITOR GM6001 | 3.4.24.83 |
4PL3 | CRYSTAL STRUCTURE OF MURINE IRE1 IN COMPLEX WITH MKC9989 INHIBITOR | 2.7.11.1 3.1.26 |
4PL4 | CRYSTAL STRUCTURE OF MURINE IRE1 IN COMPLEX WITH OICR464 INHIBITOR | 2.7.11.1 3.1.26 |
4PL5 | CRYSTAL STRUCTURE OF MURINE IRE1 IN COMPLEX WITH OICR573 INHIBITOR | 2.7.11.1 3.1.26 |
4PLA | CRYSTAL STRUCTURE OF PHOSPHATIDYL INOSITOL 4-KINASE II ALPHA IN COMPLEX WITH ATP | 2.7.1.67 3.2.1.17 |
4PM0 | PDE7A CATALYTIC DOMAIN IN COMPLEX WITH 2-(CYCLOPENTYLAMINO)THIENO[3,2-D]PYRIMIDIN-4(3H)-ONE DERIVATIVE | 3.1.4.53 |
4PM5 | CRYSTAL STRUCTURE OF CTX-M-14 S70G BETA-LACTAMASE IN COMPLEX WITH CEFOTAXIME AT 1.26 ANGSTROMS RESOLUTION | 3.5.2.6 |
4PM6 | CRYSTAL STRUCTURE OF CTX-M-14 S70G BETA-LACTAMASE AT 1.56 ANGSTROMS RESOLUTION | 3.5.2.6 |
4PM7 | CRYSTAL STRUCTURE OF CTX-M-14 S70G:S237A IN COMPLEX WITH CEFOTAXIME AT 1.29 ANGSTROMS RESOLUTION | 3.5.2.6 |
4PM8 | CRYSTAL STRUCTURE OF CTX-M-14 S70G:S237A BETA-LACTAMASE AT 1.17 ANGSTROMS RESOLUTION | 3.5.2.6 |
4PM9 | CRYSTAL STRUCTURE OF CTX-M-14 S70G:S237A:R276A BETA-LACTAMASE IN COMPLEX WITH CEFOTAXIME AT 1.45 ANGSTROMS RESOLUTION | 3.5.2.6 |
4PMA | CRYSTAL STRUCTURE OF CTX-M-14 S70G:S237A:R276A BETA-LACTAMASE AT 1.39 ANGSTROMS RESOLUTION | 3.5.2.6 |
4PMB | CRYSTAL STRUCTURE OF STAPHYLCOCCAL NUCLEASE VARIANT DELTA+PHS I92S AT CRYOGENIC TEMPERATURE | 3.1.31.1 |
4PMC | CRYSTAL STRUCTURE OF STAPHYLCOCCAL NUCLEASE VARIANT DELTA+PHS I72K V74K AT CRYOGENIC TEMPERATURE | 3.1.31.1 |
4PMD | CRYSTAL STRUCTURE OF CBXYN10B FROM CALDICELLULOSIRUPTOR BESCII AND ITS MUTANT(E139A) IN COMPLEX WITH HYDROLYZED XYLOTETRAOSE | 3.2.1.8 |
4PMH | THE STRUCTURE OF RICE WEEVIL PECTIN METHYL ESTERASE | 3.1.1.11 |
4PMU | CRYSTAL STRUCTURE OF A NOVEL REDUCING-END XYLOSE-RELEASING EXO-OLIGOXYLANASE (XYNA) BELONGING TO GH10 FAMILY (SPACE GROUP P1211) | 3.2.1.8 |
4PMV | CRYSTAL STRUCTURE OF A NOVEL REDUCING-END XYLOSE-RELEASING EXO-OLIGOXYLANASE (XYNA) BELONGING TO GH10 FAMILY (SPACE GROUP P43212) | 3.2.1.8 |
4PMW | STRUCTURE OF MOUSE DIS3L2 IN COMPLEX WITH OLIGOU RNA SUBSTRATE | 3.1.13 |
4PMX | CRYSTAL STRUCTURE OF GH10 ENDO-B-1,4-XYLANASE (XYNB) FROM XANTHOMONAS AXONOPODIS PV CITRI IN THE NATIVE FORM | 3.2.1.8 |
4PMY | CRYSTAL STRUCTURE OF GH10 ENDO-B-1,4-XYLANASE (XYNB) FROM XANTHOMONAS AXONOPODIS PV CITRI COMPLEXED WITH XYLOSE | 3.2.1.8 |
4PMZ | CRYSTAL STRUCTURE OF GH10 ENDO-B-1,4-XYLANASE (XYNB) FROM XANTHOMONAS AXONOPODIS PV CITRI COMPLEXED WITH XYLOBIOSE | 3.2.1.8 |
4PN0 | STRUCTURE OF S. POMBE PCT1 RNA TRIPHOSPHATASE | 3.1.3.33 |
4PN1 | STRUCTURE OF S. POMBE PCT1 RNA TRIPHOSPHATASE IN COMPLEX WITH THE SPT5 CTD | 3.1.3.33 |
4PN2 | CRYSTAL STRUCTURE OF GH10 ENDO-B-1,4-XYLANASE (XYNB) FROM XANTHOMONAS AXONOPODIS PV CITRI COMPLEXED WITH XYLOTRIOSE | 3.2.1.8 |
4PNC | E. COLI METHIONINE AMINOPEPTIDASE IN COMPLEX WITH INHIBITOR 7-METHOXY-2-METHYLEN-3,4-DIHYDRONAPHTHALEN-1(2H)-ONE | 3.4.11.18 |
4PNH | CRYSTAL STRUCTURE OF D,D-HEPTOSE 1,7-BISPHOSPHATE PHOSPHATASE FROM BURKHOLDERIA THAILANDENSIS | 3.1.3 |
4PNY | CRYSTAL STRUCTURE OF STAPHYLOCOCCAL NUCLEASE VARIANT DELTA+PHS I72H AT CRYOGENIC TEMPERATURE | 3.1.31.1 |
4PNZ | HUMAN DIPEPTIDYL PEPTIDASE IV/CD26 IN COMPLEX WITH THE LONG-ACTING INHIBITOR OMARIGLIPTIN (MK-3102) | 3.4.14.5 |
4PO1 | MYCOBACTERIUM TUBERCULOSIS RECA GLYCEROL BOUND ROOM TEMPERATURE STRUCTURE IIC-RT | 3.1 |
4PO8 | MYCOBACTERIUM TUBERCULOSIS RECA GLYCEROL BOUND LOW TEMPERATURE STRUCTURE IIC-CR | 3.1 |
4PO9 | MYCOBACTERIUM TUBERCULOSIS RECA GLYCEROL BOUND LOW TEMPERATURE STRUCTURE IIC-BR | 3.1 |
4POA | MYCOBACTERIUM TUBERCULOSIS RECA GLYCEROL BOUND LOW TEMPERATURE STRUCTURE IIC-BN | 3.1 |
4POF | PFMCM N-TERMINAL DOMAIN WITHOUT DNA | 3.6.4.12 |
4POU | VHH-METAL IN COMPLEX WITH RNASE A | 3.1.27.5 4.6.1.18 |
4PP1 | THE CRYSTAL STRUCTURE OF DER P 1 ALLERGEN COMPLEXED WITH FAB FRAGMENT OF MAB 5H8 | 3.4.22.65 |
4PP4 | MINUTE VIRUS OF MICE NON-STRUCTURAL PROTEIN-1N-TERMINAL NUCLEASE DOMAIN REVEALS A UNIQUE ZN2+ COORDINATION IN THE ACTIVE SITE POCKET AND SHOWS A NOVEL MODE OF DNA RECOGNITION AT THE ORIGIN OF REPLICATION | 3.1.21 3.6.4.12 |
4PPF | MYCOBACTERIUM TUBERCULOSIS RECA CITRATE BOUND LOW TEMPERATURE STRUCTURE IIA-N | 3.1 |
4PPG | MYCOBACTERIUM TUBERCULOSIS RECA CITRATE BOUND LOW TEMPERATURE STRUCTURE IIA-BR | 3.1 |
4PPN | MYCOBACTERIUM TUBERCULOSIS RECA CITRATE BOUND LOW TEMPERATURE STRUCTURE IIA-BN | 3.1 |
4PPO | FIRST CRYSTAL STRUCTURE FOR AN OXALIPLATIN-PROTEIN COMPLEX | 3.2.1.17 |
4PPQ | MYCOBACTERIUM TUBERCULOSIS RECA CITRATE BOUND LOW TEMPERATURE STRUCTURE IIA-CR | 3.1 |
4PPR | CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS D,D-PEPTIDASE RV3330 IN COMPLEX WITH MEROPENEM | 3.4.16 |
4PPZ | CRYSTAL STRUCTURE OF ZINC-BOUND SUCCINYL-DIAMINOPIMELATE DESUCCINYLASE FROM NEISSERIA MENINGITIDIS MC58 | 3.5.1.18 |
4PQA | CRYSTAL STRUCTURE OF SUCCINYL-DIAMINOPIMELATE DESUCCINYLASE FROM NEISSERIA MENINGITIDIS MC58 IN COMPLEX WITH THE INHIBITOR CAPTOPRIL | 3.5.1.18 |
4PQE | CRYSTAL STRUCTURE OF HUMAN ACETYLCHOLINESTERASE | 3.1.1.7 |
4PQF | MYCOBACTERIUM TUBERCULOSIS RECA GLYCEROL BOUND LOW TEMPERATURE STRUCTURE IIB-CR | 3.1 |
4PQR | MYCOBACTERIUM TUBERCULOSIS RECA GLYCEROL BOUND LOW TEMPERATURE STRUCTURE IIB-BN | 3.1 |
4PQT | INSIGHTS INTO THE MECHANISM OF DEUBIQUITINATION BY JAMM DEUBIQUITINASES FROM CO-CRYSTAL STRUCTURES OF ENZYME WITH SUBSTRATE AND PRODUCT | 3.4.19 |
4PQU | CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH RNA/DNA AND DATP | 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 3.4.23.16 2.7.7 3.1 |
4PQY | MYCOBACTERIUM TUBERCULOSIS RECA GLYCEROL BOUND LOW TEMPERATURE STRUCTURE IIC-N4 | 3.1 |
4PR0 | MYCOBACTERIUM TUBERCULOSIS RECA GLYCEROL BOUND LOW TEMPERATURE STRUCTURE IIC-N3 | 3.1 |
4PR3 | CRYSTAL STRUCTURE OF BRUCELLA MELITENSIS 5'-METHYLTHIOADENOSINE/S-ADENOSYLHOMOCYSTEINE NUCLEOSIDASE | 3.2.2.16 3.2.2.9 |
4PRO | ALPHA-LYTIC PROTEASE COMPLEXED WITH PRO REGION | 3.4.21.12 |
4PRQ | CRYSTAL STRUCTURE OF HEN EGG-WHITE LYSOZYME IN COMPLEX WITH SCLX4 AT 1.72 A RESOLUTION | 3.2.1.17 |
4PRU | CRYSTAL STRUCTURE OF DIMETHYLLYSINE HEN EGG-WHITE LYSOZYME IN COMPLEX WITH SCLX4 AT 2.2 A RESOLUTION | 3.2.1.17 |
4PRW | XYLANASE T6 (XT6) FROM GEOBACILLUS STEAROTHERMOPHILUS IN COMPLEX WITH XYLOHEXAOSE | 3.2.1.8 |
4PRY | CASPASE-8 SPECIFIC UNNATURAL AMINO ACID PEPTIDES | 3.4.22.56 |
4PRZ | CASPASE-8 SPECIFIC UNNATURAL AMINO ACID PEPTIDES | 3.4.22.61 |
4PS0 | CASPASE-8 SPECIFIC UNNATURAL AMINO ACID PEPTIDES | 3.4.22.56 |
4PS1 | CASPASE-8 SPECIFIC UNNATURAL AMINO ACID PEPTIDES | 3.4.22.61 |
4PSA | MYCOBACTERIUM TUBERCULOSIS RECA GLYCEROL BOUND LOW TEMPERATURE STRUCTURE IIC-N1 | 3.1 |
4PSC | STRUCTURE OF CUTINASE FROM TRICHODERMA REESEI IN ITS NATIVE FORM. | 3.1.1.74 |
4PSD | STRUCTURE OF TRICHODERMA REESEI CUTINASE NATIVE FORM. | 3.1.1.74 |
4PSE | TRICHODERMA REESEI CUTINASE IN COMPLEX WITH A C11Y4 PHOSPHONATE INHIBITOR | 3.1.1.74 |
4PSK | MYCOBACTERIUM TUBERCULOSIS RECA PHOSPHATE BOUND LOW TEMPERATURE STRUCTURE I-LT | 3.1 |
4PSP | CRYSTAL STRUCTURE OF GH29 FAMILY ALPHA-L-FUCOSIDASE FROM FUSARIUM GRAMINEARUM IN THE OPEN FORM | 3.2.1.51 |
4PSR | CRYSTAL STRUCTURE OF ALPHA-L-FUCOSIDASE FROM FUSARIUM GRAMINEARUM IN THE OPEN FORM IN COMPLEX WITH L-FUCOSE | 3.2.1.51 |
4PSU | CRYSTAL STRUCTURE OF ALPHA/BETA HYDROLASE FROM RHODOPSEUDOMONAS PALUSTRIS CGA009 | 3 |
4PSV | MYCOBACTERIUM TUBERCULOSIS RECA PHOSPHATE BOUND ROOM TEMPERATURE STRUCTURE I-RT | 3.1 |
4PT5 | CRYSTAL STRUCTURE OF PLPRO FROM MIDDLE EAST RESPIRATORY SYNDROME (MERS) CORONAVIRUS | 3.4.22.2 3.4.19.12 3.4.22.69 |
4PTD | PHOSPHATIDYLINOSITOL-SPECIFIC PHOSPHOLIPASE C MUTANT D274N | 3.1.4.10 4.6.1.13 |
4PTF | TERNARY CRYSTAL STRUCTURE OF YEAST DNA POLYMERASE EPSILON WITH TEMPLATE G | 2.7.7.7 3.1.11 |
4PTL | MYCOBACTERIUM TUBERCULOSIS RECA GLYCEROL BOUND LOW TEMPERATURE STRUCTURE IIC-GM | 3.1 |
4PTM | CRYSTAL STRUCTURE OF CHITINASE D FROM SERRATIA PROTEAMACULANS IN COMPLEX WITH N-ACETYL GLUCOSAMINE, A HYDROLYZED PRODUCT OF HEXASACCHARIDE AT 1.7 ANGSTROM RESOLUTION | 3.2.1.14 |
4PTV | HALOTHERMOTHRIX ORENII BETA-GLUCOSIDASE A, THIOCELLOBIOSE COMPLEX | 3.2.1.21 |
4PTW | HALOTHERMOTHRIX ORENII BETA-GLUCOSIDASE A, 2-DEOXY-2-FLUORO-GLUCOSE COMPLEX | 3.2.1.21 |
4PTX | HALOTHERMOTHRIX ORENII BETA-GLUCOSIDASE A, GLUCOSE COMPLEX | 3.2.1.21 |
4PU2 | CRYSTAL STRUCTURE OF AMINOPEPTIDASE N IN COMPLEX WITH THE PHOSPHONIC ACID ANALOGUE OF LEUCINE L-(R)-LEUP | 3.4.11.2 |
4PU6 | CRYSTAL STRUCTURE OF POTASSIUM-DEPENDENT PLANT-TYPE L-ASPARAGINASE FROM PHASEOLUS VULGARIS IN COMPLEX WITH K+ CATIONS | 3.5.1.1 |
4PUD | EXTRACELLULR XYLANASE FROM GEOBACILLUS STEAROTHERMOPHILUS: E159Q MUTANT, WITH XYLOPENTAOSE IN ACTIVE SITE | 3.2.1.8 |
4PUE | EXTRACELLULR XYLANASE FROM GEOBACILLUS STEAROTHERMOPHILUS: E159Q MUTANT, WITH XYLOTETRAOSE IN ACTIVE SITE | 3.2.1.8 |
4PUO | CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH RNA/DNA AND NEVIRAPINE | 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 3.4.23.16 2.7.7 3.1 |
4PUQ | MUS MUSCULUS TDP2 REACTION PRODUCT COMPLEX WITH 5'-PHOSPHORYLATED RNA/DNA, GLYCEROL, AND MG2+ | 3.1.4 |
4PUT | CRYSTAL STRUCTURE OF THE ARABIDOPSIS THALIANA TOP2 OLIGOPEPTIDASE | 3.4.24.70 |
4PV2 | CRYSTAL STRUCTURE OF POTASSIUM-DEPENDENT PLANT-TYPE L-ASPARAGINASE FROM PHASEOLUS VULGARIS IN COMPLEX WITH K+ AND NA+ CATIONS | 3.5.1.1 |
4PV3 | CRYSTAL STRUCTURE OF POTASSIUM-DEPENDENT PLANT-TYPE L-ASPARAGINASE FROM PHASEOLUS VULGARIS IN COMPLEX WITH NA+ CATIONS | 3.5.1.1 |
4PV4 | PROLINE AMINOPEPTIDASE P II FROM YERSINIA PESTIS | 3.4.11.9 |
4PV7 | COCRYSTAL STRUCTURE OF DIPEPTIDYL-PEPTIDASE 4 WITH AN INDOLE SCAFFOLD INHIBITOR | 3.4.14.5 |
4PVA | CRYSTAL STRUCTURE OF GH62 HYDROLASE FROM THERMOPHILIC FUNGUS SCYTALIDIUM THERMOPHILUM | 3.2.1.55 |
4PVB | CRYSTAL STRUCTURE OF AMINOPEPTIDASE N IN COMPLEX WITH THE PHOSPHONIC ACID ANALOGUE OF LEUCINE (D-(S)-LEUP) | 3.4.11.2 |
4PVG | CRYSTAL STRUCTURE OF PROTEIN TYROSINE PHOSPHATASE SHP2 CATALYTIC DOMAIN COMPLEX WITH SMALL MOLECULAR COMPOUND L88N79 | 3.1.3.48 |
4PVI | CRYSTAL STRUCTURE OF GH62 HYDROLASE IN COMPLEX WITH XYLOTRIOSE | 3.2.1.55 |
4PVP | CRYSTAL STRUCTURE OF MALONATE-BOUND HUMAN L-ASPARAGINASE PROTEIN | 3.4.19.5 3.5.1.1 |
4PVQ | CRYSTAL STRUCTURE OF SULFATE-BOUND HUMAN L-ASPARAGINASE PROTEIN | 3.4.19.5 3.5.1.1 |
4PVR | CRYSTAL STRUCTURE OF PARTIALLY-CLEAVED HUMAN L-ASPARAGINASE PROTEIN IN COMPLEX WITH L-ASPARTATE | 3.4.19.5 3.5.1.1 |
4PVS | CRYSTAL STRUCTURE OF FULLY-CLEAVED HUMAN L-ASPARAGINASE PROTEIN IN COMPLEX WITH L-ASPARTATE | 3.4.19.5 3.5.1.1 |
4PW4 | CRYSTAL STRUCTURE OF AMINOPEPTIDASE N IN COMPLEX WITH PHOSPHONIC ACID ANALOGUE OF HOMOPHENYLALANINE L-(R)-HPHEP | 3.4.11.2 |
4PWD | CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH BULGE-RNA/DNA AND NEVIRAPINE | 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 3.4.23.16 2.7.7 3.1 |
4PWX | CRYSTAL STRUCTURE OF AN ATP-BOUND GET3-GET4-GET5 COMPLEX FROM S.CEREVISIAE | 3.6 |
4PX7 | CRYSTAL STRUCTURE OF LIPID PHOSPHATASE E. COLI PGPB | 3.1.3.27 3.6.1.27 |
4PX8 | STRUCTURE OF P. VULGARIS HIGB TOXIN | 3.1 |
4PX9 | DEAD-BOX RNA HELICASE DDX3X DOMAIN 1 WITH N-TERMINAL ATP-BINDING LOOP | 3.6.4.13 |
4PXA | DEAD-BOX RNA HELICASE DDX3X CANCER-ASSOCIATED MUTANT D354V | 3.6.4.13 |
4PXB | THE CRYSTAL STRUCTURE OF ATUAH IN COMPLEX WITH (S)-UREIDOGLYCOLATE | 3.5.3.19 3.5.1.116 |
4PXC | THE CRYSTAL STRUCTURE OF ATUAH IN COMPLEX WITH (S)-HYDROXYGLYCINE | 3.5.3.19 3.5.1.116 |
4PXD | THE CRYSTAL STRUCTURE OF ECAAH IN COMPLEX WITH ALLANTOATE | 3.5.3 3.5.3.9 |
4PXE | THE CRYSTAL STRUCTURE OF ATUAH IN COMPLEX WITH GLYOXYLATE | 3.5.3.19 3.5.1.116 |
4PXG | CRYSTAL STRUCTURE OF TYPEII RESTRICTION ENZYME SAU3AI | 3.1.21.4 |
4PY5 | THERMOVIBRIO AMMONIFICANS RNASE H3 IN COMPLEX WITH 19-MER RNA/DNA | 3.1.26 3.1.26.4 |
4PYH | PHOSPHO-GLUCAN BOUND STRUCTURE OF STARCH PHOSPHATASE STARCH EXCESS4 REVEALS THE MECHANISM FOR C6-SPECIFICTY | 3.1.3 |
4PYS | THE CRYSTAL STRUCTURE OF BETA-N-ACETYLHEXOSAMINIDASE FROM BACTEROIDES FRAGILIS NCTC 9343 | 3.2.1.52 |
4PYV | CRYSTAL STRUCTURE OF RENIN IN COMPLEX WITH COMPOUND4 | 3.4.23.15 |
4PYZ | CRYSTAL STRUCTURE OF THE FIRST TWO UBL DOMAINS OF DEUBIQUITYLASE USP7 | 3.4.19.12 |
4PZ9 | THE NATIVE STRUCTURE OF MYCOBACTERIAL GLUCOSYL-3-PHOSPHOGLYCERATE PHOSPHATASE RV2419C | 3.1.3 3.1.3.70 3.1.3.85 |
4PZA | THE COMPLEX STRUCTURE OF MYCOBACTERIAL GLUCOSYL-3-PHOSPHOGLYCERATE PHOSPHATASE RV2419C WITH INORGANIC PHOSPHATE | 3.1.3 3.1.3.70 3.1.3.85 |
4PZW | SYNTHESIS, CHARACTERIZATION AND PK/PD STUDIES OF A SERIES OF SPIROCYCLIC PYRANOCHROMENE BACE1 INHIBITORS | 3.4.23.46 |
4PZX | SYNTHESIS, CHARACTERIZATION AND PK/PD STUDIES OF A SERIES OF SPIROCYCLIC PYRANOCHROMENE BACE1 INHIBITORS | 3.4.23.46 |
4PZY | SECOND-SITE SCREENING OF K-RAS IN THE PRESENCE OF COVALENTLY ATTACHED FIRST-SITE LIGANDS | 3.6.5.2 |
4PZZ | SECOND-SITE SCREENING OF K-RAS IN THE PRESENCE OF COVALENTLY ATTACHED FIRST-SITE LIGANDS | 3.6.5.2 |
4Q01 | SECOND-SITE SCREENING OF K-RAS IN THE PRESENCE OF COVALENTLY ATTACHED FIRST-SITE LIGANDS | 3.6.5.2 |
4Q02 | SECOND-SITE SCREENING OF K-RAS IN THE PRESENCE OF COVALENTLY ATTACHED FIRST-SITE LIGANDS | 3.6.5.2 |
4Q03 | SECOND-SITE SCREENING OF K-RAS IN THE PRESENCE OF COVALENTLY ATTACHED FIRST-SITE LIGANDS | 3.6.5.2 |
4Q0B | CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH GAP-RNA/DNA AND NEVIRAPINE | 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 3.4.23.16 2.7.7 3.1 |
4Q0F | CRYSTAL STRUCTURE OF THERMOTOGA MARITIMA FTSH PERIPLASMIC DOMAIN | 3.4.24 |
4Q0M | CRYSTAL STRUCTURE OF PYROCOCCUS FURIOSUS L-ASPARAGINASE | 3.5.1.1 |
4Q0R | THE CATALYTIC CORE OF RAD2 (COMPLEX I) | 3.1 |
4Q0W | HE CATALYTIC CORE OF RAD2 IN COMPLEX WITH DNA SUBSTRATE (COMPLEX II) | 3.1 |
4Q0X | CRYSTAL STRUCTURE OF NON-NEUTRALIZING ANTIBODY IN COMPLEX WITH EPITOPE II OF HCV E2 | 3.4.22 3.4.21.98 3.6.1.15 3.6.4.13 2.7.7.48 |
4Q0Z | THE CATALYTIC CORE OF RAD2 IN COMPLEX WITH DNA SUBSTRATE (COMPLEX III) | 3.1 |
4Q10 | THE CATALYTIC CORE OF RAD2 IN COMPLEX WITH DNA SUBSTRATE (COMPLEX IV) | 3.1 |
4Q14 | CRYSTAL STRUCTURE OF 5-HYDROXYISOURATE HYDROLASE FROM BRUCELLA MELITENSIS | 3.5.2.17 |
4Q1L | CRYSTAL STRUCTURE OF LEUCUROLYSIN-A COMPLEXED WITH AN ENDOGENOUS TRIPEPTIDE (QSW). | 3.4.24 |
4Q1N | STRUCTURE-BASED DESIGN OF 4-HYDROXY-3,5-SUBSTITUTED PIPERIDINES AS DIRECT RENIN INHIBITORS | 3.4.23.15 |
4Q1U | SERUM PARAOXONASE-1 BY DIRECTED EVOLUTION WITH THE K192Q MUTATION | 3.1.1.2 3.1.1.81 3.1.8.1 |
4Q1V | CRYSTAL STRUCTURE OF A PUTATIVE DIPEPTIDYL AMINOPEPTIDASE IV (BACOVA_01349) FROM BACTEROIDES OVATUS ATCC 8483 AT 2.48 A RESOLUTION | 3.4 |
4Q1W | MUTATIONS OUTSIDE THE ACTIVE SITE OF HIV-1 PROTEASE ALTER ENZYME STRUCTURE AND DYNAMIC ENSEMBLE OF THE ACTIVE SITE TO CONFER DRUG RESISTANCE | 3.4.23.16 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1 |
4Q1X | MUTATIONS OUTSIDE THE ACTIVE SITE OF HIV-1 PROTEASE ALTER ENZYME STRUCTURE AND DYNAMIC ENSEMBLE OF THE ACTIVE SITE TO CONFER DRUG RESISTANCE | 3.4.23.16 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1 |
4Q1Y | MUTATIONS OUTSIDE THE ACTIVE SITE OF HIV-1 PROTEASE ALTER ENZYME STRUCTURE AND DYNAMIC ENSEMBLE OF THE ACTIVE SITE TO CONFER DRUG RESISTANCE | 3.4.23.16 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1 |
4Q21 | MOLECULAR SWITCH FOR SIGNAL TRANSDUCTION: STRUCTURAL DIFFERENCES BETWEEN ACTIVE AND INACTIVE FORMS OF PROTOONCOGENIC RAS PROTEINS | 3.6.5.2 |
4Q22 | CRYSTAL STRUCTURE OF CHITINASE D FROM SERRATIA PROTEAMACULANS IN COMPLEX WITH N-ACETYL GLUCOSAMINE AT 1.93 ANGSTROM RESOLUTION | 3.2.1.14 |
4Q2B | THE CRYSTAL STRUCTURE OF AN ENDO-1,4-D-GLUCANASE FROM PSEUDOMONAS PUTIDA KT2440 | 3.2.1 |
4Q2K | BOVINE ALPHA CHYMOTRYPSIN BOUND TO A CYCLIC PEPTIDE INHIBITOR, 5B | 3.4.21.1 |
4Q2V | CRYSTAL STRUCTURE OF RICIN A CHAIN COMPLEXED WITH BAICALIN INHIBITOR | 3.2.2.22 |
4Q2W | CRYSTAL STRUCTURE OF PNEUMOCOCCAL PEPTIDOGLYCAN HYDROLASE LYTB | 3.2.1.96 |
4Q3P | CRYSTAL STRUCTURE OF SCHISTOSOMA MANSONI ARGINASE | 3.5.3.1 |
4Q3Q | CRYSTAL STRUCTURE OF SCHISTOSOMA MANSONI ARGINASE IN COMPLEX WITH INHIBITOR ABH | 3.5.3.1 |
4Q3R | CRYSTAL STRUCTURE OF SCHISTOSOMA MANSONI ARGINASE IN COMPLEX WITH INHIBITOR ABHDP | 3.5.3.1 |
4Q3S | CRYSTAL STRUCTURE OF SCHISTOSOMA MANSONI ARGINASE IN COMPLEX WITH INHIBITOR ABHPE | 3.5.3.1 |
4Q3T | CRYSTAL STRUCTURE OF SCHISTOSOMA MANSONI ARGINASE IN COMPLEX WITH INHIBITOR NOHA | 3.5.3.1 |
4Q3U | CRYSTAL STRUCTURE OF SCHISTOSOMA MANSONI ARGINASE IN COMPLEX WITH INHIBITOR NOR-NOHA | 3.5.3.1 |
4Q40 | CRYSTAL STRUCTURE OF SCHISTOSOMA MANSONI ARGINASE IN COMPLEX WITH L-VALINE | 3.5.3.1 |
4Q41 | CRYSTAL STRUCTURE OF SCHISTOSOMA MANSONI ARGINASE IN COMPLEX WITH L-LYSINE | 3.5.3.1 |
4Q42 | CRYSTAL STRUCTURE OF SCHISTOSOMA MANSONI ARGINASE IN COMPLEX WITH L-ORNITHINE | 3.5.3.1 |
4Q47 | STRUCTURE OF THE DRRECQ CATALYTIC CORE IN COMPLEX WITH ADP | 3.6.4.12 |
4Q48 | STRUCTURE OF THE RECQ CATALYTIC CORE FROM DEINOCOCCUS RADIODURANS | 3.6.4.12 |
4Q4E | CRYSTAL STRUCTURE OF E.COLI AMINOPEPTIDASE N IN COMPLEX WITH ACTINONIN | 3.4.11.2 |
4Q4G | STRUCTURE OF THE RESUSCITATION PROMOTING FACTOR INTERACTING PROTEIN RIPA MUTATED AT C383 | 3.4 |
4Q4I | CRYSTAL STRUCTURE OF E.COLI AMINOPEPTIDASE N IN COMPLEX WITH AMASTATIN | 3.4.11.2 |
4Q4L | CRYSTAL STRUCTURE OF AN ATP SYNTHASE SUBUNIT BETA 1 (F1-B1) FROM BURKHOLDERIA THAILANDENSIS | 3.6.3.14 7.1.2.2 |
4Q4N | STRUCTURE OF THE RESUSCITATION PROMOTING FACTOR INTERACTING PROTEIN RIPA MUTATED AT H432 | 3.4 |
4Q4T | STRUCTURE OF THE RESUSCITATION PROMOTING FACTOR INTERACTING PROTEIN RIPA MUTATED AT E444 | 3.4 |
4Q4V | CRYSTAL STRUCTURE OF COXSACKIEVIRUS A24V | 3.4.22.29 3.6.1.15 3.4.22.28 2.7.7.48 |
4Q4W | HIGH-RESOLUTION CRYSTAL STRUCTURE OF COXSACKIEVIRUS A24V | 3.4.22.29 3.6.1.15 3.4.22.28 2.7.7.48 |
4Q4X | CRYSTAL STRUCTURE OF COXSACKIEVIRUS A24V SOAKED WITH 6'-SIALYLLACTOSE (6SL) | 3.4.22.29 3.6.1.15 3.4.22.28 2.7.7.48 |
4Q4Y | CRYSTAL STRUCTURE OF COXSACKIEVIRUS A24V SOAKED WITH DISIALYLLACTO-N-TETRAOSE (DSLNT) | 3.4.22.29 3.6.1.15 3.4.22.28 2.7.7.48 |
4Q5M | D30N TETHERED HIV-1 PROTEASE DIMER/SAQUINAVIR COMPLEX | 3.4.23.16 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1 |
4Q7A | CRYSTAL STRUCTURE OF N-ACETYL-ORNITHINE/N-ACETYL-LYSINE DEACETYLASE FROM SPHAEROBACTER THERMOPHILUS | 3.5.1.130 |
4Q7H | CRYSTAL STRUCTURE OF SAMHD1 CATALYTIC CORE WITH GTP | 3.1.5 |
4Q7X | NEUTROPHIL SERINE PROTEASE 4 (PRSS57) APO FORM 1 | 3.4.21 |
4Q7Y | NEUTROPHIL SERINE PROTEASE 4 (PRSS57) APO FORM 2 | 3.4.21 |
4Q7Z | NEUTROPHIL SERINE PROTEASE 4 (PRSS57) WITH PHE-PHE-ARG-CHLOROMETHYLKETONE (FFR-CMK) | 3.4.21 |
4Q80 | NEUTROPHIL SERINE PROTEASE 4 (PRSS57) WITH VAL-LEU-LYS-CHLOROMETHYLKETONE (VLK-CMK) | 3.4.21 |
4Q8G | STRUCTURE OF THE SACCHAROMYCES CEREVISIAE PAN2 PSEUDOUBIQUITIN-HYDROLASE | 3.1.13.4 |
4Q8H | STRUCTURE OF THE SACCHAROMYCES CEREVISIAE PAN2 PSEUDOUBIQUITIN-HYDROLASE-RNASE MODULE | 3.1.13.4 |
4Q8I | CRYSTAL STRUCTURE OF BETA-LACTAMASE FROM M.TUBERCULOSIS COVALENTLY COMPLEXED WITH TEBIPENEM | 3.5.2.6 |
4Q95 | CRYSTAL STRUCTURE OF HRASLS3/LRAT CHIMERIC PROTEIN | 2.3.1.135 2.3.1 3.1.1.32 3.1.1.4 |
4Q9F | CRYSTAL STRUCTURE OF TYPE 1 RIBOSOME INACTIVATING PROTEIN FROM MOMORDICA BALSAMINA IN COMPLEX WITH GUANOSINE MONO PHOSPHATE AT 1.75 ANGSTROM RESOLUTION | 3.2.2.22 |
4Q9H | P-GLYCOPROTEIN AT 3.4 A RESOLUTION | 3.6.3.44 7.6.2.2 7.6.2.1 |
4Q9I | P-GLYCOPROTEIN COCRYSTALLISED WITH QZ-ALA | 3.6.3.44 7.6.2.2 7.6.2.1 |
4Q9J | P-GLYCOPROTEIN COCRYSTALLISED WITH QZ-VAL | 3.6.3.44 7.6.2.2 7.6.2.1 |
4Q9K | P-GLYCOPROTEIN COCRYSTALLISED WITH QZ-LEU | 3.6.3.44 7.6.2.2 7.6.2.1 |
4Q9L | P-GLYCOPROTEIN COCRYSTALLISED WITH QZ-PHE | 3.6.3.44 7.6.2.2 7.6.2.1 |
4QA0 | CRYSTAL STRUCTURE OF C153F HDAC8 IN COMPLEX WITH SAHA | 3.5.1.98 |
4QA1 | CRYSTAL STRUCTURE OF A188T HDAC8 IN COMPLEX WITH M344 | 3.5.1.98 |
4QA2 | CRYSTAL STRUCTURE OF I243N HDAC8 IN COMPLEX WITH SAHA | 3.5.1.98 |
4QA3 | CRYSTAL STRUCTURE OF T311M HDAC8 IN COMPLEX WITH TRICHOSTATIN A (TSA) | 3.5.1.98 |
4QA4 | CRYSTAL STRUCTURE OF H334R HDAC8 IN COMPLEX WITH M344 | 3.5.1.98 |
4QA5 | CRYSTAL STRUCTURE OF A188T/Y306F HDAC8 IN COMPLEX WITH A TETRAPEPTIDE SUBSTRATE | 3.5.1.98 |
4QA6 | CRYSTAL STRUCTURE OF I243N/Y306F HDAC8 IN COMPLEX WITH A TETRAPEPTIDE SUBSTRATE | 3.5.1.98 |
4QA7 | CRYSTAL STRUCTURE OF H334R/Y306F HDAC8 IN COMPLEX WITH A TETRAPEPTIDE SUBSTRATE | 3.5.1.98 |
4QAG | STRUCTURE OF A DIHYDROXYCOUMARIN ACTIVE-SITE INHIBITOR IN COMPLEX WITH THE RNASE H DOMAIN OF HIV-1 REVERSE TRANSCRIPTASE | 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 3.4.23.16 2.7.7 3.1 |
4QAH | THE SECOND SPHERE RESIDUE T263 IS IMPORTANT FOR FUNCTION AND ACTIVITY OF PTP1B THROUGH MODULATING WPD LOOP | 3.1.3.48 |
4QAJ | CRYSTAL STRUCTURE OF PEPTIDYL-TRNA HYDROLASE FROM PSEUDOMONAS AERUGINOSA AT 1.5 ANGSTROM RESOLUTION | 3.1.1.29 |
4QAK | CRYSTAL STRUCTURE OF PHOSPHOESTERASE | 6.5.1 3.1.4.58 |
4QAP | THE SECOND SPHERE RESIDUE T263 IS IMPORTANT FOR FUNCTION AND ACTIVITY OF PTP1B THROUGH MODULATING WPD LOOP | 3.1.3.48 |
4QB1 | STRUCTURE OF CBM35 FROM PAENIBACILLUS BARCINONENSIS | 3.2.1.8 |
4QB2 | STRUCTURE OF CBM35 IN COMPLEX WITH GLUCURONIC ACID | 3.2.1.8 |
4QB4 | CRYSTAL STRUCTURE OF STAPHYLOCOCCAL NUCLEASE MUTANT V23L/L25V/V66L | 3.1.31.1 |
4QB6 | STRUCTURE OF CBM35 IN COMPLEX WITH ALDOURONIC ACID | 3.2.1.8 |
4QB8 | CRYSTAL STRUCTURE OF BETA-LACTAMASE FROM M.TUBERCULOSIS FORMING MICHAELIS MENTEN WITH TEBIPENEM | 3.5.2.6 |
4QBB | STRUCTURE OF THE FOOT-AND-MOUTH DISEASE VIRUS LEADER PROTEINASE IN COMPLEX WITH INHIBITOR (N~2~-[(3S)-4-({(2R)-1-[(4-CARBAMIMIDAMIDOBUTYL)AMINO]-4-METHYL-1-OXOPENTAN-2-YL}AMINO)-3-HYDROXY-4-OXOBUTANOYL]-L-ARGINYL-L-PROLINAMIDE) | 3.4.22.46 3.6.1.15 3.4.22.28 2.7.7.48 |
4QBE | THE SECOND SPHERE RESIDUE T263 IS IMPORTANT FOR FUNCTION AND ACTIVITY OF PTP1B THROUGH MODULATING WPD LOOP | 3.1.3.48 |
4QBK | CRYSTAL STRUCTURE OF THE COMPLEX OF PEPTIDYL-TRNA HYDROLASE FROM PSEUDOMONAS AERUGINOSA WITH AMINO ACYL-TRNA ANALOGUE AT 1.77 ANGSTROM RESOLUTION | 3.1.1.29 |
4QBW | THE SECOND SPHERE RESIDUE T263 IS IMPORTANT FOR FUNCTION AND ACTIVITY OF PTP1B THROUGH MODULATING WPD LOOP | 3.1.3.48 |
4QC9 | CRYSTAL STRUCTURE OF VACCINIA VIRUS URACIL-DNA GLYCOSYLASE MUTANT 3GD4 | 3.2.2.27 |
4QCA | CRYSTAL STRUCTURE OF VACCINIA VIRUS URACIL-DNA GLYCOSYLASE MUTANT R167AD4 | 3.2.2.27 |
4QCB | PROTEIN-DNA COMPLEX OF VACCINIA VIRUS D4 WITH DOUBLE-STRANDED NON-SPECIFIC DNA | 3.2.2.27 |
4QCE | CRYSTAL STRUCTURE OF RECOMBINANT ALKALI THERMOSTABLE GH10 XYLANASE FROM BACILLUS SP. NG-27 | 3.2.1.8 |
4QCF | CRYSTAL STRUCTURE OF N-TERMINAL MUTANT (V1A) OF AN ALKALI THERMOSTABLE GH10 XYLANASE FROM BACILLUS SP. NG-27 | 3.2.1.8 |
4QD3 | CRYSTAL STRUCTURE OF PEPTIDYL-TRNA HYDROLASE FROM PSEUDOMONAS AERUGINOSA WITH 5-AZACYTIDINE AT 1.89 ANGSTROM RESOLUTION | 3.1.1.29 |
4QD4 | STRUCTURE OF ADC-68, A NOVEL CARBAPENEM-HYDROLYZING CLASS C EXTENDED-SPECTRUM -LACTAMASE FROM ACINETOBACTER BAUMANNII | 3.5.2.6 |
4QD7 | CRYSTAL STRUCTURE OF THIOESTERASE PA1618 FROM PSEUDOMONAS AERUGINOSA | 3.1.2 |
4QD8 | CRYSTAL STRUCTURE OF THIOESTERASE PA1618 FROM PSEUDOMONAS AERUGINOSA IN COMPLEX WITH PHENACYL-COA | 3.1.2 |
4QD9 | CRYSTAL STRUCTURE OF THIOESTERASE PA1618 FROM PSEUDOMONAS AERUGINOSA IN COMPLEX WITH BENZOYL-DO-COA | 3.1.2 |
4QDA | CRYSTAL STRUCTURE OF MUTANT THIOESTERASE PA1618 (E64A) FROM PSEUDOMONAS AERUGINOSA | 3.1.2 |
4QDB | CRYSTAL STRUCTURE OF MUTANT THIOESTERASE PA1618 (Q49A) FROM PSEUDOMONAS AERUGINOSA | 3.1.2 |
4QDE | DCPS IN COMPLEX WITH COVALENT INHIBITOR | 3.6.1.59 |
4QDL | CRYSTAL STRUCTURE OF E.COLI CAS1-CAS2 COMPLEX | 3.1 |
4QDM | CRYSTAL STRUCTURE OF N-TERMINAL MUTANT (V1L) OF AN ALKALI THERMOSTABLE GH10 XYLANASE FROM BACILLUS SP. NG-27 | 3.2.1.8 |
4QDN | CRYSTAL STRUCTURE OF THE ENDO-BETA-N-ACETYLGLUCOSAMINIDASE FROM THERMOTOGA MARITIMA | 3.2.1 |
4QDV | DCPS IN COMPLEX WITH COVALENT LIGAND | 3.6.1.59 |
4QEB | DCPS IN COMPLEX WITH COVALENT INHIBITOR TARGETING TYROSINE | 3.6.1.59 |
4QEM | CRYSTAL STRUCTURE OF THE COMPLEX OF PHOSPHOLIPASE A2 WITH P-COUMARIC ACID AT 1.2 A RESOLUTION | 3.1.1.4 |
4QEQ | HIGH RESOLUTION STRUCTURE OF EGG WHITE LYSOZYME | 3.2.1.17 |
4QER | CRYSTAL STRUCTURE OF THE COMPLEX OF PHOSPHOLIPASE A2 WITH RESVERATROL AT 1.20 A RESOLUTION | 3.1.1.4 |
4QEZ | CRYSTAL STRUCTURE OF 5'-METHYLTHIOADENOSINE/S-ADENOSYLHOMOCYSTEINE NUCLEOSIDASE FROM BACILLUS ANTHRACIS | 3.2.2.9 |
4QF4 | CRYSTAL STRUCTURE OF STAPHYLOCOCCAL NUCLEASE VARIANT V23M AT CRYOGENIC TEMPERATURE | 3.1.31.1 |
4QF7 | CRYSTAL STRUCTURE OF THE COMPLEX OF PHOSPHOLIPASE A2 WITH CORTICOSTERONE AT 1.48 A RESOLUTION | 3.1.1.4 |
4QF8 | CRYSTAL STRUCTURE OF THE COMPLEX OF PHOSPHOLIPASE A2 WITH SPERMIDINE AT 1.65 A RESOLUTION | 3.1.1.4 |
4QFM | THE STRUCTURE OF AIF2GAMMA SUBUNIT D152A FROM ARCHAEON SULFOLOBUS SOLFATARICUS COMPLEXED WITH GDPCP | 3.6.5.3 |
4QFW | CRYSTAL STRUCTURE OF ACYL-COA THIOESTERASE TESB FROM YERSINIA PESTIS | 3.1.2 3.1.2.20 |
4QFX | CRYSTAL STRUCTURE OF THE TETRAMERIC DGTP/DATP-BOUND SAMHD1 (RN206) MUTANT CATALYTIC CORE | 3.1.5 |
4QFY | CRYSTAL STRUCTURE OF THE TETRAMERIC DGTP/DCTP-BOUND SAMHD1 (RN206) MUTANT CATALYTIC CORE | 3.1.5 |
4QFZ | CRYSTAL STRUCTURE OF THE TETRAMERIC DGTP/DTTP-BOUND SAMHD1 (RN206) MUTANT CATALYTIC CORE | 3.1.5 |
4QG0 | CRYSTAL STRUCTURE OF THE TETRAMERIC DGTP/DUTP-BOUND SAMHD1 (RN206) MUTANT CATALYTIC CORE | 3.1.5 |
4QG1 | CRYSTAL STRUCTURE OF THE TETRAMERIC GTP/DATP-BOUND SAMHD1 (RN206) MUTANT CATALYTIC CORE | 3.1.5 |
4QG2 | CRYSTAL STRUCTURE OF THE TETRAMERIC GTP/DATP/ATP-BOUND SAMHD1 (RN206) MUTANT CATALYTIC CORE | 3.1.5 |
4QG4 | CRYSTAL STRUCTURE OF THE TETRAMERIC GTP/DATP/ATP-BOUND SAMHD1 (H210A) MUTANT CATALYTIC CORE | 3.1.5 |
4QGD | CRYSTAL STRUCTURE OF THE COMPLEX OF PHOSPHOLIPASE A2 WITH GRAMINE DERIVATIVE AT 1.80 A RESOLUTION | 3.1.1.4 |
4QGE | PHOSPHODIESTERASE-9A IN COMPLEX WITH INHIBITOR WYQ-C36D | 3.1.4.35 |
4QGI | X-RAY CRYSTAL STRUCTURE OF HIV-1 PROTEASE VARIANT G48T/L89M IN COMPLEX WITH SAQUINAVIR | 3.4.23.16 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1 |
4QGZ | X-RAY STRUCTURE OF THE ADDUCT FORMED BETWEEN HEN EGG WHITE LYSOZYME AND TRANS-DIMETHYLAMINE METHYLAMINE DICHLORIDO PLATINUM(II) | 3.2.1.17 |
4QH3 | X-RAY STRUCTURE OF THE ADDUCT FORMED BETWEEN BOVINE PANCREATIC RIBONUCLEASE AND TRANS-DIMETHYLAMINE METHYLAMINE DICHLORIDO PLATINUM(II) | 3.1.27.5 4.6.1.18 |
4QH6 | CRYSTAL STRUCTURE OF CRUZAIN WITH NITRILE INHIBITOR N-(2-AMINOETHYL)-NALPHA-BENZOYL-L-PHENYLALANINAMIDE | 3.4.22.51 |
4QH9 | CRYSTAL STRUCTURE OF MN2+ BOUND HUMAN APE1 | 3.1 4.2.99.18 |
4QHC | STRUCTURE OF M.TUBERCULOSIS BETALACTAMASE (BLAC) WITH INHIBITOR HAVING NOVEL MECHANISM | 3.5.2.6 |
4QHD | CRYSTAL STRUCTURE OF APO HUMAN APE1 | 3.1 4.2.99.18 |
4QHE | CRYSTAL STRUCTURE OF MG2+ BOUND HUMAN APE1 | 3.1 4.2.99.18 |
4QHP | CRYSTAL STRUCTURE OF AMINOPEPTIDASE N IN COMPLEX WITH THE PHOSPHINIC DIPEPTIDE ANALOGUE LL-(R,S)-HPHEP[CH2]PHE(4-CH2NH2) | 3.4.11.2 |
4QHY | THE STRUCTURE OF AIF2GAMMA SUBUNIT H20F/D152A FROM ARCHAEON SULFOLOBUS SOLFATARICUS COMPLEXED WITH GDPCP | 3.6.5.3 |
4QIH | THE STRUCTURE OF MYCOBACTERIAL GLUCOSYL-3-PHOSPHOGLYCERATE PHOSPHATASE RV2419C COMPLEXES WITH VO3 | 3.1.3 3.1.3.70 3.1.3.85 |
4QIR | CRYSTAL STRUCTURE OF AMINOPEPTIDASE N IN COMPLEX WITH THE PHOSPHINIC DIPEPTIDE ANALOGUE LL-(R,S)-2-(PYRIDIN-3-YL)ETHYLGLYP[CH2]PHE | 3.4.11.2 |
4QJ6 | CRYSTAL STRUCTURE OF INACTIVE HIV-1 PROTEASE VARIANT (I50V/A71V) IN COMPLEX WITH P1-P6 SUBSTRATE VARIANT (L449F) | 3.4.23.16 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1 |
4QJ7 | CRYSTAL STRUCTURE OF INACTIVE HIV-1 PROTEASE VARIANT (I50V/A71V) IN COMPLEX WITH P1-P6 SUBSTRATE VARIANT (R452S) | 3.4.23.16 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1 |
4QJ8 | CRYSTAL STRUCTURE OF INACTIVE HIV-1 PROTEASE VARIANT (I50V/A71V) IN COMPLEX WITH P1-P6 SUBSTRATE VARIANT (P453L) | 3.4.23.16 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1 |
4QJ9 | CRYSTAL STRUCTURE OF INACTIVE HIV-1 PROTEASE IN COMPLEX WITH P1-P6 SUBSTRATE VARIANT (R452S) | 3.4.23.16 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1 |
4QJA | CRYSTAL STRUCTURE OF INACTIVE HIV-1 PROTEASE IN COMPLEX WITH P1-P6 SUBSTRATE VARIANT (P453L) | 3.4.23.16 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1 |
4QJB | CRYSTAL STRUCTURE OF THE SUGAR PHOSPHATASE PFHAD1 FROM PLASMODIUM FALCIPARUM | 3.8.1 |
4QKU | CRYSTAL STRUCTURE OF A PUTATIVE HYDROLASE FROM BURKHOLDERIA CENOCEPACIA | 3.7.1.2 4.3.2.3 |
4QKX | STRUCTURE OF BETA2 ADRENOCEPTOR BOUND TO A COVALENT AGONIST AND AN ENGINEERED NANOBODY | 3.2.1.17 |
4QKZ | X-RAY STRUCTURE OF THE CATALYTIC DOMAIN OF MMP-8 WITH THE INHIBITOR ML115 | 3.4.24.34 |
4QL3 | CRYSTAL STRUCTURE OF A GDP-BOUND G12R ONCOGENIC MUTANT OF HUMAN GTPASE KRAS | 3.6.5.2 |
4QL6 | STRUCTURE OF C. TRACHOMATIS CT441 | 3.4.21 |
4QLA | CRYSTAL STRUCTURE OF JUVENILE HORMONE EPOXIDE HYDROLASE FROM THE SILKWORM BOMBYX MORI | 3.3.2.9 |
4QLH | CRYSTAL STRUCTURE OF DRUG RESISTANT V82S/V1082S HIV-1 PROTEASE | 3.4.23.16 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1 |
4QLJ | CRYSTAL STRUCTURE OF RICE BGLU1 E386G/Y341A/Q187A MUTANT COMPLEXED WITH CELLOTETRAOSE | 3.2.1.21 |
4QLK | CRYSTAL STRUCTURE OF RICE BGLU1 E176Q/Y341A MUTANT COMPLEXED WITH CELLOTETRAOSE | 3.2.1.21 |
4QLL | CRYSTAL STRUCTURE OF RICE BGLU1 E176Q/Y341A/Q187A MUTANT COMPLEXED WITH CELLOTETRAOSE | 3.2.1.21 |
4QLZ | THE STRUCTURE OF INORGANIC PYROPHOSPHATASE FROM SCHISTOSOMA JAPONICUM | 3.6.1.1 |
4QMB | THE STRUCTURE OF INORGANIC PYROPHOSPHATASE FROM SCHISTOSOMA JAPONICUM | 3.6.1.1 |
4QMC | CRYSTAL STRUCTURE OF COMPLEX FORMED BETWEEN PHOSPHOLIPASE A2 AND BIOTIN-SULFOXIDE AT 1.09 A RESOLUTION | 3.1.1.4 |
4QME | CRYSTAL STRUCTURE OF AMINOPEPTIDASE N IN COMPLEX WITH THE PHOSPHINIC DIPEPTIDE ANALOGUE LL-(R,S)-HPHEP[CH2]PHE | 3.4.11.2 |
4QN0 | CRYSTAL STRUCTURE OF THE CPS-6 MUTANT Q130K | 3.1.30 |
4QN1 | CRYSTAL STRUCTURE OF A FUNCTIONALLY UNCHARACTERIZED DOMAIN OF E3 UBIQUITIN LIGASE SHPRH | 2.3.2.27 3.6.4 |
4QN3 | CRYSTAL STRUCTURE OF NEURAMINIDASE N7 | 3.2.1.18 |
4QN4 | CRYSTAL STRUCTURE OF NEURAMINIDASE N6 | 3.2.1.18 |
4QN5 | NEURAMINIDASE N5 BINDS LSTA AT THE SECOND SIA BINDING SITE | 3.2.1.18 |
4QN6 | CRYSTAL STRUCTURE OF NEURAMINIDASE N6 COMPLEXED WITH LANINAMIVIR | 3.2.1.18 |
4QN7 | CRYSTAL STRUCTURE OF NEURAMNIDASE N7 COMPLEXED WITH OSELTAMIVIR | 3.2.1.18 |
4QN9 | STRUCTURE OF HUMAN NAPE-PLD | 3.1.4.54 |
4QNB | DISULFIDE STABILIZED HIV-1 CA HEXAMER IN COMPLEX WITH PHENYL-L-PHENYLALANINAMIDE INHIBITOR | 3.4.23.16 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1 |
4QNN | CRYSTAL STRUCTURE OF PHOSPHOLIPASE A 1 FROM HORNET(VESPA BASALIS) VENOM | 3.1.1.32 |
4QNZ | CRYSTAL STRUCTURE OF RHOMBOID INTRAMEMBRANE PROTEASE GLPG F146I IN COMPLEX WITH PEPTIDE DERIVED INHIBITOR AC-FATA-CMK | 3.4.21.105 |
4QO0 | CRYSTAL STRUCTURE OF RHOMBOID INTRAMEMBRANE PROTEASE GLPG IN COMPLEX WITH PEPTIDE DERIVED INHIBITOR AC-FATA-CMK | 3.4.21.105 |
4QO2 | CRYSTAL STRUCTURE OF RHOMBOID INTRAMEMBRANE PROTEASE GLPG IN COMPLEX WITH PEPTIDE DERIVED INHIBITOR AC-IATA-CMK | 3.4.21.105 |
4QOT | CRYSTAL STRUCTURE OF HUMAN COPPER CHAPERONE BOUND TO THE PLATINUM ION | 3.6.3.54 |
4QP0 | CRYSTAL STRUCTURE ANALYSIS OF THE ENDO-1,4-BETA-MANNANASE FROM RHIZOMUCOR MIEHEI | 3.2.1.78 |
4QP5 | CATALYTIC DOMAIN OF THE ANTIMICROBIAL PEPTIDASE LYSOSTAPHIN FROM STAPHYLOCOCCUS SIMULANS CRYSTALLIZED IN THE PRESENCE OF PHOSPHATE | 3.4.24.75 |
4QPB | CATALYTIC DOMAIN OF THE ANTIMICROBIAL PEPTIDASE LYSOSTAPHIN FROM STAPHYLOCOCCUS SIMULANS CRYSTALLIZED IN THE ABSENCE OF PHOSPHATE | 3.4.24.75 |
4QPE | CRYSTAL STRUCTURE OF AMINOPEPTIDASE N IN COMPLEX WITH N-CYCLOHEXYL-1,2-DIAMINOETHYLPHOSPHONIC ACID | 3.4.11.2 |
4QPX | NV POLYMERASE POST-INCORPORATION-LIKE COMPLEX | 2.7.7.48 3.4.22.66 3.6.1.15 |
4QR0 | CRYSTAL STRUCTURE OF STREPTOCOCCUS PYOGENES CAS2 AT PH 5.6 | 3.1 |
4QR1 | CRYSTAL STRUCTURE OF STREPTOCOCCUS PYOGENES CAS2 AT PH 6.5 | 3.1 |
4QR2 | CRYSTAL STRUCTURE OF STREPTOCOCCUS PYOGENES CAS2 AT PH 7.5 | 3.1 |
4QR8 | CRYSTAL STRUCTURE OF E COLI PEPQ | 3.4.13.9 |
4QRG | CRYSTAL STRUCTURE OF I86L MUTANT OF PAPAIN | 3.4.22.2 |
4QRV | CRYSTAL STRUCTURE OF I86F MUTANT OF PAPAIN | 3.4.22.2 |
4QRX | CRYSTAL STRUCTURE OF PRO-PAPAIN MUTANT AT PH 4.0 | 3.4.22.2 |
4QSP | STRUCTURE OF THE BROMODOMAIN OF HUMAN ATPASE FAMILY AAA DOMAIN-CONTAINING PROTEIN 2 (ATAD2) IN COMPLEX WITH ACETYL-LYSINE | 3.6.1.3 3.6.1 |
4QSQ | STRUCTURE OF THE BROMODOMAIN OF HUMAN ATPASE FAMILY AAA DOMAIN-CONTAINING PROTEIN 2 (ATAD2) WITH BOUND DMSO | 3.6.1.3 3.6.1 |
4QSR | STRUCTURE OF THE BROMODOMAIN OF HUMAN ATPASE FAMILY AAA DOMAIN-CONTAINING PROTEIN 2 (ATAD2) WITH BOUND MPD | 3.6.1.3 3.6.1 |
4QSS | STRUCTURE OF THE BROMODOMAIN OF HUMAN ATPASE FAMILY AAA DOMAIN-CONTAINING PROTEIN 2 (ATAD2) IN COMPLEX WITH N-METHYL-2-PYRROLIDONE (NMP) | 3.6.1.3 3.6.1 |
4QST | STRUCTURE OF THE BROMODOMAIN OF HUMAN ATPASE FAMILY AAA DOMAIN-CONTAINING PROTEIN 2 (ATAD2) IN COMPLEX WITH 1-METHYLQUINOLIN 2-ONE | 3.6.1.3 3.6.1 |
4QSU | STRUCTURE OF THE BROMODOMAIN OF HUMAN ATPASE FAMILY AAA DOMAIN-CONTAINING PROTEIN 2 (ATAD2) IN COMPLEX WITH THYMINE | 3.6.1.3 3.6.1 |
4QSV | STRUCTURE OF THE BROMODOMAIN OF HUMAN ATPASE FAMILY AAA DOMAIN-CONTAINING PROTEIN 2 (ATAD2) IN COMPLEX WITH THYMIDINE | 3.6.1.3 3.6.1 |
4QSW | STRUCTURE OF THE BROMODOMAIN OF HUMAN ATPASE FAMILY AAA DOMAIN-CONTAINING PROTEIN 2 (ATAD2) IN COMPLEX WITH 5-METHYL URIDINE | 3.6.1.3 3.6.1 |
4QSX | STRUCTURE OF THE BROMODOMAIN OF HUMAN ATPASE FAMILY AAA DOMAIN-CONTAINING PROTEIN 2 (ATAD2) IN COMPLEX WITH 3'-DEOXY THYMIDINE | 3.6.1.3 3.6.1 |
4QSY | SHP2 SH2 DOMAIN IN COMPLEX WITH GAB1 PEPTIDE | 3.1.3.48 |
4QSZ | CRYSTAL STRUCTURE OF MOUSE JMJD7 FUSED WITH MALTOSE-BINDING PROTEIN | 1.14.11.63 3.4 |
4QT4 | CRYSTAL STRUCTURE OF PEPTIDYL-TRNA HYDROLASE FROM A GRAM-POSITIVE BACTERIUM, STREPTOCOCCUS PYOGENES AT 2.19 ANGSTROM RESOLUTION SHOWS THE CLOSED STRUCTURE OF THE SUBSTRATE BINDING CLEFT | 3.1.1.29 |
4QTX | CASPASE-3 Y195A | 3.4.22.56 |
4QTY | CASPASE-3 E190A | 3.4.22.56 |
4QU0 | CASPASE-3 Y195AV266H | 3.4.22.56 |
4QU1 | CRYSTAL STRUCTURE OF HUMAN JMJD5 JMJ-C DOMAIN | 1.14.11.27 1.14.11 3.4 |
4QU2 | THE STRUCTURE OF JMJD7 WITH ALPHA-KG | 1.14.11.63 3.4 |
4QU3 | GES-2 ERTAPENEM ACYL-ENZYME COMPLEX | 3.5.2.6 |
4QU4 | IMPROVED REFINEMENT OF THE MTR4 APO CRYSTAL STRUCTURE | 3.6.4.13 |
4QU5 | CASPASE-3 T140V | 3.4.22.56 |
4QU8 | CASPASE-3 M61A V266H | 3.4.22.56 |
4QU9 | CASPASE-3 F128A | 3.4.22.56 |
4QUA | CASPASE-3 Y195F | 3.4.22.56 |
4QUB | CASPASE-3 K137A | 3.4.22.56 |
4QUD | CASPASE-3 T140F | 3.4.22.56 |
4QUE | CASPASE-3 Y195FV266H | 3.4.22.56 |
4QUG | CASPASE-3 M61A | 3.4.22.56 |
4QUH | CASPASE-3 T140G | 3.4.22.56 |
4QUI | CASPASE-3 F128AV266H | 3.4.22.56 |
4QUJ | CASPASE-3 T140GV266H | 3.4.22.56 |
4QUL | CASPASE-3 F55W | 3.4.22.56 |
4QUM | CRYSTAL STRUCTURE OF PTPN3 (PTPH1) IN COMPLEX WITH A DUALLY PHOSPHORYLATED MAPK12 PEPTIDE | 3.1.3.48 |
4QUN | CRYSTAL STRUCTURE OF THE PTPN3 (PTPH1) CATALYTIC DOMAIN C842S MUTANT | 3.1.3.48 |
4QUO | CRYSTAL STRUCTURE OF AMINOPEPTIDASE N IN COMPLEX WITH THE PHOSPHINIC DIPEPTIDE ANALOGUE LL-(R,S)-HPHEP[CH2]PHE(3-CH2NH2) | 3.4.11.2 |
4QUT | STRUCTURE OF THE BROMODOMAIN OF HUMAN ATPASE FAMILY AAA DOMAIN-CONTAINING PROTEIN 2 (ATAD2) COMPLEXED WITH HISTONE H4-K(AC)12 | 3.6.1.3 3.6.1 |
4QUU | STRUCTURE OF THE BROMODOMAIN OF HUMAN ATPASE FAMILY AAA DOMAIN-CONTAINING PROTEIN 2 (ATAD2) COMPLEXED WITH HISTONE H4-K(AC)5 | 3.6.1.3 3.6.1 |
4QWM | KINETIC CRYSTALLOGRAPHY OF ALPHA_E7-CARBOXYLESTERSE FROM LUCILLA CUPRINA - ABSORBED X-RAY DOSE 1.85 MGY | 3.1.1 |
4QWP | CO-CRYSTAL STRUCTURE OF CHITOSANASE OU01 WITH SUBSTRATE | 3.2.1.132 |
4QXD | CRYSTAL STRUCTURE OF INOSITOL POLYPHOSPHATE 1-PHOSPHATASE FROM ENTAMOEBA HISTOLYTICA | 3.1.3.57 |
4QY4 | CRYSTAL STRUCTURE OF THE BROMODOMAIN OF HUMAN SMARCA2 | 3.6.4 |
4QY5 | CRYSTAL STRUCTURES OF CHIMERIC BETA-LACTAMASE CTEM-19M SHOWING DIFFERENT CONFORMATIONS | 3.5.2.6 |
4QY6 | CRYSTAL STRUCTURES OF CHIMERIC BETA-LACTAMASE CTEM-19M SHOWING DIFFERENT CONFORMATIONS | 3.5.2.6 |
4QY9 | X-RAY STRUCTURE OF THE ADDUCT BETWEEN HEN EGG WHITE LYSOZYME AND AUOXO3, A CYTOTOXIC GOLD(III) COMPOUND | 3.2.1.17 |
4QYX | CRYSTAL STRUCTURE OF YDR533CP | 3.2 4.2.1.130 |
4QZ8 | MOUSE TDT IN COMPLEX WITH A DSB SUBSTRATE, C-G BASE PAIR | 2.7.7.31 3.1.11 |
4QZ9 | MOUSE TDT IN COMPLEX WITH A DSB SUBSTRATE, C-A BASE PAIR | 2.7.7.31 3.1.11 |
4QZA | MOUSE TDT IN COMPLEX WITH A DSB SUBSTRATE, C-C BASE PAIR | 2.7.7.31 3.1.11 |
4QZB | MOUSE TDT IN COMPLEX WITH A DSB SUBSTRATE, C-T BASE PAIR | 2.7.7.31 3.1.11 |
4QZC | MOUSE TDT, F405A MUTANT, IN COMPLEX WITH A DSB SUBSTRATE, C-G BASE PAIR | 2.7.7.31 3.1.11 |
4QZD | MOUSE TDT, F405A MUTANT, IN COMPLEX WITH A DSB SUBSTRATE, C-C BASE PAIR | 2.7.7.31 3.1.11 |
4QZE | MOUSE TDT, F401A MUTANT, IN COMPLEX WITH A DSB SUBSTRATE, C-G BASE PAIR | 2.7.7.31 3.1.11 |
4QZF | MOUSE TDT, F401A MUTANT, IN COMPLEX WITH A DSB SUBSTRATE, C-A BASE PAIR | 2.7.7.31 3.1.11 |
4QZG | MOUSE TDT, F401A MUTANT, IN COMPLEX WITH A DSB SUBSTRATE, C-C BASE PAIR | 2.7.7.31 3.1.11 |
4QZH | MOUSE TDT, F401A MUTANT, IN COMPLEX WITH A DSB SUBSTRATE, C-T BASE PAIR | 2.7.7.31 3.1.11 |
4QZI | MOUSE TDT, F401A MUTANT, IN COMPLEX WITH A DSB SUBSTRATE AND ZN2+ | 2.7.7.31 3.1.11 |
4QZV | BAT-DERIVED CORONAVIRUS HKU4 USES MERS-COV RECEPTOR HUMAN CD26 FOR CELL ENTRY | 3.4.14.5 |
4R04 | CLOSTRIDIUM DIFFICILE TOXIN A (TCDA) | 3.4.22 2.4.1 |
4R05 | CRYSTAL STRUCTURE OF THE REFOLDED DENV3 METHYLTRANSFERASE | 3.4.21.91 3.6.1.15 3.6.4.13 |
4R0E | CRYSTAL STRUCTURE OF THE POLIOVIRUS RNA-DEPENDENT RNA POLYMERASE LOW-FIDELITY MUTANT 3DPOL H273R | 2.7.7.48 3.4.22.29 3.6.1.15 3.4.22.28 |
4R0F | STRUCTURE OF LYSOZYME DIMER AT 318K | 3.2.1.17 |
4R0I | CRYSTAL STRUCTURE OF MATRIPTASE IN COMPLEX WITH INHIBITOR | 3.4.21.109 |
4R27 | CRYSTAL STRUCTURE OF BETA-GLYCOSIDASE BGL167 | 3.2.1 |
4R30 | STRUCTURE OF HUMAN LAFORIN DUAL SPECIFICITY PHOSPHATASE DOMAIN | 3.1.3 3.1.3.16 3.1.3.48 |
4R3B | CRYSTAL STRUCTURE OF SHV-1 B-LACTAMASE IN COMPLEX WITH 6B-(HYDROXYMETHYL)PENICILLANIC ACID SULFONE PSR-283A | 3.5.2.6 |
4R3D | CRYSTAL STRUCTURE OF MERS CORONAVIRUS PAPAIN LIKE PROTEASE | 3.4.19.12 3.4.22.69 3.4.22 |
4R3V | STRUCTURE OF KARILYSIN PROPEPTIDE AND CATALYTIC MMP DOMAIN | 3.4.24 |
4R4R | CRYSTAL STRUCTURE OF CHIMERIC BETA-LACTAMASE CTEM-19M AT 1.2 ANGSTROM RESOLUTION | 3.5.2.6 |
4R4S | CRYSTAL STRUCTURE OF CHIMERIC BETA-LACTAMASE CTEM-19M AT 1.1 ANGSTROM RESOLUTION | 3.5.2.6 |
4R4Y | STRUCTURAL BASIS OF A POINT MUTATION THAT CAUSES THE GENETIC DISEASE ASPARTYLGLUCOSAMINURIA | 3.5.1.26 |
4R5E | CRYSTAL STRUCTURE OF FAMILY GH18 CHITINASE FROM CYCAS REVOLUTA A COMPLEX WITH ALLOSAMIDIN | 3.2.1.14 |
4R5N | 8-TETRAHYDROPYRAN-2-YL CHROMANS: HIGHLY SELECTIVE BETA-SITE AMYLOID PRECURSOR PROTEIN CLEAVING ENZYME 1 (BACE1) INHIBITORS | 3.4.23.46 |
4R5P | CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE (RT) WITH DNA AND A NUCLEOSIDE TRIPHOSPHATE MIMIC ALPHA-CARBOXY NUCLEOSIDE PHOSPHONATE INHIBITOR | 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 3.4.23.16 2.7.7 3.1 |
4R5Q | CRYSTAL STRUCTURE AND NUCLEASE ACTIVITY OF THE CRISPR-ASSOCIATED CAS4 PROTEIN PCAL_0546 FROM PYROBACULUM CALIDIFONTIS CONTAINING A [2FE-2S] CLUSTER | 3.1.12.1 |
4R5R | CRYSTAL STRUCTURE OF RHODOSTOMIN KKKRT MUTANT | 3.4.24 |
4R5T | STRUCTURE OF THE M1 ALANYLAMINOPEPTIDASE FROM MALARIA COMPLEXED WITH A HYDROXAMIC ACID-BASED INHIBITOR | 3.4.11 |
4R5U | CRYSTAL STRUCTURE OF RHODOSTOMIN R46E MUTANT | 3.4.24 |
4R5V | STRUCTURE OF THE M1 ALANYLAMINOPEPTIDASE FROM MALARIA COMPLEXED WITH A HYDROXAMIC ACID-BASED INHIBITOR | 3.4.11 |
4R5X | STRUCTURE OF THE M1 ALANYLAMINOPEPTIDASE FROM MALARIA COMPLEXED WITH A HYDROXAMIC ACID-BASED INHIBITOR | 3.4.11 |
4R60 | CRYSTAL STRUCTURE OF XAA-PRO DIPEPTIDASE FROM XANTHOMONAS CAMPESTRIS | 3.4.13.9 |
4R6C | X-RAY DIFFRACTION IN TEMPORALLY AND SPATIALLY RESOLVED BIOMOLECULAR SCIENCE: THE X-RAY CRYSTAL STRUCTURE OF HEN EGG WHITE LYSOZYME COCRYSTALLIZED WITH TA6BR12 AND THEN A CRYSTAL SOAKED IN K2PTBR6 | 3.2.1.17 |
4R6U | IL-18 RECEPTOR COMPLEX | 3.2.2.6 |
4R79 | MOS1 TRANSPOSASE PAIRED-END COMPLEX WITH LEFT TRANSPOSON END | 3.1 |
4R7L | STRUCTURE OF HUMAN LEUKOTRIENE A4 HYDROLASE IN COMPLEX WITH INHIBITOR H1 | 3.3.2.6 3.4.11.4 |
4R7T | CRYSTAL STRUCTURE OF GLUCOSAMINE-6-PHOSPHATE DEAMINASE FROM VIBRIO CHOLERAE | 3.5.99.6 |
4R7Y | CRYSTAL STRUCTURE OF AN ACTIVE MCM HEXAMER | 3.6.4.12 |
4R8A | CRYSTAL STRUCTURE OF PAFAN1 - 5' FLAP DNA COMPLEX | 3.1.4.1 |
4R8F | CRYSTAL STRUCTURE OF YEAST AMINOPEPTIDASE 1 (APE1) | 3.4.11.22 |
4R8K | CRYSTAL STRUCTURE OF THE GUINEA PIG L-ASPARAGINASE 1 CATALYTIC DOMAIN | 3.5.1.1 |
4R8L | CRYSTAL STRUCTURE OF THE ASP-BOUND GUINEA PIG L-ASPARAGINASE 1 CATALYTIC DOMAIN | 3.5.1.1 |
4R8M | HUMAN SIRT2 CRYSTAL STRUCTURE IN COMPLEX WITH BHJH-TM1 | 3.5.1 2.3.1.286 |
4R8N | CRYSTAL STRUCTURE OF STAPHYLOCOCCAL NUCLEASE VARIANT V23I/V66I/I72V/I92V AT CRYOGENIC TEMPERATURE | 3.1.31.1 |
4R8R | DENGUE VIRUS SEROTYPE 3 METHYLTRANSFERASE WITHOUT A BOUND S-ADENOSYL METHIONINE | 2.1.1.56 2.1.1.57 3.4.21.91 3.6.1.15 3.6.4.13 |
4R8S | DENGUE SEROTYPE 3 METHYLTRANSFERASE BOUND TO SINEFUNGIN | 2.1.1.56 2.1.1.57 3.4.21.91 3.6.1.15 3.6.4.13 |
4R8T | STRUCTURE OF JEV PROTEASE | 3.4.21.91 3.6.1.15 3.6.4.13 |
4R8X | CRYSTAL STRUCTURE OF A URICASE FROM BACILLUS FASTIDIOUS | 3.1.2.4 1.7.3.3 |
4R8Y | BACE-1 IN COMPLEX WITH (R)-4-(2-CYCLOHEXYLETHYL)-4-(((R)-1-(2-CYCLOPENTYLACETYL)PYRROLIDIN-3-YL)METHYL)-1-METHYL-5-OXOIMIDAZOLIDIN-2-IMINIUM | 3.4.23.46 |
4R8Z | CRYSTAL STRUCTURE OF PA4781 HD-GYP DOMAIN FROM PSEUDOMONAS AERUGINOSA AT 2.2A RESOLUTION SHOWING A BI-METALLIC NI ION CENTER | 3.1.4.1 3.1.4 |
4R91 | BACE-1 IN COMPLEX WITH (R)-4-(2-CYCLOHEXYLETHYL)-4-(((1S,3R)-3-(CYCLOPENTYLAMINO)CYCLOHEXYL)METHYL)-1-METHYL-5-OXOIMIDAZOLIDIN-2-IMINIUM | 3.4.23.46 |
4R92 | BACE-1 IN COMPLEX WITH (R)-4-(2-CYCLOHEXYLETHYL)-4-(((1S,3R)-3-(ISONICOTINAMIDO)CYCLOHEXYL)METHYL)-1-METHYL-5-OXOIMIDAZOLIDIN-2-IMINIUM | 3.4.23.46 |
4R93 | BACE-1 IN COMPLEX WITH (R)-4-(2-CYCLOHEXYLETHYL)-1-METHYL-5-OXO-4-(((1S,3R)-3-(3-PHENYLUREIDO)CYCLOHEXYL)METHYL)IMIDAZOLIDIN-2-IMINIUM | 3.4.23.46 |
4R94 | STRUCTURE OF THE NICKASE DOMAIN OF NS1 FROM MVM COMPLEXED WITH MAGNESIUM | 3.1.21 3.6.4.12 |
4R95 | BACE-1 IN COMPLEX WITH 2-(((1R,3S)-3-(((R)-4-(2-CYCLOHEXYLETHYL)-2-IMINIO-1-METHYL-5-OXOIMIDAZOLIDIN-4-YL)METHYL)CYCLOHEXYL)AMINO)QUINOLIN-1-IUM | 3.4.23.46 |
4R99 | CRYSTAL STRUCTURE OF A URICASE FROM BACILLUS FASTIDIOUS | 3.1.2.4 1.7.3.3 |
4R9K | STRUCTURE OF THERMOSTABLE EIGHTFOLD MUTANT OF LIMONENE EPOXIDE HYDROLASE FROM RHODOCOCCUS ERYTHROPOLIS | 3.3.2.8 |
4R9L | STRUCTURE OF A THERMOSTABLE ELEVENFOLD MUTANT OF LIMONENE EPOXIDE HYDROLASE FROM RHODOCOCCUS ERYTHROPOLIS, CONTAINING TWO STABILIZING DISULFIDE BONDS | 3.3.2.8 |
4R9U | STRUCTURE OF VITAMIN B12 TRANSPORTER BTUCD IN A NUCLEOTIDE-BOUND OUTWARD FACING STATE | 3.6.3.33 |
4RA2 | PP2CA | 3.1.3.16 |
4RA6 | CRYSTAL STRUCTURE OF LINKER LESS PYROCOCCUS FURIOSUS L-ASPARAGINASE | 3.5.1.1 |
4RA9 | CRYSTAL STRUCTURE OF CONJOINT PYROCOCCUS FURIOSUS L-ASPARAGINASE WITH CITRATE | 3.5.1.1 |
4RAF | CRYSTAL STRUCTURE OF PP2CA-D38A | 3.1.3.16 |
4RAG | CRYSTAL STRUCTURE OF PPC2A-D38K | 3.1.3.16 |
4RAL | CRYSTAL STRUCTURE OF INSULIN DEGRADING ENZYME IN COMPLEX WITH MACROPHAGE INFLAMMATORY PROTEIN 1 BETA | 3.4.24.56 |
4RAM | CRYSTAL STRUCTURE OF NEW DELHI METALLO-BETA-LACTAMASE-1 MUTANT M67V COMPLEXED WITH HYDROLYZED PENICILLIN G | 3.5.2.6 |
4RAT | EFFECTS OF TEMPERATURE ON PROTEIN STRUCTURE AND DYNAMICS: X-RAY CRYSTALLOGRAPHIC STUDIES OF THE PROTEIN RIBONUCLEASE-A AT NINE DIFFERENT TEMPERATURES FROM 98 TO 320 K | 3.1.27.5 4.6.1.18 |
4RAW | CRYSTAL STRUCTURE OF NEW DELHI METALLO-BETA-LACTAMASE-1 MUTANT M67V COMPLEXED WITH HYDROLYZED AMPICILLIN | 3.5.2.6 |
4RBM | PORPHYROMONAS GINGIVALIS GINGIPAIN K (KGP) CATALYTIC AND IMMUNOGLOBULIN SUPERFAMILY-LIKE DOMAINS | 3.4.22.47 |
4RBS | CRYSTAL STRUCTURE OF NEW DELHI METALLO-BETA-LACTAMASE-1 IN THE COMPLEX WITH HYDROLYZED MEROPENEM | 3.5.2.6 |
4RCA | CRYSTAL STRUCTURE OF HUMAN PTPDELTA AND HUMAN SLITRK1 COMPLEX | 3.1.3.48 |
4RCD | CRYSTAL STRUCTURE OF BACE1 IN COMPLEX WITH A 2-AMINOOXAZOLINE 4-AZAXANTHENE INHIBITOR | 3.4.23.46 |
4RCE | CRYSTAL STRUCTURE OF BACE1 IN COMPLEX WITH AMINOOXAZOLINE XANTHENE INHIBITOR 2 | 3.4.23.46 |
4RCF | CRYSTAL STRUCTURE OF BACE1 IN COMPLEX WITH 2-AMINOOXAZOLINE 4-FLUOROXANTHENE INHIBITOR 49 | 3.4.23.46 |
4RCT | CRYSTAL STRUCTURE OF R-PROTEIN OF NGOAVII RESTRICTION ENDONUCLEASE | 3.1.21.4 |
4RCY | STRUCTURE OF AIF2-GAMMA D19A VARIANT FROM SULFOLOBUS SOLFATARICUS BOUND TO GTP | 3.6.5.3 |
4RCZ | STRUCTURE OF AIF2-GAMMA D19A VARIANT FROM SULFOLOBUS SOLFATARICUS BOUND TO GDPNP | 3.6.5.3 |
4RD0 | STRUCTURE OF AIF2-GAMMA D19A VARIANT FROM SULFOLOBUS SOLFATARICUS BOUND TO GDP | 3.6.5.3 |
4RD1 | STRUCTURE OF AIF2-GAMMA H97A VARIANT FROM SULFOLOBUS SOLFATARICUS BOUND TO GTP | 3.6.5.3 |
4RD2 | STRUCTURE OF AIF2-GAMMA H97A VARIANT FROM SULFOLOBUS SOLFATARICUS BOUND TO GDPNP | 3.6.5.3 |
4RD3 | STRUCTURE OF AIF2-GAMMA H97A VARIANT FROM SULFOLOBUS SOLFATARICUS BOUND TO GDP AND PI | 3.6.5.3 |
4RD4 | STRUCTURE OF AIF2 GAMMA FROM SULFOLOBUS SOLFATARICUS BOUND TO GDPNP | 3.6.5.3 |
4RD5 | CRYSTAL STRUCTURE OF R.NGOAVII RESTRICTION ENDONUCLEASE B3 DOMAIN WITH COGNATE DNA | 3.1.21.4 |
4RD6 | STRUCTURE OF AIF2-GAMMA FROM SULFOLOBUS SOLFATARICUS BOUND TO GDP | 3.6.5.3 |
4RDD | CO-CRYSTAL STRUCTURE OF SHP2 IN COMPLEX WITH A CEFSULODIN DERIVATIVE | 3.1.3.48 |
4RDM | CRYSTAL STRUCTURE OF R.NGOAVII RESTRICTION ENDONUCLEASE B3 DOMAIN WITH COGNATE DNA | 3.1.21.4 |
4RDP | CRYSTAL STRUCTURE OF CMR4 | 3.1 |
4RDS | LYSOZYME CRYSTALLIZED WITH RED FOOD COLORING DYE | 3.2.1.17 |
4RE2 | DIFFERENT TRANSITION STATE CONFORMATIONS FOR THE HYDROLYSIS OF BETA-MANNOSIDES AND BETA-GLUCOSIDES IN THE RICE OS7BGLU26 FAMILY GH1 BETA-MANNOSIDASE/BETA-GLUCOSIDASE | 3.2.1.25 |
4RE3 | DIFFERENT TRANSITION STATE CONFORMATIONS FOR THE HYDROLYSIS OF BETA-MANNOSIDES AND BETA-GLUCOSIDES IN THE RICE OS7BGLU26 FAMILY GH1 BETA-MANNOSIDASE/BETA-GLUCOSIDASE | 3.2.1.25 |
4RE4 | DIFFERENT TRANSITION STATE CONFORMATIONS FOR THE HYDROLYSIS OF BETA-MANNOSIDES AND BETA-GLUCOSIDES IN THE RICE OS7BGLU26 FAMILY GH1 BETA-MANNOSIDASE/BETA-GLUCOSIDASE | 3.2.1.25 |
4RE5 | ACYLAMINOACYL PEPTIDASE COMPLEXED WITH A CHLOROMETHYLKETONE INHIBITOR | 3.4.19.1 |
4RE6 | ACYLAMINOACYL PEPTIDASE COMPLEXED WITH A CHLOROMETHYLKETONE INHIBITOR | 3.4.19.1 |
4RE9 | CRYSTAL STRUCTURE OF HUMAN INSULIN DEGRADING ENZYME (IDE) IN COMPLEX WITH COMPOUND 71290 | 3.4.24.56 |
4REA | A NUCLEASE DNA COMPLEX | 3.1.21 3.1.4.1 |
4REB | STRUCTURAL INSIGHTS INTO 5' FLAP DNA UNWINDING AND INCISION BY THE HUMAN FAN1 DIMER | 3.1.21 3.1.4.1 |
4REC | A NUCLEASE-DNA COMPLEX FORM 3 | 3.1.21 3.1.4.1 |
4RES | CRYSTAL STRUCTURE OF THE NA,K-ATPASE E2P-BUFALIN COMPLEX WITH BOUND POTASSIUM | 3.6.3.9 7.2.2.13 |
4REZ | CRYSTAL STRUCTURE OF THE MIDDLE-EAST RESPIRATORY SYNDROME CORONAVIRUS PAPAIN-LIKE PROTEASE | 2.7.7.48 3.4.19.12 3.4.22.69 3.6.4.12 3.6.4.13 |
4RF0 | CRYSTAL STRUCTURE OF THE MIDDLE-EAST RESPIRATORY SYNDROME CORONAVIRUS PAPAIN-LIKE PROTEASE IN COMPLEX WITH UBIQUITIN (SPACE GROUP P6522) | 2.7.7.48 3.4.19.12 3.4.22.69 3.6.4.12 3.6.4.13 |
4RF1 | CRYSTAL STRUCTURE OF THE MIDDLE-EAST RESPIRATORY SYNDROME CORONAVIRUS PAPAIN-LIKE PROTEASE IN COMPLEX WITH UBIQUITIN (SPACE GROUP P63) | 2.7.7.48 3.4.19.12 3.4.22.69 3.6.4.12 3.6.4.13 |
4RFP | CRYSTAL STRUCTURE OF A ACIDIC PLA2 FROM TRIMERESURUS STEJNEGERI VENOM | 3.1.1.4 |
4RFS | STRUCTURE OF A PANTOTHENATE ENERGY COUPLING FACTOR TRANSPORTER | 3.6.3 |
4RG8 | STRUCTURAL AND BIOCHEMICAL STUDIES OF A MODERATELY THERMOPHILIC EXONUCLEASE I FROM METHYLOCALDUM SZEGEDIENSE | 3.1.11.1 |
4RGH | HUMAN DNA DAMAGE-INDUCIBLE PROTEIN: FROM PROTEIN CHEMISTRY AND 3D STRUCTURE TO DECIPHERING ITS CELLULAR ROLE | 3.4.23 |
4RH5 | CRYSTAL STRUCTURE OF PTPN3 (PTPH1) IN COMPLEX WITH EPS15 PTYR849 PEPTIDE | 3.1.3.48 |
4RH9 | CRYSTAL STRUCTURE OF PTPN3 (PTPH1) H812F, M883G MUTANT IN COMPLEX WITH EPS15 PTYR849 PEPTIDE | 3.1.3.48 |
4RHG | CRYSTAL STRUCTURE OF PTPN3 (PTPH1) D811E, C842S MUTANT IN COMPLEX WITH EPS15 PTYR849 PEPTIDE | 3.1.3.48 |
4RHI | CRYSTAL STRUCTURE OF SEMET-LABELED WILD-TYPE T. BRUCEI ARGINASE-LIKE PROTEIN IN P321 SPACE GROUP | 3.5.3.1 |
4RHK | CRYSTAL STRUCTURE OF T. BRUCEI ARGINASE-LIKE PROTEIN IN AN OXIDIZED FORM | 3.5.3.1 |
4RHL | CRYSTAL STRUCTURE OF T. BRUCEI ARGINASE-LIKE PROTEIN TRIPLE MUTANT S149D/R151H/S226D BOUND WITH MN2+ | 3.5.3.1 |
4RHM | CRYSTAL STRUCTURE OF T. BRUCEI ARGINASE-LIKE PROTEIN QUADRUPLE MUTANT S149D/R151H/S153D/S226D | 3.5.3.1 |
4RHN | HISTIDINE TRIAD NUCLEOTIDE-BINDING PROTEIN (HINT) FROM RABBIT COMPLEXED WITH ADENOSINE | 3 |
4RHQ | CRYSTAL STRUCTURE OF T. BRUCEI ARGINASE-LIKE PROTEIN DOUBLE MUTANT S149D/S153D | 3.5.3.1 |
4RHV | THE USE OF MOLECULAR-REPLACEMENT PHASES FOR THE REFINEMENT OF THE HUMAN RHINOVIRUS 14 STRUCTURE | 3.4.22.29 3.6.1.15 3.4.22.28 2.7.7.48 |
4RI0 | SERINE PROTEASE HTRA3, MUTATIONALLY INACTIVATED | 3.4.21 |
4RI4 | CRYSTAL STRUCTURE OF PTPN3 (PTPH1) Y676I MUTANT IN COMPLEX WITH VANADATE | 3.1.3.48 |
4RI5 | CRYSTAL STRUCTURE OF PTPN3 (PTPH1) D811E MUTANT IN COMPLEX WITH METAVANADATE | 3.1.3.48 |
4RIA | FAN1 NUCLEASE BOUND TO 5' PHOSPHORYLATED NICKED DNA | 3.1.21 3.1.4.1 |
4RIB | FAN1 NUCLEASE BOUND TO 5' PHOSPHORYLATED P(DT) SINGLE FLAP DNA | 3.1.21 3.1.4.1 |
4RIC | FAN1 NUCLEASE BOUND TO 5' HYDROXYL (DT-DT) SINGLE FLAP DNA | 3.1.21 3.1.4.1 |
4RID | HUMAN FAN1 NUCLEASE | 3.1.21 3.1.4.1 |
4RJL | GAMMA SUBUNIT OF THE TRANSLATION INITIATION FACTOR 2 FROM SULFOLOBUS SOLFATARICUS COMPLEXED WITH GDPCP | 3.6.5.3 |
4RKB | CRYSTAL STRUCTURE OF STAPHYLOCOCCAL NUCLEASE VARIANT DELTA+PHS V66T/V99T AT CRYOGENIC TEMPERATURE | 3.1.31.1 |
4RKJ | CRYSTAL STRUCTURE OF THROMBIN MUTANT S195T (FREE FORM) | 3.4.21.5 |
4RKK | STRUCTURE OF A PRODUCT BOUND PHOSPHATASE | 3.1.3 3.1.3.16 3.1.3.48 |
4RKL | CRYSTAL STRUCTURE OF STAPHYLOCOCCAL NUCLEASE VARIANT DELTA+PHS V23T/V66T AT CRYOGENIC TEMPERATURE | 3.1.31.1 |
4RKO | CRYSTAL STRUCTURE OF THROMBIN MUTANT S195T BOUND WITH PPACK | 3.4.21.5 |
4RKW | CRYSTAL STRUCTURE OF DJ-1 | 3.4 3.1.2 3.5.1 3.5.1.124 |
4RKX | IDENTIFICATION AND CHARACTERIZATION OF A SMALL MOLECULE INHIBITOR OF S. PYOGENES SPEB. | 3.4.22.10 |
4RKY | CRYSTAL STRUCTURE OF DJ-1 ISOFORM X1 | 3.4 3.1.2 3.5.1 3.5.1.124 |
4RL0 | STRUCTURAL AND MECHANISTIC INSIGHTS INTO NDM-1 CATALYZED HYDROLYSIS OF CEPHALOSPORINS | 3.5.2.6 |
4RL2 | STRUCTURAL AND MECHANISTIC INSIGHTS INTO NDM-1 CATALYZED HYDROLYSIS OF CEPHALOSPORINS | 3.5.2.6 |
4RL3 | CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF A FAMILY GH18 CHITINASE FROM FERN, PETERIS RYUKYUENSIS | 3.2.1.14 |
4RL4 | CRYSTAL STRUCTURE OF GTP CYCLOHYDROLASE II FROM HELICOBACTER PYLORI 26695 | 3.5.4.25 |
4RLA | ALTERING THE BINUCLEAR MANGANESE CLUSTER OF ARGINASE DIMINISHES THERMOSTABILITY AND CATALYTIC FUNCTION | 3.5.3.1 |
4RLD | CRYSTAL STRUCTURE OF KKF MUTANT OF BLA G 2 PROTEIN | 3.4.23 |
4RLM | HEN EGG-WHITE LYSOZYME SOLVED FROM SERIAL CRYSTALLOGRAPHY AT A SYNCHROTRON SOURCE, DATA PROCESSED WITH CRYSTFEL | 3.2.1.17 |
4RLN | HEN EGG-WHITE LYSOZYME SOLVED FROM SERIAL CRYSTALLOGRAPHY AT A SYNCHROTRON SOURCE, DATA PROCESSED WITH NXDS | 3.2.1.17 |
4RM5 | STRUCTURAL AND MECHANISTIC INSIGHTS INTO NDM-1 CATALYZED HYDROLYSIS OF CEPHALOSPORINS | 3.5.2.6 |
4RMG | HUMAN SIRT2 IN COMPLEX WITH SIRREAL2 AND NAD+ | 3.5.1 2.3.1.286 |
4RMH | HUMAN SIRT2 IN COMPLEX WITH SIRREAL2 AND AC-LYS-H3 PEPTIDE | 3.5.1 2.3.1.286 |
4RMI | HUMAN SIRT2 IN COMPLEX WITH SIRREAL1 AND AC-LYS-OTC PEPTIDE | 3.5.1 2.3.1.286 |
4RMJ | HUMAN SIRT2 IN COMPLEX WITH ADP RIBOSE AND NICOTINAMIDE | 3.5.1 2.3.1.286 |
4RN0 | CRYSTAL STRUCTURE OF S39D HDAC8 IN COMPLEX WITH A LARGAZOLE ANALOGUE. | 3.5.1.98 |
4RN1 | CRYSTAL STRUCTURE OF S39D HDAC8 IN COMPLEX WITH A LARGAZOLE ANALOGUE. | 3.5.1.98 |
4RN2 | CRYSTAL STRUCTURE OF S39D HDAC8 IN COMPLEX WITH A LARGAZOLE ANALOGUE. | 3.5.1.98 |
4RN6 | STRUCTURE OF PRETHROMBIN-2 MUTANT S195A BOUND TO THE ACTIVE SITE INHIBITOR ARGATROBAN | 3.4.21.5 |
4RN7 | THE CRYSTAL STRUCTURE OF N-ACETYLMURAMOYL-L-ALANINE AMIDASE FROM CLOSTRIDIUM DIFFICILE 630 | 3.5.1.28 |
4RNA | CRYSTAL STRUCTURE OF PLPRO FROM MIDDLE EAST RESPIRATORY SYNDROME (MERS) CORONAVIRUS | 3.4.22 3.4.19.12 3.4.22.69 |
4RNC | CRYSTAL STRUCTURE OF AN ESTERASE RHEST1 FROM RHODOCOCCUS SP. ECU1013 | 3.1.1.1 |
4RNF | PAMORA TANDEM DIGUANYLATE CYCLASE - MUTANT PHOSPHODIESTERASE, APO FORM | 2.7.7.65 3.1.4.52 |
4RNH | PAMORA TANDEM DIGUANYLATE CYCLASE - PHOSPHODIESTERASE, C-DI-GMP COMPLEX | 2.7.7.65 3.1.4.52 |
4RNI | PAMORA DIMERIC PHOSPHODIESTERASE. APO FORM | 3.1.4.52 |
4RNJ | PAMORA PHOSPHODIESTERASE DOMAIN, APO FORM | 3.1.4.52 |
4RNT | HIS 92 ALA MUTATION IN RIBONUCLEASE T1 INDUCES SEGMENTAL FLEXIBILITY. AN X-RAY STUDY | 3.1.27.3 4.6.1.24 |
4RO1 | AN 3'-5'-EXORIBONUCLEASE THAT SPECIFICALLY RECOGNIZES RNAS. | 3.1.13 |
4ROT | CRYSTAL STRUCTURE OF ESTERASE A FROM STREPTOCOCCUS PYOGENES | 3.1.1.1 3.1.1.2 |
4ROU | AUTO-INHIBITION MECHANISM OF HUMAN MITOCHONDRIAL RNASE P PROTEIN COMPLEX | 3.1.26.5 |
4ROV | THE CRYSTAL STRUCTURE OF NOVEL APOBEC3G CD2 HEAD-TO-TAIL DIMER SUGGESTS THE BINDING MODE OF FULL-LENGTH APOBEC3G TO HIV-1 SSDNA | 3.5.4 |
4ROW | THE CRYSTAL STRUCTURE OF NOVEL APOBEC3G CD2 HEAD-TO-TAIL DIMER SUGGESTS THE BINDING MODE OF FULL-LENGTH APOBEC3G TO HIV-1 SSDNA | 3.5.4 |
4RPA | CRYSTAL STRUCTURE OF INORGANIC PYROPHOSPHATASE FROM STAPHYLOCOCCUS AUREUS IN COMPLEX WITH MN2+ | 3.6.1.1 |
4RPT | THE 1.35A STRUCTURE OF A VIRAL RNASE L ANTAGONIST REVEALS BASIS FOR THE 2'-5'-OLIGOADENYLATE BINDING AND ENZYME ACTIVITY. | 3.1.4 2.7.7.50 2.1.1.56 |
4RPU | CRYSTAL STRUCTURE OF HUMAN PRESEQUENCE PROTEASE IN COMPLEX WITH INHIBITOR MITOBLOCK-60 | 3.4.24 |
4RQG | CRYSTAL STRUCTURE OF RHODOSTOMIN | 3.4.24 |
4RQY | RE-REFINED STRUCTURE OF 1TE0 - STRUCTURAL ANALYSIS OF DEGS, A STRESS SENSOR OF THE BACTERIAL PERIPLASM | 3.4.21.107 |
4RQZ | RE-REFINEMENT OF 1SOZ, CRYSTAL STRUCTURE OF DEGS PROTEASE IN COMPLEX WITH AN ACTIVATING PEPTIDE | 3.4.21.107 |
4RR0 | RE-REFINED 1VCW, CRYSTAL STRUCTURE OF DEGS AFTER BACKSOAKING THE ACTIVATING PEPTIDE | 3.4.21.107 |
4RR1 | RE-REFINEMENT OF ENTRY 1SOT, CRYSTAL STRUCTURE OF THE DEGS STRESS SENSOR | 3.4.21.107 |
4RRN | 8-TETRAHYDROPYRAN-2-YL CHROMANS: HIGHLY SELECTIVE BETA-SITE AMYLOID PRECURSOR PROTEIN CLEAVING ENZYME 1 (BACE1) INHIBITORS | 3.4.23.46 |
4RRO | 8-TETRAHYDROPYRAN-2-YL CHROMANS: HIGHLY SELECTIVE BETA-SITE AMYLOID PRECURSOR PROTEIN CLEAVING ENZYME 1 (BACE1) INHIBITORS | 3.4.23.46 |
4RRS | 8-TETRAHYDROPYRAN-2-YL CHROMANS: HIGHLY SELECTIVE BETA-SITE AMYLOID PRECURSOR PROTEIN CLEAVING ENZYME 1 (BACE1) INHIBITORS | 3.4.23.46 |
4RS3 | CRYSTAL STRUCTURE OF CARBOHYDRATE TRANSPORTER A0QYB3 FROM MYCOBACTERIUM SMEGMATIS STR. MC2 155, TARGET EFI-510969, IN COMPLEX WITH XYLITOL | 3.6.3.17 |
4RS4 | CRYSTAL STRUCTURE AND MUTATIONAL ANALYSIS OF THE ENDORIBONUCLEASE FROM HUMAN CORONAVIRUS 229E | 3.1 3.4.19.12 3.4.22 2.7.7.48 3.6.4.12 3.6.4.13 3.1.13 2.1.1 |
4RSC | CRYSTAL STRUCTURE OF RPE65 IN COMPLEX WITH EMIXUSTAT AND PALMITATE | 3.1.1.64 5.3.3.22 |
4RSD | STRUCTURE OF THE D121A VARIANT OF RIBONUCLEASE A | 3.1.27.5 4.6.1.18 |
4RSE | CRYSTAL STRUCTURE OF RPE65 IN COMPLEX WITH MB-001 AND PALMITATE | 3.1.1.64 5.3.3.22 |
4RSG | NEUTRON CRYSTAL STRUCTURE OF RAS BOUND TO THE GTP ANALOGUE GPPNHP | 3.6.5.2 |
4RSK | STRUCTURE OF THE K7A/R10A/K66A VARIANT OF RIBONUCLEASE A COMPLEXED WITH 3'-UMP | 3.1.27.5 4.6.1.18 |
4RSP | X-RAY STRUCTURE OF MERS-COV NSP5 PROTEASE BOUND WITH A DESIGNED INHIBITOR | 3.4.19.12 3.4.22.69 |
4RSY | CRYSTAL STRUCTURES OF THE HUMAN LEUKOTRIENE A4 HYDROLASE COMPLEX WITH A POTENTIAL INHIBITOR H7 | 3.3.2.6 3.4.11.4 |
4RTE | THE X-RAY STRUCTURE OF BOVINE PANCREATIC RIBONUCLEASE INCUBATED IN THE PRESENCE OF AN EXCESS OF CISPLATIN (1:10 RATIO) | 3.1.27.5 4.6.1.18 |
4RUH | CRYSTAL STRUCTURE OF HUMAN CARNOSINASE-2 (CN2) IN COMPLEX WITH INHIBITOR, BESTATIN AT 2.25 A | 3.4.13.18 |
4RUW | THE CRYSTAL STRUCTURE OF ENDONUCLEASE/EXONUCLEASE/PHOSPHATASE FROM BEUTENBERGIA CAVERNAE DSM 12333 | 3.1.4 |
4RV0 | CRYSTAL STRUCTURE OF TN COMPLEX | 3.6.4.6 |
4RVA | A TRIPLE MUTANT IN THE OMEGA-LOOP OF TEM-1 BETA-LACTAMASE CHANGES THE SUBSTRATE PROFILE VIA A LARGE CONFORMATIONAL CHANGE AND AN ALTERED GENERAL BASE FOR DEACYLATION | 3.5.2.6 |
4RVB | CRYSTAL STRUCTURE ANALYSIS OF THE HUMAN LEUKOTRIENE A4 HYDROLASE | 3.3.2.6 3.4.11.4 |
4RVE | THE CRYSTAL STRUCTURE OF ECORV ENDONUCLEASE AND OF ITS COMPLEXES WITH COGNATE AND NON-COGNATE DNA SEGMENTS | 3.1.21.4 |
4RW1 | HEN EGG-WHITE LYSOZYME STRUCTURE FROM A SPENT-BEAM EXPERIMENT AT LCLS: ORIGINAL BEAM | 3.2.1.17 |
4RW2 | HEN EGG-WHITE LYSOZYME STRUCTURE FROM A SPENT-BEAM EXPERIMENT AT LCLS: REFOCUSED BEAM | 3.2.1.17 |
4RW3 | STRUCTURAL INSIGHTS INTO SUBSTRATE BINDING OF BROWN SPIDER VENOM CLASS II PHOSPHOLIPASES D | 3.1.4.4 4.6.1 |
4RW4 | CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE (K103N,Y181C) VARIANT IN COMPLEX WITH (E)-3-(3-CHLORO-5-(4-CHLORO-2-(2-(2,4-DIOXO-3,4- DIHYDROPYRIMIDIN-1(2H)-YL)ETHOXY)PHENOXY)PHENYL)ACRYLONITRILE (JLJ494), A NON-NUCLEOSIDE INHIBITOR | 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 3.4.23.16 2.7.7 3.1 |
4RW5 | STRUCTURAL INSIGHTS INTO SUBSTRATE BINDING OF BROWN SPIDER VENOM CLASS II PHOSPHOLIPASES D | 3.1.4.4 4.6.1 |
4RW6 | CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE (Y181C) VARIANT IN COMPLEX WITH (E)-3-(3-CHLORO-5-(4-CHLORO-2-(2-(2,4-DIOXO-3,4- DIHYDROPYRIMIDIN-1(2H)-YL)ETHOXY)PHENOXY)PHENYL)ACRYLONITRILE (JLJ494), A NON-NUCLEOSIDE INHIBITOR | 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 3.4.23.16 2.7.7 3.1 |
4RW7 | CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE (K103N, Y181C) VARIANT IN COMPLEX WITH (E)-3-(3-CHLORO-5-(2-(2-(2,4-DIOXO-3,4-DIHYDROPYRIMIDIN-1(2H)-YL)ETHOXY)PHENOXY)PHENYL)ACRYLONITRILE (JLJ532), A NON-NUCLEOSIDE INHIBITOR | 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 3.4.23.16 2.7.7 3.1 |
4RW8 | CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH (E)-3-(3-CHLORO-5-(2-(2-(2,4-DIOXO-3,4-DIHYDROPYRIMIDIN-1(2H)-YL)ETHOXY)PHENOXY)PHENYL)ACRYLONITRILE (JLJ532), A NON-NUCLEOSIDE INHIBITOR' | 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 3.4.23.16 2.7.7 3.1 |
4RW9 | CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE (Y181C) VARIANT IN COMPLEX WITH (E)-3-(3-CHLORO-5-(2-(2-(2,4-DIOXO-3,4-DIHYDROPYRIMIDIN-1(2H)-YL)ETHOXY)PHENOXY)PHENYL)ACRYLONITRILE (JLJ532), A NON-NUCLEOSIDE INHIBITOR | 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 3.4.23.16 2.7.7 3.1 |
4RWS | CRYSTAL STRUCTURE OF CXCR4 AND VIRAL CHEMOKINE ANTAGONIST VMIP-II COMPLEX (PSI COMMUNITY TARGET) | 3.2.1.17 |
4RX2 | A TRIPLE MUTANT IN THE OMEGA-LOOP OF TEM-1 BETA-LACTAMASE CHANGES THE SUBSTRATE PROFILE VIA A LARGE CONFORMATIONAL CHANGE AND AN ALTERED GENERAL BASE FOR CATALYSIS | 3.5.2.6 |
4RX3 | A TRIPLE MUTANT IN THE OMEGA-LOOP OF TEM-1 BETA-LACTAMASE CHANGES THE SUBSTRATE PROFILE VIA A LARGE CONFORMATIONAL CHANGE AND AN ALTERED GENERAL BASE FOR CATALYSIS | 3.5.2.6 |
4RXH | CRYSTAL STRUCTURE OF IMPORTIN-ALPHA FROM NEUROSPORA CRASSA COMPLEXED WITH SV40NLS | 3.6.4 |
4RXO | THE STRUCTURE OF GTP-BOUND SAMHD1 | 3.1.5 |
4RXP | THE STRUCTURE OF GTP-DATP-BOUND SAMHD1 | 3.1.5 |
4RXQ | THE STRUCTURE OF GTP-DUTP-BOUND SAMHD1 | 3.1.5 |
4RXR | THE STRUCTURE OF GTP-DCTP-BOUND SAMHD1 | 3.1.5 |
4RXS | THE STRUCTURE OF GTP-DTTP-BOUND SAMHD1 | 3.1.5 |
4RXX | CRYSTAL STRUCTURE OF THE N-TERMINAL DOMAIN OF HUMAN UBIQUITIN SPECIFIC PROTEASE 38 | 3.4.19.12 |
4RY2 | CRYSTAL STRUCTURE OF THE PEPTIDASE-CONTAINING ABC TRANSPORTER PCAT1 | 3.4.22 |
4RY3 | CRYSTAL STRUCTURE OF HUMAN FANCONI-ASSOCIATED NUCLEASE 1 | 3.1.21 3.1.4.1 |
4RY4 | C-TERMINAL MUTANT (Y448F) OF HCV/J4 RNA POLYMERASE | 2.7.7.48 3.4.22 3.4.21.98 3.6.1.15 3.6.4.13 |
4RY5 | C-TERMINAL MUTANT (W550N) OF HCV/J4 RNA POLYMERASE | 2.7.7.48 3.4.22 3.4.21.98 3.6.1.15 3.6.4.13 |
4RY6 | C-TERMINAL MUTANT (W550A) OF HCV/J4 RNA POLYMERASE | 2.7.7.48 3.4.22 3.4.21.98 3.6.1.15 3.6.4.13 |
4RY7 | C-TERMINAL MUTANT (D559E) OF HCV/J4 RNA POLYMERASE | 2.7.7.48 3.4.22 3.4.21.98 3.6.1.15 3.6.4.13 |
4RYC | RENIN IN COMPLEXED WITH 4-METHOXY-3-(3-METHOXYPROPOXY)-N-{[(3S,4S)-4-{[(4-METHYLPHENYL)SULFONYL]AMINO}PYRROLIDIN-3-YL]METHYL}-N-(PROPAN-2-YL)BENZAMIDE INHIBITOR | 3.4.23.15 |
4RYE | THE CRYSTAL STRUCTURE OF D-ALANYL-D-ALANINE CARBOXYPEPTIDASE FROM MYCOBACTERIUM TUBERCULOSIS H37RV | 3.4.16 |
4RYF | CLPP1/2 HETEROCOMPLEX FROM LISTERIA MONOCYTOGENES | 3.4.21.92 |
4RYG | RENIN IN COMPLEXED WITH N-({(3S,4S)-4-[(BENZYLSULFONYL)AMINO]PYRROLIDIN-3-YL}METHYL)-4-METHOXY-3-(3-METHOXYPROPOXY)-N-(PROPAN-2-YL)BENZAMIDE INHIBITOR | 3.4.23.15 |
4RYT | CRYSTAL STRUCTURE OF F222 FORM OF E112A MUTANT OF STATIONARY PHASE SURVIVAL PROTEIN (SURE) FROM SALMONELLA TYPHIMURIUM | 3.1.3.5 3.1.3.6 3.6.1.11 |
4RYU | CRYSTAL STRUCTURE OF C2 FORM OF E112A MUTANT OF STATIONARY PHASE SURVIVAL PROTEIN (SURE) FROM SALMONELLA TYPHIMURIUM | 3.1.3.5 3.1.3.6 3.6.1.11 |
4RYV | CRYSTAL STRUCTURE OF YELLOW LUPIN LLPR-10.1A PROTEIN IN COMPLEX WITH TRANS-ZEATIN | 3.1.27 |
4RYX | CRYSTAL STRUCTURE OF RPE65 IN COMPLEX WITH EMIXUSTAT AND PALMITATE, P6522 CRYSTAL FORM | 3.1.1.64 5.3.3.22 |
4RYY | CRYSTAL STRUCTURE OF RPE65 IN COMPLEX WITH R-EMIXUSTAT AND PALMITATE | 3.1.1.64 5.3.3.22 |
4RYZ | CRYSTAL STRUCTURE OF RPE65 IN COMPLEX WITH S-EMIXUSTAT AND PALMITATE | 3.1.1.64 5.3.3.22 |
4RZ1 | RENIN IN COMPLEXED WITH (3S,4S)-4-({[4-METHOXY-3-(3-METHOXYPROPOXY)BENZOYL](PROPAN-2-YL)AMINO}METHYL)PYRROLIDIN-3-YL BENZYLCARBAMATE INHIBITOR | 3.4.23.15 |
4RZJ | STRUCTURE OF THE COMPLEX OF TYPE 1 RIBOSOME INACTIVATING PROTEIN FROM MOMORDICA BALSAMINA WITH N-ACETYLGLUCOSAMINE AT 1.98 ANGSTROM RESOLUTION USING CRYSTALS GROWN IN DIFFERENT CONDITIONS | 3.2.2.22 |
4S0F | CRYSTAL STRUCTURE OF THE PEPTIDASE-CONTAINING ABC TRANSPORTER PCAT1 E648Q MUTANT COMPLEXED WITH ATPGS IN AN OCCLUDED CONFORMATION | 3.4.22 |
4S0G | CRYSTAL STRUCTURE OF PTPN3 (PTPH1) IN COMPLEX WITH EPS15 PTYR849 P850V PEPTIDE | 3.1.3.48 |
4S0N | CRYSTAL STRUCTURE OF HLTF HIRAN DOMAIN BOUND TO DNA | 3.6.4 6.3.2 2.3.2.27 |
4S0Q | THE X-RAY STRUCTURE OF THE ADDUCT FORMED IN THE REACTION BETWEEN BOVINE PANCREATIC RIBONUCLEASE AND CARBOPLATIN | 3.1.27.5 4.6.1.18 |
4S0W | WILD TYPE T4 LYSOZYME STRUCTURE | 3.2.1.17 |
4S0X | STRUCTURE OF THREE PHASE PARTITION - TREATED LIPASE FROM THERMOMYCES LANUGINOSA IN COMPLEX WITH LAURIC ACID AT 2.1 A RESOLUTION | 3.1.1.3 |
4S0Z | CRYSTAL STRUCTURE OF M26V HUMAN DJ-1 | 3.4 3.1.2 3.5.1 3.5.1.124 |
4S18 | THE X-RAY STRUCTURE OF THE ADDUCT FORMED IN THE REACTION BETWEEN BOVINE PANCREATIC RIBONUCLEASE AND OXALIPLATIN | 3.1.27.5 4.6.1.18 |
4S1G | RENIN IN COMPLEX WITH (S)-1-(3-FLUORO-5-(((S)-1-PHENYLETHYL)CARBAMOYL)BENZYL)-4-ISOPROPYL-4-METHYL-6-OXOTETRAHYDROPYRIMIDIN-2(1H)-IMINIUM | 3.4.23.15 |
4S1T | CRYSTAL STRUCTURE OF THE MUTANT I26A/N52A OF THE ENDORIBONUCLEASE FROM HUMAN CORONAVIRUS 229E | 3.1 3.4.19.12 3.4.22 2.7.7.48 3.6.4.12 3.6.4.13 3.1.13 2.1.1 |
4S2D | JOINT X-RAY/NEUTRON STRUCTURE OF TRICHODERMA REESEI XYLANASE II IN COMPLEX WITH MES AT PH 5.7 | 3.2.1.8 |
4S2F | JOINT X-RAY/NEUTRON STRUCTURE OF TRICHODERMA REESEI XYLANASE II AT PH 4.4 | 3.2.1.8 |
4S2G | JOINT X-RAY/NEUTRON STRUCTURE OF TRICHODERMA REESEI XYLANASE II AT PH 5.8 | 3.2.1.8 |
4S2H | JOINT X-RAY/NEUTRON STRUCTURE OF TRICHODERMA REESEI XYLANASE II AT PH 8.5 | 3.2.1.8 |
4S2I | CTX-M-15 IN COMPLEX WITH AVIBACTAM | 3.5.2.6 |
4S2J | OXA-48 IN COMPLEX WITH AVIBACTAM AT PH 6.5 | 3.5.2.6 |
4S2K | OXA-48 IN COMPLEX WITH AVIBACTAM AT PH 7.5 | 3.5.2.6 |
4S2L | CRYSTAL STRUCTURE OF OXA-163 BETA-LACTAMASE | 3.5.2.6 |
4S2M | CRYSTAL STRUCTURE OF OXA-163 COMPLEXED WITH IODIDE IN THE ACTIVE SITE | 3.5.2.6 |
4S2N | OXA-48 IN COMPLEX WITH AVIBACTAM AT PH 8.5 | 3.5.2.6 |
4S2O | OXA-10 IN COMPLEX WITH AVIBACTAM | 3.5.2.6 |
4S2P | CRYSTAL STRUCTURE OF UNBOUND OXA-48 | 3.5.2.6 |
4S2R | CRYSTAL STRUCTURE OF X-PROLYL AMINOPEPTIDASE FROM CAENORHABDITIS ELEGANS: A CYTOSOLIC ENZYME WITH A DI-NUCLEAR ACTIVE SITE | 3.4.11.9 |
4S2V | E. COLI RPPH STRUCTURE, KI SOAK | 3.6.1 |
4S2W | STRUCTURE OF E. COLI RPPH BOUND TO SULFATE IONS | 3.6.1 |
4S2X | STRUCTURE OF E. COLI RPPH BOUND TO RNA AND TWO MAGNESIUM IONS | 3.6.1 |
4S2Y | STRUCTURE OF E. COLI RPPH BOUND TO RNA AND THREE MAGNESIUM IONS | 3.6.1 |
4S3K | CRYSTAL STRUCTURE OF THE BACILLUS MEGATERIUM QM B1551 SPORE CORTEX-LYTIC ENZYME SLEL | 3.2.1 |
4S3S | CRYSTAL STRUCTURE OF STAPHYLOCOCCAL NUCLEASE VARIANT DELTA+PHS I92K/V23A AT CRYOGENIC TEMPERATURE | 3.1.31.1 |
4SGA | STRUCTURES OF PRODUCT AND INHIBITOR COMPLEXES OF STREPTOMYCES GRISEUS PROTEASE A AT 1.8 ANGSTROMS RESOLUTION. A MODEL FOR SERINE PROTEASE CATALYSIS | 3.4.21.80 |
4SGB | STRUCTURE OF THE COMPLEX OF STREPTOMYCES GRISEUS PROTEINASE B AND POLYPEPTIDE CHYMOTRYPSIN INHIBITOR-1 FROM RUSSET BURBANK POTATO TUBERS AT 2.1 ANGSTROMS RESOLUTION | 3.4.21.81 |
4SLI | LEECH INTRAMOLECULAR TRANS-SIALIDASE COMPLEXED WITH 2-PROPENYL-NEU5AC, AN INACTIVE SUBSTRATE ANALOGUE | 3.2.1.18 4.2.2.15 |
4SRN | STRUCTURAL CHANGES THAT ACCOMPANY THE REDUCED CATALYTIC EFFICIENCY OF TWO SEMISYNTHETIC RIBONUCLEASE ANALOGS | 3.1.27.5 4.6.1.18 |
4TF4 | ENDO/EXOCELLULASE:CELLOPENTAOSE FROM THERMOMONOSPORA | 3.2.1.4 |
4TGL | CATALYSIS AT THE INTERFACE: THE ANATOMY OF A CONFORMATIONAL CHANGE IN A TRIGLYCERIDE LIPASE | 3.1.1.3 |
4THN | THE CRYSTAL STRUCTURE OF ALPHA-THROMBIN-HIRUNORM IV COMPLEX REVEALS A NOVEL SPECIFICITY SITE RECOGNITION MODE. | 3.4.21.5 |
4TKD | SULFOLOBUS SOLFATARICUS HJC MUTANTS | 3.1.22.4 |
4TKK | SULFOLOBUS SOLFATARICUS HJC MUTANTS | 3.1.22.4 |
4TKX | STRUCTURE OF PROTEASE | 3.4.22.47 |
4TLI | THERMOLYSIN (25% ISOPROPANOL SOAKED CRYSTALS) | 3.4.24.27 |
4TLN | BINDING OF HYDROXAMIC ACID INHIBITORS TO CRYSTALLINE THERMOLYSIN SUGGESTS A PENTACOORDINATE ZINC INTERMEDIATE IN CATALYSIS | 3.4.24.27 |
4TM7 | CRYSTAL STRUCTURE OF 6-PHOSPHOGLUCONOLACTONASE FROM MYCOBACTERIUM SMEGMATIS N131D MUTANT SOAKED WITH CUSO4 | 3.1.1.31 |
4TM8 | CRYSTAL STRUCTURE OF 6-PHOSPHOGLUCONOLACTONASE FROM MYCOBACTERIUM SMEGMATIS N131D MUTANT | 3.1.1.31 |
4TMF | CRYSTAL STRUCTURE OF HUMAN CD38 IN COMPLEX WITH HYDROLYSED COMPOUND JMS713 | 3.2.2.6 2.4.99.20 |
4TMN | SLOW-AND FAST-BINDING INHIBITORS OF THERMOLYSIN DISPLAY DIFFERENT MODES OF BINDING. CRYSTALLOGRAPHIC ANALYSIS OF EXTENDED PHOSPHONAMIDATE TRANSITION-STATE ANALOGUES | 3.4.24.27 |
4TMT | TRANSLATION INITIATION FACTOR EIF5B (517-858) MUTANT D533A FROM C. THERMOPHILUM, BOUND TO GTPGAMMAS | 3.6.5.3 |
4TMU | CRYSTAL STRUCTURE OF RECQ CATALYTIC CORE FROM C. SAKAZAKII BOUND TO DNA | 3.6.4.12 |
4TMV | TRANSLATION INITIATION FACTOR EIF5B (517-858) FROM C. THERMOPHILUM, BOUND TO GTPGAMMAS AND SODIUM | 3.6.5.3 |
4TMW | TRANSLATION INITIATION FACTOR EIF5B (517-858) FROM C. THERMOPHILUM, BOUND TO GTP AND SODIUM | 3.6.5.3 |
4TMX | TRANSLATION INITIATION FACTOR EIF5B (517-858) MUTANT D533N FROM C. THERMOPHILUM, BOUND TO GTP AND SODIUM | 3.6.5.3 |
4TMZ | TRANSLATION INITIATION FACTOR EIF5B (517-858) FROM C. THERMOPHILUM, BOUND TO GTPGAMMAS AND POTASSIUM | 3.6.5.3 |
4TN1 | TRANSLATION INITIATION FACTOR EIF5B (517-858) MUTANT D533R FROM C. THERMOPHILUM, BOUND TO GTPGAMMAS | 3.6.5.3 |
4TN2 | NS5B IN COMPLEX WITH LACTAM-THIOPHENE CARBOXYLIC ACIDS | 3.4.22 3.4.21.98 3.6.1.15 3.6.4.13 2.7.7.48 |
4TN3 | STRUCTURE OF THE BBOX-COILED-COIL REGION OF RHESUS TRIM5ALPHA | 3.2.1.17 |
4TN9 | CRYSTAL STRUCTURE OF CLOSTRIDIUM HISTOLYTICUM COLG COLLAGENASE POLYCYSTIC KIDNEY DISEASE-LIKE DOMAIN AT 1.4 ANGSTROM RESOLUTION | 3.4.24.3 |
4TNL | 1.8 A RESOLUTION ROOM TEMPERATURE STRUCTURE OF THERMOLYSIN RECORDED USING AN XFEL | 3.4.24.27 |
4TNO | HYPOTHETICAL PROTEIN PF1117 FROM PYROCOCCUS FURIOSUS: STRUCTURE SOLVED BY SULFUR-SAD USING SWISS LIGHT SOURCE DATA | 3.1 |
4TNP | STRUCTURAL BASIS OF CELLULAR DNTP REGULATION, SAMHD1-GTP-DCTP-CCTP COMPLEX | 3.1.5 |
4TNQ | STRUCTURAL BASIS OF CELLULAR DNTP REGULATION, SAMHD1-GTP-DTTP-DTTP COMPLEX | 3.1.5 |
4TNR | STRUCTURE BASIS OF CELLULAR DNTP REGULATION, SAMHD1-GTP-DATP-DATP COMPLEX | 3.1.5 |
4TNU | HUMAN BRAIN ASPARTOACYLASE MUTANT Y231C COMPLEX WITH INTERMEDIATE ANALOG (N-PHOSPHONOMETHYL-L-ASPARTATE) | 3.5.1.15 |
4TNX | STRUCTURE BASIS OF CELLULAR DNTP REGULATION, SAMHD1-GTP-DGTP COMPLEX | 3.1.5 |
4TNY | STRUCTURAL BASIS OF CELLULAR DNTP REGULATION, SAMHD1-DGTP-DATP-DGTP COMPLEX | 3.1.5 |
4TNZ | STRUCTURE BASIS OF CELLULAR DNTP REGULATION, SAMHD1-GTP-DATP-DTTP COMPLEX | 3.1.5 |
4TO0 | STRUCTURE BASIS OF CELLULAR DNTP REGULATION, SAMHD1-GTP-DATP-DCTP COMPLEX | 3.1.5 |
4TO1 | STRUCTURE BASIS OF CELLULAR DNTP REGULATION, SAMHD1-GTP-DATP/DCTP-DCTP COMPLEX | 3.1.5 |
4TO2 | STRUCTURE BASIS OF CELLULAR DNTP REGULATION, SAMHD1-DGTP-DGTP-DGTP/DTTP COMPLEX | 3.1.5 |
4TO3 | STRUCTURAL BASIS OF CELLULAR DNTP REGULATION, SAMHD1-DGTP-DGTP-DCTP COMPLEX | 3.1.5 |
4TO4 | STRUCTURE BASIS OF CELLULAR DNTP REGULATION, SAMHD1-GTP-DGTP-DCTP COMPLEX | 3.1.5 |
4TO5 | STRUCTURE BASIS OF CELLULAR DNTP REGULATION, SAMHD1-GTP-DTTP-DCTP COMPLEX | 3.1.5 |
4TO6 | STRUCTURE BASIS OF CELLULAR DNTP REGULATION, SAMHD1-DGTP-DATP-DTTP/DGTP COMPLEX | 3.1.5 |
4TOQ | CRYSTAL STRUCTURE OF CLASS III CHITINASE FROM POMEGRANATE PROVIDES THE INSIGHT INTO ITS METAL STORAGE CAPACITY | 3.2.1.14 |
4TPK | HUMAN BUTYRYLCHOLINESTERASE IN COMPLEX WITH N-((1-(2,3-DIHYDRO-1H-INDEN-2-YL)PIPERIDIN-3-YL)METHYL)-N-(2-METHOXYETHYL)-2-NAPHTHAMIDE | 3.1.1.8 |
4TPL | WEST NILE VIRUS NON-STRUCTURAL PROTEIN 1 (NS1) FORM 1 CRYSTAL | 3.4.21.91 3.6.1.15 3.6.4.13 |
4TPM | CRYSTAL STRUCTURE OF 2-(3-ALKOXY-1-AZETIDINYL) QUINOLINES AS PDE10A INHIBITORS | 3.1.4.17 3.1.4.35 |
4TPP | 2-(3-ALKOXY-1-AZETIDINYL) QUINOLINES AS NOVEL PDE10A INHIBITORS | 3.1.4.17 3.1.4.35 |
4TPY | HIGH THROUGHPUT SCREENING USING ACOUSTIC DROPLET EJECTION TO COMBINE PROTEIN CRYSTALS AND CHEMICAL LIBRARIES ON CRYSTALLIZATION PLATES AT HIGH DENSITY | 3.4.21.4 |
4TQ9 | CRYSTAL STRUCTURE OF A GDP-BOUND G12V ONCOGENIC MUTANT OF HUMAN GTPASE KRAS | 3.6.5.2 |
4TQA | CRYSTAL STRUCTURE OF A GDP-BOUND G13D ONCOGENIC MUTANT OF HUMAN GTPASE KRAS | 3.6.5.2 |
4TQT | CRYSTAL STRUCTURE OF DIHYDROPYRIMIDINASE FROM BRUCELLA SUIS | 3.5.2.2 |
4TR2 | CRYSTAL STRUCTURE OF PVSUB1 | 3.4.21.62 |
4TRD | CRYSTAL STRUCTURE OF STAPHYLCOCCAL NUCLEASE VARIANT DELTA+PHS I72K/V74K AT PH 9.0 AT CRYOGENIC TEMPERATURE | 3.1.31.1 |
4TRW | STRUCTURE OF BACE1 COMPLEX WITH A SYN-HEA-TYPE INHIBITOR | 3.4.23.46 |
4TRY | STRUCTURE OF BACE1 COMPLEX WITH A HEA-TYPE INHIBITOR | 3.4.23.46 |
4TRZ | STRUCTURE OF BACE1 COMPLEX WITH 2-THIOPHENYL HEA-TYPE INHIBITOR | 3.4.23.46 |
4TSA | STRUCTURE OF A LYSOZYME FAB COMPLEX | 3.2.1.17 |
4TSB | STRUCTURE OF A LYSOZYME ANTIBODY COMPLEX | 3.2.1.17 |
4TSC | STRUCTURE OF A LYSOZYME ANTIBODY COMPLEX | 3.2.1.17 |
4TSR | THE COMPLEX STRUCTURE OF MUTANT PHYTASE WITH IHS | 3.1.3.2 3.1.3.26 |
4TT0 | CRYSTAL STRUCTURE OF FRAGMENT 1600-1733 OF HSV1 UL36 IN THE PRESENCE OF 1M POTASSIUM IODIDE | 3.4.19.12 3.4.22 |
4TT1 | CRYSTAL STRUCTURE OF FRAGMENT 1600-1733 OF HSV1 UL36, NATIVE | 3.4.19.12 3.4.22 |
4TT2 | CRYSTAL STRUCTURE OF ATAD2A BROMODOMAIN COMPLEXED WITH H4(1-20)K5AC PEPTIDE | 3.6.1.3 3.6.1 |
4TT4 | CRYSTAL STRUCTURE OF ATAD2A BROMODOMAIN COMPLEXED WITH H3(1-21)K14AC PEPTIDE | 3.6.1.3 3.6.1 |
4TT6 | CRYSTAL STRUCTURE OF ATAD2A BROMODOMAIN DOUBLE MUTANT N1063A-Y1064A IN APO FORM | 3.6.1.3 3.6.1 |
4TTD | STRUCTURE OF A LYSOZYME ANTIBODY COMPLEX | 3.2.1.17 |
4TTE | CRYSTAL STRUCTURE OF ATAD2A BROMODOMAIN COMPLEXED WITH METHYL 3-AMINO-5-(3,5-DIMETHYL-1,2-OXAZOL-4-YL)BENZOATE | 3.6.1.3 3.6.1 |
4TU0 | CRYSTAL STRUCTURE OF CHIKUNGUNYA VIRUS NSP3 MACRO DOMAIN IN COMPLEX WITH A 2'-5' OLIGOADENYLATE TRIMER | 2.1.1 2.7.7 3.1.3.33 3.4.22 3.6.1.15 3.6.4.13 2.7.7.48 3.1.3.84 2.7.7.19 |
4TU4 | CRYSTAL STRUCTURE OF ATAD2A BROMODOMAIN COMPLEXED WITH 3-(3,5-DIMETHYL-1,2-OXAZOL-4-YL)-5-[(PHENYLSULFONYL)AMINO]BENZOICACID | 3.6.1.3 3.6.1 |
4TU6 | CRYSTAL STRUCTURE OF APO ATAD2A BROMODOMAIN WITH N1064 ALTERNATE CONFORMATION | 3.6.1.3 3.6.1 |
4TUF | CATALYTIC DOMAIN OF THE MAJOR ENDOGLUCANASE FROM XANTHOMONAS CAMPESTRIS PV. CAMPESTRIS | 3.2.1.4 |
4TUG | CRYSTAL STRUCTURE OF MJMRE11-DNA2 COMPLEX | 3.1 |
4TUI | CRYSTAL STRUCTURE OF MJMRE11-DNA1 COMPLEX | 3.1 |
4TUN | CRYSTAL STRUCTURE OF CHICKEN EGG WHITE LYSOZYME ADDUCT WITH ORGANOPHOSPHORUS PESTICIDE MONOCHROTOPHOS | 3.2.1.17 |
4TVK | TORPEDO CALIFORNICA ACETYLCHOLINESTERASE IN COMPLEX WITH A CHLOROTACRINE-JUGLONE HYBRID INHIBITOR | 3.1.1.7 |
4TWE | STRUCTURE OF LIGAND-FREE N-ACETYLATED-ALPHA-LINKED-ACIDIC-DIPEPTIDASE LIKE PROTEIN (NAALADASEL) | 3.4.17.21 3.4.11 |
4TWI | THE STRUCTURE OF SIR2AF1 BOUND TO A SUCCINYLATED HISTONE PEPTIDE | 3.5.1 2.3.1.286 |
4TWJ | THE STRUCTURE OF SIR2AF2 BOUND TO A MYRISTOYLATED HISTONE PEPTIDE | 3.5.1 2.3.1.286 |
4TWS | GADOLINIUM DERIVATIVE OF TETRAGONAL HEN EGG-WHITE LYSOZYME AT 1.45 A RESOLUTION | 3.2.1.17 |
4TWW | STRUCTURE OF SARS-3CL PROTEASE COMPLEX WITH A BROMOBENZOYL (S,R)-N-DECALIN TYPE INHIBITOR | 3.4.22.69 3.4.19.12 3.4.22 2.7.7.48 3.6.4.12 3.6.4.13 2.1.1 3.1.13 3.1 |
4TWY | STRUCTURE OF SARS-3CL PROTEASE COMPLEX WITH A PHENYLBENZOYL (S,R)-N-DECALIN TYPE INHIBITOR | 3.4.22.69 3.4.19.12 3.4.22 2.7.7.48 3.6.4.12 3.6.4.13 2.1.1 3.1.13 3.1 |
4TX1 | THE CRYSTAL STRUCTURE OF CARBOHYDRATE ACETYLESTERASE FAMILY MEMBER FROM SINORHIZOBIUM MELILOTI | 3.1.1.2 |
4TX6 | AFCHIA1 IN COMPLEX WITH COMPOUND 1 | 3.2.1.14 |
4TX7 | CRYSTAL STRUCTURE OF CHITINASE (GH19) FROM VIGNA UNGUICULATA | 3.2.1.14 |
4TXE | SCCTS1 IN COMPLEX WITH COMPOUND 5 | 3.2.1.14 |
4TXT | CRYSTAL STRUCTURE OF A GH48 CELLOBIOHYDROLASE FROM CALDICELLULOSIRUPTOR BESCII | 3.2.1.4 |
4TXW | CRYSTAL STRUCTURE OF CBM32-4 FROM THE CLOSTRIDIUM PERFRINGENS NAGH | 3.2.1.35 |
4TY6 | FACTOR XIA IN COMPLEX WITH THE INHIBITOR 4-{2-[(1S)-1-({[TRANS-4-(AMINOMETHYL)CYCLOHEXYL]CARBONYL}AMINO)-2-PHENYLETHYL]-1H-IMIDAZOL-4-YL}BENZAMIDE | 3.4.21.27 |
4TY7 | FACTOR XIA IN COMPLEX WITH THE INHIBITOR (2S)-6-AMINO-N-{(1S)-1-[4-(3-AMINO-2H-INDAZOL-6-YL)-5-CHLORO-1H-IMIDAZOL-2-YL]-2-PHENYLETHYL}-2-ETHYLHEXANAMIDE | 3.4.21.27 |
4TYL | FRAGMENT-BASED SCREENING OF THE BROMODOMAIN OF ATAD2 | 3.6.1.3 3.6.1 |
4TYN | DEAD-BOX HELICASE MSS116 BOUND TO SSDNA AND ADP-BEF | 3.6.4.13 |
4TYT | CRYSTAL STRUCTURE OF BCII METALLO-BETA-LACTAMASE IN COMPLEX WITH ML302F | 3.5.2.6 |
4TYV | ENSEMBLE REFINEMENT OF THE E502A VARIANT OF SACTELAM55A FROM STREPTOMYCES SP. SIREXAA-E IN COMPLEX WITH GLUCOSE | 3.2.1.58 |
4TYW | DEAD-BOX HELICASE MSS116 BOUND TO SSRNA AND ADP-BEF | 3.6.4.13 |
4TYY | DEAD-BOX HELICASE MSS116 BOUND TO SSRNA AND CDP-BEF | 3.6.4.13 |
4TZ0 | DEAD-BOX HELICASE MSS116 BOUND TO SSRNA AND GDP-BEF | 3.6.4.13 |
4TZ1 | ENSEMBLE REFINEMENT OF THE E502A VARIANT OF SACTELAM55A FROM STREPTOMYCES SP. SIREXAA-E IN COMPLEX WITH LAMINARITRIOSE | 3.2.1.58 |
4TZ2 | FRAGMENT-BASED SCREENING OF THE BROMODOMAIN OF ATAD2 | 3.6.1.3 3.6.1 |
4TZ3 | ENSEMBLE REFINEMENT OF THE E502A VARIANT OF SACTELAM55A FROM STREPTOMYCES SP. SIREXAA-E IN COMPLEX WITH LAMINARITETRAOSE | 3.2.1.58 |
4TZ5 | ENSEMBLE REFINEMENT OF THE E502A VARIANT OF SACTELAM55A FROM STREPTOMYCES SP. SIREXAA-E IN COMPLEX WITH LAMINARIHEXAOSE | 3.2.1.58 |
4TZ6 | DEAD-BOX HELICASE MSS116 BOUND TO SSRNA AND UDP-BEF | 3.6.4.13 |
4TZ8 | STRUCTURE OF HUMAN ATAD2 BROMODOMAIN BOUND TO FRAGMENT INHIBITOR | 3.6.1.3 3.6.1 |
4U01 | HCV NS3/4A SERINE PROTEASE IN COMPLEX WITH 6570 | 3.4.22 3.4.21.98 3.6.1.15 3.6.4.13 2.7.7.48 |
4U04 | STRUCTURE OF A EUKARYOTIC FIC DOMAIN CONTAINING PROTEIN | 2.7.7 3.1.4 |
4U0H | CRYSTAL STRUCTURE OF M. TUBERCULOSIS CLPP1P1 | 3.4.21.92 |
4U0T | CRYSTAL STRUCTURE OF ADC-7 BETA-LACTAMASE | 3.5.2.6 |
4U0U | WILD TYPE EUKARYOTIC FIC DOMAIN CONTAINING PROTEIN WITH ADP | 2.7.7 3.1.4 |
4U0X | STRUCTURE OF ADC-7 BETA-LACTAMASE IN COMPLEX WITH BORONIC ACID INHIBITOR S02030 | 3.5.2.6 |
4U14 | STRUCTURE OF THE M3 MUSCARINIC ACETYLCHOLINE RECEPTOR BOUND TO THE ANTAGONIST TIOTROPIUM CRYSTALLIZED WITH DISULFIDE-STABILIZED T4 LYSOZYME (DST4L) | 3.2.1.17 |
4U15 | M3-MT4L RECEPTOR BOUND TO TIOTROPIUM | 3.2.1.17 |
4U16 | M3-MT4L RECEPTOR BOUND TO NMS | 3.2.1.17 |
4U1B | HSMETAP IN COMPLEX WITH (1-AMINO-2-PROPYLPENTYL)PHOSPHONIC ACID | 3.4.11.18 |
4U2B | CRYSTAL STRUCTURE OF DIENELACTONE HYDROLASE (C123S) AT 1.70 A RESOLUTION | 3.1.1.45 |
4U2C | CRYSTAL STRUCTURE OF DIENELACTONE HYDROLASE A-6 VARIANT (S7T, A24V, Q35H, F38L, Q110L, C123S, Y145C, E199G AND S208G) AT 1.95 A RESOLUTION | 3.1.1.45 |
4U2D | CRYSTAL STRUCTURE OF DIENELACTONE HYDROLASE S-2 VARIANT (Q35H, F38L, Q110L, C123S, Y137C, Y145C, N154D, E199G, S208G AND G211D) AT 1.67 A RESOLUTION | 3.1.1.45 |
4U2E | CRYSTAL STRUCTURE OF DIENELACTONE HYDROLASE S-3 VARIANT (Q35H, F38L, Q110L, C123S, Y137C, Y145C, N154D, E199G, S208G, G211D AND K234N) AT 1.70 A RESOLUTION | 3.1.1.45 |
4U2F | CRYSTAL STRUCTURE OF DIENELACTONE HYDROLASE B-1 VARIANT (Q35H, F38L, Y64H, Q110L, C123S, Y137C, Y145C, N154D, E199G, S208G AND G211D) AT 1.80 A RESOLUTION | 3.1.1.45 |
4U2G | CRYSTAL STRUCTURE OF DIENELACTONE HYDROLASE B-4 VARIANT (Q35H, F38L, Y64H, Q76L, Q110L, C123S, Y137C, A141V, Y145C, N154D, E199G, S208G, G211D, S233G AND 237Q) AT 1.80 A RESOLUTION | 3.1.1.45 |
4U2W | ATOMIC RESOLUTION CRYSTAL STRUCTURE OF HV-BBI PROTEASE INHIBITOR FROM AMPHIBIAN SKIN IN COMPLEX WITH BOVINE TRYPSIN | 3.4.21.4 |
4U30 | HUMAN MESOTRYPSIN COMPLEXED WITH BIKUNIN KUNITZ DOMAIN 2 | 3.4.21.4 |
4U32 | HUMAN MESOTRYPSIN COMPLEXED WITH HAI-2 KUNITZ DOMAIN 1 | 3.4.21.4 |
4U3A | CRYSTAL STRUCTURE OF CTCEL5E | 3.2.1.4 |
4U3B | LPXC FROM A.AAEOLICUS IN COMPLEX WITH THE MMP INHIBITOR 4-[[4-(4-CHLOROPHENOXY)PHENYL]SULFANYLMETHYL]TETRAHYDROPYRAN-4-CARBOHYDROXAMIC ACID - COMPOUND 2 | 3.5.1 3.5.1.108 |
4U3D | LPXC FROM A.AAEOLICUS IN COMPLEX WITH 4-[[4-[2-[4-(MORPHOLINOMETHYL)PHENYL]ETHYNYL]PHENOXY]METHYL]TETRAHYDROPYRAN-4-CARBOHYDROXAMIC ACID (COMPOUND 9) | 3.5.1 3.5.1.108 |
4U3T | CRYSTAL STRUCTURE OF THE TRANSPEPTIDASE DOMAIN OF NEISSERIA GONORRHOEAE PENICILLIN-BINDING PROTEIN 2 DERIVED FROM THE PENICILLIN-RESISTANT STRAIN 6140 | 3.4.16.4 |
4U4C | THE MOLECULAR ARCHITECTURE OF THE TRAMP COMPLEX REVEALS THE ORGANIZATION AND INTERPLAY OF ITS TWO CATALYTIC ACTIVITIES | 3.6.4.13 |
4U4L | CRYSTAL STRUCTURE OF THE METALLO-BETA-LACTAMASE NDM-1 IN COMPLEX WITH A BISTHIAZOLIDINE INHIBITOR | 3.5.2.6 |
4U5I | COMPLEX STRUCTURE OF MUTANT CTCEL5E (E314A) WITH XYLOBIOSE | 3.2.1.4 |
4U5K | COMPLEX STRUCTURE OF MUTANT CTCEL5E (E314A) WITH CELLOBIOSE | 3.2.1.4 |
4U69 | HSMETAP COMPLEX WITH (1-AMINO-2-METHYLPENTYL)PHOSPHONIC ACID | 3.4.11.18 |
4U6B | ZG3597, A FAMILY 117 GLYCOSIDE HYDROLASE, PRODUCED BY THE MARINE BACTERIUM ZOBELLIA GALACTANIVORANS | 3.2.1 |
4U6C | HSMETAP IN COMPLEX WITH [(1R)-1-AMINO-3-CYCLOPENTYLPROPYL]PHOSPHONIC ACID | 3.4.11.18 |
4U6D | ZG3615, A FAMILY 117 GLYCOSIDE HYDROLASE IN COMPLEX WITH BETA-3,6-ANHYDRO-L-GALACTOSE | 3.2.1 |
4U6E | HSMETAP IN COMPLEX WITH (AMINO(PHENYL)METHYL)PHOSPHONIC ACID | 3.4.11.18 |
4U6J | HSMETAP IN COMPLEX WITH METHIONINE | 3.4.11.18 |
4U6R | CRYSTAL STRUCTURE OF HUMAN IRE1 CYTOPLASMIC DOMAINS IN COMPLEX WITH A SULFONAMIDE INHIBITOR. | 2.7.11.1 3.1.26 |
4U6T | CRYSTAL STRUCTURE OF THE CLOSTRIDIUM HISTOLYTICUM COLH COLLAGENASE POLYCYSTIC KIDNEY DISEASE-LIKE DOMAIN 2A AT 1.76 ANGSTROM RESOLUTION | 3.4.24.3 |
4U6W | HSMETAP (F220M) IN COMPLEX WITH 1-AMINO-2-PROPYLPENTYL]PHOSPHONIC ACID | 3.4.11.18 |
4U6Z | HSMETAP(F309M) IN COMPLEX WITH 1-AMINO-2-PROPYLPENTYL)PHOSPHONIC ACID | 3.4.11.18 |
4U70 | HSMETAP (F309M) IN COMPLEX WITH (1-AMINO-2-CYCLOHEXYLETHYL)PHOSPHONIC ACID | 3.4.11.18 |
4U71 | HSMETAP(F309M) IN COMPLEX WITH 1- AMINO(CYCLOHEXYL)METHY)PHOSPHONIC ACID | 3.4.11.18 |
4U73 | HSMETAP(F309M) IN COMPLEX WITH (AMINO(PHENYL)METHYL)PHOSPHONIC ACID | 3.4.11.18 |
4U75 | HSMETAP (F309M) IN COMPLEX WITH METHIONINE | 3.4.11.18 |
4U76 | HSMETAP (F309M) HOLO FORM | 3.4.11.18 |
4U7D | STRUCTURE OF HUMAN RECQ-LIKE HELICASE IN COMPLEX WITH AN OLIGONUCLEOTIDE | 3.6.4.12 |
4U7K | CRYSTAL STRUCTURE OF THE CLOSTRIDIUM HISTOLYTICUM COLH COLLAGENASE POLYCYSTIC KIDNEY DISEASE-LIKE DOMAIN 2A IN THE PRESENCE OF CALCIUM AT 1.9 ANGSTROM RESOLUTION | 3.4.24.3 |
4U7Q | STRUCTURE OF WILD-TYPE HIV PROTEASE IN COMPLEX WITH PHOTOSENSITIVE INHIBITOR PDI-6 | 3.4.23.16 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1 |
4U7V | STRUCTURE OF WILD-TYPE HIV PROTEASE IN COMPLEX WITH DEGRADED PHOTOSENSITIVE INHIBITOR | 3.4.23.16 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1 |
4U7Y | STRUCTURE OF THE COMPLEX OF VPS4B MIT AND IST1 MIM | 3.6.4.6 |
4U8W | HIV-1 WILD TYPE PROTEASE WITH GRL-050-10A (A GEM-DIFLUORO-BIS-TETRAHYDROFURAN AS P2-LIGAND) | 3.4.23.16 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1 |
4UA6 | CTX-M-14 CLASS A BETA-LACTAMASE APO CRYSTAL STRUCTURE AT 0.79 ANGSTROM RESOLUTION | 3.5.2.6 |
4UA7 | CTX-M-14 CLASS A BETA-LACTAMASE IN COMPLEX WITH A NON-COVALENT INHIBITOR AT SUB-ANGSTROM RESOLUTION | 3.5.2.6 |
4UA9 | CTX-M-14 CLASS A BETA-LACTAMASE IN COMPLEX WITH A BORONIC ACID ACYLATION TRANSITION STATE ANALOG AT SUB-ANGSTROM RESOLUTION | 3.5.2.6 |
4UAA | CTX-M-14 CLASS A BETA-LACTAMASE IN COMPLEX WITH A NON-COVALENT INHIBITOR AT SUB-ANGSTROM RESOLUTION | 3.5.2.6 |
4UAR | CRYSTAL STRUCTURE OF APO-CBBY FROM RHODOBACTER SPHAEROIDES | 3.1.3 |
4UAS | CRYSTAL STRUCTURE OF CBBY FROM RHODOBACTER SPHAEROIDES IN COMPLEX WITH PHOSPHATE | 3.1.3 |
4UAT | CRYSTAL STRUCTURE OF CBBY (MUTANT D10N) FROM RHODOBACTER SPHAEROIDES IN COMPLEX WITH XYLULOSE-(1,5)BISPHOSPHATE, CRYSTAL FORM I | 3.1.3 |
4UAU | CRYSTAL STRUCTURE OF CBBY (MUTANT D10N) FROM RHODOBACTER SPHAEROIDES IN COMPLEX WITH XYLULOSE-(1,5)BISPHOSPHATE, CRYSTAL FORM II | 3.1.3 |
4UAV | CRYSTAL STRUCTURE OF CBBY (AT3G48420) FROM ARABIDOBSIS THALIANA | 3.1.3 |
4UBI | KINETIC CRYSTALLOGRAPHY OF ALPHA_E7-CARBOXYLESTERSE FROM LUCILLA CUPRINA - ABSORBED X-RAY DOSE 3.70 MGY AT 100K | 3.1.1 |
4UBJ | KINETIC CRYSTALLOGRAPHY OF ALPHA_E7-CARBOXYLESTERSE FROM LUCILLA CUPRINA - ABSORBED X-RAY DOSE 5.55 MGY AT 100K | 3.1.1 |
4UBK | KINETIC CRYSTALLOGRAPHY OF ALPHA_E7-CARBOXYLESTERSE FROM LUCILLA CUPRINA - ABSORBED X-RAY DOSE 7.40 MGY AT 100K | 3.1.1 |
4UBL | KINETIC CRYSTALLOGRAPHY OF ALPHA_E7-CARBOXYLESTERSE FROM LUCILLA CUPRINA - ABSORBED X-RAY DOSE 9.26 MGY | 3.1.1 |
4UBM | KINETIC CRYSTALLOGRAPHY OF ALPHA_E7-CARBOXYLESTERSE FROM LUCILLA CUPRINA - ABSORBED X-RAY DOSE 11.11 MGY AT 100K | 3.1.1 |
4UBN | KINETIC CRYSTALLOGRAPHY OF ALPHA_E7-CARBOXYLESTERSE FROM LUCILLA CUPRINA - ABSORBED X-RAY DOSE 1.85 MGY TEMP 150K | 3.1.1 |
4UBO | KINETIC CRYSTALLOGRAPHY OF ALPHA_E7-CARBOXYLESTERSE FROM LUCILLA CUPRINA - ABSORBED X-RAY DOSE 3.70 MGY TEMP 150K | 3.1.1 |
4UBP | STRUCTURE OF BACILLUS PASTEURII UREASE INHIBITED WITH ACETOHYDROXAMIC ACID AT 1.55 A RESOLUTION | 3.5.1.5 |
4UBQ | CRYSTAL STRUCTURE OF IMP-2 METALLO-BETA-LACTAMASE FROM ACINETOBACTER SPP. | 3.5.2.6 |
4UCF | CRYSTAL STRUCTURE OF BIFIDOBACTERIUM BIFIDUM BETA-GALACTOSIDASE IN COMPLEX WITH ALPHA-GALACTOSE | 3.2.1.23 |
4UD9 | THROMBIN IN COMPLEX WITH 5-CHLOROTHIOPHENE-2-CARBOXAMIDE | 3.4.21.5 |
4UDW | THROMBIN IN COMPLEX WITH 1-(2R)-2-AMINO-3-PHENYL-PROPANOYL-N-(2, 5DICHLOROPHENYL)METHYLPYRROLIDINE-2-CARBOXAMIDE | 3.4.21.5 |
4UE7 | THROMBIN IN COMPLEX WITH 1-AMIDINOPIPERIDINE | 3.4.21.5 |
4UEE | CRYSTAL STRUCTURE OF THE HUMAN CARBOXYPEPTIDASE A1 IN COMPLEX WITH THE PHOSPHINIC INHIBITOR ACETYL-LEU-ALA-Y(PO2CH2)-HOMOPHE-OH | 3.4.17.1 |
4UEF | CRYSTAL STRUCTURE OF THE HUMAN CARBOXYPEPTIDASE A1 IN COMPLEX WITH THE PHOSPHINIC INHIBITOR ACETYL-TYR-ALA-Y(PO2CH2)-HOMOPHE-OH | 3.4.17.1 |
4UEH | THROMBIN IN COMPLEX WITH BENZAMIDINE | 3.4.21.5 |
4UEL | UCH-L5 IN COMPLEX WITH UBIQUITIN-PROPARGYL BOUND TO THE RPN13 DEUBAD DOMAIN | 3.4.19.12 |
4UEM | UCH-L5 IN COMPLEX WITH THE RPN13 DEUBAD DOMAIN | 3.4.19.12 |
4UEY | STRUCTURE OF THE PERIPLASMIC DOMAIN PHOQ DOUBLE MUTANT (W104C-A128C) | 2.7.13.3 3.1.3 |
4UEZ | CRYSTAL STRUCTURE OF THE HUMAN CARBOXYPEPTIDASE A1 IN COMPLEX WITH THE PHOSPHINIC INHIBITOR ACETYL-LEU-PHE-Y(PO2CH2)-PHE-OH | 3.4.17.1 |
4UF4 | CRYSTAL STRUCTURE OF THE HUMAN CARBOXYPEPTIDASE A1 IN COMPLEX WITH A THIIRANE MECHANISM-BASED INHIBITOR | 3.4.17.1 |
4UF5 | CRYSTAL STRUCTURE OF UCH-L5 IN COMPLEX WITH INHIBITORY FRAGMENT OF INO80G | 3.4.19.12 |
4UF6 | UCH-L5 IN COMPLEX WITH UBIQUITIN-PROPARGYL BOUND TO AN ACTIVATING FRAGMENT OF INO80G | 3.4.19.12 |
4UFA | CRYSTAL STRUCTURE OF THE ANGIOTENSIN-1 CONVERTING ENZYME N-DOMAIN IN COMPLEX WITH AC-SD | 3.2.1 3.4.15.1 |
4UFD | THROMBIN IN COMPLEX WITH 4-(((1-((2S)-1-((2R)-2-(BENZYLSULFONYLAMINO)- 3-PHENYL-PROPANOYL)PYRROLIDIN-2-YL)-1-OXO-ETHYL)AMINO)METHYL) BENZAMIDINE | 3.4.21.5 |
4UFE | THROMBIN IN COMPLEX WITH (2R)-2-(BENZYLSULFONYLAMINO)-N-(2-((4- CARBAMIMIDOYLPHENYL)METHYLAMINO)-2-OXO-BUTYL)-3-PHENYL-PROPANAMIDE | 3.4.21.5 |
4UFF | THROMBIN IN COMPLEX WITH (2R)-2-(BENZYLSULFONYLAMINO)-N-(2-((4- CARBAMIMIDOYLPHENYL)METHYLAMINO)-2-OXO-ETHYL)-N-METHYL-3-PHENYL- PROPANAMIDE | 3.4.21.5 |
4UFG | THROMBIN IN COMPLEX WITH (2R)-2-(BENZYLSULFONYLAMINO)-N-((1S)-2-((4- CARBAMIMIDOYLPHENYL)METHYLAMINO)-1-METHYL-2-OXO-ETHYL)-N-METHYL-3- PHENYL-PROPANAMIDE ETHANE | 3.4.21.5 |
4UFH | MOUSE GALACTOCEREBROSIDASE COMPLEXED WITH ISO-GALACTO-FAGOMINE IGF | 3.2.1.46 |
4UFI | MOUSE GALACTOCEREBROSIDASE COMPLEXED WITH AZA-GALACTO-FAGOMINE AGF | 3.2.1.46 |
4UFJ | MOUSE GALACTOCEREBROSIDASE COMPLEXED WITH ISO-GALACTO-FAGOMINE LACTAM IGL | 3.2.1.46 |
4UFK | MOUSE GALACTOCEREBROSIDASE COMPLEXED WITH DIDEOXY-IMINO-LYXITOL DIL | 3.2.1.46 |
4UFL | MOUSE GALACTOCEREBROSIDASE COMPLEXED WITH DEOXY-GALACTO-NOEUROSTEGINE DGN | 3.2.1.46 |
4UFM | MOUSE GALACTOCEREBROSIDASE COMPLEXED WITH 1-DEOXY-GALACTO-NOJIRIMYCIN DGJ | 3.2.1.46 |
4UHC | STRUCTURAL STUDIES OF A THERMOPHILIC ESTERASE FROM THERMOGUTTA TERRIFONTIS (NATIVE) | 3.1.1.1 |
4UHD | STRUCTURAL STUDIES OF A THERMOPHILIC ESTERASE FROM THERMOGUTTA TERRIFONTIS (ACETATE BOUND) | 3.1.1.1 |
4UHE | STRUCTURAL STUDIES OF A THERMOPHILIC ESTERASE FROM THERMOGUTTA TERRIFONTIS (MALATE BOUND) | 3.1.1.1 |
4UHF | STRUCTURAL STUDIES OF A THERMOPHILIC ESTERASE FROM THERMOGUTTA TERRIFONTIS (L37A MUTANT WITH BUTYRATE BOUND) | 3.1.1.1 |
4UHH | STRUCTURAL STUDIES OF A THERMOPHILIC ESTERASE FROM THERMOGUTTA TERRIFONTIS (CACODYLATE COMPLEX) | 3.1.1.1 |
4UIA | CRYSTAL STRUCTURE OF 3A IN COMPLEX WITH TAFCPB | 3.4.17.2 3.4.17.20 |
4UIB | CRYSTAL STRUCTURE OF 3P IN COMPLEX WITH TAFCPB | 3.4.17.2 |
4UM2 | CRYSTAL STRUCTURE OF THE TPR DOMAIN OF SMG6 | 3.1 |
4UM4 | STRUCTURE OF INORGANIC PYROPHOSPHATASE FROM ESCHERICHIA COLI IN COMPLEX WITH SULFATE | 3.6.1.1 |
4UM5 | CRYSTAL STRUCTURE OF 3-DEOXY-D-MANNO-OCTULOSONATE 8-PHOSPHATE PHOSPHATASE FROM MORAXELLA CATARRHALIS IN COMPLEX WITH MAGNESIUM ION AND PHOSPHATE ION | 3.1.3.45 |
4UM7 | CRYSTAL STRUCTURE OF 3-DEOXY-D-MANNO-OCTULOSONATE 8-PHOSPHATE PHOSPHATASE (KDSC) FROM MORAXELLA CATARRHALIS IN COMPLEX WITH MAGNESIUM ION | 3.1.3.45 |
4UMD | CRYSTAL STRUCTURE OF 3-DEOXY-D-MANNO-OCTULOSONATE 8-PHOSPHATE PHOSPHATASE FROM MORAXELLA CATARRHALIS IN COMPLEX WITH CITRATE | 3.1.3.45 |
4UME | CRYSTAL STRUCTURE OF 3-DEOXY-D-MANNO-OCTULOSONATE 8-PHOSPHATE PHOSPHATASE FROM MORAXELLA CATARRHALIS IN COMPLEX WITH MAGNESIUM ION AND KDO MOLECULE | 3.1.3.45 |
4UMF | CRYSTAL STRUCTURE OF 3-DEOXY-D-MANNO-OCTULOSONATE 8-PHOSPHATE PHOSPHATASE FROM MORAXELLA CATARRHALIS IN COMPLEX WITH MAGNESIUM ION, PHOSPHATE ION AND KDO MOLECULE | 3.1.3.45 |
4UMV | CRYSTAL STRUCTURE OF A ZINC-TRANSPORTING PIB-TYPE ATPASE IN THE E2P STATE | 3.6.3.5 7.2.2 7.2.2.12 7.2.2.21 |
4UMW | CRYSTAL STRUCTURE OF A ZINC-TRANSPORTING PIB-TYPE ATPASE IN E2.PI STATE | 3.6.3.5 7.2.2 7.2.2.12 7.2.2.21 |
4UN7 | THE CRYSTAL STRUCTURE OF I-DMOI IN COMPLEX WITH ITS TARGET DNA BEFORE INCUBATION IN 5MM MN (STATE 1) | 3.1 |
4UN8 | THE CRYSTAL STRUCTURE OF I-DMOI IN COMPLEX WITH ITS TARGET DNA AT 1H INCUBATION IN 5MM MN (STATE 2) | 3.1 |
4UN9 | THE CRYSTAL STRUCTURE OF I-DMOI IN COMPLEX WITH ITS TARGET DNA AT 8H INCUBATION IN 5MM MN (STATE 3) | 3.1 |
4UNA | THE CRYSTAL STRUCTURE OF I-DMOI IN COMPLEX WITH ITS TARGET DNA AT 2 DAYS INCUBATION IN 5MM MN (STATE 4) | 3.1 |
4UNB | THE CRYSTAL STRUCTURE OF I-DMOI IN COMPLEX WITH ITS TARGET DNA AT 6 DAYS INCUBATION IN 5MM MN (STATE 5) | 3.1 |
4UNC | THE CRYSTAL STRUCTURE OF I-DMOI IN COMPLEX WITH ITS TARGET DNA AT 8 DAYS INCUBATION IN 5MM MN (STATE 6) | 3.1 |
4UNI | BETA-(1,6)-GALACTOSIDASE FROM BIFIDOBACTERIUM ANIMALIS SUBSP. LACTIS BL-04 IN COMPLEX WITH GALACTOSE | 3.2.1.23 |
4UOJ | STRUCTURE OF FUNGAL BETA-MANNOSIDASE (GH2) FROM TRICHODERMA HARZIANUM | 3.2.1.25 |
4UON | CRYSTAL STRUCTURE OF C-TERMINAL TRUNCATED (110-265) AURA VIRUS CAPSID PROTEASE. | 3.4.21.90 |
4UOQ | NUCLEOPHILE MUTANT (E324A) OF BETA-(1,6)-GALACTOSIDASE FROM BIFIDOBACTERIUM ANIMALIS SUBSP. LACTIS BL-04 | 3.2.1.23 |
4UOZ | BETA-(1,6)-GALACTOSIDASE FROM BIFIDOBACTERIUM ANIMALIS SUBSP. LACTIS BL-04 NUCLEOPHILE MUTANT E324A IN COMPLEX WITH GALACTOSE | 3.2.1.23 |
4UPD | OPEN CONFORMATION OF O. PICEAE STEROL ESTERASE MUTANT I544W | 3.1.1.13 3.1.1 |
4UPJ | HUMAN IMMUNODEFICIENCY VIRUS TYPE 2 PROTEASE MUTANT WITH LYS 57 REPLACED BY LEU (K57L) COMPLEX WITH U097410 [4-HYDROXY-3-[1-[3-[[[[(TERT-BUTYLOXYCARBONYL) AMINOMETHYL]CARBONYL]AMINO]PHENYL]PROPYL]COUMARIN | 3.4.23.16 3.4.23.47 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1 |
4UQ9 | X-RAY STRUCTURE OF GLUCURONOXYLAN-XYLANOHYDROLASE (XYN30A) FROM CLOSTRIDIUM THERMOCELLUM AT 1.77 A RESOLUTION | 3.2.1.8 |
4UQA | X-RAY STRUCTURE OF GLUCURONOXYLAN-XYLANOHYDROLASE (XYN30A) FROM CLOSTRIDIUM THERMOCELLUM | 3.2.1.8 |
4UQB | X-RAY STRUCTURE OF GLUCURONOXYLAN-XYLANOHYDROLASE (XYN30A) FROM CLOSTRIDIUM THERMOCELLUM AT 1.68 A RESOLUTION | 3.2.1.8 |
4UQC | X-RAY STRUCTURE OF GLUCURONOXYLAN-XYLANOHYDROLASE (XYN30A) FROM CLOSTRIDIUM THERMOCELLUM AT 1.30 A RESOLUTION | 3.2.1.8 |
4UQD | X-RAY STRUCTURE OF GLUCURONOXYLAN-XYLANOHYDROLASE (XYN30A) FROM CLOSTRIDIUM THERMOCELLUM AT 1.25 A RESOLUTION | 3.2.1.8 |
4UQE | X-RAY STRUCTURE OF GLUCURONOXYLAN-XYLANOHYDROLASE (XYN30A) FROM CLOSTRIDIUM THERMOCELLUM AT 1.28 A RESOLUTION | 3.2.1.8 |
4UQF | CRYSTAL STRUCTURE OF LISTERIA MONOCYTOGENES GTP CYCLOHYDROLASE I | 3.5.4.16 |
4UQM | CRYSTAL STRUCTURE DETERMINATION OF URACIL-DNA N-GLYCOSYLASE (UNG) FROM DEINOCOCCUS RADIODURANS IN COMPLEX WITH DNA - NEW INSIGHTS INTO THE ROLE OF THE LEUCINE-LOOP FOR DAMAGE RECOGNITION AND REPAIR | 3.2.2.27 |
4UR9 | STRUCTURE OF LIGAND BOUND GLYCOSYLHYDROLASE | 3.2.1.169 |
4URU | THE CRYSTAL STRUCTURE OF H-RAS AND SOS IN COMPLEX WITH LIGANDS | 3.6.5.2 |
4URV | THE CRYSTAL STRUCTURE OF H-RAS AND SOS IN COMPLEX WITH LIGANDS | 3.6.5.2 |
4URW | THE CRYSTAL STRUCTURE OF H-RAS AND SOS IN COMPLEX WITH LIGANDS | 3.6.5.2 |
4URX | THE CRYSTAL STRUCTURE OF H-RAS AND SOS IN COMPLEX WITH LIGANDS | 3.6.5.2 |
4URY | THE CRYSTAL STRUCTURE OF H-RAS AND SOS IN COMPLEX WITH LIGANDS | 3.6.5.2 |
4URZ | THE CRYSTAL STRUCTURE OF H-RAS AND SOS IN COMPLEX WITH LIGANDS | 3.6.5.2 |
4US0 | THE CRYSTAL STRUCTURE OF H-RAS AND SOS IN COMPLEX WITH LIGANDS | 3.6.5.2 |
4US1 | THE CRYSTAL STRUCTURE OF H-RAS AND SOS IN COMPLEX WITH LIGANDS | 3.6.5.2 |
4US2 | THE CRYSTAL STRUCTURE OF H-RAS AND SOS IN COMPLEX WITH LIGANDS | 3.6.5.2 |
4UT0 | THE CRYSTAL STRUCTURE OF I-DMOI IN COMPLEX WITH ITS TARGET DNA AT 10 DAYS INCUBATION IN 5MM MN (STATE 7) | 3.1 |
4UT2 | X-RAY STRUCTURE OF THE HUMAN PP1 GAMMA CATALYTIC SUBUNIT TREATED WITH ASCORBATE | 3.1.3.16 |
4UT3 | X-RAY STRUCTURE OF THE HUMAN PP1 GAMMA CATALYTIC SUBUNIT TREATED WITH HYDROGEN PEROXIDE | 3.1.3.16 |
4UT9 | CRYSTAL STRUCTURE OF DENGUE 2 VIRUS ENVELOPE GLYCOPROTEIN DIMER IN COMPLEX WITH THE SCFV FRAGMENT OF THE BROADLY NEUTRALIZING HUMAN ANTIBODY EDE1 C10 | 3.4.21.91 3.6.1.15 3.6.4.13 |
4UTF | STRUCTURE OF THE GH99 ENDO-ALPHA-MANNOSIDASE FROM BACTEROIDES XYLANISOLVENS IN COMPLEX WITH MANNOSE-ALPHA-1,3-ISOFAGOMINE AND ALPHA- 1,2-MANNOBIOSE | 3.2.1.130 |
4UTN | CRYSTAL STRUCTURE OF ZEBRAFISH SIRTUIN 5 IN COMPLEX WITH SUCCINYLATED CPS1-PEPTIDE | 3.5.1 2.3.1 |
4UTR | CRYSTAL STRUCTURE OF ZEBRAFISH SIRTUIN 5 IN COMPLEX WITH GLUTARYLATED CPS1-PEPTIDE | 3.5.1 2.3.1 |
4UTV | CRYSTAL STRUCTURE OF ZEBRAFISH SIRTUIN 5 IN COMPLEX WITH 3-PHENYL- SUCCINYLATED CPS1-PEPTIDE | 3.5.1 2.3.1 |
4UTX | CRYSTAL STRUCTURE OF ZEBRAFISH SIRTUIN 5 IN COMPLEX WITH 3-NITRO- PROPIONYLATED CPS1-PEPTIDE | 3.5.1 2.3.1 |
4UTZ | CRYSTAL STRUCTURE OF ZEBRAFISH SIRTUIN 5 IN COMPLEX WITH ADIPOYLATED CPS1-PEPTIDE | 3.5.1 2.3.1 |
4UU7 | CRYSTAL STRUCTURE OF ZEBRAFISH SIRTUIN 5 IN COMPLEX WITH 3-METHYL- SUCCINYLATED CPS1-PEPTIDE | 3.5.1 2.3.1 |
4UU8 | CRYSTAL STRUCTURE OF ZEBRAFISH SIRTUIN 5 IN COMPLEX WITH 3,3-DIMETHYL- SUCCINYLATED CPS1-PEPTIDE | 3.5.1 2.3.1 |
4UUA | CRYSTAL STRUCTURE OF ZEBRAFISH SIRTUIN 5 IN COMPLEX WITH 3S-Z-AMINO- SUCCINYLATED CPS1-PEPTIDE | 3.5.1 2.3.1 |
4UUB | CRYSTAL STRUCTURE OF ZEBRAFISH SIRTUIN 5 IN COMPLEX WITH 2R-BUTYL- SUCCINYLATED CPS1-PEPTIDE | 3.5.1 2.3.1 |
4UUD | HUMAN DYNAMIN 1 K44A SUPERCONSTRICTED POLYMER STABILIZED WITH GTP | 3.6.5.5 |
4UUQ | CRYSTAL STRUCTURE OF HUMAN MONO-GLYCERIDE LIPASE IN COMPLEX WITH SAR127303 | 3.1.1.23 |
4UW2 | CRYSTAL STRUCTURE OF CSM1 IN T.ONNURINEUS | 3.1 2.7.7 |
4UW7 | STRUCTURE OF THE CARBOXY-TERMINAL DOMAIN OF THE BACTERIOPHAGE T5 L- SHAPED TAIL FIBER WITHOUT ITS INTRA-MOLECULAR CHAPERONE DOMAIN | 3.4.21 |
4UWN | LYSOZYME SOAKED WITH A RUTHENIUM BASED CORM WITH A METHIONE OXIDE LIGAND (COMPLEX 6B) | 3.2.1.17 |
4UWT | HYPOCREA JECORINA CEL7A E212Q MUTANT IN COMPLEX WITH P-NITROPHENYL CELLOBIOSIDE | 3.2.1.176 3.2.1.91 |
4UWU | LYSOZYME SOAKED WITH A RUTHENIUM BASED CORM WITH A PYRIDINE LIGAND (COMPLEX 7) | 3.2.1.17 |
4UWV | LYSOZYME SOAKED WITH A RUTHENIUM BASED CORM WITH A PYRIDINE LIGAND (COMPLEX 8) | 3.2.1.17 |
4UX7 | STRUCTURE OF A CLOSTRIDIUM DIFFICILE SORTASE | 3.4.22.71 |
4UY1 | NOVEL PYRAZOLE SERIES OF GROUP X SECRETORY PHOSPHOLIPASE A2 (SPLA2-X) INHIBITORS | 3.1.1.4 |
4UYU | STRUCTURE OF THE WNT DEACYLASE NOTUM - CRYSTAL FORM I IODIDE COMPLEX - 2.3A | 3.1.1.1 3.1.1.98 |
4UYW | STRUCTURE OF THE WNT DEACYLASE NOTUM - CRYSTAL FORM I HEPARIN FRAGMENT COMPLEX - 1.7A | 3.1.1.98 |
4UYZ | STRUCTURE OF THE WNT DEACYLASE NOTUM - CRYSTAL FORM II - 2.8A | 3.1.1.1 3.1.1.98 |
4UZ1 | STRUCTURE OF THE WNT DEACYLASE NOTUM - CRYSTAL FORM III - 1.4A | 3.1.1.1 3.1.1.98 |
4UZ5 | STRUCTURE OF THE WNT DEACYLASE NOTUM - CRYSTAL FORM IV - 2.1A | 3.1.1.1 3.1.1.98 |
4UZ6 | STRUCTURE OF THE WNT DEACYLASE NOTUM - CRYSTAL FORM V - SOS COMPLEX - 1.9A | 3.1.1.1 3.1.1.98 |
4UZ7 | STRUCTURE OF THE WNT DEACYLASE NOTUM - CRYSTAL FORM VI - 2.2A | 3.1.1.1 3.1.1.98 |
4UZ9 | STRUCTURE OF THE WNT DEACYLASE NOTUM - CRYSTAL FORM VII - SOS COMPLEX - 2.2A | 3.1.1.1 3.1.1.98 |
4UZA | STRUCTURE OF THE WNT DEACYLASE NOTUM - CRYSTAL FORM VIII - PHOSPHATE COMPLEX - 2.4A | 3.1.1.1 3.1.1.98 |
4UZJ | STRUCTURE OF THE WNT DEACYLASE NOTUM FROM DROSOPHILA - CRYSTAL FORM I - 2.4A | 3.1.1.1 3.1.1.98 |
4UZK | STRUCTURE OF THE WNT DEACYLASE NOTUM FROM DROSOPHILA - CRYSTAL FORM II - 1.9A | 3.1.1.1 3.1.1.98 |
4UZL | STRUCTURE OF THE WNT DEACYLASE NOTUM - CRYSTAL FORM I MYRISTOLEATE COMPLEX - 2.1A | 3.1.1.1 3.1.1.98 |
4UZQ | STRUCTURE OF THE WNT DEACYLASE NOTUM IN COMPLEX WITH O-PALMITOLEOYL SERINE - CRYSTAL FORM IX - 1.5A | 3.1.1.1 3.1.1.98 |
4UZS | CRYSTAL STRUCTURE OF BIFIDOBACTERIUM BIFIDUM BETA-GALACTOSIDASE | 3.2.1.23 |
4UZU | THREE-DIMENSIONAL STRUCTURE OF A VARIANT `TERMAMYL-LIKE' GEOBACILLUS STEAROTHERMOPHILUS ALPHA-AMYLASE AT 1.9 A RESOLUTION | 3.2.1.1 |
4V07 | DIMERIC PSEUDORABIES VIRUS PROTEASE PUL26N AT 2.1 A RESOLUTION | 3.4.21.97 |
4V08 | INHIBITED DIMERIC PSEUDORABIES VIRUS PROTEASE PUL26N AT 2 A RESOLUTION | 3.4.21.97 |
4V0B | ESCHERICHIA COLI FTSH HEXAMERIC N-DOMAIN | 3.4.24 |
4V0H | HUMAN METALLO BETA LACTAMASE DOMAIN CONTAINING PROTEIN 1 (HMBLAC1) | 3 |
4V0Q | DENGUE VIRUS FULL LENGTH NS5 COMPLEXED WITH SAH | 3.4.21.91 3.6.1.15 3.6.4.13 2.1.1.56 2.1.1.57 2.7.7.48 |
4V0R | DENGUE VIRUS FULL LENGTH NS5 COMPLEXED WITH GTP AND SAH | 3.4.21.91 3.6.1.15 3.6.4.13 2.1.1.56 2.1.1.57 2.7.7.48 |
4V0T | MONOMERIC PSEUDORABIES VIRUS PROTEASE PUL26N AT 2.1 A RESOLUTION | 3.4.21.97 |
4V0V | THE CRYSTAL STRUCTURE OF MOUSE PP1G IN COMPLEX WITH TRUNCATED HUMAN PPP1R15B (631-660) | 3.1.3.16 |
4V0W | THE CRYSTAL STRUCTURE OF MOUSE PP1G IN COMPLEX WITH TRUNCATED HUMAN PPP1R15B (631-669) | 3.1.3.16 |
4V0X | THE CRYSTAL STRUCTURE OF MOUSE PP1G IN COMPLEX WITH TRUNCATED HUMAN PPP1R15B (631-684) | 3.1.3.16 |
4V0Z | O-NITROPHENYL CELLOBIOSIDE AS AN ACTIVE SITE PROBE FOR FAMILY 7 CELLOBIOHYDROLASES | 3.2.1.176 3.2.1.91 |
4V1F | CRYSTAL STRUCTURE OF A MYCOBACTERIAL ATP SYNTHASE ROTOR RING IN COMPLEX WITH BEDAQUILINE | 3.6.3.14 |
4V1G | CRYSTAL STRUCTURE OF A MYCOBACTERIAL ATP SYNTHASE ROTOR RING | 3.6.3.14 |
4V1H | CRYSTAL STRUCTURE OF A MYCOBACTERIAL ATP SYNTHASE ROTOR RING IN COMPLEX WITH IODO-BEDAQUILINE | 3.6.3.14 |
4V1R | STRUCTURE OF A SELENOMETHIONINE DERIVATIVE OF THE GH76 ALPHA- MANNANASE BT2949 BACTEROIDES THETAIOTAOMICRON | 3.2.1.101 |
4V1S | STRUCTURE OF THE GH76 ALPHA-MANNANASE BT2949 FROM BACTEROIDES THETAIOTAOMICRON | 3.2.1.101 |
4V1Z | THE 3-D STRUCTURE OF THE CELLOBIOHYDROLASE, CEL7A, FROM ASPERGILLUS FUMIGATUS | 3.2.1.91 |
4V20 | THE 3-D STRUCTURE OF THE CELLOBIOHYDROLASE, CEL7A, FROM ASPERGILLUS FUMIGATUS, DISACCHARIDE COMPLEX | 3.2.1.91 |
4V27 | STRUCTURE OF THE GH99 ENDO-ALPHA-MANNANASE FROM BACTEROIDES XYLANISOLVENS IN COMPLEX WITH MANNOSE-ALPHA-1,3-ISOFAGOMINE | 3.2.1.130 |
4V28 | STRUCTURE OF AN E333Q VARIANT OF THE GH99 ENDO-ALPHA-MANNANASE FROM BACTEROIDES XYLANISOLVENS IN COMPLEX WITH MAN-MAN-METHYLUMBELLIFERONE | 3.2.1.130 |
4V2I | BIOCHEMICAL CHARACTERIZATION AND STRUCTURAL ANALYSIS OF A NEW COLD- ACTIVE AND SALT TOLERANT ESTERASE FROM THE MARINE BACTERIUM THALASSOSPIRA SP | 3.1.1.1 |
4VGC | GAMMA-CHYMOTRYPSIN D-NAPHTHYL-1-ACETAMIDO BORONIC ACID INHIBITOR COMPLEX | 3.4.21.1 |
4W1O | PDE4D COMPLEXED WITH INHIBITOR | 3.1.4.53 |
4W1P | KINETIC CRYSTALLOGRAPHY OF ALPHA_E7-CARBOXYLESTERSE FROM LUCILLA CUPRINA - ABSORBED X-RAY DOSE 5.54 MGY TEMP 150K | 3.1.1 |
4W1Q | KINETIC CRYSTALLOGRAPHY OF ALPHA_E7-CARBOXYLESTERSE FROM LUCILLA CUPRINA - ABSORBED X-RAY DOSE 7.39 MGY TEMP 150K | 3.1.1 |
4W1R | KINETIC CRYSTALLOGRAPHY OF ALPHA_E7-CARBOXYLESTERSE FROM LUCILLA CUPRINA - ABSORBED X-RAY DOSE 9.24 MGY TEMP 150K | 3.1.1 |
4W1S | KINETIC CRYSTALLOGRAPHY OF ALPHA_E7-CARBOXYLESTERSE FROM LUCILLA CUPRINA - ABSORBED X-RAY DOSE 11.09 MGY TEMP 150K | 3.1.1 |
4W4U | STRUCTURE OF YEAST SAGA DUBM WITH SGF73 Y57A MUTANT AT 2.8 ANGSTROMS RESOLUTION | 3.4.19.12 |
4W51 | T4 LYSOZYME L99A WITH NO LIGAND BOUND | 3.2.1.17 |
4W52 | T4 LYSOZYME L99A WITH BENZENE BOUND | 3.2.1.17 |
4W53 | T4 LYSOZYME L99A WITH TOLUENE BOUND | 3.2.1.17 |
4W54 | T4 LYSOZYME L99A WITH ETHYLBENZENE BOUND | 3.2.1.17 |
4W55 | T4 LYSOZYME L99A WITH N-PROPYLBENZENE BOUND | 3.2.1.17 |
4W56 | T4 LYSOZYME L99A WITH SEC-BUTYLBENZENE BOUND | 3.2.1.17 |
4W57 | T4 LYSOZYME L99A WITH N-BUTYLBENZENE BOUND | 3.2.1.17 |
4W58 | T4 LYSOZYME L99A WITH N-PENTYLBENZENE BOUND | 3.2.1.17 |
4W59 | T4 LYSOZYME L99A WITH N-HEXYLBENZENE BOUND | 3.2.1.17 |
4W5A | COMPLEX STRUCTURE OF ATRX ADD BOUND TO H3K9ME3S10PH PEPTIDE | 3.6.4.12 |
4W5B | CRYSTAL STRUCTURE ANALYSIS OF CRUZAIN WITH FRAGMENT 1 (N-(1H-BENZIMIDAZOL-2-YL)-1,3-DIMETHYL-PYRAZOLE-4-CARBOXAMIDE) | 3.4.22.51 |
4W5C | CRYSTAL STRUCTURE ANALYSIS OF CRUZAIN WITH THREE FRAGMENTS: 1 (N-(1H-BENZIMIDAZOL-2-YL)-1,3-DIMETHYL-PYRAZOLE-4-CARBOXAMIDE), 6 (2-AMINO-4,6-DIFLUOROBENZOTHIAZOLE) AND 9 (N-(1H-BENZIMIDAZOL-2-YL)-3-(4-FLUOROPHENYL)-1H-PYRAZOLE-4-CARBOXAMIDE). | 3.4.22.51 |
4W5N | THE CRYSTAL STRUCTURE OF HUMAN ARGONAUTE2 BOUND TO A DEFINED GUIDE RNA | 3.1.26 |
4W5O | THE CRYSTAL STRUCTURE OF HUMAN ARGONAUTE2 BOUND TO A GUIDE AND TARGET RNA CONTAINING SEED PAIRING FROM 2-9 | 3.1.26 |
4W5Q | THE CRYSTAL STRUCTURE OF HUMAN ARGONAUTE2 BOUND TO A GUIDE AND TARGET RNA CONTAINING SEED PAIRING FROM 2-8 | 3.1.26 |
4W5R | THE CRYSTAL STRUCTURE OF HUMAN ARGONAUTE2 BOUND TO A GUIDE AND TARGET RNA CONTAINING SEED PAIRING FROM 2-8 (LONG TARGET) | 3.1.26 |
4W5T | THE CRYSTAL STRUCTURE OF HUMAN ARGONAUTE2 BOUND TO A GUIDE AND TARGET RNA CONTAINING SEED PAIRING FROM 2-7 | 3.1.26 |
4W5U | CRYSTAL STRUCTURE OF CHITINASE 40 FROM THERMOPHILIC BACTERIA STREPTOMYCES THERMOVIOLACEUS. | 3.2.1.14 |
4W5Z | HIGH RESOLUTION CRYSTAL STRUCTURE OF CATALYTIC DOMAIN OF CHITINASE 60 FROM PSYCHROPHILIC BACTERIA MORITELLA MARINA. | 3.2.1.14 |
4W63 | TORPEDO CALIFORNICA ACETYLCHOLINESTERASE IN COMPLEX WITH A TACRINE-BENZOFURAN HYBRID INHIBITOR | 3.1.1.7 |
4W65 | CRYSTAL STRUCTURE OF GLYCOSYL HYDROLASE FAMILY PROTEIN FROM MYCOBACTERIUM FORTUITUM | 3.2.1.4 |
4W79 | CRYSTAL STRUCTURE OF HUMAN PROTEIN N-TERMINAL GLUTAMINE AMIDOHYDROLASE | 3.5.1 3.5.1.122 |
4W7S | CRYSTAL STRUCTURE OF THE YEAST DEAD-BOX SPLICING FACTOR PRP28 AT 2.54 ANGSTROMS RESOLUTION | 3.6.4.13 |
4W84 | CRYSTAL STRUCTURE OF XEG5A, A GH5 XYLOGLUCAN-SPECIFIC ENDO-BETA-1,4-GLUCANASE FROM RUMINAL METAGENOMIC LIBRARY, IN THE NATIVE FORM | 3.2.1.151 |
4W85 | CRYSTAL STRUCTURE OF XEG5A, A GH5 XYLOGLUCAN-SPECIFIC ENDO-BETA-1,4-GLUCANASE FROM RUMINAL METAGENOMIC LIBRARY, IN COMPLEX WITH GLUCOSE | 3.2.1.151 |
4W86 | CRYSTAL STRUCTURE OF XEG5A, A GH5 XYLOGLUCAN-SPECIFIC ENDO-BETA-1,4-GLUCANASE FROM RUMINAL METAGENOMIC LIBRARY, IN COMPLEX WITH GLUCOSE AND TRIS | 3.2.1.151 |
4W87 | CRYSTAL STRUCTURE OF XEG5A, A GH5 XYLOGLUCAN-SPECIFIC ENDO-BETA-1,4-GLUCANASE FROM METAGENOMIC LIBRARY, IN COMPLEX WITH A XYLOGLUCAN OLIGOSACCHARIDE | 3.2.1.151 |
4W88 | CRYSTAL STRUCTURE OF XEG5A, A GH5 XYLOGLUCAN-SPECIFIC ENDO-BETA-1,4-GLUCANASE FROM RUMINAL METAGENOMIC LIBRARY, IN COMPLEX WITH A XYLOGLUCAN OLIGOSACCHARIDE AND TRIS | 3.2.1.151 |
4W89 | CRYSTAL STRUCTURE OF XEG5A, A GH5 XYLOGLUCAN-SPECIFIC ENDO-BETA-1,4-GLUCANASE FROM METAGENOMIC LIBRARY, IN COMPLEX WITH CELLOTRIOSE | 3.2.1.151 |
4W8L | STRUCTURE OF GH10 FROM PAENIBACILLUS BARCINONENSIS | 3.2.1.8 |
4W8W | CRYSTAL STRUCTURE OF OLIGOMERIC CMR4 FROM PYROCOCCUS FURIOSUS | 3.1 |
4W93 | HUMAN PANCREATIC ALPHA-AMYLASE IN COMPLEX WITH MONTBRETIN A | 3.2.1.1 |
4W94 | CRYSTAL STRUCTURE OF CROSS-LINKED TETRAGONAL HEN EGG WHITE LYSOZYME SOAKED WITH 5MM [RU(CO)3CL2]2 | 3.2.1.17 |
4W96 | CRYSTAL STRUCTURE OF CROSS-LINKED TETRAGONAL HEN EGG WHITE LYSOZYME SOAKED WITH 5MM [RU(CO)3CL2]2 FOLLOWED BY THE REACTION IN DEOXY-MYOGLOBIN SOLUTION | 3.2.1.17 |
4W9N | ENOYL-ACYL CARRIER PROTEIN-REDUCTASE DOMAIN FROM HUMAN FATTY ACID SYNTHASE COMPLEXED WITH TRICLOSAN | 2.3.1.39 2.3.1.85 2.3.1.38 2.3.1.41 1.1.1.100 4.2.1.59 1.3.1.39 3.1.2.14 |
4W9S | 2-(4-(1H-TETRAZOL-5-YL)PHENYL)-5-HYDROXYPYRIMIDIN-4(3H)-ONE BOUND TO INFLUENZA 2009 H1N1 ENDONUCLEASE | 3.1 |
4W9Y | X-RAY STRUCTURE OF HUMAN GLUTAMATE CARBOXYPEPTIDASE II (GCPII) IN COMPLEX WITH A GLUTAMYL SULFAMIDE INHIBITOR CJC47 | 3.4.17.21 |
4WA3 | THE CRYSTAL STRUCTURE OF NEURAMINIDASE FROM A H3N8 INFLUENZA VIRUS ISOLATED FROM NEW ENGLAND HARBOR SEALS | 3.2.1.18 |
4WA4 | THE CRYSTAL STRUCTURE OF NEURAMINIDASE FROM A H3N8 INFLUENZA VIRUS ISOLATED FROM NEW ENGLAND HARBOR SEALS IN COMPLEX WITH OSELTAMIVIR CARBOXYLATE | 3.2.1.18 |
4WA5 | THE CRYSTAL STRUCTURE OF NEURAMINIDASE FROM A H3N8 INFLUENZA VIRUS ISOLATED FROM NEW ENGLAND HARBOR SEALS IN COMPLEX WITH ZANAMIVIR | 3.2.1.18 |
4WA6 | STRUCTURE OF YEAST SAGA DUBM WITH SGF73 N59D MUTANT AT 2.36 ANGSTROMS RESOLUTION | 3.4.19.12 |
4WA7 | CRYSTAL STRUCTURE OF A GDP-BOUND Q61L ONCOGENIC MUTANT OF HUMAN GT- PASE KRAS | 3.6.5.2 |
4WA8 | METHANOPYRUS KANDLERI FEN-1 NUCLEASE | 3.1 |
4WBG | CRYSTAL STRUCTURE OF CLASS C BETA-LACTAMASE MOX-1 COVALENTLY COMPLEXED WITH AZTORENAM | 3.5.2.6 |
4WBH | STRUCTURE OF THE WNT DEACYLASE NOTUM - CRYSTAL FORM I APO - 2.2A | 3 3.1.1.98 |
4WBI | CATALYTIC DOMAIN OF MOUSE 2',3'-CYCLIC NUCLEOTIDE 3'- PHOSPHODIESTERASE, WITH MUTATIONS H230Q AND H309Q | 3.1.4.37 |
4WBL | CATALYTIC DOMAIN OF MOUSE 2',3'-CYCLIC NUCLEOTIDE 3'- PHOSPHODIESTERASE, WITH MUTATION F235A | 3.1.4.37 |
4WC9 | CATALYTIC DOMAIN OF MOUSE 2',3'-CYCLIC NUCLEOTIDE 3'- PHOSPHODIESTERASE, WITH MUTATION F235L | 3.1.4.37 |
4WCA | CATALYTIC DOMAIN OF MOUSE 2',3'-CYCLIC NUCLEOTIDE 3'- PHOSPHODIESTERASE, WITH MUTATION H230Q, COMPLEXED WITH CITRATE | 3.1.4.37 |
4WCB | CATALYTIC DOMAIN OF MOUSE 2',3'-CYCLIC NUCLEOTIDE 3'- PHOSPHODIESTERASE, WITH MUTATION H309Q | 3.1.4.37 |
4WCC | CATALYTIC DOMAIN OF MOUSE 2',3'-CYCLIC NUCLEOTIDE 3'- PHOSPHODIESTERASE, WITH MUTATION P225G | 3.1.4.37 |
4WCU | PDE4 COMPLEXED WITH INHIBITOR | 3.1.4.53 |
4WCV | HALOALKANE DEHALOGENASE DHAA MUTANT FROM RHODOCOCCUS RHODOCHROUS (T148L+G171Q+A172V+C176G) | 3.8.1.5 |
4WDA | CATALYTIC DOMAIN OF MOUSE 2',3'-CYCLIC NUCLEOTIDE 3'- PHOSPHODIESTERASE, WITH MUTATION P296G, COMPLEXED WITH 2'-AMP | 3.1.4.37 |
4WDB | CATALYTIC DOMAIN OF MOUSE 2',3'-CYCLIC NUCLEOTIDE 3'- PHOSPHODIESTERASE, WITH MUTATION R307Q, COMPLEXED WITH 2'-AMP | 3.1.4.37 |
4WDD | CATALYTIC DOMAIN OF MOUSE 2',3'-CYCLIC NUCLEOTIDE 3'- PHOSPHODIESTERASE, WITH MUTATION T232A, COMPLEXED WITH CITRATE | 3.1.4.37 |
4WDE | CATALYTIC DOMAIN OF MOUSE 2',3'-CYCLIC NUCLEOTIDE 3'- PHOSPHODIESTERASE, WITH MUTATION T311A | 3.1.4.37 |
4WDF | CATALYTIC DOMAIN OF MOUSE 2',3'-CYCLIC NUCLEOTIDE 3'- PHOSPHODIESTERASE, WITH MUTATION V321A, COMPLEXED WITH 2',5'-ADP | 3.1.4.37 |
4WDG | CATALYTIC DOMAIN OF MOUSE 2',3'-CYCLIC NUCLEOTIDE 3'- PHOSPHODIESTERASE, WITH MUTATION V321A, COMPLEXED WITH 2',5'-ADP | 3.1.4.37 |
4WDH | CATALYTIC DOMAIN OF MOUSE 2',3'-CYCLIC NUCLEOTIDE 3'- PHOSPHODIESTERASE, WITH MUTATION Y168A | 3.1.4.37 |
4WDQ | CRYSTAL STRUCTURE OF HALOALKANE DEHALOGENASE LINB32 MUTANT (L177W) FROM SPHINGOBIUM JAPONICUM UT26 | 3.8.1.5 |
4WDR | CRYSTAL STRUCTURE OF HALOALKANE DEHALOGENASE LINB 140A+143L+177W+211L MUTANT (LINB86) FROM SPHINGOBIUM JAPONICUM UT26 | 3.8.1.5 |
4WE1 | CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH 5-(2-(2-(2,4-DIOXO-3,4-DIHYDROPYRIMIDIN-1(2H)-YL)ETHOXY)PHENOXY)-2-NAPHTHONITRILE (JLJ600) | 3.4.23.16 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1 |
4WEB | STRUCTURE OF THE CORE ECTODOMAIN OF THE HEPATITIS C VIRUS ENVELOPE GLYCOPROTEIN 2 | 2.7.7.48 3.4.21.98 3.6.1.15 3.6.4.13 |
4WEF | STRUCTURE OF THE HEMAGGLUTININ-NEURAMINIDASE FROM HUMAN PARAINFLUENZA VIRUS TYPE III: COMPLEX WITH DIFLUOROSIALIC ACID | 3.2.1.18 |
4WEG | INFLUENZA VIRUS NEURAMINIDASE N9 IN COMPLEX 2,3-DIFLUOROSIALIC ACID | 3.2.1.18 |
4WEX | CATALYTIC DOMAIN OF MOUSE 2',3'-CYCLIC NUCLEOTIDE 3'- PHOSPHODIESTERASE, WITH MUTATION Y168S | 3.1.4.37 |
4WF6 | ANTHRAX TOXIN LETHAL FACTOR WITH BOUND SMALL MOLECULE INHIBITOR MK-31 | 3.4.24.83 |
4WFC | STRUCTURE OF THE RRP6-RRP47 INTERACTION | 3.1.13 |
4WFD | STRUCTURE OF THE RRP6-RRP47-MTR4 INTERACTION | 3.1.13 |
4WFR | CATALYTIC DOMAIN OF MOUSE 2',3'-CYCLIC NUCLEOTIDE 3'- PHOSPHODIESTERASE, WITH MUTATION T232A, COMPLEXED WITH 2'-AMP | 3.1.4.37 |
4WFX | COXSACKIEVIRUS B3 POLYMERASE - F232L MUTANT - NACL CRYSTAL FORM | 2.7.7.48 3.4.22.29 3.6.1.15 3.4.22.28 |
4WFY | COXSACKIEVIRUS B3 POLYMERASE - F232L MUTANT - AMSO4 CRYSTAL FORM | 2.7.7.48 3.4.22.29 3.6.1.15 3.4.22.28 |
4WFZ | COXSACKIEVIRUS B3 3DPOL RNA DEPENDENT RNA POLYMERASE - NACL CRYSTAL FORM | 2.7.7.48 3.4.22.29 3.6.1.15 3.4.22.28 |
4WG1 | ROOM TEMPERATURE CRYSTAL STRUCTURE OF LYSOZYME DETERMINED BY SERIAL SYNCHROTRON CRYSTALLOGRAPHY (MICRO FOCUSED BEAM - CRYSTFEL) | 3.2.1.17 |
4WG7 | ROOM-TEMPERATURE CRYSTAL STRUCTURE OF LYSOZYME DETERMINED BY SERIAL SYNCHROTRON CRYSTALLOGRAPHY USING A NANO FOCUSED BEAM. | 3.2.1.17 |
4WGK | CRYSTAL STRUCTURE OF HUMAN NEUTRAL CERAMIDASE WITH ZN-BOUND PHOSPHATE | 3.5.1.23 3.5.1 |
4WH6 | CRYSTAL STRUCTURE OF HCV NS3/4A PROTEASE VARIANT R155K IN COMPLEX WITH ASUNAPREVIR | 2.7.7.48 3.4.21.98 3.6.1.15 3.6.4.13 |
4WH7 | STRUCTURE OF THE CDC25B PHOSPHATASE CATALYTIC DOMAIN WITH BOUND LIGAND | 3.1.3.48 |
4WH8 | CRYSTAL STRUCTURE OF HCV NS3/4A PROTEASE IN COMPLEX WITH AN ASUNAPREVIR P1-P3 MACROCYCLIC ANALOG. | 2.7.7.48 3.4.21.98 3.6.1.15 3.6.4.13 |
4WH9 | STRUCTURE OF THE CDC25B PHOSPHATASE CATALYTIC DOMAIN WITH BOUND INHIBITOR | 3.1.3.48 |
4WIF | CRYSTAL STRUCTURE OF E47Q MUTANT CYTIDINE DEAMINASE FROM MYCOBACTERIUM TUBERCULOSIS (MTCDA E47Q) | 3.5.4.5 |
4WIG | CRYSTAL STRUCTURE OF E47D MUTANT CYTIDINE DEAMINASE FROM MYCOBACTERIUM TUBERCULOSIS (MTCDA E47D) | 3.5.4.5 |
4WJ0 | STRUCTURE OF PH1245, A CAS1 FROM PYROCOCCUS HORIKOSHII | 3.1 |
4WJB | X-RAY CRYSTAL STRUCTURE OF A PUTATIVE AMIDOHYDROLASE/PEPTIDASE FROM BURKHOLDERIA CENOCEPACIA | 3.5.1.87 |
4WJX | CRYSTAL STRUCTURE OF HUMAN CHITOTRIOSIDASE-1 CATALYTIC DOMAIN AT 1.0 A RESOLUTION | 3.2.1.14 |
4WK7 | CRYSTAL STRUCTURE OF HUMAN ADAMTS-4 IN COMPLEX WITH INHIBITOR (COMPOUND 1, 2-(4-CHLOROPHENOXY)-N-{[(4R)-4-METHYL-2,5-DIOXOIMIDAZOLIDIN-4-YL]METHYL} ACETAMIDE) | 3.4.24.82 |
4WK9 | CRYSTAL STRUCTURE OF HUMAN CHITOTRIOSIDASE-1 CATALYTIC DOMAIN IN COMPLEX WITH CHITOBIOSE (0.3MM) AT 1.10 A RESOLUTION | 3.2.1.14 |
4WKA | CRYSTAL STRUCTURE OF HUMAN CHITOTRIOSIDASE-1 CATALYTIC DOMAIN AT 0.95 A RESOLUTION | 3.2.1.14 |
4WKB | CRYSTAL STRUCTURE OF VIBRIO CHOLERAE 5'-METHYLTHIOADENOSINE/S-ADENOSYL HOMOCYSTEINE NUCLEOSIDASE (MTAN) COMPLEXED WITH METHYLTHIO-DADME-IMMUCILLIN-A | 3.2.2.9 |
4WKC | CRYSTAL STRUCTURE OF ESCHERICHIA COLI 5'-METHYLTHIOADENOSINE/S-ADENOSYL HOMOCYSTEINE NUCLEOSIDASE (MTAN) COMPLEXED WITH BUTYLTHIO-DADME-IMMUCILLIN-A | 3.2.2.9 |
4WKE | CRYSTAL STRUCTURE OF HUMAN ADAMTS-4 IN COMPLEX WITH INHIBITOR 5-CHLORO-N-{[(4R)-2,5-DIOXO-4-(1,3-THIAZOL-2-YL)IMIDAZOLIDIN-4-YL]METHYL}-1-BENZOFURAN-2-CARBOXAMIDE (COMPOUND 10) | 3.4.24.82 |
4WKF | CRYSTAL STRUCTURE OF HUMAN CHITOTRIOSIDASE-1 CATALYTIC DOMAIN IN COMPLEX WITH CHITOBIOSE (2.5MM) AT 1.10 A RESOLUTION | 3.2.1.14 |
4WKH | CRYSTAL STRUCTURE OF HUMAN CHITOTRIOSIDASE-1 CATALYTIC DOMAIN IN COMPLEX WITH CHITOBIOSE (1MM) AT 1.05 A RESOLUTION | 3.2.1.14 |
4WKI | CRYSTAL STRUCTURE OF HUMAN ADAMTS-4 IN COMPLEX WITH INHIBITOR 5-CHLORO-N-{[(4S)-4-(1-METHYL-1H-IMIDAZOL-2-YL)-2,5-DIOXOIMIDAZOLIDIN-4-YL]METHYL}-1-BENZOFURAN-2-CARBOXAMIDE (COMPOUND 11) | 3.4.24.82 |
4WKN | CRYSTAL STRUCTURE OF HELICOBACTER PYLORI 5'-METHYLTHIOADENOSINE/S-ADENOSYL HOMOCYSTEINE NUCLEOSIDASE (MTAN) COMPLEXED WITH METHYLTHIO-DADME-IMMUCILLIN-A | 3.2.2.9 3.2.2.30 |
4WKO | CRYSTAL STRUCTURE OF HELICOBACTER PYLORI 5'-METHYLTHIOADENOSINE/S-ADENOSYL HOMOCYSTEINE NUCLEOSIDASE (MTAN) COMPLEXED WITH HYDROXYBUTYLTHIO-DADME-IMMUCILLIN-A | 3.2.2.9 3.2.2.30 |
4WKP | CRYSTAL STRUCTURE OF HELICOBACTER PYLORI 5'-METHYLTHIOADENOSINE/S-ADENOSYL HOMOCYSTEINE NUCLEOSIDASE (MTAN) COMPLEXED WITH 2-(2-HYDROXYETHOXY)ETHYLTHIOMETHYL-DADME-IMMUCILLIN-A | 3.2.2.9 3.2.2.30 |
4WKS | N-ALKYLBORONIC ACID INHIBITORS REVEAL DETERMINANTS OF LIGAND SPECIFICITY IN THE QUORUM-QUENCHING AND SIDEROPHORE BIOSYNTHETIC ENZYME PVDQ | 3.5.1.97 |
4WKT | N-ALKYLBORONIC ACID INHIBITORS REVEAL DETERMINANTS OF LIGAND SPECIFICITY IN THE QUORUM-QUENCHING AND SIDEROPHORE BIOSYNTHETIC ENZYME PVDQ | 3.5.1.97 |
4WKU | N-ALKYLBORONIC ACID INHIBITORS REVEAL DETERMINANTS OF LIGAND SPECIFICITY IN THE QUORUM-QUENCHING AND SIDEROPHORE BIOSYNTHETIC ENZYME PVDQ | 3.5.1.97 |
4WKV | N-ALKYLBORONIC ACID INHIBITORS REVEAL DETERMINANTS OF LIGAND SPECIFICITY IN THE QUORUM-QUENCHING AND SIDEROPHORE BIOSYNTHETIC ENZYME PVDQ | 3.5.1.97 |
4WL3 | CRYSTAL STRUCTURE DETERMINATION OF BILE SALT HYDROLASE FROM ENTEROCOCCUS FEACALIS | 3.5.1.24 |
4WL6 | RASTER-SCANNING PROTEIN CRYSTALLOGRAPHY USING MICRO AND NANO-FOCUSED SYNCHROTRON BEAMS | 3.2.1.17 |
4WL7 | ROOM-TEMPERATURE CRYSTAL STRUCTURE OF LYSOZYME DETERMINED BY SERIAL SYNCHROTRON CRYSTALLOGRAPHY USING A MICRO FOCUSED BEAM (CONVENTIONAL RESOLUTION CUT-OFF) | 3.2.1.17 |
4WLC | STRUCTURE OF DEXTRAN GLUCOSIDASE WITH GLUCOSE | 3.2.1.70 |
4WLD | HIGH PRESSURE PROTEIN CRYSTALLOGRAPHY OF HEN EGG WHITE LYSOZYME AT 0.1 MPA | 3.2.1.17 |
4WLP | CRYSTAL STRUCTURE OF UCH37-NFRKB INHIBITED DEUBIQUITYLATING COMPLEX | 3.4.19.12 |
4WLQ | CRYSTAL STRUCTURE OF MUCH37-HRPN13 CTD COMPLEX | 3.4.19.12 |
4WLR | CRYSTAL STRUCTURE OF MUCH37-HRPN13 CTD-HUB COMPLEX | 3.4.19.12 |
4WLT | HIGH PRESSURE PROTEIN CRYSTALLOGRAPHY OF HEN EGG WHITE LYSOZYME AT 190 MPA | 3.2.1.17 |
4WLX | HIGH PRESSURE PROTEIN CRYSTALLOGRAPHY OF HEN EGG WHITE LYSOZYME AT 280 MPA | 3.2.1.17 |
4WLY | HIGH PRESSURE PROTEIN CRYSTALLOGRAPHY OF HEN EGG WHITE LYSOZYME AT 380 MPA | 3.2.1.17 |
4WM1 | HIGH PRESSURE PROTEIN CRYSTALLOGRAPHY OF HEN EGG WHITE LYSOZYME AT 500 MPA | 3.2.1.17 |
4WM2 | HIGH PRESSURE PROTEIN CRYSTALLOGRAPHY OF HEN EGG WHITE LYSOZYME AT 600 MPA | 3.2.1.17 |
4WM3 | HIGH PRESSURE PROTEIN CRYSTALLOGRAPHY OF HEN EGG WHITE LYSOZYME AT 710 MPA | 3.2.1.17 |
4WM4 | HIGH PRESSURE PROTEIN CRYSTALLOGRAPHY OF HEN EGG WHITE LYSOZYME AT 800 MPA | 3.2.1.17 |
4WM5 | HIGH PRESSURE PROTEIN CRYSTALLOGRAPHY OF HEN EGG WHITE LYSOZYME AT 890 MPA | 3.2.1.17 |
4WM6 | HIGH PRESSURE PROTEIN CRYSTALLOGRAPHY OF HEN EGG WHITE LYSOZYME AT 950 MPA | 3.2.1.17 |
4WM9 | ACINETOBACTER BAUMANII OXA-24 COMPLEX WITH AVIBACTAM | 3.5.2.6 |
4WMD | CRYSTAL STRUCTURE OF CATALYTICALLY INACTIVE MERS-COV 3CL PROTEASE (C148A) IN SPACEGROUP C2221 | 3.4.19.12 3.4.22.69 |
4WME | CRYSTAL STRUCTURE OF CATALYTICALLY INACTIVE MERS-COV 3CL PROTEASE (C148A) IN SPACEGROUP C2 | 3.4.19.12 3.4.22.69 |
4WMF | CRYSTAL STRUCTURE OF CATALYTICALLY INACTIVE MERS-COV 3CL PROTEASE (C148A) IN SPACEGROUP P212121 | 3.4.19.12 3.4.22.69 |
4WMG | STRUCTURE OF HEN EGG-WHITE LYSOZYME FROM A MICROFLUDIC HARVESTING DEVICE USING SYNCHROTRON RADIATION (2.5A) | 3.2.1.17 |
4WN1 | CRYSTAL STRUCTURE OF PDE10A IN COMPLEX WITH 1-METHYL-5-(1-METHYL-3-{[4-(QUINOLIN-2-YL)PHENOXY]METHYL}-1H-PYRAZOL-4-YL)PYRIDIN-2(1H)-ONE | 3.1.4.17 3.1.4.35 |
4WNZ | CRYSTAL STRUCTURE OF PYROCOCCUS FURIOSUS CMR4 (CAS7) | 3.1 |
4WO6 | LYSOZYME PRE-SURFACE ACOUSTIC WAVE | 3.2.1.17 |
4WO9 | LYSOZYME POST-SURFACE ACOUSTIC WAVES | 3.2.1.17 |
4WOA | LYSOZYME MULTIPLE CRYSTALS AFTER SURFACE ACOUSTIC WAVE ALIGNMENT | 3.2.1.17 |
4WOB | PROTEINASE-K PRE-SURFACE ACOUSTIC WAVE | 3.4.21.64 |
4WOC | PROTEINASE-K POST-SURFACE ACOUSTIC WAVES | 3.4.21.64 |
4WOH | STRUCTURE OF OF HUMAN DUAL-SPECIFICITY PHOSPHATASE 22 (E24A/K28A/K30A/C88S) COMPLEXED WITH 4-NITROPHENOLPHOSPHATE | 3.1.3.16 3.1.3.48 |
4WOR | STAPHYLOCOCCAL NUCLEASE IN COMPLEX WITH CA2+ AND THYMIDINE-3'-5'-DIPHOSPHATE (PDTP) AT ROOM TEMPERATURE | 3.1.31.1 |
4WPH | CRYSTAL STRUCTURE OF USP7 UBIQUITIN-LIKE DOMAINS IN COMPACT CONFORMATION | 3.4.19.12 |
4WPI | CRYSTAL STRUCTURE OF USP7 UBIQUITIN-LIKE DOMAINS IN EXTENDED CONFORMATION | 3.4.19.12 |
4WPK | CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS URACIL-DNA GLYCOSYLASE, FORM I | 3.2.2.27 |
4WPL | CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS URACIL-DNA GLYCOSYLASE IN COMPLEX WITH URACIL, FORM I | 3.2.2.27 |
4WR2 | CRYSTAL STRUCTURE OF A PUTATIVE PYRIMIDINE-SPECIFIC RIBONUCLEOSIDE HYDROLASE (RIHA) PROTEIN FROM SHEWANELLA LOIHICA PV-4 (SHEW_0697, TARGET PSI-029635) WITH DIVALENT CATION AND PEG 400 BOUND AT THE ACTIVE SITE | 3.2 |
4WRD | CRYSTAL STRUCTURE OF STAPHYLCOCCAL NULEASE VARIANT DELTA+PHS V66E L125E AT CRYOGENIC TEMPERATURE | 3.1.31.1 |
4WRK | THE 3D STRUCTURE OF D95N MUTANT DUTPASE FROM PHAGE PHI11 OF S. AUREUS REVEALS THE MOLECULAR DETAILS FOR THE COORDINATION OF A STRUCTURAL MG(II) ION | 3.6.1.23 |
4WRT | CRYSTAL STRUCTURE OF INFLUENZA B POLYMERASE WITH BOUND VRNA PROMOTER (FORM FLUB2) | 3.1 |
4WRU | CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS URACIL-DNA GLYCOSYLASE IN COMPLEX WITH URACIL, FORM II | 3.2.2.27 |
4WRV | CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS URACIL-DNA GLYCOSYLASE IN COMPLEX WITH URACIL, FORM III | 3.2.2.27 |
4WRW | CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS URACIL-DNA GLYCOSYLASE, FORM IV | 3.2.2.27 |
4WRX | CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS URACIL-DNA GLYCOSYLASE, FORM V | 3.2.2.27 |
4WRY | CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS URACIL-DNA GLYCOSYLASE IN COMPLEX WITH 5-FLUOROURACIL(B), FORM I | 3.2.2.27 |
4WRZ | CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS URACIL-DNA GLYCOSYLASE IN COMPLEX WITH 5-FLUOROURACIL (AB), FORM I | 3.2.2.27 |
4WS0 | CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS URACIL-DNA GLYCOSYLASE IN COMPLEX WITH 5-FLUOROURACIL (A), FORM II | 3.2.2.27 |
4WS1 | CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS URACIL-DNA GLYCOSYLASE IN COMPLEX WITH 5-FLUOROURACIL (AB), FORM II | 3.2.2.27 |
4WS2 | CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS URACIL-DNA GLYCOSYLASE IN COMPLEX WITH 6-AMINOURACIL, FORM I | 3.2.2.27 |
4WS3 | CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS URACIL-DNA GLYCOSYLASE IN COMPLEX WITH 6-AMINOURACIL, FORM IV | 3.2.2.27 |
4WS4 | CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS URACIL-DNA GLYCOSYLASE IN COMPLEX WITH 5-NITROURACIL, FORM I | 3.2.2.27 |
4WS5 | CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS URACIL-DNA GLYCOSYLASE IN COMPLEX WITH 5-NITROURACIL, FORM III | 3.2.2.27 |
4WS6 | CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS URACIL-DNA GLYCOSYLASE IN COMPLEX WITH 5-AMINOURACIL, FORM I | 3.2.2.27 |
4WS7 | CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS URACIL-DNA GLYCOSYLASE IN COMPLEX WITH 5-CHLOROURACIL, FORM II | 3.2.2.27 |
4WS8 | CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS URACIL-DNA GLYCOSYLASE IN COMPLEX WITH 2-THIOURACIL, FORM V | 3.2.2.27 |
4WSA | CRYSTAL STRUCTURE OF INFLUENZA B POLYMERASE BOUND TO THE VRNA PROMOTER (FLUB1 FORM) | 3.1 |
4WT9 | APO CRYSTAL STRUCTURE OF HCV NS5B GENOTYPE 2A JFH-1 ISOLATE WITH E86Q E87Q S15G C223H V321I AND DELTA8 MUTATIONS | 2.7.7.48 3.4.22 3.4.21.98 3.6.1.15 3.6.4.13 |
4WTA | CRYSTAL STRUCTURE OF HCV NS5B GENOTYPE 2A JFH-1 ISOLATE WITH S15G E86Q E87Q C223H V321I MUTATIONS AND DELTA8 BETA HAIRPIN LOOP DELETION IN COMPLEX WITH UDP, MN2+ AND SYMMETRICAL PRIMER TEMPLATE 5'-CAAAAUUU | 2.7.7.48 3.4.22 3.4.21.98 3.6.1.15 3.6.4.13 |
4WTC | CRYSTAL STRUCTURE OF HCV NS5B GENOTYPE 2A JFH-1 ISOLATE WITH S15G E86Q E87Q C223H V321I MUTATIONS AND DELTA8 BETA HAIRPIN LOOP DELETION IN COMPLEX WITH CDP, MN2+ AND SYMMETRICAL PRIMER TEMPLATE 5'-AGAAAUUU | 2.7.7.48 3.4.22 3.4.21.98 3.6.1.15 3.6.4.13 |
4WTD | CRYSTAL STRUCTURE OF HCV NS5B GENOTYPE 2A JFH-1 ISOLATE WITH S15G E86Q E87Q C223H V321I MUTATIONS AND DELTA8 BETA HAIRPIN LOOP DELETION IN COMPLEX WITH ADP, MN2+ AND SYMMETRICAL PRIMER TEMPLATE 5'-AUAAAUUU | 2.7.7.48 3.4.22 3.4.21.98 3.6.1.15 3.6.4.13 |
4WTE | CRYSTAL STRUCTURE OF HCV NS5B GENOTYPE 2A JFH-1 ISOLATE WITH S15G E86Q E87Q C223H V321I MUTATIONS AND DELTA8 BETA HAIRPIN LOOP DELETION IN COMPLEX WITH GDP, MN2+ AND SYMMETRICAL PRIMER TEMPLATE 5'-ACAAAUUU | 2.7.7.48 3.4.22 3.4.21.98 3.6.1.15 3.6.4.13 |
4WTF | CRYSTAL STRUCTURE OF HCV NS5B GENOTYPE 2A JFH-1 ISOLATE WITH S15G E86Q E87Q C223H V321I MUTATIONS AND DELTA8 BETA HAIRPIN LOOP DELETION IN COMPLEX WITH GS-639475, MN2+ AND SYMMETRICAL PRIMER TEMPLATE 5'-CAAAAUUU | 2.7.7.48 3.4.22 3.4.21.98 3.6.1.15 3.6.4.13 |
4WTG | CRYSTAL STRUCTURE OF HCV NS5B GENOTYPE 2A JFH-1 ISOLATE WITH S15G E86Q E87Q C223H V321I MUTATIONS AND DELTA8 BETA HAIRPIN LOOP DELETION IN COMPLEX WITH SOFOSBUVIR DIPHOSPHATE GS-607596, MN2+ AND SYMMETRICAL PRIMER TEMPLATE 5'-CAAAAUUU | 2.7.7.48 3.4.22 3.4.21.98 3.6.1.15 3.6.4.13 |
4WTI | CRYSTAL STRUCTURE OF HCV NS5B GENOTYPE 2A JFH-1 ISOLATE WITH S15G E86Q E87Q C223H V321I MUTATIONS IN COMPLEX WITH RNA TEMPLATE 5'-ACGG, RNA PRIMER 5'-PCC, MN2+, AND GDP | 2.7.7.48 3.4.22 3.4.21.98 3.6.1.15 3.6.4.13 |
4WTJ | CRYSTAL STRUCTURE OF HCV NS5B GENOTYPE 2A JFH-1 ISOLATE WITH S15G E86Q E87Q C223H V321I MUTATIONS IN COMPLEX WITH RNA TEMPLATE 5'-AUCC, RNA PRIMER 5'-PGG, MN2+, AND ADP | 2.7.7.48 3.4.22 3.4.21.98 3.6.1.15 3.6.4.13 |
4WTK | CRYSTAL STRUCTURE OF HCV NS5B GENOTYPE 2A JFH-1 ISOLATE WITH S15G E86Q E87Q C223H V321I MUTATIONS IN COMPLEX WITH RNA TEMPLATE 5'-AGCC, RNA PRIMER 5'-PGG, MN2+, AND CDP | 2.7.7.48 3.4.22 3.4.21.98 3.6.1.15 3.6.4.13 |
4WTL | CRYSTAL STRUCTURE OF HCV NS5B GENOTYPE 2A JFH-1 ISOLATE WITH S15G E86Q E87Q C223H V321I MUTATIONS IN COMPLEX WITH RNA TEMPLATE 5'-UACC, RNA PRIMER 5'-PGG, MN2+, AND UDP | 2.7.7.48 3.4.22 3.4.21.98 3.6.1.15 3.6.4.13 |
4WTM | CRYSTAL STRUCTURE OF HCV NS5B GENOTYPE 2A JFH-1 ISOLATE WITH S15G E86Q E87Q C223H V321I MUTATIONS IN COMPLEX WITH RNA TEMPLATE 5'-UAGG, RNA PRIMER 5'-PCC, MN2+, AND UDP | 2.7.7.48 3.4.22 3.4.21.98 3.6.1.15 3.6.4.13 |
4WTU | CRYSTAL STRUCTURE OF BACE1 IN COMPLEX WITH 2-AMINOOXAZOLINE 3-AZA-4-FLUORO-XANTHENE INHIBITOR 22 | 3.4.23.46 |
4WTV | CRYSTAL STRUCTURE OF THE PHOSPHATIDYLINOSITOL 4-KINASE IIBETA | 2.7.1.67 3.2.1.17 |
4WU2 | STRUCTURE OF THE PTP-LIKE MYO-INOSITOL PHOSPHATASE FROM SELENOMONAS RUMINANTIUM IN COMPLEX WITH MYO-INOSITOL-(1,4,5)-TRIKISPHOSPHATE | 3.1.3.8 |
4WU3 | STRUCTURE OF THE PTP-LIKE MYO-INOSITOL PHOSPHATASE FROM MITSUOKELLA MULTACIDA IN COMPLEX WITH MYO-INOSITOL-(1,3,4,5)-TETRAKISPHOSPHATE | 3.1.3.8 |
4WUR | THE CRYSTAL STRUCTURE OF THE MERS-COV PAPAIN-LIKE PROTEASE (C111S) WITH HUMAN UBIQUITIN | 3.4.19.12 3.4.22.69 3.4.22 2.7.7.48 3.6.4.12 3.6.4.13 2.1.1 3.1.13 3.1 |
4WUZ | CRYSTAL STRUCTURE OF LAMBDA EXONUCLEASE IN COMPLEX WITH DNA AND CA2+ | 3.1.11.3 |
4WVG | CRYSTAL STRUCTURE OF THE TYPE-I SIGNAL PEPTIDASE FROM STAPHYLOCOCCUS AUREUS (SPSB). | 3.4.21.89 |
4WVH | CRYSTAL STRUCTURE OF THE TYPE-I SIGNAL PEPTIDASE FROM STAPHYLOCOCCUS AUREUS (SPSB) IN COMPLEX WITH A SUBSTRATE PEPTIDE (PEP1). | 3.4.21.89 |
4WVI | CRYSTAL STRUCTURE OF THE TYPE-I SIGNAL PEPTIDASE FROM STAPHYLOCOCCUS AUREUS (SPSB) IN COMPLEX WITH A SUBSTRATE PEPTIDE (PEP2). | 3.4.21.89 |
4WVJ | CRYSTAL STRUCTURE OF THE TYPE-I SIGNAL PEPTIDASE FROM STAPHYLOCOCCUS AUREUS (SPSB) IN COMPLEX WITH AN INHIBITOR PEPTIDE (PEP3). | 3.4.21.89 |
4WVP | CRYSTAL STRUCTURE OF AN ACTIVITY-BASED PROBE HNE COMPLEX | 3.4.21.37 |
4WVX | CRYSTAL STRUCTURE OF A PHOSPHOTRIESTERASE-LIKE LACTONASE GKAP IN NATIVE FORM | 3.5 |
4WVY | DOUBLE-HETEROHEXAMERIC RINGS OF FULL-LENGTH RVB1(ATP)/RVB2(APO) | 3.6.4.12 |
4WW0 | TRUNCATED FTSH FROM A. AEOLICUS | 3.4.24 |
4WW4 | DOUBLE-HETEROHEXAMERIC RINGS OF FULL-LENGTH RVB1(ADP)/RVB2(ADP) | 3.6.4.12 |
4WW5 | CRYSTAL STRUCTURE OF BINARY COMPLEX BUD32-CGI121 IN COMPLEX WITH AMPP | 3.6 2.7.11.1 |
4WW7 | CRYSTAL STRUCTURE OF BINARY COMPLEX BUD32-CGI121 IN COMPLEX WITH AMP | 3.6 2.7.11.1 |
4WW9 | CRYSTAL STRUCTURE OF BINARY COMPLEX BUD32-CGI121 IN COMPLEX WITH ADP | 3.6 2.7.11.1 |
4WWA | CRYSTAL STRUCTURE OF BINARY COMPLEX BUD32-CGI121 | 3.6 2.7.11.1 |
4WWH | CRYSTAL STRUCTURE OF AN ABC TRANSPORTER SOLUTE BINDING PROTEIN (IPR025997) FROM MYCOBACTERIUM SMEGMATIS (MSMEG_1704, TARGET EFI-510967) WITH BOUND D-GALACTOSE | 3.6.3.17 |
4WWL | E. COLI 5'-NUCLEOTIDASE MUTANT I521C LABELED WITH MTSL (INTERMEDIATE FORM) | 3.6.1.45 3.1.3.5 |
4WWX | CRYSTAL STRUCTURE OF THE CORE RAG1/2 RECOMBINASE | 3.1 6.3.2 2.3.2.27 |
4WWY | HUMAN CATIONIC TRYPSIN G193R MUTANT IN COMPLEX WITH BOVINE PANCREATIC TRYPSIN INHIBITOR | 3.4.21.4 |
4WX4 | CRYSTAL STRUCTURE OF ADENOVIRUS 8 PROTEASE IN COMPLEX WITH A NITRILE INHIBITOR | 3.4.22.39 |
4WX6 | CRYSTAL STRUCTURE OF HUMAN ADENOVIRUS 8 PROTEASE WITH AN IRREVERSIBLE VINYL SULFONE INHIBITOR | 3.4.22.39 |
4WX7 | CRYSTAL STRUCTURE OF ADENOVIRUS 8 PROTEASE WITH A NITRILE INHIBITOR | 3.4.22.39 |
4WXI | FACTOR XIA IN COMPLEX WITH THE INHIBITOR TRANS-N-{(1S)-1-[4-(3-AMINO-2H-INDAZOL-6-YL)PYRIDIN-2-YL]-2-PHENYLETHYL}-4-(AMINOMETHYL)CYCLOHEXANECARBOXAMIDE | 3.4.21.27 |
4WXK | CRYSTAL STRUCTURE OF A PEPTIDE DEFORMYLASE FROM HAEMOPHILUS INFLUENZAE | 3.5.1.88 |
4WXL | CRYSTAL STRUCTURE OF A PEPTIDE DEFORMYLASE FROM HAEMOPHILUS INFLUENZAE COMPLEX WITH ACTINONIN | 3.5.1.88 |
4WXP | X-RAY CRYSTAL STRUCTURE OF NS3 HELICASE FROM HCV WITH A BOUND FRAGMENT INHIBITOR AT 2.08 A RESOLUTION | 3.4.22 3.4.21.98 3.6.1.15 3.6.4.13 2.7.7.48 |
4WXR | X-RAY CRYSTAL STRUCTURE OF NS3 HELICASE FROM HCV WITH A BOUND INHIBITOR AT 2.42 A RESOLUTION | 3.6.1.15 3.6.4.13 |
4WXV | HUMAN CATIONIC TRYPSIN K97D MUTANT IN COMPLEX WITH BOVINE PANCREATIC TRYPSIN INHIBITOR (BPTI) | 3.4.21.4 |
4WY1 | CRYSTAL STRUCTURE OF HUMAN BACE-1 BOUND TO COMPOUND 24B | 3.4.23.46 |
4WY3 | STRUCTURE OF SARS-3CL PROTEASE COMPLEX WITH A PHENYLBENZOYL (R,S)-N-DECALIN TYPE INHIBITOR | 3.4.22 3.4.19.12 3.4.22.69 2.7.7.48 3.6.4.12 3.6.4.13 2.1.1 3.1.13 3.1 |
4WY6 | CRYSTAL STRUCTURE OF HUMAN BACE-1 BOUND TO COMPOUND 36 | 3.4.23.46 |
4WY8 | STRUCTURAL ANALYSIS OF TWO FUNGAL ESTERASES FROM RHIZOMUCOR MIEHEI EXPLAINING THEIR SUBSTRATE SPECIFICITY | 3.1.1.1 |
4WYL | MUTANT K18E OF 3D POLYMERASE FROM FOOT-AND-MOTH DISEASE VIRUS | 2.7.7.48 3.4.22.46 3.6.1.15 3.4.22.28 |
4WYN | THE CRYSTAL STRUCTURE OF THE A109G MUTANT OF RNASE A | 3.1.27.5 4.6.1.18 |
4WYP | THE CRYSTAL STRUCTURE OF THE A109G MUTANT OF RNASE A IN COMPLEX WITH 5'AMP | 3.1.27.5 4.6.1.18 |
4WYQ | CRYSTAL STRUCTURE OF THE DICER-TRBP INTERFACE | 3.1.26.3 |
4WYV | CRYSTAL STRUCTURE OF HUMAN TRANSLIN IN OPEN CONFORMATION | 3.1 |
4WYW | MUTANT K20E OF 3D POLYMERASE FROM FOOT-AND-MOUTH DISEASE VIRUS | 2.7.7.48 3.4.22.46 3.6.1.15 3.4.22.28 |
4WYY | CRYSTAL STRUCTURE OF P. AERUGINOSA AMPC | 3.5.2.6 |
4WYZ | THE CRYSTAL STRUCTURE OF THE A109G MUTANT OF RNASE A IN COMPLEX WITH 3'UMP | 3.1.27.5 4.6.1.18 |
4WZ4 | CRYSTAL STRUCTURE OF P. AERUGINOSA AMPC | 3.5.2.6 |
4WZ5 | CRYSTAL STRUCTURE OF P. AERUGINOSA OXA10 | 3.5.2.6 |
4WZ6 | HUMAN CFTR AA389-678 (NBD1), DELTAF508 WITH THREE SOLUBILIZING MUTATIONS, BOUND ATP | 3.6.3.49 5.6.1.6 |
4WZI | CRYSTAL STRUCTURE OF CROSSLINK STABILIZED LONG-FORM PDE4B | 3.1.4.53 |
4WZM | MUTANT K18E OF RNA DEPENDENT RNA POLYMERASE FROM FOOT-AND-MOUTH DISEASE VIRUS COMPLEXED WITH RNA | 2.7.7.48 3.4.22.46 3.6.1.15 3.4.22.28 |
4WZN | CRYSTAL STRUCTURE OF THE 2B PROTEIN SOLUBLE DOMAIN FROM HEPATITIS A VIRUS | 3.6.1.15 3.4.22.28 2.7.7.48 |
4WZQ | MUTANT K20E OF RNA DEPENDENT RNA POLYMERASE 3D FROM FOOT-AND-MOUTH DISEASE VIRUS COMPLEXED WITH RNA | 3.4.22.46 3.6.1.15 3.4.22.28 2.7.7.48 |
4WZV | CRYSTAL STRUCTURE OF A HYDROXAMATE BASED INHIBITOR EN140 IN COMPLEX WITH THE MMP-9 CATALYTIC DOMAIN | 3.4.24.35 |
4X01 | S. POMBE CTP1 TETRAMERIZATION DOMAIN | 3.1 |
4X08 | STRUCTURE OF H128N/ECP MUTANT IN COMPLEX WITH SULPHATE ANIONS AT 1.34 ANGSTROMS. | 3.1.27 3.1.27.5 |
4X0F | CRYSTAL STRUCTURE OF CROSSLINK STABILIZED LONG-FORM PDE4B IN COMPLEX WITH (R)-(-)-ROLIPRAM | 3.1.4.53 |
4X0N | PORCINE PANCREATIC ALPHA-AMYLASE IN COMPLEX WITH HELIANTHAMIDE, A NOVEL PROTEINACEOUS INHIBITOR | 3.2.1.1 |
4X24 | CRYSTAL STRUCTURE OF VIBRIO CHOLERAE 5'-METHYLTHIOADENOSINE/S-ADENOSYL HOMOCYSTEINE NUCLEOSIDASE (MTAN) COMPLEXED WITH METHYLTHIO-DADME-IMMUCILLIN-A | 3.2.2.9 |
4X2B | K20A RNA DEPENDENT RNA POLYMERASE MUTANT FROM FOOT-AND-MOUTH DISEASE VIRUS COMPLEXED WITH AN RNA | 2.7.7.48 3.4.22.46 3.6.1.15 3.4.22.28 |
4X2L | CRYSTAL STRUCTURE OF HUMAN BACE-1 BOUND TO COMPOUND 6 | 3.4.23.46 |
4X2U | X-RAY CRYSTAL STRUCTURE OF THE ORALLY AVAILABLE AMINOPEPTIDASE INHIBITOR, TOSEDOSTAT, BOUND TO THE M1 ALANYL AMINOPEPTIDASE FROM P. FALCIPARUM | 3.4.11 |
4X2V | CRYSTAL STRUCTURE OF THE MURINE NOROVIRUS NS6 PROTEASE (INACTIVE C139A MUTANT) WITH A C-TERMINAL EXTENSION TO INCLUDE RESIDUE P1 PRIME OF NS7 | 2.7.7.48 3.4.22.66 3.6.1.15 |
4X2W | CRYSTAL STRUCTURE OF THE MURINE NOROVIRUS NS6 PROTEASE (INACTIVE C139A MUTANT) WITH A C-TERMINAL EXTENSION TO INCLUDE RESIDUES P1 PRIME - P2 PRIME OF NS7 | 2.7.7.48 3.4.22.66 3.6.1.15 |
4X2X | CRYSTAL STRUCTURE OF THE MURINE NOROVIRUS NS6 PROTEASE (INACTIVE C139A MUTANT) WITH A C-TERMINAL EXTENSION TO INCLUDE RESIDUES P1 PRIME - P4 PRIME OF NS7 | 2.7.7.48 3.4.22.66 3.6.1.15 |
4X2Y | CRYSTAL STRUCTURE OF A CHIMERIC MURINE NOROVIRUS NS6 PROTEASE (INACTIVE C139A MUTANT) IN WHICH THE P4-P4 PRIME RESIDUES OF THE CLEAVAGE JUNCTION IN THE EXTENDED C-TERMINUS HAVE BEEN REPLACED BY THE CORRESPONDING RESIDUES FROM THE NS2-3 JUNCTION. | 2.7.7.48 3.4.22.66 3.6.1.15 |
4X2Z | STRUCTURAL VIEW AND SUBSTRATE SPECIFICITY OF PAPAIN-LIKE PROTEASE FROM AVIAN INFECTIOUS BRONCHITIS VIRUS | 3.4.22 2.7.7.48 3.6.4.12 3.6.4.13 3.1.13 3.1 2.1.1 |
4X36 | CRYSTAL STRUCTURE OF THE AUTOLYSIN LYTA FROM STREPTOCOCCUS PNEUMONIAE TIGR4 | 3.5.1.28 |
4X3B | A MICRO-PATTERNED SILICON CHIP AS SAMPLE HOLDER FOR MACROMOLECULAR CRYSTALLOGRAPHY EXPERIMENTS WITH MINIMAL BACKGROUND SCATTERING | 3.2.1.17 |
4X3C | TORPEDO CALIFORNICA ACETYLCHOLINESTERASE IN COMPLEX WITH A TACRINE-NICOTINAMIDE HYBRID INHIBITOR | 3.1.1.7 |
4X3O | SIRT2 IN COMPLEX WITH A MYRISTOYL PEPTIDE | 3.5.1 2.3.1.286 |
4X3P | SIRT2 IN COMPLEX WITH A MYRISTOYL PEPTIDE | 3.5.1 2.3.1.286 |
4X3R | AVI-GCPII STRUCTURE IN COMPLEX WITH FITC-CONJUGATED GCPII-SPECIFIC INHIBITOR | 3.4.17.21 |
4X42 | CRYSTAL STRUCTURE OF DEN4 ED3 MUTANT WITH EPITOPE TWO RESIDUES SUBSTITUTED FROM DEN3 ED3 | 3.4.21.91 3.6.1.15 3.6.4.13 2.1.1.56 2.1.1.57 2.7.7.48 |
4X47 | CRYSTAL STRUCTURE OF THE INTRAMOLECULAR TRANS-SIALIDASE FROM RUMINOCOCCUS GNAVUS IN COMPLEX WITH NEU5AC2EN | 3.2.1.18 |
4X68 | CRYSTAL STRUCTURE OF OP0595 COMPLEXED WITH AMPC | 3.5.2.6 |
4X69 | CRYSTAL STRUCTURE OF OP0595 COMPLEXED WITH CTX-M-44 | 3.5.2.6 |
4X6H | DEVELOPMENT OF N-(FUNCTIONALIZED BENZOYL)-HOMOCYCLOLEUCYL-GLYCINONITRILES AS POTENT CATHEPSIN K INHIBITORS. | 3.4.22.38 |
4X6I | DEVELOPMENT OF N-(FUNCTIONALIZED BENZOYL)-HOMOCYCLOLEUCYL-GLYCINONITRILES AS POTENT CATHEPSIN K INHIBITORS. | 3.4.22.38 |
4X6J | DEVELOPMENT OF N-(FUNCTIONALIZED BENZOYL)-HOMOCYCLOLEUCYL-GLYCINONITRILES AS POTENT CATHEPSIN K INHIBITORS. | 3.4.22.38 |
4X6M | FACTOR XIA IN COMPLEX WITH THE INHIBITOR 1-{(1S)-1-[4-(3-AMINO-1H-INDAZOL-6-YL)-5-CHLORO-1H-IMIDAZOL-2-YL]-2-PHENYLETHYL}-3-[2-(AMINOMETHYL)-5-CHLOROBENZYL]UREA | 3.4.21.27 |
4X6N | FACTOR XIA IN COMPLEX WITH THE INHIBITOR 1-{(1S)-1-[4-(3-AMINO-1H-INDAZOL-6-YL)-5-CHLORO-1H-IMIDAZOL-2-YL]-2-PHENYLETHYL}-3-[5-CHLORO-2-(1H-TETRAZOL-1-YL)BENZYL]UREA | 3.4.21.27 |
4X6O | FACTOR XIA IN COMPLEX WITH THE INHIBITOR METHYL (4-{4-CHLORO-2-[(1S)-1-({3-[5-CHLORO-2-(1H-TETRAZOL-1-YL)PHENYL]PROPANOYL}AMINO)-2-PHENYLETHYL]-1H-IMIDAZOL-5-YL}PHENYL)CARBAMATE | 3.4.21.27 |
4X6P | FACTOR XIA (PICHIA PASTORIS; C500S [C122S]) IN COMPLEX WITH THE INHIBITOR (2E)-N-{(1S)-1-[4-(3-AMINO-1H-INDAZOL-6-YL)-1H-IMIDAZOL-2-YL]-2-PHENYLETHYL}-3-[5-CHLORO-2-(1H-TETRAZOL-1-YL)PHENYL]PROP-2-ENAMIDE | 3.4.21.27 |
4X6T | M.TUBERCULOSIS BETALACTAMASE COMPLEXED WITH INHIBITOR EC19 | 3.5.2.6 |
4X6U | CRYSTAL STRUCTURE OF LIPASE FROM GEOBACILLUS STEAROTHERMOPHILUS T6 | 3.1.1.3 |
4X6X | HUMAN SOLUBLE EPOXIDE HYDROLASE IN COMPLEX WITH A THREE SUBSTITUTED CYCLOPROPANE DERIVATIVE | 3.3.2.10 3.1.3.76 |
4X6Y | HUMAN SOLUBLE EPOXIDE HYDROLASE IN COMPLEX WITH A CYCLOPROPYL UREA DERIVATIVE | 3.3.2.10 3.1.3.76 |
4X71 | CRYSTAL STRUCTURE OF LIPASE FROM GEOBACILLUS STEAROTHERMOPHILUS T6 METHANOL STABLE VARIANT A269T | 3.1.1.3 |
4X7B | CRYSTAL STRUCTURE OF LIPASE FROM GEOBACILLUS STEAROTHERMOPHILUS T6 METHANOL STABLE VARIANT H86Y/A269T | 3.1.1.3 |
4X7I | CRYSTAL STRUCTURE OF BACE WITH AMINO THIAZINE INHIBITOR LY2886721 | 3.4.23.46 |
4X85 | CRYSTAL STRUCTURE OF LIPASE FROM GEOBACILLUS STEAROTHERMOPHILUS T6 METHANOL STABLE VARIANT H86Y/A269T/R374W | 3.1.1.3 |
4X8C | CRYSTAL STRUCTURE OF HUMAN PEPTIDYLARGININE DEIMINASE TYPE4 (PAD4) IN COMPLEX WITH GSK147 | 3.5.3.15 |
4X8G | CRYSTAL STRUCTURE OF HUMAN PEPTIDYLARGININE DEIMINASE TYPE4 (PAD4) IN COMPLEX WITH GSK199 | 3.5.3.15 |
4X8I | DE NOVO CRYSTAL STRUCTURE OF THE PYROCOCCUS FURIOSUS TET3 AMINOPEPTIDASE | 3.4.11.15 |
4X8S | FACTOR VIIA IN COMPLEX WITH THE INHIBITOR 4-BROMO-2-METHOXYPHENOL | 3.4.21.21 |
4X8T | FACTOR VIIA IN COMPLEX WITH THE INHIBITOR 7-CHLORO-3,4-DIHYDROISOQUINOLIN-1(2H)-ONE | 3.4.21.21 |
4X8U | FACTOR VIIA IN COMPLEX WITH THE INHIBITOR 5-CHLORO-1H-INDOLE-2-CARBOXYLIC ACID | 3.4.21.21 |
4X8V | FACTOR VIIA IN COMPLEX WITH THE INHIBITOR (METHYL {3-[(2R)-1-{(2R)-2-(3,4-DIMETHOXYPHENYL)-2-[(1-OXO-1,2,3,4-TETRAHYDROISOQUINOLIN-7-YL)AMINO]ACETYL}PYRROLIDIN-2-YL]-4-(PROPAN-2-YLSULFONYL)PHENYL}CARBAMATE) | 3.4.21.21 |
4X90 | CRYSTAL STRUCTURE OF LYSOSOMAL PHOSPHOLIPASE A2 | 2.3.1 3.1.1.5 3.1.1.32 3.1.1.4 |
4X91 | CRYSTAL STRUCTURE OF LYSOSOMAL PHOSPHOLIPASE A2 IN COMPLEX WITH ISOPROPYL DODEC-11-ENYLFLUOROPHOSPHONATE (IDFP) | 2.3.1 3.1.1.5 3.1.1.32 3.1.1.4 |
4X92 | CRYSTAL STRUCTURE OF LYSOSOMAL PHOSPHOLIPASE A2-S165A | 2.3.1 3.1.1.5 3.1.1.32 3.1.1.4 |
4X93 | CRYSTAL STRUCTURE OF LYSOSOMAL PHOSPHOLIPASE A2 CRYSTALLIZED IN THE PRESENCE OF METHYL ARACHIDONYL FLUOROPHOSPHONATE (TETRAGONAL FORM) | 2.3.1 3.1.1.5 3.1.1.32 3.1.1.4 |
4X94 | CRYSTAL STRUCTURE OF LYSOSOMAL PHOSPHOLIPASE A2 CRYSTALLIZED IN THE PRESENCE OF METHYL ARACHIDONYL FLUOROPHOSPHONATE (HEXAGONAL FORM) | 2.3.1 3.1.1.5 3.1.1.32 3.1.1.4 |
4X95 | CRYSTAL STRUCTURE OF FULLY GLYCOSYLATED LYSOSOMAL PHOSPHOLIPASE A2 IN COMPLEX WITH METHYL ARACHIDONYL FLUOROPHOSPHONATE (MAFP) | 2.3.1 3.1.1.5 3.1.1.32 3.1.1.4 |
4X97 | CRYSTAL STRUCTURE OF LYSOSOMAL PHOSPHOLIPASE A2 IN COMPLEX WITH METHYL ARACHIDONYL FLUOROPHOSPHONATE (MAFP) | 2.3.1 3.1.1.5 3.1.1.32 3.1.1.4 |
4X9Y | WILD-TYPE HUMAN PANCREATIC ALPHA-AMYLASE AT TRUE ATOMIC RESOLUTION (1.07 A) | 3.2.1.1 |
4XAD | CRYSTAL STRUCTURE OF HEN EGG WHITE LYSOZYME IN COMPLEX WITH GALF-GLCNAC | 3.2.1.17 |
4XB3 | STRUCTURE OF DEXTRAN GLUCOSIDASE | 3.2.1.70 |
4XBA | HNT3 | 3 3.6.1.71 3.6.1.72 |
4XBB | 1.85A RESOLUTION STRUCTURE OF NOROVIRUS 3CL PROTEASE COMPLEX WITH A COVALENTLY BOUND DIPEPTIDYL INHIBITOR DIETHYL [(1R,2S)-2-[(N-{[(3-CHLOROBENZYL)OXY]CARBONYL}-3-CYCLOHEXYL-L-ALANYL)AMINO]-1-HYDROXY-3-(2-OXO-2H-PYRROL-3-YL)PROPYL]PHOSPHONATE | 3.4.22.66 3.6.1.15 2.7.7.48 |
4XBC | 1.60 A RESOLUTION STRUCTURE OF NOROVIRUS 3CL PROTEASE COMPLEX WITH A COVALENTLY BOUND DIPEPTIDYL INHIBITOR (1R,2S)-2-({N-[(BENZYLOXY)CARBONYL]-3-CYCLOHEXYL-L-ALANYL}AMINO)-1-HYDROXY-3-[(3S)-2-OXOPYRROLIDIN-3-YL]PROPANE-1-SULFONIC ACID (HEXAGONAL FORM) | 3.4.22.66 3.6.1.15 2.7.7.48 |
4XBD | 1.45A RESOLUTION STRUCTURE OF NOROVIRUS 3CL PROTEASE COMPLEX WITH A COVALENTLY BOUND DIPEPTIDYL INHIBITOR (1R,2S)-2-({N-[(BENZYLOXY)CARBONYL]-3-CYCLOHEXYL-L-ALANYL}AMINO)-1-HYDROXY-3-[(3S)-2-OXOPYRROLIDIN-3-YL]PROPANE-1-SULFONIC ACID (ORTHORHOMBIC P FORM) | 3.4.22.66 3.6.1.15 2.7.7.48 |
4XBT | CRYSTAL STRUCTURE OF THE L74F/M78F/L103V/L114V/I116V/F139V/L147V MUTANT OF LEH COMPLEXED WITH (S,S)-CYCLOHEXANEDIOL | 3.3.2.8 |
4XBX | CRYSTAL STRUCTURE OF THE L74F/M78F/L103V/L114V/I116V/F139V/L147V MUTANT OF LEH | 3.3.2.8 |
4XBY | CRYSTAL STRUCTURE OF THE L74F/M78V/I80V/L114F MUTANT OF LEH COMPLEXED WITH CYCLOPENTENE OXIDE | 3.3.2.8 |
4XCT | CRYSTAL STRUCTURE OF A HYDROXAMATE BASED INHIBITOR ARP101 (EN73) IN COMPLEX WITH THE MMP-9 CATALYTIC DOMAIN. | 3.4.24.35 |
4XDE | COAGULATION FACTOR XII PROTEASE DOMAIN CRYSTAL STRUCTURE | 3.4.21.38 |
4XDV | CRYSTAL STRUCTURE OF THE L74F/M78V/I80V/L114F MUTANT OF LEH COMPLEXED WITH CYCLOHEXANEDIOL | 3.3.2.8 |
4XDW | CRYSTAL STRUCTURE OF THE L74F/M78V/I80V/L114F MUTANT OF LEH | 3.3.2.8 |
4XE4 | COAGULATION FACTOR XII PROTEASE DOMAIN CRYSTAL STRUCTURE | 3.4.21.38 |
4XE9 | CRYSTAL STRUCTURE OF THE NANB SIALIDASE FROM STREPTOCOCCUS PNEUMONIAE IN COMPLEX WITH OPTACTIN | 3.2.1.18 |
4XEE | STRUCTURE OF ACTIVE-LIKE NEUROTENSIN RECEPTOR | 3.2.1.17 |
4XEG | STRUCTURE OF THE ENZYME-PRODUCT COMPLEX RESULTING FROM TDG ACTION ON A G/HMU MISMATCH | 3.2.2.29 |
4XEL | CRYSTAL STRUCTURE OF INORGANIC PYROPHOSPHATASE (PPASE) FROM PSEUDOMONAS AERUGINOSA | 3.6.1.1 |
4XEN | HIGH PRESSURE PROTEIN CRYSTALLOGRAPHY OF HEN EGG WHITE LYSOZYME IN COMPLEX WITH TETRA-N-ACETYLCHITOTETRAOSE AT 920 MPA | 3.2.1.17 |
4XEP | CRYSTAL STRUCTURE OF F222 FORM OF E112A/H234A MUTANT OF STATIONARY PHASE SURVIVAL PROTEIN (SURE) FROM SALMONELLA TYPHIMURIUM | 3.1.3.5 3.1.3.6 3.6.1.11 |
4XER | CRYSTAL STRUCTURE OF C2 FORM OF E112A/H234A MUTANT OF STATIONARY PHASE SURVIVAL PROTEIN (SURE) FROM SALMONELLA TYPHIMURIUM | 3.1.3.5 3.1.3.6 3.6.1.11 |
4XES | STRUCTURE OF ACTIVE-LIKE NEUROTENSIN RECEPTOR | 3.2.1.17 |
4XFQ | CRYSTAL STRUCTURE BASIS FOR PEDV 3C LIKE PROTEASE | 2.7.7.48 3.4.19.12 3.6.4.12 3.6.4.13 |
4XGB | CRYSTAL STRUCTURE OF E112A/H234A MUTANT OF STATIONARY PHASE SURVIVAL PROTEIN (SURE) FROM SALMONELLA TYPHIMURIUM CO-CRYSTALLIZED WITH AMP | 3.1.3.5 3.1.3.6 3.6.1.11 |
4XGL | STRUCTURE OF THE NUCLEASE SUBUNIT OF HUMAN MITOCHONDRIAL RNASE P (MRPP3) AT 1.8A | 3.1.26.5 |
4XGM | STRUCTURE OF THE NUCLEASE SUBUNIT OF HUMAN MITOCHONDRIAL RNASE P (MRPP3) AT 1.98A | 3.1.26.5 |
4XGP | CRYSTAL STRUCTURE OF E112A/H234A MUTANT OF STATIONARY PHASE SURVIVAL PROTEIN (SURE) FROM SALMONELLA TYPHIMURIUM CO-CRYSTALLIZED AND SOAKED WITH AMP. | 3.1.3.5 3.1.3.6 3.6.1.11 |
4XGQ | CRYSTAL STRUCTURE OF ADDICTION MODULE FROM MYCOBACTERIAL SPECIES | 3.1 |
4XGR | CRYSTAL STRUCTURE OF ADDICTION MODULE FROM MYCOBACTERIAL SPECIES | 3.1 |
4XH8 | CRYSTAL STRUCTURE OF E112A/D230A MUTANT OF STATIONARY PHASE SURVIVAL PROTEIN (SURE) FROM SALMONELLA TYPHIMURIUM | 3.1.3.5 3.1.3.6 3.6.1.11 |
4XHB | CRYSTAL STRUCTURE OF THE NANB SIALIDASE FROM STREPTOCOCCUS PNEUMONIAE IN COMPLEX WITH PENTANEDIOL AND CHES | 3.2.1.18 |
4XHC | RHAMNOSIDASE FROM KLEBSIELLA OXYTOCA WITH RHAMNOSE BOUND | 3.2.1.40 |
4XHX | CRYSTAL STRUCTURE OF THE NANB SIALIDASE FROM STREPTOCOCCUS PNEUMONIAE IN COMPLEX WITH OPTACTIN AND 2-[(3-CHLOROBENZYL)AMMONIO]ETHANESULFONATE | 3.2.1.18 |
4XII | X-RAY STRUCTURE OF HUMAN BUTYRYLCHOLINESTERASE IN COMPLEX WITH N-((1-(2,3-DIHYDRO-1H-INDEN-2-YL)PIPERIDIN-3-YL)METHYL)-8-HYDROXY-N-(2-METHOXYETHYL)-5-NITROQUINOLINE-7-CARBOXAMIDE | 3.1.1.8 |
4XIK | CRYSTAL STRUCTURE OF NANB SIALIDASE FROM STREPTOCOCCUS PNEUMONIAE IN COMPLEX WITH DMSO | 3.2.1.18 |
4XIL | CRYSTAL STRUCTURE OF THE NANB SIALIDASE FROM STREPTOCOCCUS PNEUMONIAE IN COMPLEX WITH OPTACTIN AT PH 7.4 IN PBS WITH MPD AS THE CRYOPROTECTANT | 3.2.1.18 |
4XIO | CRYSTAL STRUCTURE OF APO NANB SIALIDASE FROM STREPTOCOCCUS PNEUMONIAE AT PH 8.0 WITH MPD AS THE CRYOPROTECTANT | 3.2.1.18 |
4XJ7 | CRYSTAL STRUCTURE OF E112A MUTANT OF STATIONARY PHASE SURVIVAL PROTEIN (SURE) FROM SALMONELLA TYPHIMURIUM SOAKED WITH AMP | 3.1.3.5 3.1.3.6 3.6.1.11 |
4XJ8 | CRYSTAL STRUCTURE OF APO NANB SIALIDASE FROM STREPTOCOCCUS PNEUMONIAE AT PH 5.0 IN 50MM SODIUM ACETATE WITH DMSO | 3.2.1.18 |
4XJ9 | CRYSTAL STRUCTURE OF THE NANB SIALIDASE FROM STREPTOCOCCUS PNEUMONIAE IN COMPLEX WITH OPTACTIN AT PH 5.0 IN 50MM SODIUM ACETATE WITH DMSO AS THE CRYOPROTECTANT | 3.2.1.18 |
4XJA | CRYSTAL STRUCTURE OF THE NANB SIALIDASE FROM STREPTOCOCCUS PNEUMONIAE IN COMPLEX WITH 5-ACETAMIDO-2,3-DIFLUORO-3-HYDROXY-6-[1,2,3-TRIHYDROXYPROPYL]OXANE-2-CARBOXYLIC ACID | 3.2.1.18 |
4XJB | X-RAY STRUCTURE OF LYSOZYME1 | 3.2.1.17 |
4XJC | DCTP DEAMINASE-DUTPASE FROM BACILLUS HALODURANS | 3.5.4.13 3.5.4.30 |
4XJD | X-RAY STRUCTURE OF LYSOZYME2 | 3.2.1.17 |
4XJF | X-RAY STRUCTURE OF LYSOZYME B1 | 3.2.1.17 |
4XJG | X-RAY STRUCTURE OF LYSOZYME B2 | 3.2.1.17 |
4XJH | X-RAY STRUCTURE OF LYSOZYMES1 | 3.2.1.17 |
4XJI | X-RAY STRUCTURE OF LYSOZYMES2 | 3.2.1.17 |
4XJQ | THE CATALYTIC MECHANISM OF HUMAN PARAINFLUENZA VIRUS TYPE 3 HAEMAGGLUTININ-NEURAMINIDASE REVEALED | 3.2.1.18 |
4XJR | THE CATALYTIC MECHANISM OF HUMAN PARAINFLUENZA VIRUS TYPE 3 HAEMAGGLUTININ-NEURAMINIDASE REVEALED | 3.2.1.18 |
4XJS | HUMAN CD38 COMPLEXED WITH INHIBITOR 1 [6-FLUORO-2-METHYL-4-[(2,3,6-TRICHLOROBENZYL)AMINO]QUINOLINE-8-CARBOXAMIDE] | 3.2.2.6 2.4.99.20 |
4XJT | HUMAN CD38 COMPLEXED WITH INHIBITOR 2 [4-[(2,6-DIMETHYLBENZYL)AMINO]-2-METHYLQUINOLINE-8-CARBOXAMIDE] | 3.2.2.6 2.4.99.20 |
4XJU | CRYSTAL STRUCTURE OF THE NANB SIALIDASE FROM STREPTOCOCCUS PNEUMONIAE IN COMPLEX WITH 4-ACETAMIDO-2-FLUORO-3-HYDROXY-6-[1,2-DIHYDROXYETHYL]-7,8-DIOXABICYCLO[3.2.1]OCTANE-1-CARBOXYLIC ACID | 3.2.1.18 |
4XJV | CRYSTAL STRUCTURE OF HUMAN THIOESTERASE 2 | 3.1.2.14 |
4XJW | CRYSTAL STRUCTURE OF THE NANB SIALIDASE FROM STREPTOCOCCUS PNEUMONIAE IN COMPLEX WITH OPTACTIN AT PH 7.4 IN PBS WITH DMSO AS THE CRYOPROTECTANT | 3.2.1.18 |
4XJX | STRUCTURE OF MUTANT (E165H) OF THE HSDR SUBUNIT OF THE ECOR124I RESTRICTION ENZYME IN COMPLEX WITH ATP | 3.1.21.3 |
4XJZ | CRYSTAL STRUCTURE OF APO NANB SIALIDASE FROM STREPTOCOCCUS PNEUMONIAE AT PH 7.4 IN PBS WITH DMSO | 3.2.1.18 |
4XKX | CRYSTAL STRUCTURE OF BACE1 IN COMPLEX WITH 2-AMINOOXAZOLINE 3-AZAXANTHENE INHIBITOR 28 | 3.4.23.46 |
4XLG | C. GLABRATA SLX1 IN COMPLEX WITH SLX4CCD. | 3.1 |
4XM5 | C. GLABRATA SLX1. | 3.1 |
4XM6 | ANTHRAX TOXIN LETHAL FACTOR WITH LIGAND-INDUCED BINDING POCKET | 3.4.24.83 |
4XM7 | ANTHRAX TOXIN LETHAL FACTOR WITH LIGAND-INDUCED BINDING POCKET | 3.4.24.83 |
4XM8 | ANTHRAX TOXIN LETHAL FACTOR WITH LIGAND-INDUCED BINDING POCKET | 3.4.24.83 |
4XMA | CRYSTAL STRUCTURE OF THE K499G MUTANT OF NANB SIALIDASE FROM STREPTOCOCCUS PNEUMONIAE IN COMPLEX WITH OPTACTIN | 3.2.1.18 |
4XMI | CRYSTAL STRUCTURE OF THE K499G MUTANT OF NANB SIALIDASE FROM STREPTOCOCCUS PNEUMONIAE | 3.2.1.18 |
4XMT | CRYSTAL STRUCTURE OF MET260ALA MUTANT OF E. COLI AMINOPEPTIDASE N IN COMPLEX WITH L-2,3-DIAMINOPROPIONIC ACID | 3.4.11.2 |
4XMU | CRYSTAL STRUCTURE OF MET260ALA MUTANT OF E. COLI AMINOPEPTIDASE N IN COMPLEX WITH L-ALANINE | 3.4.11.2 |
4XMV | CRYSTAL STRUCTURE OF MET260ALA MUTANT OF E. COLI AMINOPEPTIDASE N IN COMPLEX WITH L-ARGININE | 3.4.11.2 |
4XMW | CRYSTAL STRUCTURE OF MET260ALA MUTANT OF E. COLI AMINOPEPTIDASE N IN COMPLEX WITH L-ASPARTIC ACID | 3.4.11.2 |
4XMX | CRYSTAL STRUCTURE OF MET260ALA MUTANT OF E. COLI AMINOPEPTIDASE N IN COMPLEX WITH BESTATIN | 3.4.11.2 |
4XMZ | CRYSTAL STRUCTURE OF MET260ALA MUTANT OF E. COLI AMINOPEPTIDASE N IN COMPLEX WITH 2,4-DIAMINOBUTYRIC ACID | 3.4.11.2 |
4XN1 | CRYSTAL STRUCTURE OF MET260ALA MUTANT OF E. COLI AMINOPEPTIDASE N IN COMPLEX WITH L-GLUTAMATE | 3.4.11.2 |
4XN2 | CRYSTAL STRUCTURE OF MET260ALA MUTANT OF E. COLI AMINOPEPTIDASE N IN COMPLEX WITH L-LEUCINE | 3.4.11.2 |
4XN4 | CRYSTAL STRUCTURE OF MET260ALA MUTANT OF E. COLI AMINOPEPTIDASE N IN COMPLEX WITH L-METHIONINE | 3.4.11.2 |
4XN5 | CRYSTAL STRUCTURE OF MET260ALA MUTANT OF E. COLI AMINOPEPTIDASE N IN COMPLEX WITH L-PHENYLALANINE | 3.4.11.2 |
4XN6 | CRYSTAL STRUCTURE AT ROOM TEMPERATURE OF HEN-EGG LYSOZYME IN COMPLEX WITH BENZAMIDINE | 3.2.1.17 |
4XN7 | CRYSTAL STRUCTURE OF E. COLI AMINOPEPTIDASE N IN COMPLEX WITH L-2,3-DIAMINOPROPIONIC ACID | 3.4.11.2 |
4XN8 | CRYSTAL STRUCTURE OF E. COLI AMINOPEPTIDASE N IN COMPLEX WITH L-ALANINE | 3.4.11.2 |
4XN9 | CRYSTAL STRUCTURE OF E. COLI AMINOPEPTIDASE N IN COMPLEX WITH BETA ALANINE | 3.4.11.2 |
4XNA | CRYSTAL STRUCTURE OF E. COLI AMINOPEPTIDASE N IN COMPLEX WITH L-BETA HOMOLYSINE | 3.4.11.2 |
4XNB | CRYSTAL STRUCTURE OF E. COLI AMINOPEPTIDASE N IN COMPLEX WITH L-BETA HOMOPHENYLALANINE | 3.4.11.2 |
4XND | CRYSTAL STRUCTURE OF E. COLI AMINOPEPTIDASE N IN COMPLEX WITH L-BETA HOMOTRYPTOPHAN | 3.4.11.2 |
4XNN | CRYSTAL STRUCTURE OF A GH7 FAMILY CELLOBIOHYDROLASE FROM DAPHNIA PULEX | 3.2.1.91 |
4XO0 | CRYSTAL STRUCTURE OF 5'-CTTATPPTAZZATAAG IN A HOST-GUEST COMPLEX | 2.7.7.49 2.7.7.7 3.1.26.4 3.4.23 2.7.7 3.1 |
4XO3 | CRYSTAL STRUCTURE OF E. COLI AMINOPEPTIDASE N IN COMPLEX WITH L-LEUCINE | 3.4.11.2 |
4XO4 | CRYSTAL STRUCTURE OF E. COLI AMINOPEPTIDASE N IN COMPLEX WITH L-METHIONINE | 3.4.11.2 |
4XO5 | CRYSTAL STRUCTURE OF E. COLI AMINOPEPTIDASE N IN COMPLEX WITH L-GLUTAMATE | 3.4.11.2 |
4XOG | CRYSTAL STRUCTURE OF THE NANB SIALIDASE FROM STREPTOCOCCUS PNEUMONIAE IN COMPLEX WITH OPTACTIN AND DANA | 3.2.1.18 |
4XOI | STRUCTURE OF HSANILLIN BOUND WITH RHOA(Q63L) AT 2.1 ANGSTROMS RESOLUTION | 3.6.5.2 |
4XOJ | STRUCTURE OF BOVINE TRYPSIN IN COMPLEX WITH ANALOGUES OF SUNFLOWER INHIBITOR 1 (SFTI-1) | 3.4.21.4 |
4XOU | CRYSTAL STRUCTURE OF THE SR CA2+-ATPASE IN THE CA2-E1-MGAMPPCP FORM DETERMINED BY SERIAL FEMTOSECOND CRYSTALLOGRAPHY USING AN X-RAY FREE-ELECTRON LASER. | 3.6.3.8 7.2.2.10 |
4XPC | CRYSTAL STRUCTURE OF 5'- CTTATAAATTTATAAG IN A HOST-GUEST COMPLEX | 2.7.7.49 2.7.7.7 3.1.26.4 3.4.23 2.7.7 3.1 |
4XPE | CRYSTAL STRUCTURE OF 5'-CTTATGGGCCCATAAG IN A HOST-GUEST COMPLEX | 2.7.7.49 2.7.7.7 3.1.26.4 3.4.23 2.7.7 3.1 |
4XPN | CRYSTAL STRUCTURE OF PROTEIN PHOSPHATE 1 COMPLEXED WITH PP1 BINDING DOMAIN OF GADD34 | 3.1.3.16 |
4XPO | CRYSTAL STRUCTURE OF A NOVEL ALPHA-GALACTOSIDASE FROM PEDOBACTER SALTANS | 3.2.1.22 |
4XPP | CRYSTAL STRUCTURE OF PEDOBACTER SALTANS GH31 ALPHA-GALACTOSIDASE COMPLEXED WITH D-GALACTOSE | 3.2.1.22 |
4XPQ | CRYSTAL STRUCTURE OF PEDOBACTER SALTANS GH31 ALPHA-GALACTOSIDASE COMPLEXED WITH L-FUCOSE | 3.2.1.22 |
4XPR | CRYSTAL STRUCTURE OF THE MUTANT D365A OF PEDOBACTER SALTANS GH31 ALPHA-GALACTOSIDASE | 3.2.1.22 |
4XPS | CRYSTAL STRUCTURE OF THE MUTANT D365A OF PEDOBACTER SALTANS GH31 ALPHA-GALACTOSIDASE COMPLEXED WITH P-NITROPHENYL-ALPHA-GALACTOPYRANOSIDE | 3.2.1.22 |
4XPU | THE CRYSTAL STRUCTURE OF ENDOV FROM E.COLI | 3.1.21.7 |
4XPV | NEUTRON AND X-RAY STRUCTURE ANALYSIS OF XYLANASE: N44D AT PH6 | 3.2.1.8 |
4XPZ | STRUCTURE OF FISSION YEAST RNA POLYMERASE II CTD PHOSPHATASE FCP1-R271A BOUND TO ALUMINUM FLUORIDE | 3.1.3.16 |
4XQ0 | STRUCTURE OF FISSION YEAST RNA POLYMERASE II CTD PHOSPHATASE FCP1-R271A BOUND TO BERYLLIUM FLUORIDE | 3.1.3.16 |
4XQ4 | X-RAY STRUCTURE ANALYSIS OF XYLANASE - N44D | 3.2.1.8 |
4XQD | X-RAY STRUCTURE ANALYSIS OF XYLANASE-WT AT PH4.0 | 3.2.1.8 |
4XQM | CRYSTAL STRUCTURE OF THE MRH DOMAIN OF GLUCOSIDASE II BETA BOUND TO MANNOSE | 3.2.1.84 |
4XQW | X-RAY STRUCTURE ANALYSIS OF XYLANASE-N44E WITH MES AT PH6.0 | 3.2.1.8 |
4XSG | THE COMPLEX STRUCTURE OF C3CER EXOENZYME AND GTP BOUND RHOA (NADH-FREE STATE) | 3.6.5.2 |
4XSH | THE COMPLEX STRUCTURE OF C3CER EXOENZYME AND GTP BOUND RHOA (NADH-BOUND STATE) | 3.6.5.2 |
4XSJ | CRYSTAL STRUCTURE OF THE N-TERMINAL DOMAIN OF THE HUMAN MITOCHONDRIAL CALCIUM UNIPORTER FUSED WITH T4 LYSOZYME | 3.2.1.17 |
4XSK | STRUCTURE OF PAITRAP, AN UPA MUTANT | 3.4.21.73 |
4XTK | STRUCTURE OF TM1797, A CAS1 PROTEIN FROM THERMOTOGA MARITIMA | 3.1 |
4XUI | CRYSTAL STRUCTURE ANALYSIS OF CRUZAIN BOUND TO THE NO-COVALENT ANALOG OF WRR-483 (WRR-669) | 3.4.22.51 |
4XUN | STRUCTURE OF THE CBM22-2 XYLAN-BINDING DOMAIN FROM PAENIBACILLUS BARCINONENSIS XYN10C | 3.2.1.8 |
4XUO | STRUCTURE OF THE CBM22-1 XYLAN-BINDING DOMAIN FROM PAENIBACILLUS BARCINONENSIS XYN10C | 3.2.1.8 |
4XUP | STRUCTURE OF THE N-TERMINAL CBM22-1-CBM22-2 TANDEM DOMAIN FROM PAENIBACILLUS BARCINONENSIS XYN10C | 3.2.1.8 |
4XUQ | STRUCTURE OF THE CBM22-2 XYLAN-BINDING DOMAIN FROM PAENIBACILLUS BARCINONENSIS XYN10C IN COMPLEX WITH XYLOTRIOSE | 3.2.1.8 |
4XUR | STRUCTURE OF THE CBM22-2 XYLAN-BINDING DOMAIN FROM PAENIBACILLUS BARCINONENSIS XYN10C IN COMPLEX WITH XYLOTETRAOSE | 3.2.1.8 |
4XUT | STRUCTURE OF THE CBM22-2 XYLAN-BINDING DOMAIN IN COMPLEX WITH 1,3:1,4 BETA-GLUCOTETRAOSE B FROM PAENIBACILLUS BARCINONENSIS XYN10C | 3.2.1.8 |
4XUU | THE HSAC2 DOMAIN FROM HUMAN PHOSPHOINOSITIDE PHOSPHATASE SAC2 | 3.1.3 3.1.3.25 |
4XUX | STRUCTURE OF AMPC BOUND TO RPX-7009 AT 1.75 A | 3.5.2.6 |
4XUY | CRYSTAL STRUCTURE OF AN ENDO-BETA-1,4-XYLANASE (GLYCOSIDE HYDROLASE FAMILY 10/GH10) ENZYME FROM ASPERGILLUS NIGER | 3.2.1.8 |
4XUZ | STRUCTURE OF CTX-M-15 BOUND TO RPX-7009 AT 1.5 A | 3.5.2.6 |
4XV0 | CRYSTAL STRUCTURE OF AN ENDO-BETA-1,4-XYLANASE (GLYCOSIDE HYDROLASE FAMILY 10/GH10) ENZYME FROM TRICHODERMA REESEI | 3.2.1.8 |
4XVC | CRYSTAL STRUCTURE OF AN ESTERASE FROM THE BACTERIAL HORMONE-SENSITIVE LIPASE (HSL) FAMILY | 3.1.1.1 |
4XVJ | STRUCTURE OF THE HEPATITIS C VIRUS ENVELOPE GLYCOPROTEIN E2 ANTIGENIC 2 REGION 412-423 BOUND TO THE BROADLY NEUTRALIZING ANTIBODY HC33.1 | 3.4.22 3.4.21.98 3.6.1.15 3.6.4.13 2.7.7.48 |
4XVQ | H-RAS Y137E | 3.6.5.2 |
4XVR | H-RAS Y137F | 3.6.5.2 |
4XW3 | CRYSTAL STRUCTURE OF THE SPRY DOMAIN OF THE HUMAN DEAD-BOX PROTEIN DDX1 | 3.6.4.13 |
4XWG | CRYSTAL STRUCTURE OF LCAT (C31Y) IN COMPLEX WITH FAB1 | 2.3.1.43 3.1.1.47 |
4XWH | CRYSTAL STRUCTURE OF THE HUMAN N-ACETYL-ALPHA-GLUCOSAMINIDASE | 3.2.1.50 |
4XWL | CATALYTIC DOMAIN OF CLOSTRIDIUM CELLULOVORANS EXGS | 3.2.1.91 |
4XWM | COMPLEX STRUCTURE OF CATALYTIC DOMAIN OF CLOSTRIDIUM CELLULOVORANS EXGS AND CELLOBIOSE | 3.2.1.91 |
4XWN | COMPLEX STRUCTURE OF CATALYTIC DOMAIN OF CLOSTRIDIUM CELLULOVORANS EXGS AND CELLOTETRAOSE | 3.2.1.91 |
4XWT | CRYSTAL STRUCTURE OF RNASE J COMPLEXED WITH UMP | 3.1 |
4XWW | CRYSTAL STRUCTURE OF RNASE J COMPLEXED WITH RNA | 3.1 |
4XX3 | RENIN IN COMPLEX WITH (S)-1-(3-(BENZYLCARBAMOYL)BENZYL)-4-ISOPROPYL-4-METHYL-6-OXOTETRAHYDROPYRIMIDIN-2(1H)-IMINIUM | 3.4.23.15 |
4XX4 | RENIN IN COMPLEX WITH (4S)-4-ISOPROPYL-4-METHYL-6-OXO-1-(3-(2-OXO-4-PHENYLPYRROLIDIN-1-YL)BENZYL)TETRAHYDROPYRIMIDIN-2(1H)-IMINIUM | 3.4.23.15 |
4XX6 | CRYSTAL STRUCTURE OF A GLYCOSYLATED ENDO-BETA-1,4-XYLANASE (GLYCOSIDE HYDROLASE FAMILY 10/GH10) ENZYME FROM GLOEOPHYLLUM TRABEUM | 3.2.1.8 |
4XXO | CRYSTAL STRUCTURE OF HUMAN APOBEC3A | 3.5.4 3.5.4.38 |
4XXR | ATOMIC RESOLUTION X-RAY CRYSTAL STRUCTURE OF A RUTHENOCENE CONJUGATED BETA-LACTAM ANTIBIOTIC IN COMPLEX WITH CTX-M-14 E166A BETA-LACTAMASE | 3.5.2.6 |
4XXS | CRYSTAL STRUCTURE OF BACE1 WITH A PYRAZOLE-SUBSTITUTED TETRAHYDROPYRAN THIOAMIDINE | 3.4.23.46 |
4XY2 | CRYSTAL STRUCTURE OF PDE10A IN COMPLEX WITH ASP9436 | 3.1.4.17 3.1.4.35 |
4XY7 | CRYSTAL STRUCTURE OF THE COMPLEX OF RIBOSOME INACTIVATING PROTEIN FROM MOMORDICA BALSAMINA WITH N-ACETYLGLUCOSAMINE AT 2.5 A RESOLUTION | 3.2.2.22 |
4XYX | NANB PLUS OPTACTAMIDE | 3.2.1.18 |
4XYY | HEN EGG-WHITE LYSOZYME (HEWL) COMPLEXED WITH ZR(IV)-SUBSTITUTED KEGGIN-TYPE POLYOXOMETALATE | 3.2.1.17 |
4XZB | ENDO-GLUCANASE GSCELA P1 | 3.1.2.4 3.2.1.4 |
4XZF | CRYSTAL STRUCTURE OF HIRAN DOMAIN OF HUMAN HLTF IN COMPLEX WITH DNA | 3.6.4 6.3.2 2.3.2.27 |
4XZG | CRYSTAL STRUCTURE OF HIRAN DOMAIN OF HUMAN HLTF | 2.3.2.27 3.6.4 |
4XZW | ENDO-GLUCANASE CHIMERA C10 | 3.2.1.4 |
4XZY | CRYSTAL STRUCTURE OF DIPEPTIDYL PEPTIDASE 11 (DPP11) FROM PORPHYROMONAS GINGIVALIS | 3.4.14 |
4Y01 | CRYSTAL STRUCTURE OF DIPEPTIDYL PEPTIDASE 11 (DPP11) FROM PORPHYROMONAS GINGIVALIS | 3.4.14 |
4Y02 | CRYSTAL STRUCTURE OF DIPEPTIDYL PEPTIDASE 11 (DPP11) FROM PORPHYROMONAS GINGIVALIS (GROUND) | 3.4.14 |
4Y04 | CRYSTAL STRUCTURE OF DIPEPTIDYL PEPTIDASE 11 (DPP11) FROM PORPHYROMONAS GINGIVALIS (SPACE) | 3.4.14 |
4Y06 | CRYSTAL STRUCTURE OF THE DAP BII (G675R) DIPEPTIDE COMPLEX | 3.4.14 |
4Y0O | CRYSTAL STRUCTURE OF OXA-58, A CARBAPENEM HYDROLYZING CLASS D BETA-LACTAMASE FROM ACINETOBACTER BAUMANII. | 3.5.2.6 |
4Y0T | CRYSTAL STRUCTURE OF APO FORM OF OXA-58, A CARBAPENEM HYDROLYZING CLASS D BETA-LACTAMASE FROM ACINETOBACTER BAUMANII (P21, 4MOL/ASU) | 3.5.2.6 |
4Y0U | CRYSTAL STRUCTURE OF 6ALPHA-HYDROXYMETHYLPENICILLANATE COMPLEXED WITH OXA-58, A CARBAPENEM HYDROLYZING CLASS D BETALACTAMASE FROM ACINETOBACTER BAUMANII. | 3.5.2.6 |
4Y0Z | TRYPSIN IN COMPLEX WITH WITH BPTI MUTANT AMINOBUTYRIC ACID | 3.4.21.4 |
4Y10 | TRYPSIN IN COMPLEX WITH WITH BPTI MUTANT (2S)-2-AMINO-4,4-DIFLUOROBUTANOIC ACID | 3.4.21.4 |
4Y11 | TRYPSIN IN COMPLEX WITH WITH BPTI MUTANT (2S)-2-AMINO-4,4,4-TRIFLUOROBUTANOIC ACID | 3.4.21.4 |
4Y14 | STRUCTURE OF PROTEIN TYROSINE PHOSPHATASE 1B COMPLEXED WITH INHIBITOR (PTP1B:CPT157633) | 3.1.3.48 |
4Y1C | CYCLIC HEXAPEPTIDE CYC[NDPOPPKID] IN COMPLEX WITH HIV-1 INTEGRASE CORE DOMAIN | 3.4.23.16 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1 |
4Y1D | CYCLIC HEXAPEPTIDE CYC[NDPOPPKID] IN COMPLEX WITH HIV-1 INTEGRASE CORE DOMAIN | 3.4.23.16 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1 |
4Y2A | CRYSTAL STRUCTURE OF COXSACKIE VIRUS B3 3D POLYMERASE IN COMPLEX WITH GPC-N114 INHIBITOR | 3.4.22.29 3.6.1.15 3.4.22.28 2.7.7.48 |
4Y2B | CO-CRYSTAL STRUCTURE OF 3-ETHYL-2-(ISOPROPYLAMINO)-7-(PYRIDIN-3-YL)THIENO[3,2-D]PYRIMIDIN-4(3H)-ONE BOUND TO PDE7A | 3.1.4.53 |
4Y2C | M300V 3D POLYMERASE MUTANT OF EMCV | 3.6.1.15 3.4.22.28 2.7.7.48 3.6.4.13 |
4Y2E | CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF HUMAN DUAL-SPECIFICITY PHOSPHATASE 7 (C232S) | 3.1.3.16 3.1.3.48 |
4Y2J | STRUCTURE OF SOLUBLE EPOXIDE HYDROLASE IN COMPLEX WITH N-[(1-METHYL-1H-PYRAZOL-3-YL)METHYL]-2-PHENYLETHANAMINE | 3.3.2.10 3.1.3.76 |
4Y2P | STRUCTURE OF SOLUBLE EPOXIDE HYDROLASE IN COMPLEX WITH N-METHYL-1-[3-(PYRIDIN-3-YL)PHENYL]METHANAMINE | 3.3.2.10 3.1.3.76 |
4Y2Q | STRUCTURE OF SOLUBLE EPOXIDE HYDROLASE IN COMPLEX WITH 1-[3-(TRIFLUOROMETHYL)PYRIDIN-2-YL]PIPERAZINE | 3.3.2.10 3.1.3.76 |
4Y2R | STRUCTURE OF SOLUBLE EPOXIDE HYDROLASE IN COMPLEX WITH 2-(PIPERAZIN-1-YL)NICOTINONITRILE | 3.3.2.10 3.1.3.76 |
4Y2S | STRUCTURE OF SOLUBLE EPOXIDE HYDROLASE IN COMPLEX WITH 1-[3-(TRIFLUOROMETHYL)PHENYL]-1H-PYRAZOL-4-OL | 3.3.2.10 3.1.3.76 |
4Y2T | STRUCTURE OF SOLUBLE EPOXIDE HYDROLASE IN COMPLEX WITH 3-[4-(BENZYLOXY)PHENYL]PROPAN-1-OL | 3.3.2.10 3.1.3.76 |
4Y2U | STRUCTURE OF SOLUBLE EPOXIDE HYDROLASE IN COMPLEX WITH TERT-BUTYL 1,2,3,4-TETRAHYDROQUINOLIN-3-YLCARBAMATE | 3.3.2.10 3.1.3.76 |
4Y2V | STRUCTURE OF SOLUBLE EPOXIDE HYDROLASE IN COMPLEX WITH (4-BROMO-3-CYCLOPROPYL-1H-PYRAZOL-1-YL)ACETIC ACID | 3.3.2.10 3.1.3.76 |
4Y2X | STRUCTURE OF SOLUBLE EPOXIDE HYDROLASE IN COMPLEX WITH 2-({[2-(ADAMANTAN-1-YL)ETHYL]AMINO}METHYL)PHENOL | 3.3.2.10 3.1.3.76 |
4Y2Y | STRUCTURE OF SOLUBLE EPOXIDE HYDROLASE IN COMPLEX WITH 2-(2-FLUOROPHENYL)-N-[(5-METHYL-2-THIENYL)METHYL]ETHANAMINE | 3.3.2.10 3.1.3.76 |
4Y31 | CRYSTAL STRUCTURE OF YELLOW LUPINE LLPR-10.1A PROTEIN IN LIGAND-FREE FORM | 3.1.27 |
4Y34 | CRYSTAL STRUCTURE OF COXSACKIEVIRUS B3 3D POLYMERASE IN COMPLEX WITH GPC-N143 | 3.4.22.29 3.6.1.15 3.4.22.28 2.7.7.48 |
4Y35 | ENDOTHIAPEPSIN IN COMPLEX WITH FRAGMENT 290 | 3.4.23.22 |
4Y36 | ENDOTHIAPEPSIN IN COMPLEX WITH FRAGMENT 4 | 3.4.23.22 |
4Y37 | ENDOTHIAPEPSIN IN COMPLEX WITH FRAGEMENT 305 | 3.4.23.22 |
4Y38 | ENDOTHIAPEPSIN IN COMPLEX WITH FRAGMENT B29 | 3.4.23.22 |
4Y39 | ENDOTHIAPEPSIN IN COMPLEX WITH FRAGMENT 75 | 3.4.23.22 |
4Y3A | ENDOTHIAPEPSIN IN COMPLEX WITH FRAGMENT 181 | 3.4.23.22 |
4Y3D | ENDOTHIAPEPSIN IN COMPLEX WITH FRAGMENT 321 | 3.4.23.22 |
4Y3E | ENDOTHIAPEPSIN IN COMPLEX WITH FRAGMENT 5 | 3.4.23.22 |
4Y3F | ENDOTHIAPEPSIN IN COMPLEX WITH FRAGMENT 78 | 3.4.23.22 |
4Y3G | ENDOTHIAPEPSIN IN COMPLEX WITH FRAGMENT 285 | 3.4.23.22 |
4Y3H | ENDOTHIAPEPSIN IN COMPLEX WITH FRAGMENT 189 | 3.4.23.22 |
4Y3J | ENDOTHIAPEPSIN IN COMPLEX WITH FRAGMENT B30 | 3.4.23.22 |
4Y3L | ENDOTHIAPEPSIN IN COMPLEX WITH FRAGMENT 205 | 3.4.23.22 |
4Y3M | ENDOTHIAPEPSIN IN COMPLEX WITH FRAGMENT 103 | 3.4.23.22 |
4Y3N | ENDOTHIAPEPSIN IN COMPLEX WITH FRAGMENT 273 | 3.4.23.22 |
4Y3P | ENDOTHIAPEPSIN IN COMPLEX WITH FRAGMENT 17 | 3.4.23.22 |
4Y3Q | ENDOTHIAPEPSIN IN COMPLEX WITH FRAGMENT 109 | 3.4.23.22 |
4Y3R | ENDOTHIAPEPSIN IN COMPLEX WITH FRAGMENT 306 | 3.4.23.22 |
4Y3S | ENDOTHIAPEPSIN IN COMPLEX WITH FRAGMENT 266 | 3.4.23.22 |
4Y3T | ENDOTHIAPEPSIN IN COMPLEX WITH FRAGMENT 207 | 3.4.23.22 |
4Y3W | ENDOTHIAPEPSIN IN COMPLEX WITH FRAGMENT 35 | 3.4.23.22 |
4Y3X | ENDOTHIAPEPSIN IN COMPLEX WITH FRAGMENT 171 | 3.4.23.22 |
4Y3Y | ENDOTHIAPEPSIN IN COMPLEX WITH FRAGMENT B42 | 3.4.23.22 |
4Y3Z | ENDOTHIAPEPSIN IN COMPLEX WITH FRAGMENT 41 | 3.4.23.22 |
4Y41 | ENDOTHIAPEPSIN IN COMPLEX WITH FRAGMENT 112 | 3.4.23.22 |
4Y43 | ENDOTHIAPEPSIN IN COMPLEX WITH FRAGMENT 42 | 3.4.23.22 |
4Y44 | ENDOTHIAPEPSIN IN COMPLEX WITH FRAGMENT 164 | 3.4.23.22 |
4Y45 | ENDOTHIAPEPSIN IN COMPLEX WITH FRAGMENT 291 | 3.4.23.22 |
4Y47 | ENDOTHIAPEPSIN IN COMPLEX WITH FRAGMENT 162 | 3.4.23.22 |
4Y48 | ENDOTHIAPEPSIN IN COMPLEX WITH FRAGMENT B50 | 3.4.23.22 |
4Y4A | ENDOTHIAPEPSIN IN COMPLEX WITH FRAGMENT 286 | 3.4.23.22 |
4Y4B | ENDOTHIAPEPSIN IN COMPLEX WITH FRAGMENT 323 | 3.4.23.22 |
4Y4D | ENDOTHIAPEPSIN IN COMPLEX WITH FRAGMENT B51 | 3.4.23.22 |
4Y4E | ENDOTHIAPEPSIN IN COMPLEX WITH FRAGMENT 131 | 3.4.23.22 |
4Y4G | ENDOTHIAPEPSIN IN COMPLEX WITH FRAGMENT B53 | 3.4.23.22 |
4Y4J | ENDOTHIAPEPSIN IN COMPLEX WITH FRAGMENT B97 | 3.4.23.22 |
4Y4T | ENDOTHIAPEPSIN IN COMPLEX WITH FRAGMENT 114 | 3.4.23.22 |
4Y4U | ENDOTHIAPEPSIN IN COMPLEX WITH FRAGMENT 14 | 3.4.23.22 |
4Y4W | ENDOTHIAPEPSIN IN COMPLEX WITH FRAGMENT 125 | 3.4.23.22 |
4Y4X | ENDOTHIAPEPSIN IN COMPLEX WITH FRAGMENT 51 | 3.4.23.22 |
4Y4Z | ENDOTHIAPEPSIN IN COMPLEX WITH FRAGMENT 73 | 3.4.23.22 |
4Y50 | ENDOTHIAPEPSIN IN COMPLEX WITH FRAGMENT 81 | 3.4.23.22 |
4Y51 | ENDOTHIAPEPSIN IN COMPLEX WITH FRAGMENT 52 | 3.4.23.22 |
4Y53 | ENDOTHIAPEPSIN IN COMPLEX WITH FRAGMENT 54 | 3.4.23.22 |
4Y54 | ENDOTHIAPEPSIN IN COMPLEX WITH FRAGMENT 56 | 3.4.23.22 |
4Y56 | ENDOTHIAPEPSIN IN COMPLEX WITH FRAGMENT 58 | 3.4.23.22 |
4Y57 | ENDOTHIAPEPSIN IN COMPLEX WITH FRAGMENT 63 | 3.4.23.22 |
4Y58 | ENDOTHIAPEPSIN IN COMPLEX WITH FRAGMENT 260 | 3.4.23.22 |
4Y5A | ENDOTHIAPEPSIN IN COMPLEX WITH FRAGMENT 206 | 3.4.23.22 |
4Y5B | ENDOTHIAPEPSIN IN COMPLEX WITH FRAGMENT 261 | 3.4.23.22 |
4Y5C | ENDOTHIAPEPSIN IN COMPLEX WITH FRAGMENT 267 | 3.4.23.22 |
4Y5E | ENDOTHIAPEPSIN IN COMPLEX WITH FRAGMENT 268 | 3.4.23.22 |
4Y5G | ENDOTHIAPEPSIN IN COMPLEX WITH FRAGMENT 272 | 3.4.23.22 |
4Y5K | ENDOTHIAPEPSIN IN COMPLEX WITH FRAGMENT 274 | 3.4.23.22 |
4Y5L | ENDOTHIAPEPSIN IN ITS APO FORM | 3.4.23.22 |
4Y5M | ENDOTHIAPEPSIN IN COMPLEX WITH FRAGMENT 328 | 3.4.23.22 |
4Y5N | ENDOTHIAPEPSIN IN COMPLEX WITH FRAGMENT 337 | 3.4.23.22 |
4Y5P | ENDOTHIAPEPSIN IN COMPLEX WITH FRAGMENT 338 | 3.4.23.22 |
4Y61 | CRYSTAL STRUCTURE OF THE COMPLEX BETWEEN SLITRK2 LRR1 AND PTP DELTA IG1-FN1 | 3.1.3.48 |
4Y6D | FACTOR XA COMPLEX WITH GTC000101 | 3.4.21.6 |
4Y6L | HUMAN SIRT2 IN COMPLEX WITH MYRISTOYLATED PEPTIDE (H3K9MYR) | 3.5.1 2.3.1.286 |
4Y6M | STRUCTURE OF PLASMEPSIN II FROM PLASMODIUM FALCIPARUM COMPLEXED WITH INHIBITOR PG418 | 3.4.23.39 |
4Y6O | HUMAN SIRT2 IN COMPLEX WITH MYRISTOYLATED PEPTIDE (TNF-ALPHAK20MYR) | 3.5.1 2.3.1.286 |
4Y6Q | HUMAN SIRT2 IN COMPLEX WITH 2-O-MYRISTOYL-ADP-RIBOSE | 3.5.1 2.3.1.286 |
4Y71 | FACTOR XA COMPLEX WITH GTC000398 | 3.4.21.6 |
4Y76 | FACTOR XA COMPLEX WITH GTC000401 | 3.4.21.6 |
4Y79 | FACTOR XA COMPLEX WITH GTC000406 | 3.4.21.6 |
4Y7A | FACTOR XA COMPLEX WITH GTC000422 | 3.4.21.6 |
4Y7B | FACTOR XA COMPLEX WITH GTC000441 | 3.4.21.6 |
4Y7E | CRYSTAL STRUCTURE OF BETA-MANNANASE FROM STREPTOMYCES THERMOLILACINUS WITH MANNOHEXAOSE | 3.2.1.4 |
4Y7I | CRYSTAL STRUCTURE OF MTMR8 | 3.1.3 3.1.3.95 3.1.3.64 |
4Y86 | CRYSTAL STRUCTURE OF PDE9 IN COMPLEX WITH RACEMIC INHIBITOR C33 | 3.1.4.35 |
4Y87 | CRYSTAL STRUCTURE OF PHOSPHODIESTERASE 9 IN COMPLEX WITH (R)-C33 (6-{[(1R)-1-(4-CHLOROPHENYL)ETHYL]AMINO}-1-CYCLOPENTYL-1,5-DIHYDRO-4H-PYRAZOLO[3,4-D]PYRIMIDIN-4-ONE) | 3.1.4.35 |
4Y8C | CRYSTAL STRUCTURE OF PHOSPHODIESTERASE 9 IN COMPLEX WITH (S)-C33 | 3.1.4.35 |
4Y8E | PA3825-EAL CA-APO STRUCTURE | 3.1.4.52 |
4Y8X | FACTOR XIA IN COMPLEX WITH THE INHIBITOR METHYL (4-{4-CHLORO-2-[(1S)-1-({(2E)-3-[5-CHLORO-2-(1H-TETRAZOL-1-YL)PHENYL]PROP-2-ENOYL}AMINO)-2-PHENYLETHYL]-1H-IMIDAZOL-5-YL}PHENYL)CARBAMATE | 3.4.21.27 |
4Y8Y | FACTOR XIA IN COMPLEX WITH THE INHIBITOR METHYL (4-{4-CHLORO-2-[(1S)-1-({(2E)-3-[5-CHLORO-2-(1H-TETRAZOL-1-YL)PHENYL]PROP-2-ENOYL}AMINO)-3-(MORPHOLIN-4-YL)-3-OXOPROPYL]-1H-IMIDAZOL-5-YL}PHENYL)CARBAMATE | 3.4.21.27 |
4Y8Z | FACTOR XIA IN COMPLEX WITH THE INHIBITOR (2E)-N-[(1S)-1-[5-CHLORO-4-(4-HYDROXY-2-OXO-1,2-DIHYDROQUINOLIN-6-YL)-1H-IMIDAZOL-2-YL]-3-(4-METHYLPIPERAZIN-1-YL)-3-OXOPROPYL]-3-[5-CHLORO-2-(1H-TETRAZOL-1-YL)PHENYL]PROP-2-ENAMIDE | 3.4.21.27 |
4Y9O | PA3825-EAL METAL-FREE-APO STRUCTURE - MANGANESE CO-CRYSTALLISATION | 3.1.4.52 |
4Y9W | ASPARTIC PROTEINASE SAPP2 SECRETED FROM CANDIDA PARAPSILOSIS AT 0.82 A RESOLUTION. | 3.4.23.24 |
4YA8 | STRUCTURE OF PLASMEPSIN II FROM PLASMODIUM FALCIPARUM COMPLEXED WITH INHIBITOR PG394 | 3.4.23.39 |
4YAA | YOPH W354Y YERSINIA ENTEROCOLITICA PTPASE APO FORM | 3.1.3.48 |
4YBF | ASPARTIC PROTEINASE SAPP2 SECRETED FROM CANDIDA PARAPSILOSIS AT 1.25 A RESOLUTION | 3.4.23.24 |
4YBI | CRYSTAL STRUCTURE OF BACE WITH AMINO THIAZINE INHIBITOR LY2811376 | 3.4.23.46 |
4YC4 | CRYSTAL STRUCTURE OF PHOSPHATIDYL INOSITOL 4-KINASE II ALPHA IN COMPLEX WITH NUCLEOTIDE ANALOG | 2.7.1.67 3.2.1.17 |
4YC7 | CRYSTAL STRUCTURE OF HUMAN FMNL2 GBD-FH3 DOMAINS BOUND TO CDC42-GPPNHP | 3.6.5.2 |
4YCK | ENDOTHIAPEPSIN IN COMPLEX WITH FRAGMENT 211 | 3.4.23.22 |
4YCL | CRYSTAL STRUCTURE OF THE SR CA2+-ATPASE WITH BOUND CPA | 3.6.3.8 7.2.2.10 |
4YCM | CRYSTAL STRUCTURE OF THE CALCIUM PUMP WITH BOUND MARINE MACROLIDE BLS | 3.6.3.8 7.2.2.10 |
4YCN | CRYSTAL STRUCTURE OF THE CALCIUM PUMP WITH BOUND MARINE MACROLIDE BLLB | 3.6.3.8 7.2.2.10 |
4YCT | ENDOTHIAPEPSIN IN COMPLEX WITH FRAGMENT 216 | 3.4.23.22 |
4YCY | ENDOTHIAPEPSIN IN COMPLEX WITH FRAGMENT 218 | 3.4.23.22 |
4YD3 | ENDOTHIAPEPSIN IN COMPLEX WITH FRAGMENT 224 | 3.4.23.22 |
4YD4 | ENDOTHIAPEPSIN IN COMPLEX WITH FRAGMENT 227 | 3.4.23.22 |
4YD5 | ENDOTHIAPEPSIN IN COMPLEX WITH FRAGMENT 236 | 3.4.23.22 |
4YD6 | ENDOTHIAPEPSIN IN COMPLEX WITH FRAGMENT 240 | 3.4.23.22 |
4YD7 | ENDOTHIAPEPSIN IN COMPLEX WITH FRAGMENT 255 | 3.4.23.22 |
4YDG | CRYSTAL STRUCTURE OF COMPOUND 10 IN COMPLEX WITH HTLV-1 PROTEASE | 3.4.23 2.7.7.49 2.7.7.7 3.1.26.4 2.7.7 3.1 |
4YDS | FLAH FROM SULFOLOBUS ACIDOCALDARIUS WITH ATP AND MG-ION | 3.6.1.3 |
4YE2 | THE 1.35 STRUCTURE OF A VIRAL RNASE L ANTAGONIST REVEALS BASIS FOR THE 2'-5'-OLIGOADENYLATE BINDING AND ENZYME ACTIVITY. | 3.1.4 2.7.7.50 2.1.1.56 |
4YE3 | CRYSTAL STRUCTURE OF MULTIDRUG RESISTANT HIV-1 PROTEASE CLINICAL ISOLATE PR20 WITH INHIBITOR GRL-4410A | 3.4.23.16 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1 |
4YEM | CARBOPLATIN BINDING TO HEWL IN NABR CRYSTALLISATION CONDITIONS STUDIED AT AN X-RAY WAVELENGTH OF 0.9163A - NEW REFINEMENT | 3.2.1.17 |
4YEN | ROOM TEMPERATURE X-RAY DIFFRACTION STUDIES OF CISPLATIN BINDING TO HEWL IN DMSO MEDIA AFTER 14 MONTHS OF CRYSTAL STORAGE - NEW REFINEMENT | 3.2.1.17 |
4YEO | TRICLINIC HEWL CO-CRYSTALLISED WITH CISPLATIN, STUDIED AT A DATA COLLECTION TEMPERATURE OF 150K - NEW REFINEMENT | 3.2.1.17 |
4YES | THROMBIN IN COMPLEX WITH (S)-(4-CHLORO-2-((1-(5-METHYL-1H-PYRROLE-2-CARBONYL)PYRROLIDINE-2-CARBOXAMIDO)METHYL)PHENYL)METHANAMINIUM | 3.4.21.5 |
4YFD | CRYSTAL STRUCTURE PTP DELTA IG1-FN2 IN COMPLEX WITH IL-1RACP | 3.1.3.48 |
4YFE | CRYSTAL STRUCTURE OF PTP DELTA FN1-FN2 | 3.1.3.48 |
4YFM | CLASS A BETA-LACTAMASE FROM MYCOBACTERIUM ABSCESSUS | 3.5.2.6 |
4YGM | VACCINIA VIRUS HIS-D4/A20(1-50) IN COMPLEX WITH URACIL | 3.2.2.27 |
4YGY | CRYSTAL STRUCTURE OF HUMAN SCP1 BOUND TO TRANS-PROLINE PEPTIDOMIMETIC CTD PHOSPHO-SER5 PEPTIDE | 3.1.3.16 |
4YH1 | STRUCTURE OF HUMAN SCP1 BOUND TO CIS-PROLINE PEPTIDOMIMETIC CTD PHOSPHO-SER5 PEPTIDE | 3.1.3.16 |
4YH6 | CRYSTAL STRUCTURE OF IL1RAPL1 ECTODOMAIN | 3.2.2.6 |
4YH7 | CRYSTAL STRUCTURE OF PTPDELTA ECTODOMAIN IN COMPLEX WITH IL1RAPL1 | 3.1.3.48 |
4YHG | NATIVE BACTEROIDETES-AFFILIATED GH5 CELLULASE LINKED WITH A POLYSACCHARIDE UTILIZATION LOCUS | 3.2.1.4 |
4YHQ | CRYSTAL STRUCTURE OF MULTIDRUG RESISTANT CLINICAL ISOLATE PR20 WITH GRL-5010A | 3.4.23.16 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1 |
4YIG | VACCINIA VIRUS D4/A20(1-50) IN COMPLEX WITH DSDNA CONTAINING AN ABASIC SITE AND FREE URACYL | 3.2.2.27 |
4YIH | CRYSTAL STRUCTURE OF HUMAN CYTOSOLIC 5'(3')-DEOXYRIBONUCLEOTIDASE IN COMPLEX WITH THE INHIBITOR PB-PVU | 3.1.3 |
4YIJ | CRYSTAL STRUCTURE OF STAPHYLCOCCAL NUCLEASE VARIANT DELTA+PHS A109E AT CRYOGENIC TEMPERATURE | 3.1.31.1 |
4YIK | CRYSTAL STRUCTURE OF HUMAN CYTOSOLIC 5'(3')-DEOXYRIBONUCLEOTIDASE IN COMPLEX WITH THE INHIBITOR PB-PVU | 3.1.3 |
4YIN | CRYSTAL STRUCTURE OF THE EXTENDED-SPECTRUM BETA-LACTAMASE OXA-145 | 3.5.2.6 |
4YJ6 | THE CRYSTAL STRUCTURE OF A BACTERIAL ARYL ACYLAMIDASE BELONGING TO THE AMIDASE SIGNATURE (AS) ENZYMES FAMILY | 3.5.1.13 |
4YJI | THE CRYSTAL STRUCTURE OF A BACTERIAL ARYL ACYLAMIDASE BELONGING TO THE AMIDASE SIGNATURE (AS) ENZYMES FAMILY | 3.5.1.13 |
4YLQ | CRYSTAL STRUCTURE OF A FVIIA-TRYPSIN CHIMERA (FT) IN COMPLEX WITH SOLUBLE TISSUE FACTOR | 3.4.21.21 |
4YLU | X-RAY STRUCTURE OF MERS-COV NSP5 PROTEASE BOUND WITH A NON-COVALENT INHIBITOR | 3.4.19.12 3.4.22.69 |
4YLY | CRYSTAL STRUCTURE OF PEPTIDYL-TRNA HYDROLASE FROM A GRAM-POSITIVE BACTERIUM, STAPHYLOCOCCUS AUREUS AT 2.25 ANGSTROM RESOLUTION | 3.1.1.29 |
4YM8 | CRYSTAL STRUCTURE OF HEN EGG-WHITE LYSOZYME | 3.2.1.17 |
4YML | CRYSTAL STRUCTURE OF ESCHERICHIA COLI 5'-METHYLTHIOADENOSINE/S-ADENOSYL HOMOCYSTEINE NUCLEOSIDASE (MTAN) COMPLEXED WITH (3S,4R)-METHYLTHIO-DADME-IMMUCILLIN-A | 3.2.2.9 |
4YNB | CRYSTAL STRUCTURE OF HELICOBACTER PYLORI 5'-METHYLTHIOADENOSINE/S-ADENOSYL HOMOCYSTEINE NUCLEOSIDASE (MTAN) COMPLEXED WITH PYRAZINYLTHIO-DADME-IMMUCILLIN-A | 3.2.2.30 3.2.2.9 |
4YNL | CRYSTAL STRUCTURE OF THE HOOD DOMAIN OF ANABAENA HETR IN COMPLEX WITH THE HEXAPEPTIDE ERGSGR DERIVED FROM PATS | 3.4.21 |
4YNQ | TREX1-DSDNA COMPLEX | 3.1.11.2 |
4YO1 | STRUCTURE OF LEGIONELLA PNEUMOPHILA DEGQ (DELTA PDZ2 VARIANT) | 3.4.21 3.4.21.107 |
4YO8 | CRYSTAL STRUCTURE OF HELICOBACTER PYLORI 5'-METHYLTHIOADENOSINE/S-ADENOSYL HOMOCYSTEINE NUCLEOSIDASE (MTAN) COMPLEXED WITH (((4-AMINO-5H-PYRROLO[3,2-D]PYRIMIDIN-7-YL)METHYL)(HEXYL)AMINO)METHANOL | 3.2.2.30 3.2.2.9 |
4YO9 | HKU4 3CLPRO UNBOUND STRUCTURE | 3.4.22 3.4.19.12 3.4.22.69 2.7.7.48 3.6.4.12 3.6.4.13 2.1.1 3.1.13 3.1 |
4YOG | HKU4-3CLPRO BOUND TO NON-COVALENT INHIBITOR 3B | 3.4.22 3.4.19.12 3.4.22.69 2.7.7.48 3.6.4.12 3.6.4.13 2.1.1 3.1.13 3.1 |
4YOI | STRUCTURE OF HKU4 3CLPRO BOUND TO NON-COVALENT INHIBITOR 1A | 3.4.22 3.4.19.12 3.4.22.69 2.7.7.48 3.6.4.12 3.6.4.13 2.1.1 3.1.13 3.1 |
4YOJ | HKU4 3CLPRO BOUND TO NON-COVALENT INHIBITOR 2A | 3.4.22 3.4.19.12 3.4.22.69 2.7.7.48 3.6.4.12 3.6.4.13 2.1.1 3.1.13 3.1 |
4YOP | CRYSTAL STRUCTURE OF HEN EGG-WHITE LYSOZYME | 3.2.1.17 |
4YOQ | CRYSTAL STRUCTURE OF MUTY BOUND TO ITS ANTI-SUBSTRATE | 3.2.2 3.2.2.31 |
4YP2 | CLEAVAGE OF NICOTINAMIDE ADENINE DINUCLEOTIDES BY THE RIBOSOME INACTIVATING PROTEIN FROM MOMORDICA CHARANTIA | 3.2.2.22 |
4YPH | CRYSTAL STRUCTURE OF MUTY BOUND TO ITS ANTI-SUBSTRATE WITH THE DISULFIDE CROSS-LINKER REDUCED | 3.2.2 3.2.2.31 |
4YPJ | X-RAY STRUCTURE OF THE MUTANT OF GLYCOSIDE HYDROLASE | 3.2.1.23 |
4YPR | CRYSTAL STRUCTURE OF D144N MUTY BOUND TO ITS ANTI-SUBSTRATE | 3.2.2 3.2.2.31 |
4YPT | X-RAY STRUCTURAL OF THREE TANDEMLY LINKED DOMAINS OF NSP3 FROM MURINE HEPATITIS VIRUS AT 2.60 ANGSTROMS RESOLUTION | 3.4.19.12 3.4.22.69 3.4.22 2.7.7.48 3.6.4.12 3.6.4.13 2.1.1 3.1.13 3.1 |
4YQH | 2-[2-(4-PHENYL-1H-IMIDAZOL-2-YL)ETHYL]QUINOXALINE (SUNOVION COMPOUND 14) CO-CRYSTALLIZED WITH PDE10A | 3.1.4.17 3.1.4.35 |
4YR1 | CRYSTAL STRUCTURE OF E. COLI ALKALINE PHOSPHATASE D101A/D153A IN COMPLEX WITH INORGANIC PHOSPHATE | 3.1.3.1 |
4YRV | CRYSTAL STRUCTURE OF ANABAENA TRANSCRIPTION FACTOR HETR COMPLEXED WITH 21-BP DNA FROM HETP PROMOTER | 3.4.21 |
4YS7 | CO-CRYSTAL STRUCTURE OF 2-[2-(5,8-DIMETHYL[1,2,4]TRIAZOLO[1,5-A]PYRAZIN-2-YL)ETHYL]-3-METHYL-3H-IMIDAZO[4,5-F]QUINOLINE (COMPOUND 39) WITH PDE10A | 3.1.4.17 3.1.4.35 |
4YSI | STRUCTURE OF USP7 WITH A NOVEL VIRAL PROTEIN | 3.4.19.12 |
4YT6 | FACTOR VIIA IN COMPLEX WITH THE INHIBITOR 4-{[(R)-[5-ETHOXY-2-FLUORO-3-(PROPAN-2-YLOXY)PHENYL](4-PHENYL-1H-IMIDAZOL-2-YL)METHYL]AMINO}BENZENECARBOXIMIDAMIDE | 3.4.21.21 |
4YT7 | FACTOR VIIA IN COMPLEX WITH THE INHIBITOR 2-(2-{(R)-[(4-CARBAMIMIDOYLPHENYL)AMINO][5-ETHOXY-2-FLUORO-3-(PROPAN-2-YLOXY)PHENYL]METHYL}-1H-IMIDAZOL-4-YL)BENZAMIDE | 3.4.21.21 |
4YT9 | CRYSTAL STRUCTURE OF PORPHYROMONAS GINGIVALIS PEPTIDYLARGININE DEIMINASE (PPAD) SUBSTRATE-UNBOUND. | 3.5.3 |
4YTA | BOND LENGTH ANALYSIS OF ASP, GLU AND HIS RESIDUES IN TRYPSIN AT 1.2A RESOLUTION | 3.4.21.4 |
4YTB | CRYSTAL STRUCTURE OF PORPHYROMONAS GINGIVALIS PEPTIDYLARGININE DEIMINASE (PPAD) IN COMPLEX WITH DIPEPTIDE ASP-GLN. | 3.5.3 |
4YTG | CRYSTAL STRUCTURE OF PORPHYROMONAS GINGIVALIS PEPTIDYLARGININE DEIMINASE (PPAD) MUTANT C351A IN COMPLEX WITH DIPEPTIDE MET-ARG. | 3.5.3 |
4YU5 | CRYSTAL STRUCTURE OF SELENOMETHIONINE VARIANT OF BACILLUS ANTHRACIS IMMUNE INHIBITOR A2 PEPTIDASE ZYMOGEN | 3.4.24 |
4YU6 | CRYSTAL STRUCTURE OF BACILLUS ANTHRACIS IMMUNE INHIBITOR A2 PEPTIDASE ZYMOGEN | 3.4.24 |
4YV7 | CRYSTAL STRUCTURE OF AN ABC TRANSPORTER SOLUTE BINDING PROTEIN (IPR025997) FROM MYCOBACTERIUM SMEGMATIS (MSMEI_3018, TARGET EFI-511327) WITH BOUND GLYCEROL | 3.6.3.17 |
4YVF | STRUCTURE OF S-ADENOSYL-L-HOMOCYSTEINE HYDROLASE | 3.3.1.1 |
4YW1 | CRYSTAL STRUCTURE OF STREPTOCOCCUS PNEUMONIAE NANC, COMPLEX WITH NEU5AC AND NEU5AC2EN FOLLOWING SOAKING WITH 3'SL | 3.2.1.18 |
4YW2 | CRYSTAL STRUCTURE OF STREPTOCOCCUS PNEUMONIAE NANC, COMPLEX 6'SL | 3.2.1.18 |
4YW3 | CRYSTAL STRUCTURE OF STREPTOCOCCUS PNEUMONIAE NANC, COMPLEX WITH NEU5AC AND NEU5AC2EN FOLLOWING SOAKING WITH NEU5AC2EN | 3.2.1.18 |
4YW5 | CRYSTAL STRUCTURE OF STREPTOCOCCUS PNEUMONIAE NANC, COMPLEX WITH OSELTAMIVIR CARBOXYLATE | 3.2.1.18 |
4YWH | CRYSTAL STRUCTURE OF AN ABC TRANSPORTER SOLUTE BINDING PROTEIN (IPR025997) FROM ACTINOBACILLUS SUCCINOGENES 130Z (ASUC_0499, TARGET EFI-511068) WITH BOUND D-XYLOSE | 3.6.3.17 |
4YWK | PYROCOCCUS FURIOSUS MCM N-TERMINAL DOMAIN WITH ZINC-BINDING SUBDOMAIN B DELETED | 3.6.4.12 |
4YXC | COMPLEX OF FLIM(SPOA)::FLIN FUSION PROTEIN AND FLIH(APAR)::T4LYSOZYME FUSION PROTEIN | 3.2.1.17 |
4YYF | THE CRYSTAL STRUCTURE OF A GLYCOSYL HYDROLASE OF GH3 FAMILY MEMBER FROM [MYCOBACTERIUM SMEGMATIS STR. MC2 155 | 3.2.1.52 |
4YYL | PHENOLIC ACID DERIVATIVE BOUND TO INFLUENZA STRAIN H1N1 POLYMERASE SUBUNIT PA ENDONUCLEASE | 3.1 |
4YZ1 | CRYSTAL STRUCTURE OF STREPTOCOCCUS PNEUMONIAE NANC, APO STRUCTURE. | 3.2.1.18 |
4YZ2 | CRYSTAL STRUCTURE OF STREPTOCOCCUS PNEUMONIAE NANC, IN COMPLEX WITH 2-DEOXY-2,3-DIDEHYDRO-N-ACETYLNEURAMINIC ACID. | 3.2.1.18 |
4YZ4 | CRYSTAL STRUCTURE OF STREPTOCOCCUS PNEUMONIAE NANC, IN COMPLEX WITH N-ACETYLNEURAMINIC ACID. | 3.2.1.18 |
4YZ5 | CRYSTAL STRUCTURE OF STREPTOCOCCUS PNEUMONIAE NANC, IN COMPLEX WITH 3-SIALYLLACTOSE | 3.2.1.18 |
4YZ9 | CRYSTAL STRUCTURE OF HUMAN PHOSPHORYLATED IRE1ALPHA IN COMPLEX WITH A TYPE III KINASE INHIBITOR (GSK2850163A) | 2.7.11.1 3.1.26 |
4YZC | CRYSTAL STRUCTURE OF PIRE1ALPHA IN COMPLEX WITH STAUROSPORINE | 2.7.11.1 3.1.26 |
4YZD | CRYSTAL STRUCTURE OF HUMAN PHOSPHORYLATED IRE1ALPHA IN COMPLEX WITH ADP-MG | 2.7.11.1 3.1.26 |
4YZG | STRUCTURE OF THE ARABIDOPSIS TAP38/PPH1, A STATE-TRANSITION PHOSPHATASE RESPONSIBLE FOR DEPHOSPHORYLATION OF LHCII | 3.1.3.16 |
4YZH | STRUCTURE OF THE ARABIDOPSIS TAP38/PPH1 IN COMPLEX WITH PLHCB1 PHOSPHOPEPTIDE SUBSTRATE | 3.1.3.16 |
4YZP | CRYSTAL STRUCTURE OF A TRI-MODULAR GH5 (SUBFAMILY 4) ENDO-BETA-1, 4-GLUCANASE FROM BACILLUS LICHENIFORMIS | 3.2.1.4 |
4YZT | CRYSTAL STRUCTURE OF A TRI-MODULAR GH5 (SUBFAMILY 4) ENDO-BETA-1, 4-GLUCANASE FROM BACILLUS LICHENIFORMIS COMPLEXED WITH CELLOTETRAOSE | 3.2.1.4 |
4YZU | RAPID DEVELOPMENT OF TWO FACTOR IXA INHIBITORS FROM HIT TO LEAD | 3.4.21.22 |
4Z0C | CRYSTAL STRUCTURE OF TLR13-SSRNA13 COMPLEX | 3.2.2.6 |
4Z0K | RAPID DEVELOPMENT OF TWO FACTOR IXA INHIBITORS FROM HIT TO LEAD | 3.4.21.22 |
4Z0U | RNASE HI/SSB-CT COMPLEX | 3.1.26.4 |
4Z0V | THE STRUCTURE OF HUMAN PDE12 RESIDUES 161-609 | 3.1.4 3.1.13.4 |
4Z22 | STRUCTURE OF PLASMEPSIN II FROM PLASMODIUM FALCIPARUM COMPLEXED WITH INHIBITOR DR718A | 3.4.23.39 |
4Z2B | THE STRUCTURE OF HUMAN PDE12 RESIDUES 161-609 IN COMPLEX WITH GSK3036342A | 3.1.4 3.1.13.4 |
4Z2G | SERRATIA MARCESCENS CHITINASE B COMPLEXED WITH MACROLIDE INHIBITOR 26 | 3.2.1.14 |
4Z2H | SERRATIA MARCESCENS CHITINASE B COMPLEXED WITH MACROLIDE INHIBITOR 29 | 3.2.1.14 |
4Z2I | SERRATIA MARCESCENS CHITINASE B COMPLEXED WITH MACROLIDE INHIBITOR 30 | 3.2.1.14 |
4Z2J | SERRATIA MARCESCENS CHITINASE B COMPLEXED WITH MACROLIDE INHIBITOR 31 | 3.2.1.14 |
4Z2K | SERRATIA MARCESCENS CHITINASE B COMPLEXED WITH MACROLIDE INHIBITOR 32 | 3.2.1.14 |
4Z2L | SERRATIA MARCESCENS CHITINASE B COMPLEXED WITH MACROLIDE INHIBITOR 33 | 3.2.1.14 |
4Z3A | ACETATE-FREE STRUCTURE OF THE ENZYME-PRODUCT COMPLEX RESULTING FROM TDG ACTION ON A GU MISMATCH | 3.2.2.29 |
4Z3M | X-RAY STRUCTURE OF THE ADDUCT FORMED IN THE REACTION BETWEEN LYSOZYME AND A PLATINUM(II) COMPLEX WITH S,O BIDENTATE LIGANDS (9B) | 3.2.1.17 |
4Z41 | X-RAY STRUCTURE OF THE ADDUCT FORMED IN THE REACTION BETWEEN LYSOZYME AND A PLATINUM(II) COMPOUND WITH A S,O BIDENTATE LIGAND (9A=CHLORO-(1-(3'-HYDROXY)-3-(METHYLTHIO)-3-THIOXO-PROP-1-EN-1-OLATE-O,S)-(DIMETHYLSULFOXIDE-S)-PLATINUM(II)) | 3.2.1.17 |
4Z46 | X-RAY STRUCTURE OF THE BIS-PLATINUM LYSOZYME ADDUCT FORMED IN THE REACTION BETWEEN THE PROTEIN AND THE TWO DRUGS CISPLATIN AND OXALIPLATIN | 3.2.1.17 |
4Z47 | STRUCTURE OF THE ENZYME-PRODUCT COMPLEX RESULTING FROM TDG ACTION ON A GU MISMATCH IN THE PRESENCE OF EXCESS BASE | 3.2.2.29 |
4Z4C | HUMAN ARGONAUTE2 BOUND TO T1-C TARGET RNA | 3.1.26 |
4Z4D | HUMAN ARGONAUTE2 BOUND TO T1-G TARGET RNA | 3.1.26 |
4Z4E | HUMAN ARGONAUTE2 BOUND TO T1-U TARGET RNA | 3.1.26 |
4Z4F | HUMAN ARGONAUTE2 BOUND TO T1-DAP TARGET RNA | 3.1.26 |
4Z4G | HUMAN ARGONAUTE2 BOUND TO T1-INOSINE TARGET RNA | 3.1.26 |
4Z4H | HUMAN ARGONAUTE2 A481T MUTANT BOUND TO T1-A TARGET RNA | 3.1.26 |
4Z4I | HUMAN ARGONAUTE2 A481T MUTANT BOUND TO T1-G TARGET RNA | 3.1.26 |
4Z65 | CARBOXYPEPTIDASE B WITH SULPHAMOIL ARGININE | 3.4.17.2 |
4Z6A | CRYSTAL STRUCTURE OF A FVIIA-TRYPSIN CHIMERA (YT) IN COMPLEX WITH SOLUBLE TISSUE FACTOR | 3.4.21.21 |
4Z6B | YOPH W354H YERSINIA ENTEROCOLITICA PTPASE IN THE APO FORM | 3.1.3.48 |
4Z70 | CRYSTAL STRUCTURE OF INORGANIC PYROPHOSPHATASE FROM MYCOBACTERIUM TUBERCULOSIS IN COMPLEX WITH CA IONS | 3.6.1.1 |
4Z71 | CRYSTAL STRUCTURE OF INORGANIC PYROPHOSPHATASE FROM MYCOBACTERIUM TUBERCULOSIS IN COMPLEX WITH MG IONS | 3.6.1.1 |
4Z72 | CRYSTAL STRUCTURE OF INORGANIC PYROPHOSPHATASE FROM MYCOBACTERIUM TUBERCULOSIS IN COMPLEX WITH TWO PHOSPHATE IONS | 3.6.1.1 |
4Z73 | CRYSTAL STRUCTURE OF INORGANIC PYROPHOSPHATASE FROM MYCOBACTERIUM TUBERCULOSIS IN COMPLEX WITH A PHOSPHATE ION AND AN INORGANIC PYROPHOSPHATE | 3.6.1.1 |
4Z74 | CRYSTAL STRUCTURE OF INORGANIC PYROPHOSPHATASE FROM MYCOBACTERIUM TUBERCULOSIS IN COMPLEX WITH INORGANIC PYROPHOSPHATE | 3.6.1.1 |
4Z7B | STRUCTURE OF THE ENZYME-PRODUCT COMPLEX RESULTING FROM TDG ACTION ON A GFC MISMATCH | 3.2.2.29 |
4Z7G | CRYSTAL STRUCTURE OF HUMAN IRE1 CYTOPLASMIC KINASE-RNASE REGION - APO | 2.7.11.1 3.1.26 |
4Z7H | CRYSTAL STRUCTURE OF HUMAN IRE1 CYTOPLASMIC KINASE-RNASE REGION - COMPLEX WITH IMIDAZOPYRIDINE COMPOUND 3 | 2.7.11.1 3.1.26 |
4Z7I | CRYSTAL STRUCTURE OF INSULIN REGULATED AMINOPEPTIDASE IN COMPLEX WITH LIGAND | 3.4.11.3 |
4Z7Z | STRUCTURE OF THE ENZYME-PRODUCT COMPLEX RESULTING FROM TDG ACTION ON A GT MISMATCH IN THE PRESENCE OF EXCESS BASE | 3.2.2.29 |
4Z8I | CRYSTAL STRUCTURE OF BRANCHIOSTOMA BELCHERI TSINGTAUENSE PEPTIDOGLYCAN RECOGNITION PROTEIN 3 | 3.5.1.28 |
4Z92 | CRYSTAL STRUCTURE OF PARECHOVIRUS-1 VIRION | 3.6.1.15 3.4.22.28 3.4.22.29 2.7.7.48 |
4Z96 | CRYSTAL STRUCTURE OF DNMT1 IN COMPLEX WITH USP7 | 3.4.19.12 |
4Z97 | CRYSTAL STRUCTURE OF USP7 IN COMPLEX WITH DNMT1(K1115Q) | 3.4.19.12 |
4Z98 | CRYSTAL STRUCTURE OF HEN EGG WHITE LYSOZYME USING SERIAL X-RAY DIFFRACTION DATA COLLECTION | 3.2.1.17 |
4Z99 | CRYSTAL STRUCTURE OF THE APO LOW MOLECULAR WEIGHT PROTEIN TYROSINE PHOSPHATASE ISOFORM A | 3.1.3.48 3.1.3.2 |
4Z9A | CRYSTAL STRUCTURE OF LOW MOLECULAR WEIGHT PROTEIN TYROSINE PHOSPHATASE ISOFORM A COMPLEXED WITH PHENYLMETHANESULFONIC ACID | 3.1.3.48 3.1.3.2 |
4Z9B | CRYSTAL STRUCTURE OF LOW MOLECULAR WEIGHT PROTEIN TYROSINE PHOSPHATASE ISOFORM A COMPLEXED WITH BENZYLPHOSPHONIC ACID | 3.1.3.48 3.1.3.2 |
4Z9O | CRYSTAL STRUCTURE OF HUMAN GGT1 | 2.3.2.2 3.4.19.13 3.4.19.14 |
4ZAE | DEVELOPMENT OF A NOVEL CLASS OF POTENT AND SELECTIVE FIXA INHIBITORS | 3.4.21.22 |
4ZAM | CRYSTAL STRUCTURE OF SHV-1 BETA-LACTAMASE BOUND TO AVIBACTAM | 3.5.2.6 |
4ZAR | CRYSTAL STRUCTURE OF PROTEINASE K FROM ENGYODONTIUM ALBUMINHIBITED BY METHOXYSUCCINYL-ALA-ALA-PRO-PHE-CHLOROMETHYL KETONE AT 1.15 A RESOLUTION | 3.4.21.64 |
4ZB3 | CRYSTAL STRUCTURE OF THE APO ATNUDT7 | 3.6.1 3.6.1.13 3.6.1.22 |
4ZBE | CRYSTAL STRUCTURE OF KPC-2 BETA-LACTAMASE COMPLEXED WITH AVIBACTAM | 3.5.2.6 |
4ZBK | CRYSTAL STRUCTURE OF HUMAN GGT1 IN COMPLEX WITH GGSTOP INHIBITOR | 2.3.2.2 3.4.19.13 3.4.19.14 |
4ZBP | CRYSTAL STRUCTURE OF THE AMPCPR-BOUND ATNUDT7 | 3.6.1 3.6.1.13 3.6.1.22 |
4ZBW | CRYSTAL STRUCTURE OF DEATH EFFECTOR DOMAIN OF CASPASE8 IN HOMO SAPIENS | 3.4.22.61 |
4ZBX | FAMILY 4 URACIL-DNA GLYCOSYLASE FROM SULFOLOBUS TOKODAII (FREE FORM, X-RAY WAVELENGTH=0.9000) | 3.2.2.27 |
4ZBY | FAMILY 4 URACIL-DNA GLYCOSYLASE FROM SULFOLOBUS TOKODAII (URACIL COMPLEX FORM) | 3.2.2.27 |
4ZBZ | FAMILY 4 URACIL-DNA GLYCOSYLASE FROM SULFOLOBUS TOKODAII (FREE FORM, X-RAY WAVELENGTH=1.5418) | 3.2.2.27 |
4ZC0 | STRUCTURE OF A DODECAMERIC BACTERIAL HELICASE | 3.6.4.12 |
4ZC6 | CRYSTAL STRUCTURE OF HUMAN GGT1 IN COMPLEX WITH SERINE BORATE | 2.3.2.2 3.4.19.13 3.4.19.14 |
4ZCG | CRYSTAL STRUCTURE OF HUMAN GGT1 IN COMPLEX WITH GLUTAMATE (WITH ALL ATOMS OF GLUTAMATE) | 2.3.2.2 3.4.19.13 3.4.19.14 |
4ZCI | CRYSTAL STRUCTURE OF ESCHERICHIA COLI GTPASE BIPA/TYPA | 3.6.5 |
4ZCK | CRYSTAL STRUCTURE OF C-TERMINAL FRAGMENT OF ESCHERICHIA COLI BIPA/TYPA | 3.6.5 |
4ZCL | CRYSTAL STRUCTURE OF ESCHERICHIA COLI GTPASE BIPA/TYPA COMPLEXED WITH GDP | 3.6.5 |
4ZCM | CRYSTAL STRUCTURE OF ESCHERICHIA COLI GTPASE BIPA/TYPA COMPLEXED WITH PPGPP | 3.6.5 |
4ZD4 | CATALYTIC DOMAIN OF SST2 F403W MUTANT | 3.4.19 |
4ZD5 | CATALYTIC DOMAIN OF SST2 F403A MUTANT | 3.4.19 |
4ZDT | CRYSTAL STRUCTURE OF THE RING FINGER DOMAIN OF SLX1 IN COMPLEX WITH THE C-TERMINAL DOMAIN OF SLX4 | 3.1 |
4ZEE | X-RAY STRUCTURE OF THE BIS-PLATINUM LYSOZYME ADDUCT FORMED IN THE REACTION BETWEEN THE PROTEIN AND THE TWO DRUGS CISPLATIN AND OXALIPLATIN (PREPARATION 2) | 3.2.1.17 |
4ZEV | CRYSTAL STRUCTURE OF PFHAD1 IN COMPLEX WITH MANNOSE-6-PHOSPHATE | 3.8.1 |
4ZEW | CRYSTAL STRUCTURE OF PFHAD1 IN COMPLEX WITH GLUCOSE-6-PHOSPHATE | 3.8.1 |
4ZEX | CRYSTAL STRUCTURE OF PFHAD1 IN COMPLEX WITH GLYCERALDEHYDE-3-PHOSPHATE | 3.8.1 |
4ZFJ | ERGOTHIONEINE-BIOSYNTHETIC NTN HYDROLASE EGTC, APO FORM | 3.5.1 3.5.1.118 |
4ZFK | ERGOTHIONEINE-BIOSYNTHETIC NTN HYDROLASE EGTC WITH GLUTAMINE | 3.5.1 3.5.1.118 |
4ZFL | ERGOTHIONEINE-BIOSYNTHETIC NTN HYDROLASE VARIANT EGTC_C2A WITH NATURAL SUBSTRATE | 3.5.1 3.5.1.118 |
4ZFP | A NEW CRYSTAL STRUCTURE FOR THE ADDUCT FORMED IN THE REACTION BETWEEN AUSAC2, A CYTOTOXIC HOMOLEPTIC GOLD(I) COMPOUND WITH THE SACCHARINATE LIGAND, AND THE MODEL PROTEIN HEN EGG WHITE LYSOZYME | 3.2.1.17 |
4ZFR | CATALYTIC DOMAIN OF SST2 F403A MUTANT BOUND TO UBIQUITIN | 3.4.19 |
4ZFT | CATALYTIC DOMAIN OF SST2 F403W MUTANT BOUND TO UBIQUITIN | 3.4.19 |
4ZG5 | STRUCTURAL AND FUNCTIONAL INSIGHTS INTO SURVIVAL ENDONUCLEASE, AN IMPORTANT VIRULENCE FACTOR OF BRUCELLA ABORTUS | 3.1.3.5 |
4ZG6 | STRUCTURAL BASIS FOR INHIBITION OF HUMAN AUTOTAXIN BY FOUR NOVEL COMPOUNDS | 3.1.4.39 |
4ZG7 | STRUCTURAL BASIS FOR INHIBITION OF HUMAN AUTOTAXIN BY FOUR NOVEL COMPOUNDS | 3.1.4.39 |
4ZG9 | STRUCTURAL BASIS FOR INHIBITION OF HUMAN AUTOTAXIN BY FOUR NOVEL COMPOUNDS | 3.1.4.39 |
4ZGA | STRUCTURAL BASIS FOR INHIBITION OF HUMAN AUTOTAXIN BY FOUR NOVEL COMPOUNDS | 3.1.4.39 |
4ZGB | STRUCTURE OF UNTREATED LIPASE FROM THERMOMYCES LANUGINOSA AT 2.3 A RESOLUTION | 3.1.1.3 |
4ZGG | CRYSTAL STRUCTURE OF A DJ-1 (PARK7) FROM HOMO SAPIENS AT 1.23 A RESOLUTION | 3.1.2 3.5.1 3.5.1.124 |
4ZH8 | FACTOR XA COMPLEX WITH GTC000006 | 3.4.21.6 |
4ZHA | FACTOR XA COMPLEX WITH GTC000102 | 3.4.21.6 |
4ZHK | CRYSTAL STRUCTURE OF RPE65 IN COMPLEX WITH MB-002 | 3.1.1.64 5.3.3.22 |
4ZHR | STRUCTURE OF HIV-1 RT Q151M MUTANT | 2.7.7.49 2.7.7.7 3.1.26.13 3.4.23.16 3.1.13.2 2.7.7 3.1 |
4ZHZ | ENDONUCLEASE INHIBITOR BOUND TO INFLUENZA STRAIN H1N1 POLYMERASE ACIDIC SUBUNIT N-TERMINAL REGION WITH EXPELLING ONE OF THE METAL IONS IN THE ACTIVE SITE | 3.1 |
4ZI0 | ENDONUCLEASE INHIBITOR BOUND TO INFLUENZA STRAIN H1N1 POLYMERASE ACIDIC SUBUNIT N-TERMINAL REGION WITHOUT A CHELATION TO THE METAL IONS IN THE ACTIVE SITE | 3.1 |
4ZI4 | YOPH W354H YERSINIA ENTEROCOLITICA PTPASE BOND WITH DIVANADATE GLYCEROL ESTER IN THE ACTIVE SITE | 3.1.3.48 |
4ZI5 | CRYSTAL STRUCTURE OF DIENELACTONE HYDROLASE-LIKE PROMISCUOUS PHOSPOTRIESTERASE P91 FROM METAGENOMIC LIBRARIES | 3.1.8.1 |
4ZI6 | CRYSTAL STRUCTURE OF LEUCINE AMINOPEPTIDASE FROM HELICOBACTER PYLORI | 3.4.11.1 3.4.11.10 |
4ZIP | HIV-1 WILD TYPE PROTEASE WITH GRL-0648A (A ISOPHTHALAMIDE-DERIVED P2-LIGAND) | 3.4.23.16 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1 |
4ZIR | CRYSTAL STRUCTURE OF ECFAA' HETERODIMER BOUND TO AMPPNP | 3.6.3 7 |
4ZIX | STRUCTURE OF HEWL USING SERIAL FEMTOSECOND CRYSTALLOGRAPHY OF SOLUBLE PROTEINS IN LIPIDIC CUBIC PHASE | 3.2.1.17 |
4ZJ1 | CRYSTAL STRUCTURE OF P-ACRYLAMIDO-PHENYLALANINE MODIFIED TEM1 BETA-LACTAMASE FROM ESCHERICHIA COLI : V216ACRF MUTANT | 3.5.2.6 |
4ZJ2 | CRYSTAL STRUCTURE OF P-ACRYLAMIDO-PHENYLALANINE MODIFIED TEM1 BETA-LACTAMASE FROM ESCHERICHIA COLI :E166N MUTANT | 3.5.2.6 |
4ZJ3 | CRYSTAL STRUCTURE OF CEPHALEXIN BOUND ACYL-ENZYME INTERMEDIATE OF VAL216ACRF MUTANT TEM1 BETA-LACTAMASE FROM ESCHERICHIA COLI: E166N AND V216ACRF MUTANT. | 3.5.2.6 |
4ZJP | STRUCTURE OF AN ABC-TRANSPORTER SOLUTE BINDING PROTEIN (SBP_IPR025997) FROM ACTINOBACILLUS SUCCINOGENES (ASUC_0197, TARGET EFI-511067) WITH BOUND BETA-D-RIBOPYRANOSE | 3.6.3.17 |
4ZKF | CRYSTAL STRUCTURE OF HUMAN PHOSPHODIESTERASE 12 | 3.1.4 3.1.13.4 |
4ZKJ | CRYSTAL STRUCTURE OF CRISPR-ASSOCIATED PROTEIN | 3.1 |
4ZKL | CRYSTAL STRUCTURE OF HUMAN HISTIDINE TRIAD NUCLEOTIDE-BINDING PROTEIN 1 (HHINT1) COMPLEXED WITH JB419 (AP4A ANALOG) | 3 |
4ZKV | CRYSTAL STRUCTURE OF HUMAN HISTIDINE TRIAD NUCLEOTIDE-BINDING PROTEIN 1 (HHINT1) REFINED TO 1.92A AT P21 SPACE GROUP | 3 |
4ZLS | HIV-1 WILD TYPE PROTEASE WITH GRL-096-13A (A BOC-DERIVATIVE P2-LIGAND, 3,-5-DIMETHYLBIPHENYL P1-LIGAND) | 3.4.23.16 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1 |
4ZM6 | A UNIQUE GCN5-RELATED GLUCOSAMINE N-ACETYLTRANSFERASE REGION EXIST IN THE FUNGAL MULTI-DOMAIN GH3 BETA-N-ACETYLGLUCOSAMINIDASE | 3.2.1.52 2.3.1.3 |
4ZM9 | CRYSTAL STRUCTURE OF CIRCULARLY PERMUTED HUMAN ASPARAGINASE-LIKE PROTEIN 1 | 3.4.19.5 3.5.1.1 |
4ZMA | CRYSTAL STRUCTURE OF A FVIIA-TRYPSIN CHIMERA (ST) IN COMPLEX WITH SOLUBLE TISSUE FACTOR | 3.4.21.21 |
4ZN5 | YOPH W354Y YERSINIA ENTEROCOLITICA PTPASE BOND WITH DIVANADATE GLYCEROL ESTER IN THE ACTIVE SITE | 3.1.3.48 |
4ZNB | METALLO-BETA-LACTAMASE (C181S MUTANT) | 3.5.2.6 |
4ZO0 | X-RAY STRUCTURE OF AAV-2 ORIGIN BINDING DOMAIN | 3.6.4.12 |
4ZO5 | PDE10 COMPLEXED WITH 4-ISOPROPOXY-2-(2-(3-(4-METHOXYPHENYL)-4-OXO-3,4-DIHYDROQUINAZOLIN-2-YL)ETHYL)ISOINDOLINE-1,3-DIONE | 3.1.4.17 3.1.4.35 |
4ZPE | BACE1 IN COMPLEX WITH 4-(CYCLOHEXYLAMINO)-1-(3-FLUOROPHENYL)-8-(3-ISOPROPOXYBENZYL)-1,3,8-TRIAZASPIRO[4.5]DEC-3-EN-2-ONE | 3.4.23.46 |
4ZPF | BACE1 IN COMPLEX WITH 8-(3-((1-AMINOPROPAN-2-YL)OXY)BENZYL)-4-(CYCLOHEXYLAMINO)-1-(3-FLUOROPHENYL)-1,3,8-TRIAZASPIRO[4.5]DEC-3-EN-2-ONE | 3.4.23.46 |
4ZPG | BACE1 IN COMPLEX WITH 8-BENZYL-4-(CYCLOHEXYLAMINO)-1-(3-FLUOROPHENYL)-7-METHYL-1,3,8-TRIAZASPIRO[4.5]DEC-3-EN-2-ONE | 3.4.23.46 |
4ZPU | THE STRUCTURE OF DLP12 ENDOLYSIN EXHIBITS LIKELY ACTIVE AND INACTIVE CONFORMATIONS. | 3.2.1.17 |
4ZQ3 | CRYSTAL STRUCTURE OF STAPHYLOCOCCAL NUCLEASE VARIANT DELTA+PHS I92T AT CRYOGENIC TEMPERATURE | 3.1.31.1 |
4ZQ9 | X-RAY STRUCTURE OF AAV-2 OBD BOUND TO AAVS1 SITE 3:1 | 3.6.4.12 |
4ZQQ | APO FORM OF INFLUENZA STRAIN H1N1 POLYMERASE ACIDIC SUBUNIT N-TERMINAL REGION | 3.1 |
4ZQT | CRYSTAL STRUCTURE OF PFA-M1 WITH VIRTUAL LIGAND INHIBITOR | 3.4.11 3.4.11.2 |
4ZQU | CDIA-CT/CDII TOXIN AND IMMUNITY COMPLEX FROM YERSINIA PSEUDOTUBERCULOSIS | 3.1 |
4ZQW | CDII FROM ESCHERICHIA COLI EC869 IN COMPLEX WITH A MACROCYCLIC PEPTIDE | 3.1 |
4ZRO | 2.1 A X-RAY STRUCTURE OF FIPV-3CLPRO BOUND TO COVALENT INHIBITOR | 3.4.22 3.4.19.12 2.7.7.48 3.6.4.12 3.6.4.13 3.1.13 3.1 2.1.1 |
4ZRT | PTP1BC215S BOUND TO NEPHRIN PEPTIDE SUBSTRATE | 3.1.3.48 |
4ZSM | BACE CRYSTAL STRUCTURE WITH BICYCLIC AMINOTHIAZINE FRAGMENT | 3.4.23.46 |
4ZSP | BACE CRYSTAL STRUCTURE WITH BICYCLIC AMINOTHIAZINE INHIBITOR | 3.4.23.46 |
4ZSQ | BACE CRYSTAL STRUCTURE WITH TRICYCLIC AMINOTHIAZINE INHIBITOR | 3.4.23.46 |
4ZSR | BACE CRYSTAL STRUCTURE WITH TRICYCLIC AMINOTHIAZINE INHIBITOR | 3.4.23.46 |
4ZST | CRYSTAL STRUCTURE OF BREVUNDIMONAS DIMINUTA PHOSPHOTRIESTERASE MUTANT L7EP-3A | 3.1.8.1 |
4ZSU | CRYSTAL STRUCTURE OF BREVUNDIMONAS DIMINUTA PHOSPHOTRIESTERASE MUTANT L7EP-3AG | 3.1.8.1 |
4ZT8 | STRUCTURE OF THE COMPLEX OF TYPE 1 RIBOSOME INACTIVATING PROTEIN FROM MOMORDICA BALSAMINA WITH A PYRIMIDINE BASE, CYTOSINE AT 1.98 A RESOLUTION | 3.2.2.22 |
4ZTF | CRYSTAL STRUCTURE OF THE PROTOTYPE FOAMY VIRUS INTASOME WITH A 2-PYRIDINONE AMINAL INHIBITOR | 2.7.7.49 2.7.7.7 3.1.26.4 3.4.23 2.7.7 3.1 |
4ZTJ | CRYSTAL STRUCTURE OF THE PROTOTYPE FOAMY VIRUS INTASOME WITH A 2-PYRIDINONE AMINAL INHIBITOR | 2.7.7.49 2.7.7.7 3.1.26.4 3.4.23 2.7.7 3.1 |
4ZU0 | STRUCTURE OF THE COMPLEX OF TYPE 1 RIBOSOME INACTIVATING PROTEIN FROM MOMORDICA BALSAMINA WITH A NUCLEOTIDE, CYTIDINE MONOPHOSPHATE AT 1.80 A RESOLUTION | 3.2.2.22 |
4ZUI | CRYSTAL STRUCTURE OF STAPHYLOCOCCAL NUCLEASE VARIANT DELTA+PHS V23H AT CRYOGENIC TEMPERATURE | 3.1.31.1 |
4ZUJ | CRYSTAL STRUCTURE OF STAPHYLOCOCCAL NUCLEASE VARIANT DELTA+PHS Y91H AT CRYOGENIC TEMPERATURE | 3.1.31.1 |
4ZUM | CRYSTAL STRUCTURE OF ACETYLPOLYAMINE AMIDOHYDROLASE FROM MYCOPLANA RAMOSA IN COMPLEX WITH A TRIFLUOROMETHYLKETONE INHIBITOR | 3.5.1 3.5.1.62 3.5.1.48 |
4ZUN | CRYSTAL STRUCTURE OF ACETYLPOLYAMINE AMIDOHYDROLASE FROM MYCOPLANA RAMOSA IN COMPLEX WITH A THIOL INHIBITOR | 3.5.1 3.5.1.62 3.5.1.48 |
4ZUO | CRYSTAL STRUCTURE OF ACETYLPOLYAMINE AMIDOHYDROLASE FROM MYCOPLANA RAMOSA IN COMPLEX WITH A HYDROXAMATE INHIBITOR | 3.5.1 3.5.1.62 3.5.1.48 |
4ZUP | CRYSTAL STRUCTURE OF ACETYLPOLYAMINE AMIDOHYDROLASE FROM MYCOPLANA RAMOSA IN COMPLEX WITH A HYDROXAMATE INHIBITOR | 3.5.1 3.5.1.62 3.5.1.48 |
4ZUQ | CRYSTAL STRUCTURE OF ACETYLPOLYAMINE AMIDOHYDROLASE FROM MYCOPLANA RAMOSA IN COMPLEX WITH A HYDROXAMATE INHIBITOR | 3.5.1 3.5.1.62 3.5.1.48 |
4ZUR | CRYSTAL STRUCTURE OF ACETYLPOLYAMINE AMIDOHYDROLASE FROM MYCOPLANA RAMOSA IN COMPLEX WITH A HYDROXAMATE INHIBITOR | 3.5.1 3.5.1.62 3.5.1.48 |
4ZV0 | STRUCTURE OF TSE6 IN COMPLEX WITH TSI6 | 3.2.2.5 |
4ZV3 | CRYSTAL STRUCTURE OF THE N- AND C-TERMINAL DOMAINS OF MOUSE ACYL-COA THIOESTERASE 7 | 3.1.2.2 |
4ZV7 | CRYSTAL STRUCTURE OF HEXAGONAL FORM OF LIPASE B FROM CANDIDA ANTARCTICA | 3.1.1.3 |
4ZWE | CRYSTAL STRUCTURE OF THE DGTP-BOUND CATALYTIC CORE OF SAMHD1 T592V MUTANT | 3.1.5 |
4ZWG | CRYSTAL STRUCTURE OF THE GTP-DATP-BOUND CATALYTIC CORE OF SAMHD1 PHOSPHOMIMETIC T592E MUTANT | 3.1.5 |
4ZWO | CRYSTAL STRUCTURE OF ORGANOPHOSPHATE ANHYDROLASE/PROLIDASE MUTANT Y212F | 3.4.13.9 3.1.8.2 3.1.8.1 |
4ZWP | CRYSTAL STRUCTURE OF ORGANOPHOSPHATE ANHYDROLASE/PROLIDASE MUTANT Y212F | 3.4.13.9 3.1.8.2 3.1.8.1 |
4ZWU | CRYSTAL STRUCTURE OF ORGANOPHOSPHATE ANHYDROLASE/PROLIDASE MUTANT Y212F, V342L, I215Y | 3.4.13.9 3.1.8.2 3.1.8.1 |
4ZXK | CARBOHYDRATE BINDING DOMAIN FROM STREPTOCOCCUS PNEUMONIAE NANA SIALIDASE | 3.2.1.18 |
4ZXL | CPOGA D298N IN COMPLEX WITH DROSOPHILA HCF -DERIVED THR-O-GLCNAC PEPTIDE | 3.2.1.169 3.2.1.52 |
4ZXM | CRYSTAL STRUCTURE OF PGRP DOMAIN FROM BRANCHIOSTOMA BELCHERI TSINGTAUENSE PEPTIDOGLYCAN RECOGNITION PROTEIN 3 | 3.5.1.28 |
4ZXX | FACTOR VIIA IN COMPLEX WITH THE INHIBITOR N-{3-[(2R)-1-{(2R)-2-[(1-AMINOISOQUINOLIN-6-YL)AMINO]-2-PHENYLACETYL}PYRROLIDIN-2-YL]-4-(PROPAN-2-YLSULFONYL)PHENYL}ACETAMIDE | 3.4.21.21 |
4ZXY | FACTOR VIIA IN COMPLEX WITH THE INHIBITOR (2R)-2-[(1-AMINOISOQUINOLIN-6-YL)AMINO]-4,11-DIAZATRICYCLO[14.2.2.1~6,10~]HENICOSA-1(18),6(21),7,9,16,19-HEXAENE-3,12-DIONE | 3.4.21.21 |
4ZYB | HIGH RESOLUTION STRUCTURE OF M23 PEPTIDASE LYTM WITH SUBSTRATE ANALOGUE | 3.4.24.75 |
4ZZ6 | STRUCTURE OF THE COMPLEX OF TYPE 1 RIBOSOME INACTIVATING PROTEIN FROM MOMORDICA BALSAMINA WITH A NUCLEOTIDE, CYTIDINE TRIPHOSPHATE AT 2.0A RESOLUTION | 3.2.2.22 |
4ZZH | SIRT1/ACTIVATOR COMPLEX | 3.5.1 2.3.1.286 2.3.1 |
4ZZI | SIRT1/ACTIVATOR/INHIBITOR COMPLEX | 3.5.1 2.3.1.286 2.3.1 |
4ZZJ | SIRT1/ACTIVATOR/SUBSTRATE COMPLEX | 3.5.1 2.3.1.286 2.3.1 |
4ZZT | GEOTRICHUM CANDIDUM CEL7A STRUCTURE COMPLEX WITH THIO-LINKED CELLOTRIOSE AT 1.56A | 3.2.1.176 3.2.1 |
4ZZU | GEOTRICHUM CANDIDUM CEL7A STRUCTURE COMPLEX WITH THIO-LINKED CELLOTETRAOSE AT 1.4A | 3.2.1.176 3.2.1 |
4ZZV | GEOTRICHUM CANDIDUM CEL7A APO STRUCTURE AT 1.4A | 3.2.1.176 3.2.1 |
4ZZW | GEOTRICHUM CANDIDUM CEL7A STRUCTURE COMPLEX WITH CELLOBIOSE AT 1.5A | 3.2.1.176 3.2.1 |
521P | THREE-DIMENSIONAL STRUCTURES OF H-RAS P21 MUTANTS: MOLECULAR BASIS FOR THEIR INABILITY TO FUNCTION AS SIGNAL SWITCH MOLECULES | 3.6.5.2 |
5A09 | CRYSTAL STRUCTURE OF HUMAN NEUTROPHIL ELASTASE IN COMPLEX WITH A DIHYDROPYRIMIDONE INHIBITOR | 3.4.21.37 |
5A0A | CRYSTAL STRUCTURE OF HUMAN NEUTROPHIL ELASTASE IN COMPLEX WITH A DIHYDROPYRIMIDONE INHIBITOR | 3.4.21.37 |
5A0B | CRYSTAL STRUCTURE OF HUMAN NEUTROPHIL ELASTASE IN COMPLEX WITH A DIHYDROPYRIMIDONE INHIBITOR | 3.4.21.37 |
5A0C | CRYSTAL STRUCTURE OF HUMAN NEUTROPHIL ELASTASE IN COMPLEX WITH A DIHYDROPYRIMIDONE INHIBITOR | 3.4.21.37 |
5A0F | CRYSTAL STRUCTURE OF YERSINIA AFP18-MODIFIED RHOA | 3.6.5.2 |
5A0P | APO-STRUCTURE OF METALLOPROTEASE ZMP1 FROM CLOSTRIDIUM DIFFICILE | 3.4.24 3.4.24.89 |
5A0R | PRODUCT PEPTIDE-BOUND STRUCTURE OF METALLOPROTEASE ZMP1 VARIANT E143A FROM CLOSTRIDIUM DIFFICILE | 3.4.24 3.4.24.89 |
5A0S | APO-STRUCTURE OF METALLOPROTEASE ZMP1 VARIANT E143A FROM CLOSTRIDIUM DIFFICILE | 3.4.24 3.4.24.89 |
5A0T | CATALYSIS AND 5' END SENSING BY RIBONUCLEASE RNASE J OF THE METALLO- BETA-LACTAMASE FAMILY | 3.1 |
5A0V | CATALYSIS AND 5' END SENSING BY RIBONUCLEASE RNASE J OF THE METALLO- BETA-LACTAMASE FAMILY | 3.1 |
5A0X | SUBSTRATE PEPTIDE-BOUND STRUCTURE OF METALLOPROTEASE ZMP1 VARIANT E143AY178F FROM CLOSTRIDIUM DIFFICILE | 3.4.24 3.4.24.89 |
5A2G | AN ESTERASE FROM ANAEROBIC CLOSTRIDIUM HATHEWAYI CAN HYDROLYZE ALIPHATIC AROMATIC POLYESTERS | 3.1.1 |
5A2R | A NEW CRYSTAL STRUCTURE OF THE DROSOPHILA MELANOGASTER ANGIOTENSIN CONVERTING ENZYME HOMOLOGUE ANCE. | 3.4.15.1 |
5A3E | 2.5A STRUCTURE OF LYSOZYME DETERMINED BY MICROED WITH DATA FROM A SINGLE CRYSTAL | 3.2.1.17 |
5A3H | 2-DEOXY-2-FLURO-B-D-CELLOBIOSYL/ENZYME INTERMEDIATE COMPLEX OF THE ENDOGLUCANASE CEL5A FROM BACILLUS AGARADHEARANS AT 1.8 ANGSTROMS RESOLUTION | 3.2.1.4 |
5A3Y | SAD STRUCTURE OF THERMOLYSIN OBTAINED BY MULTI CRYSTAL DATA COLLECTION | 3.4.24.27 |
5A3Z | STRUCTURE OF MONOCLINIC LYSOZYME OBTAINED BY MULTI CRYSTAL DATA COLLECTION | 3.2.1.17 |
5A55 | THE NATIVE STRUCTURE OF GH101 FROM STREPTOCOCCUS PNEUMONIAE TIGR4 | 3.2.1.97 |
5A56 | THE STRUCTURE OF GH101 FROM STREPTOCOCCUS PNEUMONIAE TIGR4 IN COMPLEX WITH 1-O-METHYL-T-ANTIGEN | 3.2.1.97 |
5A57 | THE STRUCTURE OF GH101 FROM STREPTOCOCCUS PNEUMONIAE TIGR4 IN COMPLEX WITH PUGT | 3.2.1.97 |
5A58 | THE STRUCTURE OF GH101 D764N MUTANT FROM STREPTOCOCCUS PNEUMONIAE TIGR4 IN COMPLEX WITH SERINYL T-ANTIGEN | 3.2.1.97 |
5A59 | THE STRUCTURE OF GH101 E796Q MUTANT FROM STREPTOCOCCUS PNEUMONIAE TIGR4 IN COMPLEX WITH T-ANTIGEN | 3.2.1.97 |
5A5A | THE STRUCTURE OF GH101 E796Q MUTANT FROM STREPTOCOCCUS PNEUMONIAE TIGR4 IN COMPLEX WITH PNP-T-ANTIGEN | 3.2.1.97 |
5A5L | STRUCTURE OF DUAL FUNCTION FBPASE SBPASE FROM THERMOSYNECHOCOCCUS ELONGATUS | 3.1.3.37 3.1.3.11 |
5A5N | CRYSTAL STRUCTURE OF HUMAN ATAD2 BROMODOMAIN IN COMPLEX WITH (2S)-2,6- DIACETAMIDO-N-METHYLHEXANAMIDE | 3.6.1.3 3.6.1 |
5A5O | CRYSTAL STRUCTURE OF HUMAN ATAD2 BROMODOMAIN IN COMPLEX WITH 3-METHYL- 1,2-DIHYDROQUINOLIN-2-ONE | 3.6.1.3 3.6.1 |
5A5P | CRYSTAL STRUCTURE OF HUMAN ATAD2 BROMODOMAIN IN COMPLEX WITH 8-2-(DIMETHYLAMINO)ETHYLAMINO-3-METHYL-1,2-DIHYDROQUINOLIN-2-ONE | 3.6.1.3 3.6.1 |
5A5Q | CRYSTAL STRUCTURE OF HUMAN ATAD2 BROMODOMAIN IN COMPLEX WITH 3-METHYL- 8-PIPERIDIN-4-YLAMINO-1,2-DIHYDRO-1,7-NAPHTHYRIDIN-2-ONE HYDROCHLORIDE | 3.6.1.3 3.6.1 |
5A5R | CRYSTAL STRUCTURE OF HUMAN ATAD2 BROMODOMAIN IN COMPLEX WITH 5-5- METHOXYPYRIDIN-3-YL-3-METHYL-8-PIPERIDIN-4-YLAMINO-1,2-DIHYDRO-1,7- NAPHTHYRIDIN-2-ONE | 3.6.1.3 3.6.1 |
5A5Y | CRYSTAL STRUCTURE OF ATTTM3 IN COMPLEX WITH TRIPOLYPHOSPHATE AND MAGNESIUM ION (FORM A) | 3.6.1.3 3.6.1.25 3.6.1 |
5A5Z | APPROVED DRUGS CONTAINING THIOLS AS INHIBITORS OF METALLO-BETA- LACTAMASES: STRATEGY TO COMBAT MULTIDRUG-RESISTANT BACTERIA | 3.5.2.6 |
5A60 | CRYSTAL STRUCTURE OF FULL-LENGTH E. COLI YGIF IN COMPLEX WITH TRIPOLYPHOSPHATE AND TWO MAGNESIUM IONS | 3.6.1.25 |
5A61 | CRYSTAL STRUCTURE OF FULL-LENGTH E. COLI YGIF IN COMPLEX WITH TRIPOLYPHOSPHATE AND TWO MANGANESE IONS. | 3.6.1.25 |
5A64 | CRYSTAL STRUCTURE OF MOUSE THIAMINE TRIPHOSPHATASE IN COMPLEX WITH THIAMINE TRIPHOSPHATE. | 3.6.1.28 |
5A65 | CRYSTAL STRUCTURE OF MOUSE THIAMINE TRIPHOSPHATASE IN COMPLEX WITH THIAMINE DIPHOSPHATE, ORTHOPHOSPHATE AND MAGNESIUM IONS. | 3.6.1.28 |
5A66 | CRYSTAL STRUCTURE OF ATTTM3 IN COMPLEX WITH TRIPOLYPHOSPHATE AND MANGANESE ION (FORM A) | 3.6.1.3 3.6.1.25 3.6.1 |
5A67 | CRYSTAL STRUCTURE OF ATTTM3 IN COMPLEX WITH TRIPOLYPHOSPHATE AND MANGANESE ION (FORM B) | 3.6.1.3 3.6.1.25 3.6.1 |
5A68 | CRYSTAL STRUCTURE OF THE ATTTM3 PRODUCT COMPLEX WITH TWO ORTHOPHOSPHATES AND MANGANESE IONS (FORM B) | 3.6.1.3 3.6.1.25 3.6.1 |
5A69 | GH20C, BETA-HEXOSAMINIDASE FROM STREPTOCOCCUS PNEUMONIAE IN COMPLEX WITH GAL-PUGNAC | 3.2.1.52 |
5A6A | GH20C, BETA-HEXOSAMINIDASE FROM STREPTOCOCCUS PNEUMONIAE IN COMPLEX WITH NGT | 3.2.1.52 |
5A6K | GH20C, BETA-HEXOSAMINIDASE FROM STREPTOCOCCUS PNEUMONIAE IN COMPLEX WITH GAL-NGT | 3.2.1.52 |
5A6L | HIGH RESOLUTION STRUCTURE OF THE THERMOSTABLE GLUCURONOXYLAN ENDO-BETA-1, 4-XYLANASE, CTXYN30A, FROM CLOSTRIDIUM THERMOCELLUM WITH TWO XYLOBIOSE UNITS BOUND | 3.2.1.8 |
5A6M | DETERMINING THE SPECIFICITIES OF THE CATALYTIC SITE FROM THE VERY HIGH RESOLUTION STRUCTURE OF THE THERMOSTABLE GLUCURONOXYLAN ENDO-BETA-1, 4-XYLANASE, CTXYN30A, FROM CLOSTRIDIUM THERMOCELLUM WITH A XYLOTETRAOSE BOUND | 3.2.1.8 |
5A6S | CRYSTAL STRUCTURE OF THE CTP1L ENDOLYSIN REVEALS HOW ITS ACTIVITY IS REGULATED BY A SECONDARY TRANSLATION PRODUCT | 3.2.1.17 |
5A6T | 1.65 A RESOLUTION SULPHITE INHIBITED SPOROSARCINA PASTEURII UREASE | 3.5.1.5 |
5A6V | OPEN AND CLOSED CONFORMATIONS AND PROTONATION STATES OF CANDIDA ANTARCTICA LIPASE B: XENON COMPLEX | 3.1.1.3 |
5A71 | OPEN AND CLOSED CONFORMATIONS AND PROTONATION STATES OF CANDIDA ANTARCTICA LIPASE B: ATOMIC RESOLUTION NATIVE | 3.1.1.3 |
5A72 | CRYSTAL STRUCTURE OF THE HOMING ENDONUCLEASE I-CVUI IN COMPLEX WITH ITS TARGET (SRO1.3) IN THE PRESENCE OF 2 MM CA | 3.1 |
5A74 | CRYSTAL STRUCTURE OF THE HOMING ENDONUCLEASE I-CVUI IN COMPLEX WITH ITS TARGET (SRO1.3) IN THE PRESENCE OF 2 MM MN | 3.1 |
5A77 | CRYSTAL STRUCTURE OF THE HOMING ENDONUCLEASE I-CVUI IN COMPLEX WITH I- CREI TARGET (C1221) IN THE PRESENCE OF 2 MM MG REVEALING DNA CLEAVED | 3.1 |
5A78 | CRYSTAL STRUCTURE OF THE HOMING ENDONUCLEASE I-CVUI IN COMPLEX WITH I- CREI TARGET (C1221) IN THE PRESENCE OF 2 MM MG REVEALING DNA NOT CLEAVED | 3.1 |
5A7F | COMPARISON OF THE STRUCTURE AND ACTIVITY OF GLYCOSYLATED AND AGLYCOSYLATED HUMAN CARBOXYLESTERASE 1 | 3.1.1.1 3.1.1.56 3.1.1.13 |
5A7G | COMPARISON OF THE STRUCTURE AND ACTIVITY OF GLYCOSYLATED AND AGLYCOSYLATED HUMAN CARBOXYLESTERASE 1 | 3.1.1.1 3.1.1.56 3.1.1.13 |
5A7H | COMPARISON OF THE STRUCTURE AND ACTIVITY OF GLYCOSYLATED AND AGLYCOSYLATED HUMAN CARBOXYLESTERASE 1 | 3.1.1.1 3.1.1.56 3.1.1.13 |
5A7R | HUMAN POLY(ADP-RIBOSE) GLYCOHYDROLASE IN COMPLEX WITH SYNTHETIC DIMERIC ADP-RIBOSE | 3.2.1.143 |
5A81 | CRYSTAL STRUCTURE OF HUMAN ATAD2 BROMODOMAIN IN COMPLEX WITH 8-(3R,4R) -3-(CYCLOHEXYLMETHOXY)PIPERIDIN-4-YL-AMINO-3-METHYL-1,2-DIHYDRO-1,7- NAPHTHYRIDIN-2-ONE | 3.6.1.3 3.6.1 |
5A82 | CRYSTAL STRUCTURE OF HUMAN ATAD2 BROMODOMAIN IN COMPLEX WITH 4-(3R,4R) -4-(3-METHYL-2-OXO-1,2-DIHYDRO-1,7-NAPHTHYRIDIN-8-YL)AMINOPIPERIDIN-3- YLOXYMETHYL)-1-THIANE-1,1-DIONE | 3.6.1.3 3.6.1 |
5A83 | CRYSTAL STRUCTURE OF HUMAN ATAD2 BROMODOMAIN IN COMPLEX WITH 4-((3R, 4R)-4-3-METHYL-5-(5-METHYLPYRIDIN-3-YL)-2-OXO-1,2-DIHYDROQUINOLIN-8- YL-AMINOPIPERIDIN-3-YLOXYMETHYL)-1-THIANE-1,1-DIONE | 3.6.1.3 3.6.1 |
5A87 | CRYSTAL STRUCTURE OF THE METALLO-BETA-LACTAMASE VIM-5 | 3.5.2.6 |
5A8M | CRYSTAL STRUCTURE OF THE SELENOMETHIONINE DERIVATIVE OF BETA-GLUCANASE SDGLUC5_26A FROM SACCHAROPHAGUS DEGRADANS | 3.2.1.73 |
5A8N | CRYSTAL STRUCTURE OF THE NATIVE FORM OF BETA-GLUCANASE SDGLUC5_26A FROM SACCHAROPHAGUS DEGRADANS | 3.2.1.73 |
5A8O | CRYSTAL STRUCTURE OF BETA-GLUCANASE SDGLUC5_26A FROM SACCHAROPHAGUS DEGRADANS IN COMPLEX WITH CELLOTETRAOSE | 3.2.1.73 |
5A8P | CRYSTAL STRUCTURE BETA-GLUCANASE SDGLUC5_26A FROM SACCHAROPHAGUS DEGRADANS IN COMPLEX WITH TETRASACCHARIDE B | 3.2.1.73 |
5A8Q | CRYSTAL STRUCTURE BETA-GLUCANASE SDGLUC5_26A FROM SACCHAROPHAGUS DEGRADANS IN COMPLEX WITH TETRASACCHARIDE A OBTAINED BY SOAKING | 3.2.1.73 |
5A90 | 100K NEUTRON LIGAND FREE: EXPLORING THE MECHANISM OF BETA-LACTAM RING PROTONATION IN THE CLASS A BETA-LACTAMASE ACYLATION MECHANISM USING NEUTRON AND X-RAY CRYSTALLOGRAPHY | 3.5.2.6 |
5A91 | 15K X-RAY LIGAND FREE: EXPLORING THE MECHANISM OF BETA-LACTAM RING PROTONATION IN THE CLASS A BETA-LACTAMASE ACYLATION MECHANISM USING NEUTRON AND X-RAY CRYSTALLOGRAPHY | 3.5.2.6 |
5A92 | 15K X-RAY STRUCTURE WITH CEFOTAXIME: EXPLORING THE MECHANISM OF BETA- LACTAM RING PROTONATION IN THE CLASS A BETA-LACTAMASE ACYLATION MECHANISM USING NEUTRON AND X-RAY CRYSTALLOGRAPHY | 3.5.2.6 |
5A93 | 293K JOINT X-RAY NEUTRON WITH CEFOTAXIME: EXPLORING THE MECHANISM OF BETA-LACTAM RING PROTONATION IN THE CLASS A BETA-LACTAMASE ACYLATION MECHANISM USING NEUTRON AND X-RAY CRYSTALLOGRAPHY | 3.5.2.6 |
5A94 | CRYSTAL STRUCTURE OF BETA-GLUCANASE SDGLUC5_26A FROM SACCHAROPHAGUS DEGRADANS IN COMPLEX WITH TETRASACCHARIDE A, FORM 1 | 3.2.1.73 |
5A95 | CRYSTAL STRUCTURE OF BETA-GLUCANASE SDGLUC5_26A FROM SACCHAROPHAGUS DEGRADANS IN COMPLEX WITH TETRASACCHARIDE A, FORM 2 | 3.2.1.73 |
5A9K | STRUCTURAL BASIS FOR DNA STRAND SEPARATION BY A HEXAMERIC REPLICATIVE HELICASE | 3.6.4.12 |
5A9W | STRUCTURE OF GDPCP BIPA | 3.6.5 |
5A9X | STRUCTURE OF GDP BOUND BIPA | 3.6.5 |
5A9Y | STRUCTURE OF PPGPP BIPA | 3.6.5 |
5AA7 | STRUCTURAL AND FUNCTIONAL CHARACTERIZATION OF A CHITIN-ACTIVE 15.5 KDA LYTIC POLYSACCHARIDE MONOOXYGENASE DOMAIN FROM A MODULAR CHITINASE FROM JONESIA DENITRIFICANS | 3.2.1.14 |
5AB0 | CRYSTAL STRUCTURE OF AMINOPEPTIDASE ERAP2 WITH LIGAND | 3.4.11.1 3.4.11.6 3.4.11 |
5AB2 | CRYSTAL STRUCTURE OF AMINOPEPTIDASE ERAP2 WITH LIGAND | 3.4.11 |
5ABE | STRUCTURE OF GH84 WITH LIGAND | 3.2.1.169 |
5ABF | STRUCTURE OF GH84 WITH LIGAND | 3.2.1.169 |
5ABG | STRUCTURE OF GH84 WITH LIGAND | 3.2.1.169 3.2.1.52 |
5ABH | STRUCTURE OF GH84 WITH LIGAND | 3.2.1.169 3.2.1.52 |
5ABJ | STRUCTURE OF COXSACKIEVIRUS A16 IN COMPLEX WITH GPP3 | 3.4.22.29 3.6.1.15 3.4.22.28 2.7.7.48 |
5ABK | STRUCTURE OF THE N-TERMINAL DOMAIN OF THE METALLOPROTEASE PRTV FROM VIBRIO CHOLERAE | 3.4.24 |
5ABW | NEUTROPHIL ELASTASE INHIBITORS FOR THE TREATMENT OF (CARDIO)PULMONARY DISEASES | 3.4.21.37 |
5AC4 | GH20C, BETA-HEXOSAMINIDASE FROM STREPTOCOCCUS PNEUMONIAE IN COMPLEX WITH GALNAC | 3.2.1.52 |
5AC5 | GH20C, BETA-HEXOSAMINIDASE FROM STREPTOCOCCUS PNEUMONIAE IN COMPLEX WITH GLCNAC | 3.2.1.52 |
5AC9 | STRUCTURE-BASED ENERGETICS OF PROTEIN INTERFACES GUIDE FOOT-AND-MOUTH DISEASE VIRUS VACCINE DESIGN | 2.7.7.48 3.4.22.28 3.4.22.46 3.6.1.15 |
5ACA | STRUCTURE-BASED ENERGETICS OF PROTEIN INTERFACES GUIDE FOOT-AND-MOUTH DISEASE VIRUS VACCINE DESIGN | 2.7.7.48 3.4.22.28 3.4.22.46 3.6.1.15 |
5ACU | VIM-2-NAT, DISCOVERY OF NOVEL INHIBITOR SCAFFOLDS AGAINST THE METALLO- BETA-LACTAMASE VIM-2 BY SPR BASED FRAGMENT SCREENING | 3.5.2.6 |
5ACV | VIM-2-OX, DISCOVERY OF NOVEL INHIBITOR SCAFFOLDS AGAINST THE METALLO- BETA-LACTAMASE VIM-2 BY SPR BASED FRAGMENT SCREENING | 3.5.2.6 |
5ACW | VIM-2-1, DISCOVERY OF NOVEL INHIBITOR SCAFFOLDS AGAINST THE METALLO- BETA-LACTAMASE VIM-2 BY SPR BASED FRAGMENT SCREENING | 3.5.2.6 |
5ACX | VIM-2-2, DISCOVERY OF NOVEL INHIBITOR SCAFFOLDS AGAINST THE METALLO- BETA-LACTAMASE VIM-2 BY SPR BASED FRAGMENT SCREENING | 3.5.2.6 |
5AE0 | PERDEUTERATED MOUSE CNPASE CATALYTIC DOMAIN AT ATOMIC RESOLUTION | 3.1.4.37 |
5AEB | CRYSTAL STRUCTURE OF THE CLASS B3 DI-ZINC METALLO-BETA-LACTAMASE LRA- 12 FROM AN ALASKAN SOIL METAGENOME. | 3.5.2.6 |
5AED | A BACTERIAL PROTEIN STRUCTURE IN GLYCOSIDE HYDROLASE FAMILY 31 | 3.2.1 3.2.1.199 |
5AEE | A BACTERIAL PROTEIN STRUCTURE IN GLYCOSIDE HYDROLASE FAMILY 31 | 3.2.1.20 3.2.1.199 |
5AEG | A BACTERIAL PROTEIN STRUCTURE IN GLYCOSIDE HYDROLASE FAMILY 31. | 3.2.1.20 3.2.1.199 |
5AEN | STRUCTURE OF HUMAN LEUKOTRIENE A4 HYDROLASE IN COMPLEX WITH INHIBITOR DIMETHYL(2- (4-PHENOXYPHENOXY)ETHYL)AMINE | 3.3.2.6 3.4.11.4 |
5AES | CRYSTAL STRUCTURE OF MURINE CHRONOPHIN (PYRIDOXAL PHOSPHATE PHOSPHATASE) IN COMPLEX WITH A PNP-DERIVED INHIBITOR | 3.1.3.74 3.1.3.3 |
5AF2 | CRYSTAL STRUCTURE OF THE C-TERMINAL 2',5'-PHOSPHODIESTERASE DOMAIN OF GROUP A ROTAVIRUS PROTEIN VP3 | 3.1.4 2.7.7.50 2.1.1.56 |
5AF7 | 3-SULFINOPROPIONYL-COENZYME A (3SP-COA) DESULFINASE FROM ADVENELLA MIMIGARDEFORDENSIS DPN7T: CRYSTAL STRUCTURE AND FUNCTION OF A DESULFINASE WITH AN ACYL-COA DEHYDROGENASE FOLD. NATIVE CRYSTAL STRUCTURE | 3.13.1.4 1.3.99 |
5AF9 | THROMBIN IN COMPLEX WITH 4-METHOXY-N-(2-PYRIDINYL)BENZAMIDE | 3.4.21.5 |
5AFE | MEDIUM RESOLUTION STRUCTURE OF THE C-TERMINAL FAMILY 65 CARBOHYDRATE BINDING MODULE (CBM65B) OF ENDOGLUCANASE CEL5A FROM EUBACTERIUM CELLULOSOLVENS WITH A BOUND XYLOGLUCAN HEPTASACCHARIDE (XXXG) | 3.2.1.4 |
5AFW | ASSEMBLY OF METHYLATED LSD1 AND CHD1 DRIVES AR-DEPENDENT TRANSCRIPTION AND TRANSLOCATION | 3.6.4.12 |
5AFY | THROMBIN IN COMPLEX WITH 3-CHLORO-BENZAMIDE | 3.4.21.5 |
5AFZ | THROMBIN IN COMPLEX WITH (2R)-2-(BENZYLSULFONYLAMINO)-N-(2-((4- CARBAMIMIDOYLPHENYL)METHYLAMINO)-2-OXO-PROPYL)-3-PHENYL-PROPANAMIDE | 3.4.21.5 |
5AGD | AN INACTIVE (D125N) VARIANT OF THE CATALYTIC DOMAIN, BCGH76, OF BACILLUS CIRCULANS AMAN6 IN COMPLEX WITH ALPHA-1,6-MANNOPENTAOSE | 3.2.1.101 |
5AGZ | DISUBSTITUTED BIS-THF MOIETIES AS NEW P2 LIGANDS IN NON-PEPTIDAL HIV- 1 PROTEASE INHIBITORS (II) | 3.4.23.16 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1 |
5AH0 | STRUCTURE OF LIPASE 1 FROM PELOSINUS FERMENTANS | 3.1.1.3 |
5AH1 | STRUCTURE OF ESTA FROM CLOSTRIDIUM BOTULINUM | 3.1.1.3 |
5AH6 | DISUBSTITUTED BIS-THF MOIETIES AS NEW P2 LIGANDS IN NON-PEPTIDAL HIV- 1 PROTEASE INHIBITORS (II) | 3.4.23.16 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1 |
5AH7 | DISUBSTITUTED BIS-THF MOIETIES AS NEW P2 LIGANDS IN NON-PEPTIDAL HIV- 1 PROTEASE INHIBITORS (II) | 3.4.23.16 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1 |
5AH8 | DISUBSTITUTED BIS-THF MOIETIES AS NEW P2 LIGANDS IN NON-PEPTIDAL HIV- 1 PROTEASE INHIBITORS (II) | 3.4.23.16 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1 |
5AH9 | DISUBSTITUTED BIS-THF MOIETIES AS NEW P2 LIGANDS IN NON-PEPTIDAL HIV- 1 PROTEASE INHIBITORS (II) | 3.4.23.16 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1 |
5AHA | DISUBSTITUTED BIS-THF MOIETIES AS NEW P2 LIGANDS IN NON-PEPTIDAL HIV- 1 PROTEASE INHIBITORS (II) | 3.4.23.16 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1 |
5AHB | DISUBSTITUTED BIS-THF MOIETIES AS NEW P2 LIGANDS IN NON-PEPTIDAL HIV- 1 PROTEASE INHIBITORS (II) | 3.4.23.16 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1 |
5AHC | DISUBSTITUTED BIS-THF MOIETIES AS NEW P2 LIGANDS IN NON-PEPTIDAL HIV- 1 PROTEASE INHIBITORS (II) | 3.4.23.16 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1 |
5AHG | THROMBIN IN COMPLEX WITH ((4-CHLOROPHENYL)SULFAMOYL))DIEMETHYLAMINE | 3.4.21.5 |
5AHO | CRYSTAL STRUCTURE OF HUMAN 5' EXONUCLEASE APOLLO | 3.1 |
5AHS | 3-SULFINOPROPIONYL-COENZYME A (3SP-COA) DESULFINASE FROM ADVENELLA MIMGARDEFORDENSIS DPN7T: HOLO CRYSTAL STRUCTURE WITH THE SUBSTRATE ANALOG SUCCINYL-COA | 3.13.1.4 1.3.99 |
5AHX | APO STRUCTURE OF SOLUBLE EPOXIDE HYDROLASE | 3.3.2.10 3.1.3.76 |
5AI0 | LIGAND COMPLEX STRUCTURE OF SOLUBLE EPOXIDE HYDROLASE | 3.3.2.10 3.1.3.76 |
5AI4 | LIGAND COMPLEX STRUCTURE OF SOLUBLE EPOXIDE HYDROLASE | 3.3.2.10 3.1.3.76 |
5AI5 | LIGAND COMPLEX STRUCTURE OF SOLUBLE EPOXIDE HYDROLASE | 3.3.2.10 3.1.3.76 |
5AI6 | LIGAND COMPLEX STRUCTURE OF SOLUBLE EPOXIDE HYDROLASE | 3.3.2.10 3.1.3.76 |
5AI8 | LIGAND COMPLEX STRUCTURE OF SOLUBLE EPOXIDE HYDROLASE | 3.3.2.10 3.1.3.76 |
5AI9 | LIGAND COMPLEX STRUCTURE OF SOLUBLE EPOXIDE HYDROLASE | 3.3.2.10 3.1.3.76 |
5AIA | LIGAND COMPLEX STRUCTURE OF SOLUBLE EPOXIDE HYDROLASE | 3.3.2.10 3.1.3.76 |
5AIB | LIGAND COMPLEX STRUCTURE OF SOLUBLE EPOXIDE HYDROLASE | 3.3.2.10 3.1.3.76 |
5AIC | LIGAND COMPLEX STRUCTURE OF SOLUBLE EPOXIDE HYDROLASE | 3.3.2.10 3.1.3.76 |
5AIF | DISCOVERY AND CHARACTERIZATION OF THERMOPHILIC LIMONENE-1,2-EPOXIDE HYDROLASES FROM HOT SPRING METAGENOMIC LIBRARIES. TOMSK-SAMPLE-NATIVE | 3.3.2.8 |
5AIG | DISCOVERY AND CHARACTERIZATION OF THERMOPHILIC LIMONENE-1,2-EPOXIDE HYDROLASES FROM HOT SPRING METAGENOMIC LIBRARIES. TOMSK-SAMPLE- VALPROMIDE COMPLEX | 3.3.2.8 |
5AIH | DISCOVERY AND CHARACTERIZATION OF THERMOPHILIC LIMONENE-1,2-EPOXIDE HYDROLASES FROM HOT SPRING METAGENOMIC LIBRARIES. CH55-SAMPLE-NATIVE | 3.3.2.8 |
5AII | DISCOVERY AND CHARACTERIZATION OF THERMOPHILIC LIMONENE-1,2-EPOXIDE HYDROLASES FROM HOT SPRING METAGENOMIC LIBRARIES. CH55-SAMPLE-PEG COMPLEX | 3.3.2.8 |
5AJH | CRYSTAL STRUCTURE OF FUSARIUM OXYSPORUM CUTINASE | 3.1.1.74 |
5AJV | HUMAN PFKFB3 IN COMPLEX WITH AN INDOLE INHIBITOR 1 | 2.7.1.105 3.1.3.46 |
5AJW | HUMAN PFKFB3 IN COMPLEX WITH AN INDOLE INHIBITOR 2 | 2.7.1.105 3.1.3.46 |
5AJX | HUMAN PFKFB3 IN COMPLEX WITH AN INDOLE INHIBITOR 3 | 2.7.1.105 3.1.3.46 |
5AJY | HUMAN PFKFB3 IN COMPLEX WITH AN INDOLE INHIBITOR 4 | 2.7.1.105 3.1.3.46 |
5AJZ | HUMAN PFKFB3 IN COMPLEX WITH AN INDOLE INHIBITOR 5 | 2.7.1.105 3.1.3.46 |
5AK0 | HUMAN PFKFB3 IN COMPLEX WITH AN INDOLE INHIBITOR 6 | 2.7.1.105 3.1.3.46 |
5AK3 | LIGAND COMPLEX STRUCTURE OF SOLUBLE EPOXIDE HYDROLASE | 3.3.2.10 3.1.3.76 |
5AK4 | LIGAND COMPLEX STRUCTURE OF SOLUBLE EPOXIDE HYDROLASE | 3.3.2.10 3.1.3.76 |
5AK5 | LIGAND COMPLEX STRUCTURE OF SOLUBLE EPOXIDE HYDROLASE | 3.3.2.10 3.1.3.76 |
5AK6 | LIGAND COMPLEX STRUCTURE OF SOLUBLE EPOXIDE HYDROLASE | 3.3.2.10 3.1.3.76 |
5AK7 | STRUCTURE OF WT PORPHYROMONAS GINGIVALIS PEPTIDYLARGININE DEIMINASE | 3.5.3 |
5AK8 | STRUCTURE OF C351A MUTANT OF PORPHYROMONAS GINGIVALIS PEPTIDYLARGININE DEIMINASE | 3.5.3 |
5AK9 | THE CRYSTAL STRUCTURE OF I-DMOI Q42AK120M IN COMPLEX WITH ITS TARGET DNA IN THE PRESENCE OF 2MM MN | 3.1 |
5AKE | LIGAND COMPLEX STRUCTURE OF SOLUBLE EPOXIDE HYDROLASE | 3.3.2.10 3.1.3.76 |
5AKF | THE CRYSTAL STRUCTURE OF I-DMOI Q42AK120M IN COMPLEX WITH ITS TARGET DNA NICKED IN THE CODING STRAND A AND IN THE PRESENCE OF 2MM MN | 3.1 |
5AKG | LIGAND COMPLEX STRUCTURE OF SOLUBLE EPOXIDE HYDROLASE | 3.3.2.10 3.1.3.76 |
5AKH | LIGAND COMPLEX STRUCTURE OF SOLUBLE EPOXIDE HYDROLASE | 3.3.2.10 3.1.3.76 |
5AKI | LIGAND COMPLEX STRUCTURE OF SOLUBLE EPOXIDE HYDROLASE | 3.3.2.10 3.1.3.76 |
5AKJ | LIGAND COMPLEX STRUCTURE OF SOLUBLE EPOXIDE HYDROLASE | 3.3.2.10 3.1.3.76 |
5AKK | LIGAND COMPLEX STRUCTURE OF SOLUBLE EPOXIDE HYDROLASE | 3.3.2.10 3.1.3.76 |
5AKL | LIGAND COMPLEX STRUCTURE OF SOLUBLE EPOXIDE HYDROLASE | 3.3.2.10 3.1.3.76 |
5AKM | THE CRYSTAL STRUCTURE OF I-DMOI G20S IN COMPLEX WITH ITS TARGET DNA IN THE PRESENCE OF 2MM MG | 3.1 |
5AKN | THE CRYSTAL STRUCTURE OF I-DMOI Q42AK120M IN COMPLEX WITH ITS TARGET DNA NICKED IN THE NON-CODING STRAND B AND IN THE PRESENCE OF 2MM MN | 3.1 |
5AKQ | X-RAY STRUCTURE AND MUTAGENESIS STUDIES OF THE N-ISOPROPYLAMMELIDE ISOPROPYLAMINOHYDROLASE, ATZC | 3.5.99.4 3.5.4.42 |
5AKX | LIGAND COMPLEX STRUCTURE OF SOLUBLE EPOXIDE HYDROLASE | 3.3.2.10 3.1.3.76 |
5AKY | LIGAND COMPLEX STRUCTURE OF SOLUBLE EPOXIDE HYDROLASE | 3.3.2.10 3.1.3.76 |
5AKZ | LIGAND COMPLEX STRUCTURE OF SOLUBLE EPOXIDE HYDROLASE | 3.3.2.10 3.1.3.76 |
5ALD | LIGAND COMPLEX STRUCTURE OF SOLUBLE EPOXIDE HYDROLASE | 3.3.2.10 3.1.3.76 |
5ALE | LIGAND COMPLEX STRUCTURE OF SOLUBLE EPOXIDE HYDROLASE | 3.3.2.10 3.1.3.76 |
5ALF | LIGAND COMPLEX STRUCTURE OF SOLUBLE EPOXIDE HYDROLASE | 3.3.2.10 3.1.3.76 |
5ALG | LIGAND COMPLEX STRUCTURE OF SOLUBLE EPOXIDE HYDROLASE | 3.3.2.10 3.1.3.76 |
5ALH | LIGAND COMPLEX STRUCTURE OF SOLUBLE EPOXIDE HYDROLASE | 3.3.2.10 3.1.3.76 |
5ALI | LIGAND COMPLEX STRUCTURE OF SOLUBLE EPOXIDE HYDROLASE | 3.3.2.10 3.1.3.76 |
5ALJ | LIGAND COMPLEX STRUCTURE OF SOLUBLE EPOXIDE HYDROLASE | 3.3.2.10 3.1.3.76 |
5ALK | LIGAND COMPLEX STRUCTURE OF SOLUBLE EPOXIDE HYDROLASE | 3.3.2.10 3.1.3.76 |
5ALL | LIGAND COMPLEX STRUCTURE OF SOLUBLE EPOXIDE HYDROLASE | 3.3.2.10 3.1.3.76 |
5ALM | LIGAND COMPLEX STRUCTURE OF SOLUBLE EPOXIDE HYDROLASE | 3.3.2.10 3.1.3.76 |
5ALN | LIGAND COMPLEX STRUCTURE OF SOLUBLE EPOXIDE HYDROLASE | 3.3.2.10 3.1.3.76 |
5ALO | LIGAND COMPLEX STRUCTURE OF SOLUBLE EPOXIDE HYDROLASE | 3.3.2.10 3.1.3.76 |
5ALP | LIGAND COMPLEX STRUCTURE OF SOLUBLE EPOXIDE HYDROLASE | 3.3.2.10 3.1.3.76 |
5ALQ | LIGAND COMPLEX STRUCTURE OF SOLUBLE EPOXIDE HYDROLASE | 3.3.2.10 3.1.3.76 |
5ALR | LIGAND COMPLEX STRUCTURE OF SOLUBLE EPOXIDE HYDROLASE | 3.3.2.10 3.1.3.76 |
5ALS | LIGAND COMPLEX STRUCTURE OF SOLUBLE EPOXIDE HYDROLASE | 3.3.2.10 3.1.3.76 |
5ALT | LIGAND COMPLEX STRUCTURE OF SOLUBLE EPOXIDE HYDROLASE | 3.3.2.10 3.1.3.76 |
5ALU | LIGAND COMPLEX STRUCTURE OF SOLUBLE EPOXIDE HYDROLASE | 3.3.2.10 3.1.3.76 |
5ALV | LIGAND COMPLEX STRUCTURE OF SOLUBLE EPOXIDE HYDROLASE | 3.3.2.10 3.1.3.76 |
5ALW | LIGAND COMPLEX STRUCTURE OF SOLUBLE EPOXIDE HYDROLASE | 3.3.2.10 3.1.3.76 |
5ALX | LIGAND COMPLEX STRUCTURE OF SOLUBLE EPOXIDE HYDROLASE | 3.3.2.10 3.1.3.76 |
5ALY | LIGAND COMPLEX STRUCTURE OF SOLUBLE EPOXIDE HYDROLASE | 3.3.2.10 3.1.3.76 |
5ALZ | LIGAND COMPLEX STRUCTURE OF SOLUBLE EPOXIDE HYDROLASE | 3.3.2.10 3.1.3.76 |
5AM0 | LIGAND COMPLEX STRUCTURE OF SOLUBLE EPOXIDE HYDROLASE | 3.3.2.10 3.1.3.76 |
5AM1 | LIGAND COMPLEX STRUCTURE OF SOLUBLE EPOXIDE HYDROLASE | 3.3.2.10 3.1.3.76 |
5AM2 | LIGAND COMPLEX STRUCTURE OF SOLUBLE EPOXIDE HYDROLASE | 3.3.2.10 3.1.3.76 |
5AM3 | LIGAND COMPLEX STRUCTURE OF SOLUBLE EPOXIDE HYDROLASE | 3.3.2.10 3.1.3.76 |
5AM4 | LIGAND COMPLEX STRUCTURE OF SOLUBLE EPOXIDE HYDROLASE | 3.3.2.10 3.1.3.76 |
5AM5 | LIGAND COMPLEX STRUCTURE OF SOLUBLE EPOXIDE HYDROLASE | 3.3.2.10 3.1.3.76 |
5AMB | CRYSTAL STRUCTURE OF THE ANGIOTENSIN-1 CONVERTING ENZYME N-DOMAIN IN COMPLEX WITH AMYLOID-BETA 35-42 | 3.4.15.1 3.2.1 |
5AMC | CRYSTAL STRUCTURE OF THE ANGIOTENSIN-1 CONVERTING ENZYME N-DOMAIN IN COMPLEX WITH AMYLOID-BETA FLUOROGENIC FRAGMENT 4-10 | 3.4.15.1 3.2.1 |
5AMP | GEOTRICHUM CANDIDUM CEL7A APO STRUCTURE AT 2.1A | 3.2.1.176 3.2.1 |
5AMQ | STRUCTURE OF THE LA CROSSE BUNYAVIRUS POLYMERASE IN COMPLEX WITH THE 3' AND 5' VIRAL RNA | 2.7.7.48 3.1 |
5AMR | STRUCTURE OF THE LA CROSSE BUNYAVIRUS POLYMERASE IN COMPLEX WITH THE 3' VIRAL RNA | 2.7.7.48 3.1 |
5AMY | CRYSTAL STRUCTURE OF HEN EGG WHITE LYSOZYME PROCESSED WITH THE CRYSTALDIRECT AUTOMATED MOUNTING AND CRYO-COOLING TECHNOLOGY | 3.2.1.17 |
5ANN | STRUCTURE OF FRUCTOFURANOSIDASE FROM XANTHOPHYLLOMYCES DENDRORHOUS | 3.2.1.26 |
5ANS | POTENT AND SELECTIVE INHIBITORS OF MTH1 PROBE ITS ROLE IN CANCER CELL SURVIVAL | 3.6.1.55 3.6.1.56 |
5ANT | POTENT AND SELECTIVE INHIBITORS OF MTH1 PROBE ITS ROLE IN CANCER CELL SURVIVAL | 3.6.1.55 3.6.1.56 |
5ANU | MTH1 IN COMPLEX WITH COMPOUND 15 | 3.6.1.55 3.6.1.56 |
5ANV | MTH1 IN COMPLEX WITH COMPOUND 15 | 3.6.1.55 3.6.1.56 |
5ANW | MTH1 IN COMPLEX WITH COMPOUND 24 | 3.6.1.55 3.6.1.56 |
5AO0 | CRYSTAL STRUCTURE OF HUMAN SAMHD1 (AMINO ACID RESIDUES 41-583) BOUND TO DDGTP | 3.1.5 |
5AO1 | CRYSTAL STRUCTURE OF HUMAN SAMHD1 (AMINO ACID RESIDUES 115-583) BOUND TO DDGTP | 3.1.5 |
5AO2 | CRYSTAL STRUCTURE OF HUMAN SAMHD1 (AMINO ACID RESIDUES 115-583) R164A VARIANT BOUND TO DGTP | 3.1.5 |
5AO4 | CRYSTAL STRUCTURE OF IN VITRO PHOSPHORYLATED HUMAN SAMHD1 (AMINO ACID RESIDUES 115-626) BOUND TO GTP | 3.1.5 |
5AO9 | THE STRUCTURE OF A NOVEL THERMOPHILIC ESTERASE FROM THE PLANCTOMYCETES SPECIES, THERMOGUTTA TERRIFONTIS, EST2-NATIVE | 3.1.1.1 |
5AOA | THE STRUCTURE OF A NOVEL THERMOPHILIC ESTERASE FROM THE PLANCTOMYCETES SPECIES, THERMOGUTTA TERRIFONTIS, EST2-PROPIONATE BOUND | 3.1.1.1 |
5AOB | THE STRUCTURE OF A NOVEL THERMOPHILIC ESTERASE FROM THE PLANCTOMYCETES SPECIES, THERMOGUTTA TERRIFONTIS, EST2-BUTYRATE BOUND | 3.1.1.1 |
5AOC | THE STRUCTURE OF A NOVEL THERMOPHILIC ESTERASE FROM THE PLANCTOMYCETES SPECIES, THERMOGUTTA TERRIFONTIS, EST2-VALERATE BOUND | 3.1.1.1 |
5AOR | STRUCTURE OF MLE RNA ADP ALF4 COMPLEX | 3.6.4.13 |
5AP9 | CONTROLLED LID-OPENING IN THERMOMYCES LANUGINOSUS LIPASE - A SWITCH FOR ACTIVITY AND BINDING | 3.1.1.3 |
5APC | HEN EGG WHITE LYSOZYME ILLUMINATED WITH 0.4THZ RADIATION | 3.2.1.17 |
5APD | HEN EGG WHITE LYSOZYME NOT ILLUMINATED WITH 0.4THZ RADIATION | 3.2.1.17 |
5APE | HEN EGG WHITE LYSOZYME REFERENCE DATASET ODD FRAMES | 3.2.1.17 |
5APF | HEN EGG WHITE LYSOZYME REFERENCE DATASET EVEN FRAMES | 3.2.1.17 |
5APR | STRUCTURES OF COMPLEXES OF RHIZOPUSPEPSIN WITH PEPSTATIN AND OTHER STATINE-CONTAINING INHIBITORS | 3.4.23.6 3.4.23.21 |
5AQ0 | THE STRUCTURE OF THE TRANSTHYRETIN-LIKE DOMAIN OF THE FIRST CATALYTIC DOMAIN OF THE HUMAN CARBOXYPEPTIDASE D | 3.4.17.22 |
5AQE | COOPERATIVE BIO-METALLIC SELECTIVITY IN A TAILORED PROTEASE ENABLES CREATION OF A C-C CROSS-COUPLING HECKASE | 3.4.21.62 |
5AQF | FRAGMENT-BASED SCREENING OF HSP70 SHEDS LIGHT ON THE FUNCTIONAL ROLE OF ATP-BINDING SITE RESIDUES | 3.6.3.51 |
5AQG | FRAGMENT-BASED SCREENING OF HSP70 SHEDS LIGHT ON THE FUNCTIONAL ROLE OF ATP-BINDING SITE RESIDUES | 3.6.3.51 |
5AQH | FRAGMENT-BASED SCREENING OF HSP70 SHEDS LIGHT ON THE FUNCTIONAL ROLE OF ATP-BINDING SITE RESIDUES | 3.6.3.51 |
5AQI | FRAGMENT-BASED SCREENING OF HSP70 SHEDS LIGHT ON THE FUNCTIONAL ROLE OF ATP-BINDING SITE RESIDUES | 3.6.3.51 |
5AQJ | FRAGMENT-BASED SCREENING OF HSP70 SHEDS LIGHT ON THE FUNCTIONAL ROLE OF ATP-BINDING SITE RESIDUES | 3.6.3.51 |
5AQK | FRAGMENT-BASED SCREENING OF HSP70 SHEDS LIGHT ON THE FUNCTIONAL ROLE OF ATP-BINDING SITE RESIDUES | 3.6.3.51 |
5AQL | FRAGMENT-BASED SCREENING OF HSP70 SHEDS LIGHT ON THE FUNCTIONAL ROLE OF ATP-BINDING SITE RESIDUES | 3.6.3.51 |
5AQM | FRAGMENT-BASED SCREENING OF HSP70 SHEDS LIGHT ON THE FUNCTIONAL ROLE OF ATP-BINDING SITE RESIDUES | 3.6.3.51 |
5AQN | FRAGMENT-BASED SCREENING OF HSP70 SHEDS LIGHT ON THE FUNCTIONAL ROLE OF ATP-BINDING SITE RESIDUES | 3.6.3.51 |
5AQO | FRAGMENT-BASED SCREENING OF HSP70 SHEDS LIGHT ON THE FUNCTIONAL ROLE OF ATP-BINDING SITE RESIDUES | 3.6.3.51 |
5AQP | FRAGMENT-BASED SCREENING OF HSP70 SHEDS LIGHT ON THE FUNCTIONAL ROLE OF ATP-BINDING SITE RESIDUES | 3.6.3.51 |
5AQQ | FRAGMENT-BASED SCREENING OF HSP70 SHEDS LIGHT ON THE FUNCTIONAL ROLE OF ATP-BINDING SITE RESIDUES | 3.6.3.51 |
5AQR | FRAGMENT-BASED SCREENING OF HSP70 SHEDS LIGHT ON THE FUNCTIONAL ROLE OF ATP-BINDING SITE RESIDUES | 3.6.3.51 |
5AQS | FRAGMENT-BASED SCREENING OF HSP70 SHEDS LIGHT ON THE FUNCTIONAL ROLE OF ATP-BINDING SITE RESIDUES | 3.6.3.51 |
5AQT | FRAGMENT-BASED SCREENING OF HSP70 SHEDS LIGHT ON THE FUNCTIONAL ROLE OF ATP-BINDING SITE RESIDUES | 3.6.3.51 |
5AQU | FRAGMENT-BASED SCREENING OF HSP70 SHEDS LIGHT ON THE FUNCTIONAL ROLE OF ATP-BINDING SITE RESIDUES | 3.6.3.51 |
5AQV | FRAGMENT-BASED SCREENING OF HSP70 SHEDS LIGHT ON THE FUNCTIONAL ROLE OF ATP-BINDING SITE RESIDUES | 3.6.3.51 |
5AQW | FRAGMENT-BASED SCREENING OF HSP70 SHEDS LIGHT ON THE FUNCTIONAL ROLE OF ATP-BINDING SITE RESIDUES | 3.6.3.51 |
5AQX | FRAGMENT-BASED SCREENING OF HSP70 SHEDS LIGHT ON THE FUNCTIONAL ROLE OF ATP-BINDING SITE RESIDUES | 3.6.3.51 |
5AQY | FRAGMENT-BASED SCREENING OF HSP70 SHEDS LIGHT ON THE FUNCTIONAL ROLE OF ATP-BINDING SITE RESIDUES | 3.6.3.51 |
5AR6 | CRYSTAL STRUCTURE OF PORCINE RNASE 4 | 3.1.27 |
5ARB | COOPERATIVE BIO-METALLIC SELECTIVITY IN A TAILORED PROTEASE ENABLES CREATION OF A C-C CROSS-COUPLING HECKASE | 3.4.21.62 |
5ARC | COOPERATIVE BIO-METALLIC SELECTIVITY IN A TAILORED PROTEASE ENABLES CREATION OF A C-C CROSS-COUPLING HECKASE | 3.4.21.62 |
5ARD | COOPERATIVE BIO-METALLIC SELECTIVITY IN A TAILORED PROTEASE ENABLES CREATION OF A C-C CROSS-COUPLING HECKASE | 3.4.21.62 |
5ARJ | CRYSTAL STRUCTURE OF PORCINE RNASE 4 D80A MUTANT | 3.1.27 |
5ARK | CRYSTAL STRUCTURE OF PORCINE RNASE 4 IN COMPLEX WITH DUMP | 3.1.27 |
5ARL | CRYSTAL STRUCTURE OF PORCINE RNASE 4 D80A MUTANT IN COMPLEX WITH DCMP | 3.1.27 |
5AVD | THE 0.86 ANGSTROM STRUCTURE OF ELASTASE CRYSTALLIZED IN HIGH-STRENGTH AGAROSE HYDROGEL | 3.4.21.36 |
5AWX | CRYSTAL STRUCTURE OF HUMAN PTPRZ D1 DOMAIN | 3.1.3.48 |
5AXG | CRYSTAL STRUCTURE OF THERMOPHILIC DEXTRANASE FROM THERMOANAEROBACTER PSEUDETHANOLICUS | 3.2.1.11 |
5AXH | CRYSTAL STRUCTURE OF THERMOPHILIC DEXTRANASE FROM THERMOANAEROBACTER PSEUDETHANOLICUS, D312G MUTANT IN COMPLEX WITH ISOMALTOHEXAOSE | 3.2.1.11 |
5AXP | CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF PDE10A COMPLEXED WITH 1-(2-FLUORO-4-(2-OXO-1,3-OXAZOLIDIN-3-YL)PHENYL)-5-METHOXY-3-(1-PHENYL-1H-PYRAZOL-5-YL)PYRIDAZIN-4(1H)-ONE | 3.1.4.17 3.1.4.35 |
5AXQ | CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF PDE10A COMPLEXED WITH HIGHLY POTENT AND BRAIN-PENETRANT PDE10A INHIBITOR WITH 2-OXINDOLE SCAFFOLD | 3.1.4.17 3.1.4.35 |
5AXW | CRYSTAL STRUCTURE OF STAPHYLOCOCCUS AUREUS CAS9 IN COMPLEX WITH SGRNA AND TARGET DNA (TTGGGT PAM) | 3.1 |
5AY7 | A PSYCHROPHILIC GLYCOSIDE HYDROLASE FAMILY 10 ENDO-BETA-1,4-XYLANASE | 3.2.1.8 |
5B05 | LYSOZYME (CONTROL EXPERIMENT) | 3.2.1.17 |
5B06 | LYSOZYME (DENATURED BY NAOD AND REFOLDED) | 3.2.1.17 |
5B07 | LYSOZYME (DENATURED BY DCL AND REFOLDED) | 3.2.1.17 |
5B16 | X-RAY STRUCTURE OF DROSHA IN COMPLEX WITH THE C-TERMINAL TAIL OF DGCR8. | 3.1.26.3 |
5B1C | CRYSTAL STRUCTURE OF DEN4 ED3 MUTANT WITH L387I | 3.4.21.91 3.6.1.15 3.6.4.13 2.1.1.56 2.1.1.57 2.7.7.48 |
5B1D | CRYSTAL STRUCTURE OF PROTEINASE K FROM ENGYODONTIUM ALBUM | 3.4.21.64 |
5B1E | CRYSTAL STRUCTURE OF PROTEINASE K FROM ENGYODONTIUM ALBUM | 3.4.21.64 |
5B1F | CRYSTAL STRUCTURE OF HEN EGG-WHITE LYSOZYME | 3.2.1.17 |
5B1G | CRYSTAL STRUCTURE OF HEN EGG-WHITE LYSOZYME | 3.2.1.17 |
5B25 | CRYSTAL STRUCTURE OF HUMAN PDE1B WITH INHIBITOR 3 | 3.1.4.17 |
5B2C | CRYSTAL STRUCTURE OF MUMPS VIRUS HEMAGGLUTININ-NEURAMINIDASE | 3.2.1.18 |
5B2D | CRYSTAL STRUCTURE OF MUMPS VIRUS HEMAGGLUTININ-NEURAMINIDASE BOUND TO 3-SIALYLLACTOSE | 3.2.1.18 |
5B2G | CRYSTAL STRUCTURE OF HUMAN CLAUDIN-4 IN COMPLEX WITH C-TERMINAL FRAGMENT OF CLOSTRIDIUM PERFRINGENS ENTEROTOXIN | 3.2.1.17 |
5B2O | CRYSTAL STRUCTURE OF FRANCISELLA NOVICIDA CAS9 IN COMPLEX WITH SGRNA AND TARGET DNA (TGG PAM) | 3.1 |
5B2P | CRYSTAL STRUCTURE OF FRANCISELLA NOVICIDA CAS9 IN COMPLEX WITH SGRNA AND TARGET DNA (TGA PAM) | 3.1 |
5B2Q | CRYSTAL STRUCTURE OF FRANCISELLA NOVICIDA CAS9 RHA IN COMPLEX WITH SGRNA AND TARGET DNA (TGG PAM) | 3.1 |
5B3R | CRYSTAL STRUCTURE OF METALLO-BETA-LACTAMASE IMP-18 FROM PSEUDOMONAS AERUGINOSA | 3.5.2.6 |
5B49 | CRYSTAL STRUCTURE OF LPXH WITH MANGANESE FROM PSEUDOMONAS AERUGINOSA | 3.6.1.54 |
5B4A | CRYSTAL STRUCTURE OF LPXH WITH LIPID X IN SPACEGROUP P21 | 3.6.1.54 |
5B4B | CRYSTAL STRUCTURE OF LPXH WITH LIPID X IN SPACEGROUP C2 | 3.6.1.54 |
5B4C | CRYSTAL STRUCTURE OF H10N MUTANT OF LPXH WITH MANGANESE | 3.6.1.54 |
5B4D | CRYSTAL STRUCTURE OF H10N MUTANT OF LPXH | 3.6.1.54 |
5B59 | HEN EGG-WHITE LYSOZYME MODIFIED WITH A KETO-ABNO. | 3.2.1.17 |
5B5J | HEN EGG WHITE LYSOZYME WITH BORON TRACEDRUG UTX-97 | 3.2.1.17 |
5B5O | CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF MMP-13 COMPLEXED WITH N-PHENYL-4-((4H-1,2,4-TRIAZOL-3-YLSULFANYL)METHYL)-1,3-THIAZOL-2-AMINE | 3.4.24 |
5B5P | CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF MMP-13 COMPLEXED WITH 4-OXO-N-(3-(2-(1H-1,2,4-TRIAZOL-3-YLSULFANYL)ETHOXY)BENZYL)-3,4-DIHYDROQUINAZOLINE-2-CARBOXAMIDE | 3.4.24 |
5B5Q | 1.7 ANGSTROMS STRUCTURE OF CHLADUB1 FROM CHLAMYDIA TRACHOMATIS | 3.4.22 |
5B5T | CRYSTAL STRUCTURE OF ESCHERICHIA COLI GAMMA-GLUTAMYLTRANSPEPTIDASE IN COMPLEX WITH PEPTIDYL PHOSPHONATE INHIBITOR 1B | 2.3.2.2 3.4.19.13 |
5B5U | CRYSTAL STRUCTURE OF TRUNCATED PYROCOCCUS FURIOSUS L-ASPARAGINASE WITH PEPTIDE | 3.5.1.1 |
5B6C | STRUCTURAL DETAILS OF UFD1 BINDING TO P97 | 3.6.4.6 |
5B6J | CRYSTAL STRUCTURE OF PEPTIDYL-TRNA HYDROLASE MUTANT -H24N FROM VIBRIO CHOLERAE | 3.1.1.29 |
5B6S | CATALYTIC DOMAIN OF COPRINOPSIS CINEREA GH62 ALPHA-L-ARABINOFURANOSIDASE | 3.2.1.55 |
5B6T | CATALYTIC DOMAIN OF COPRINOPSIS CINEREA GH62 ALPHA-L-ARABINOFURANOSIDASE COMPLEXED WITH PB | 3.2.1.55 |
5B74 | CRYSTAL STRUCTURE OF CONJOINED PYROCOCCUS FURIOSUS L-ASPARAGINASE WITH PEPTIDE | 3.5.1.1 |
5B7G | STRUCTURES AND FUNCTIONAL ANALYSIS OF PERIPLASMIC 5-METHYLTHIOADENOSINE/S-ADENOSYLHOMOCYSTEINE NUCLEOSIDASE FROM AEROMONAS HYDROPHILA | 3.2.2.16 3.2.2.9 |
5B7N | CRYSTAL STRUCTURE OF PERIPLASMIC 5-METHYLTHIOADENOSINE/S-ADENOSYLHOMOCYSTEINE NUCLEOSIDASE FROM AEROMONAS HYDROPHILA | 3.2.2.16 3.2.2.9 |
5B7P | STRUCTURES AND FUNCTIONAL ANALYSIS OF PERIPLASMIC 5-METHYLTHIOADENOSINE/S-ADENOSYLHOMOCYSTEINE NUCLEOSIDASE FROM AEROMONAS HYDROPHILA | 3.2.2.16 3.2.2.9 |
5B7Q | STRUCTURES AND FUNCTIONAL ANALYSIS OF PERIPLASMIC 5-METHYLTHIOADENOSINE/S-ADENOSYLHOMOCYSTEINE NUCLEOSIDASE FROM AEROMONAS HYDROPHILA | 3.2.2.16 3.2.2.9 |
5B88 | RRM-LIKE DOMAIN OF DEAD-BOX PROTEIN, CSDA | 3.6.4.13 |
5B8I | CRYSTAL STRUCTURE OF CALCINEURIN A AND CALCINEURIN B IN COMPLEX WITH FKBP12 AND FK506 FROM COCCIDIOIDES IMMITIS RS | 3.1.3.16 |
5BCA | BETA-AMYLASE FROM BACILLUS CEREUS VAR. MYCOIDES | 3.2.1.2 |
5BIR | DISECTING HISTIDINE INTERACTIONS IN RIBONUCLEASE T1 USING ASN AND GLN MUTATIONS | 3.1.27.3 4.6.1.24 |
5BK4 | CRYO-EM STRUCTURE OF MCM2-7 DOUBLE HEXAMER ON DSDNA | 3.6.4.12 |
5BK8 | CANCER-ASSOCIATED SHP2/T507K MUTANT | 3.1.3.48 |
5BMQ | CRYSTAL STRUCTURE OF L,D-TRANSPEPTIDASE (YKU) FROM STACKEBRANDTIA NASSAUENSIS | 3 |
5BN3 | STRUCTURE OF A UNIQUE ATP SYNTHASE NEQA-NEQB IN COMPLEX WITH ADP FROM NANOARCHEAUM EQUITANS | 3.6.3.14 7.1.2.2 |
5BN4 | STRUCTURE OF A UNIQUE ATP SYNTHASE NEQA-NEQB IN COMPLEX WITH ANP FROM NANOARCHEAUM EQUITANS | 3.6.3.14 7.1.2.2 |
5BN5 | STRUCTURAL BASIS FOR A UNIQUE ATP SYNTHASE CORE COMPLEX FROM NANOARCHEAUM EQUITANS | 3.6.3.14 7.1.2.2 |
5BN7 | CRYSTAL STRUCTURE OF MALTODEXTRIN GLUCOSIDASE FROM E.COLI AT 3.7 A RESOLUTION | 3.2.1.20 |
5BNN | CRYSTAL STRUCTURE OF HUMAN ENTEROVIRUS D68 IN COMPLEX WITH 6'SL | 3.4.22.29 3.6.1.15 3.4.22.28 2.7.7.48 |
5BNO | CRYSTAL STRUCTURE OF HUMAN ENTEROVIRUS D68 IN COMPLEX WITH 6'SLN | 3.4.22.29 3.6.1.15 3.4.22.28 2.7.7.48 |
5BNP | CRYSTAL STRUCTURE OF HUMAN ENTEROVIRUS D68 IN COMPLEX WITH 3'SLN | 3.4.22.29 3.6.1.15 3.4.22.28 2.7.7.48 |
5BOH | CRYSTAL STRUCTURE OF OXA-58 WITH THE SUBSTRATE-BINDING CLEFT IN A CLOSED STATE | 3.5.2.6 |
5BON | CRYSTAL STRUCTURE OF HUMAN NUDT15 (MTH2) | 3.6.1.55 3.6.1.9 |
5BOT | X-RAY CO-STRUCTURE OF MMP-13 WITH ETHYL 5-CARBAMOYL-1H-INDOLE-2-CARBOXYLATE | 3.4.24 |
5BOY | X-RAY CO-STRUCTURE OF MMP-13 WITH ETHYL 5-(1-METHYL-1H-IMIDAZOL-5-YL)-1H-INDOLE-2-CARBOXYLATE | 3.4.24 |
5BPA | X-RAY CO-STRUCTURE OF MMP-13 WITH 4-[({5-[2-(ETHOXYCARBONYL)-1H-INDOL-5-YL]-1-METHYL-1H-PYRAZOL-3-YL}FORMAMIDO)METHYL]BENZOATE | 3.4.24 |
5BPS | STRUCTURE OF THE YEAST F1FO ATPASE C10 RING WITH OLIGOMYCIN A | 3.6 |
5BQ6 | STRUCTURE OF THE YEAST F1FO ATPASE C10 RING WITH OLIGOMYCIN B | 3.6 |
5BQA | STRUCTURE OF THE YEAST F1FO ATPASE C10 RING WITH OLIGOMYCIN C | 3.6 |
5BQJ | STRUCTURE OF THE YEAST F1FO ATPASE C10 RING WITH 21-HYDROXY-OLIGOMYCIN | 3.6 |
5BQM | CRYSTAL STRUCTURE OF SXN101959, A CLOSTRIDIUM BOTULINUM NEUROTOXIN TYPE D DERIVATIVE AND TARGETED SECRETION INHIBITOR | 3.4.24.69 |
5BRR | MICHAELIS COMPLEX OF TPA-S195A:PAI-1 | 3.4.21.68 |
5BRY | HIV-1 WILD TYPE PROTEASE WITH GRL-011-11A (A METHYLAMINE BIS-TETRAHYDROFURAN P2-LIGAND, SULFONAMIDE ISOSTERE DERIVATE) | 3.4.23.16 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1 |
5BS4 | HIV-1 WILD TYPE PROTEASE WITH GRL-047-11A (A METHYLAMINE BIS-TETRAHYDROFURAN P2-LIGAND, 4-AMINO SULFONAMIDE DERIVATIVE) | 3.4.23.16 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1 |
5BTB | CRYSTAL STRUCTURE OF ASHBYA GOSSYPII RAI1 | 3.6.1 3.1.13 |
5BTE | CRYSTAL STRUCTURE OF ASHBYA GOSSYPII RAI1 IN COMPLEX WITH PU(S)6-MN2+ | 3.6.1 3.1.13 |
5BTH | CRYSTAL STRUCTURE OF CANDIDA ALBICANS RAI1 | 3.6.1 |
5BTO | CRYSTAL STRUCTURE OF SCHEFFERSOMYCES STIPITIS RAI1 | 3.6.1 |
5BTR | CRYSTAL STRUCTURE OF SIRT1 IN COMPLEX WITH RESVERATROL AND AN AMC-CONTAINING PEPTIDE | 3.5.1 2.3.1.286 2.3.1 |
5BU4 | RIBONUCLEASE T1 COMPLEX WITH 2'GMP | 3.1.27.3 4.6.1.24 |
5BU6 | STRUCTURE OF BPSB DEACEYLASE DOMAIN FROM BORDETELLA BRONCHISEPTICA | 3.5.1.33 |
5BU9 | CRYSTAL STRUCTURE OF BETA-N-ACETYLHEXOSAMINIDASE FROM BEUTENBERGIA CAVERNAE DSM 12333 | 3.2.1.52 |
5BUD | CRYSTAL STRUCTURE OF CANDIDA ALBICANS RAI1 IN COMPLEX WITH PU5-MN2+ | 3.6.1 |
5BUG | CRYSTAL STRUCTURE OF HUMAN PHOSPHATASE PTEN OXIDIZED BY H2O2 | 3.1.3.16 3.1.3.48 3.1.3.67 |
5BV3 | YEAST SCAVENGER DECAPPING ENZYME IN COMPLEX WITH M7GDP | 3.6.1.59 |
5BV9 | THE STRUCTURE OF BACILLUS PUMILUS GH48 IN COMPLEX WITH CELLOBIOSE | 3.2.1.91 |
5BW8 | 2.8 A CRYSTAL STRUCTURE OF A GET3-GET4-GET5 INTERMEDIATE COMPLEX FROM S.CEREVISIAE | 3.6 |
5BWB | ACETYLCHOLINESTERASE (E.C. 3.1.1.7) FROM TORPEDO CALIFORNICA IN COMPLEX WITH THE BIS-IMIDAZOLIUM OXIME 2BIM-7 | 3.1.1.7 |
5BWC | ACETYLCHOLINESTERASE (E.C. 3.1.1.7) FROM TORPEDO CALIFORNICA IN COMPLEX WITH THE BIS-PYRIDINIUM OXIME ORTHO-7 | 3.1.1.7 |
5BWM | THE COMPLEX STRUCTURE OF C3CER EXOENZYME AND GDP BOUND RHOA (NADH-BOUND STATE) | 3.6.5.2 |
5BWY | STRUCTURE OF PROPLASMEPSIN II FROM PLASMODIUM FALCIPARUM, SPACE GROUP P43212 | 3.4.23.39 |
5BX1 | CRYSTAL STRUCTURE OF PRL-1 COMPLEX WITH COMPOUND ANALOGY 3 | 3.1.3.48 |
5BXP | LNBASE IN COMPLEX WITH LNB-LOGNAC | 3.2.1.140 3.2.1.52 |
5BXR | LNBASE IN COMPLEX WITH LNB-NHACDNJ | 3.2.1.140 3.2.1.52 |
5BXS | LNBASE IN COMPLEX WITH LNB-NHACCAS | 3.2.1.140 3.2.1.52 |
5BXT | LNBASE IN COMPLEX WITH LNB-NHACAUS | 3.2.1.140 3.2.1.52 |
5BY0 | CRYSTAL STRUCTURE OF MAGNESIUM-BOUND DUF89 PROTEIN SACCHAROMYCES CEREVISIAE | 2.1.1 3.1.3 |
5BZ6 | CRYSTAL STRUCTURE OF THE N-TERMINAL DOMAIN SINGLE MUTANT (S92A) OF THE HUMAN MITOCHONDRIAL CALCIUM UNIPORTER FUSED WITH T4 LYSOZYME | 3.2.1.17 |
5BZA | CRYSTAL STRUCTURE OF CBSA FROM THERMOTOGA NEAPOLITANA | 3.2.1.52 |
5BZX | CRYSTAL STRUCTURE OF HUMAN PHOSPHATASE PTEN TREATED WITH A BISPEROXOVANADIUM COMPLEX | 3.1.3.16 3.1.3.48 3.1.3.67 |
5C0Q | CRYSTAL STRUCTURE OF ZN BOUND CBSA FROM THERMOTOGA NEAPOLITANA | 3.2.1.52 |
5C0Y | CRYSTAL STRUCTURE OF THE RRP6 CATALYTIC DOMAIN BOUND TO POLY(U) RNA | 3.1.13 |
5C1C | CRYSTAL STRUCTURE OF THE PECTIN METHYLESTERASE FROM ASPERGILLUS NIGER IN DEGLYCOSYLATED FORM | 3.1.1.11 |
5C1E | CRYSTAL STRUCTURE OF THE PECTIN METHYLESTERASE FROM ASPERGILLUS NIGER IN PENULTIMATELY DEGLYCOSYLATED FORM (N-ACETYLGLUCOSAMINE STUB AT ASN84) | 3.1.1.11 |
5C1V | CRYSTAL STRUCTURE ANALYSIS OF CATALYTIC SUBUNIT OF HUMAN CALCINEURIN | 3.1.3.16 |
5C1W | PDE10 COMPLEXED WITH 4,6-DICHLORO-2-CYCLOPROPYL-5-METHYL-PYRIMIDINE | 3.1.4.17 3.1.4.35 |
5C24 | CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH 7-((4-((4-CYANOPHENYL)AMINO)-1,3,5-TRIAZIN-2-YL)AMINO)-6,8-DIMETHYLINDOLIZINE-2-CARBONITRILE (JLJ605), A NON-NUCLEOSIDE INHIBITOR | 3.4.23.16 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1 |
5C25 | CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH 6-((4-((4-CYANOPHENYL)AMINO)-1,3,5-TRIAZIN-2-YL)AMINO)-5,7-DIMETHYL-2-NAPHTHONITRILE (JLJ639), A NON-NUCLEOSIDE INHIBITOR | 3.4.23.16 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1 |
5C28 | PDE10 COMPLEXED WITH 6-CHLORO-2-CYCLOPROPYL-5-METHYL-PYRIMIDIN-4-AMINE | 3.1.4.17 3.1.4.35 |
5C29 | PDE10 COMPLEXED WITH 6-CHLORO-2-CYCLOPROPYL-5-METHYL-N-PROPYL-PYRIMIDIN-4-AMINE | 3.1.4.17 3.1.4.35 |
5C2A | PDE10 COMPLEXED WITH 6-CHLORO-2-CYCLOPROPYL-N-[(2,4-DIMETHYLTHIAZOL-5-YL)METHYL]-5-METHYL-PYRIMIDIN-4-AMINE | 3.1.4.17 3.1.4.35 |
5C2E | PDE10 COMPLEXED WITH6-CHLORO-N-[(2,4-DIMETHYLTHIAZOL-5-YL)METHYL]-5-METHYL-2-[2-(2-PYRIDYL)ETHOXY]PYRIMIDIN-4-AMINE | 3.1.4.17 3.1.4.35 |
5C2H | PDE10 COMPLEXED WITH 6-CHLORO-N-[(2,4-DIMETHYLTHIAZOL-5-YL)METHYL]-5-METHYL-2-[3-(2-QUINOLYL)PROPOXY]PYRIMIDIN-4-AMINE | 3.1.4.17 3.1.4.35 |
5C3N | CRYSTAL STRUCTURE OF MERS CORONAVIRUS MAIN PROTEASE IN SPACEGROUP C2221 | 3.4.19.12 3.4.22.69 |
5C3W | CRYSTAL STRUCTURE OF STAPHYLOCOCCAL NUCLEASE VARIANT DELTA+PHS V66H AT CRYOGENIC TEMPERATURE | 3.1.31.1 |
5C3X | CRYSTAL STRUCTURE OF STAPHYLOCOCCAL NUCLEASE VARIANT DELTA+PHS I72D/N100E AT CRYOGENIC TEMPERATURE | 3.1.31.1 |
5C42 | CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE (K101P) VARIANT IN COMPLEX WITH 8-(2-(2-(2,4-DIOXO-3,4-DIHYDROPYRIMIDIN-1(2H)-YL)ETHOXY)PHENOXY)INDOLIZINE-2-CARBONITRILE (JLJ555), A NON-NUCLEOSIDE INHIBITOR | 3.4.23.16 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1 |
5C4H | CRYSTAL STRUCTURE OF STAPHYLOCOCCAL NUCLEASE VARIANT DELTA+PHS I92H AT CRYOGENIC TEMPERATURE | 3.1.31.1 |
5C4W | CRYSTAL STRUCTURE OF COXSACKIEVIRUS A16 | 3.4.22.29 3.6.1.15 3.4.22.28 2.7.7.48 |
5C4Z | CRYSTAL STRUCTURE OF STAPHYLOCOCCAL NUCLEASE VARIANT DELTA+PHS L25H AT CRYOGENIC TEMPERATURE | 3.1.31.1 |
5C56 | CRYSTAL STRUCTURE OF USP7/HAUSP IN COMPLEX WITH ICP0 | 3.4.19.12 |
5C5L | CRYSTAL STRUCTURE OF STAPHYLOCOCCAL NUCLEASE VARIANT DELTA+PHS T62E / L125E AT CRYOGENIC TEMPERATURE | 3.1.31.1 |
5C5M | CRYSTAL STRUCTURE OF STAPHYLOCOCCAL NUCLEASE VARIANT DELTA+PHS T62D / V104E AT CRYOGENIC TEMPERATURE | 3.1.31.1 |
5C5V | RECOMBINANT INORGANIC PYROPHOSPHATASE FROM T BRUCEI BRUCEI | 3.6.1.1 |
5C5Z | CRYSTAL STRUCTURE ANALYSIS OF C4763, A UROPATHOGENIC E. COLI-SPECIFIC PROTEIN | 3.5.1.54 |
5C6A | CRYSTAL STRUCTURE OF STAPHYLOCOCCAL NUCLEASE VARIANT DELTA+PHS L25E / N100E AT CRYOGENIC TEMPERATURE | 3.1.31.1 |
5C6D | CRYSTAL STRUCTURE OF USP7 IN COMPLEX WITH UHRF1 | 3.4.19.12 |
5C6I | CRYSTAL STRUCTURE OF GADOLINIUM DERIVATIVE OF HEWL SOLVED USING FREE-ELECTRON LASER RADIATION | 3.2.1.17 |
5C6J | CRYSTAL STRUCTURE OF GADOLINIUM DERIVATIVE OF HEWL SOLVED USING FREE-ELECTRON LASER RADIATION | 3.2.1.17 |
5C6K | BACTERIOPHAGE P2 INTEGRASE CATALYTIC DOMAIN | 2.7.7 3.1 |
5C6L | CRYSTAL STRUCTURE OF GADOLINIUM DERIVATIVE OF HEWL SOLVED USING INTENSE FREE-ELECTRON LASER RADIATION | 3.2.1.17 |
5C7Q | CRYSTAL STRUCTURE OF THE BDELLOVIBRIO BACTERIOVORUS NUCLEOSIDE DIPHOSPHATE SUGAR HYDROLASE | 3.6.1.13 |
5C7T | CRYSTAL STRUCTURE OF THE BDELLOVIBRIO BACTERIOVORUS NUCLEOSIDE DIPHOSPHATE SUGAR HYDROLASE IN COMPLEX WITH ADP-RIBOSE | 3.6.1.13 |
5C8C | CRYSTAL STRUCTURE OF RECOMBINANT COXSACKIEVIRUS A16 CAPSID | 3.4.22.29 3.6.1.15 3.4.22.28 2.7.7.48 |
5C8L | CRYSTAL STRUCTURE OF THE BDELLOVIBRIO BACTERIOVORUS NUCLEOSIDE DIPHOSPHATE SUGAR HYDROLASE | 3.6.1.13 |
5C97 | INSULIN REGULATED AMINOPEPTIDASE | 3.4.11.3 |
5C9A | CRYSTAL STRUCTURE OF EMPTY COXSACKIEVIRUS A16 PARTICLE | 3.4.22.29 3.6.1.15 3.4.22.28 2.7.7.48 |
5C9B | CRYSTAL STRUCTURE OF A RETROPEPSIN-LIKE ASPARTIC PROTEASE FROM RICKETTSIA CONORII | 3 |
5C9F | CRYSTAL STRUCTURE OF A RETROPEPSIN-LIKE ASPARTIC PROTEASE FROM RICKETTSIA CONORII | 3 |
5C9Y | CRYSTAL STRUCTURE OF YELLOW LUPINE LLPR-10.1A PROTEIN PARTIALLY SATURATED WITH TRANS-ZEATIN | 3.1.27 |
5CA8 | STRUCTURES OF THE YEAST DYNAMIN-LIKE GTPASE SEY1P IN COMPLEX WITH GDP | 3.6.5.5 3.6.5 |
5CA9 | STRUCTURES OF THE CANDIDA ALBICANS SEY1P GTPASE IN COMPLEX WITH GDPALF4- | 3.6.5.5 3.6.5 |
5CB2 | THE STRUCTURE OF CANDIDA ALBICANS SEY1P IN COMPLEX WITH GMPPNP | 3.6.5.5 3.6.5 |
5CB3 | STRUCTURAL INSIGHTS INTO THE MECHANISM OF ESCHERICHIA COLI YMDB | 3.5.1 3.1.1.106 |
5CC4 | CRYSTAL STRUCTURE OF STAPHYLOCOCCAL NUCLEASE VARIANT DELTA+PHS T62E/V66E AT CRYOGENIC TEMPERATURE | 3.1.31.1 |
5CCA | CRYSTAL STRUCTURE OF MTB TOXIN | 3.1 |
5CCD | JOINT X-RAY/NEUTRON STRUCTURE OF MTAN D198N COMPLEX WITH SAH | 3.2.2.30 3.2.2.9 |
5CCE | JOINT X-RAY/NEUTRON STRUCTURE OF WILD TYPE MTAN COMPLEXED WITH SRH AND ADENINE | 3.2.2.30 3.2.2.9 |
5CD2 | THE CRYSTAL STRUCTURE OF ENDO-1,4-D-GLUCANASE FROM VIBRIO FISCHERI ES114 | 3.2.1.4 |
5CE5 | PROBING THE ROLES OF TWO TRYPTOPHANS SURROUNDING THE UNIQUE ZINC COORDINATION SITE IN LIPASE FAMILY I.5 | 3.1.1.3 |
5CEC | BD3459 PREDATORY ENDOPEPTIDASE FROM BDELLOVIBRIO BACTERIOVORUS IN COMPLEX WITH IMMUNITY PROTEIN BD3460 | 3.4.16.4 |
5CED | PENICILLIN G ACYLATED BD3459 PREDATORY ENDOPEPTIDASE FROM BDELLOVIBRIO BACTERIOVORUS IN COMPLEX WITH IMMUNITY PROTEIN BD3460 | 3.4.16.4 |
5CEL | CBH1 (E212Q) CELLOTETRAOSE COMPLEX | 3.2.1.91 |
5CET | CRYSTAL STRUCTURE OF RV2837C | 3.1 3.1.3.7 |
5CEV | ARGINASE FROM BACILLUS CALDEVELOX, L-LYSINE COMPLEX | 3.5.3.1 |
5CF9 | CLEAVAGE OF NICOTINAMIDE ADENINE DINUCLEOTIDE BY THE RIBOSOME INACTIVATING PROTEIN OF MOMORDICA CHARANTIA - ENZYME-NADP+ CO-CRYSTALLISATION. | 3.2.2.22 |
5CFI | STRUCTURAL AND FUNCTIONAL ATTRIBUTES OF MALARIA PARASITE AP4A HYDROLASE | 3.6.1.17 |
5CFJ | STRUCTURAL AND FUNCTIONAL ATTRIBUTES OF MALARIA PARASITE AP4A HYDROLASE | 3.6.1.17 |
5CGC | STRUCTURE OF THE HUMAN CLASS C GPCR METABOTROPIC GLUTAMATE RECEPTOR 5 TRANSMEMBRANE DOMAIN IN COMPLEX WITH THE NEGATIVE ALLOSTERIC MODULATOR 3-CHLORO-4-FLUORO-5-[6-(1H-PYRAZOL-1-YL)PYRIMIDIN-4-YL]BENZONITRILE | 3.2.1.17 |
5CGD | STRUCTURE OF THE HUMAN CLASS C GPCR METABOTROPIC GLUTAMATE RECEPTOR 5 TRANSMEMBRANE DOMAIN IN COMPLEX WITH THE NEGATIVE ALLOSTERIC MODULATOR 3-CHLORO-5-[6-(5-FLUOROPYRIDIN-2-YL)PYRIMIDIN-4-YL]BENZONITRILE - (HTL14242) | 3.2.1.17 |
5CGK | CRYSTAL STRUCTURE OF STAPHYLOCOCCAL NUCLEASE VARIANT DELTA+PHS V66D/N100E AT CRYOGENIC TEMPERATURE | 3.1.31.1 |
5CGS | CRYSTAL STRUCTURE OF FOX-4 CEPHAMYCINASE | 3.5.2.6 |
5CGW | CRYSTAL STRUCTURE OF FOX-4 CEPHAMYCINASE MUTANT Y150F | 3.5.2.6 |
5CGX | CRYSTAL STRUCTURE OF FOX-4 CEPHAMYCINASE MUTANT Y150F COMPLEXED WITH CEFOXITIN | 3.5.2.6 |
5CH9 | GKAP MUTANT B12 | 3.5 |
5CHA | THE REFINEMENT AND THE STRUCTURE OF THE DIMER OF ALPHA-*CHYMOTRYPSIN AT 1.67-*ANGSTROMS RESOLUTION | 3.4.21.1 |
5CHV | CRYSTAL STRUCTURE OF USP18-ISG15 COMPLEX | 3.4.19 |
5CIS | THE CUB1-EGF-CUB2 DOMAINS OF RAT MBL-ASSOCIATED SERINE PROTEASE-2 (MASP-2) BOUND TO CA2+ | 3.4.21.104 |
5CIX | STRUCTURE OF THE COMPLEX OF TYPE 1 RIBOSOME INACTIVATING PROTEIN WITH TRIETHANOLAMINE AT 1.88 ANGSTROM RESOLUTION | 3.2.2.22 |
5CKM | THE CUB1-EGF-CUB2 DOMAINS OF RAT MBL-ASSOCIATED SERINE PROTEASE-2 (MASP-2) BOUND TO CA2+ | 3.4.21.104 |
5CKQ | CUB1-EGF-CUB2 DOMAINS OF RAT MASP-1 | 3.4.21 |
5CL3 | ALKYLPURINE DNA GLYCOSYLASE ALKD BOUND TO DNA CONTAINING A 3-METHYLADENINE ANALOG (100% SUBSTRATE AT 4 HOURS) | 3.2.2 |
5CL4 | ALKYLPURINE DNA GLYCOSYLASE ALKD BOUND TO DNA CONTAINING A 3-METHYLADENINE ANALOG OR DNA CONTAINING AN ABASIC SITE AND A FREE NUCLEOBASE (71% SUBSTRATE/29% PRODUCT AT 24 HOURS) | 3.2.2 |
5CL5 | ALKYLPURINE DNA GLYCOSYLASE ALKD BOUND TO DNA CONTAINING A 3-METHYLADENINE ANALOG OR DNA CONTAINING AN ABASIC SITE AND A FREE NUCLEOBASE (51% SUBSTRATE/49% PRODUCT AT 48 HOURS) | 3.2.2 |
5CL6 | ALKYLPURINE DNA GLYCOSYLASE ALKD BOUND TO DNA CONTAINING A 3-METHYLADENINE ANALOG OR DNA CONTAINING AN ABASIC SITE AND A FREE NUCLEOBASE (33% SUBSTRATE/67% PRODUCT AT 72 HOURS) | 3.2.2 |
5CL7 | ALKYLPURINE DNA GLYCOSYLASE ALKD BOUND TO DNA CONTAINING A 3-METHYLADENINE ANALOG OR DNA CONTAINING AN ABASIC SITE AND A FREE NUCLEOBASE (18% SUBSTRATE/82% PRODUCT AT 96 HOURS) | 3.2.2 |
5CL8 | ALKYLPURINE DNA GLYCOSYLASE ALKD BOUND TO DNA CONTAINING AN ABASIC SITE AND A FREE NUCLEOBASE (100% PRODUCT AT 144 HOURS) | 3.2.2 |
5CL9 | ALKYLPURINE DNA GLYCOSYLASE ALKD BOUND TO DNA CONTAINING AN ABASIC SITE AND A FREE NUCLEOBASE (100% PRODUCT AT 240 HOURS) | 3.2.2 |
5CLA | ALKYLPURINE DNA GLYCOSYLASE ALKD BOUND TO DNA CONTAINING AN ABASIC SITE AND A FREE NUCLEOBASE (100% PRODUCT AT 360 HOURS) | 3.2.2 |
5CLB | ALKYLPURINE DNA GLYCOSYLASE ALKD BOUND TO DNA CONTAINING A 3-METHYLADENINE ANALOG (9-MER A) | 3.2.2 |
5CLC | ALKYLPURINE DNA GLYCOSYLASE ALKD BOUND TO DNA CONTAINING A 3-METHYLADENINE ANALOG (9-MER B) | 3.2.2 |
5CLD | ALKYLPURINE DNA GLYCOSYLASE ALKD BOUND TO DNA CONTAINING AN OXOCARBENIUM-INTERMEDIATE ANALOG AND A FREE 3-METHYLADENINE NUCLEOBASE | 3.2.2 |
5CLE | ALKYLPURINE DNA GLYCOSYLASE ALKD BOUND TO DNA CONTAINING AN ABASIC-SITE ANALOG AND A FREE 3-METHYLADENINE NUCLEOBASE | 3.2.2 |
5CLM | 1,4-OXAZINE BACE1 INHIBITORS | 3.4.23.46 |
5CLS | STRUCTURE OF HUMAN METHIONINE AMINOPEPTIDASE-2 COMPLEXED WITH SPIROEPOXYTRIAZOLE INHIBITOR (+)-31A | 3.4.11.18 |
5CPA | REFINED CRYSTAL STRUCTURE OF CARBOXYPEPTIDASE A AT 1.54 ANGSTROMS RESOLUTION. | 3.4.17.1 |
5CQD | CRYSTAL STRUCTURE OF THE CANCER GENOMIC DNA MUTATOR APOBEC3B | 3.5.4 3.5.4.38 |
5CQH | CRYSTAL STRUCTURE OF THE CANCER GENOMIC DNA MUTATOR APOBEC3B | 3.5.4 3.5.4.38 |
5CQI | CRYSTAL STRUCTURE OF THE CANCER GENOMIC DNA MUTATOR APOBEC3B | 3.5.4 3.5.4.38 |
5CQK | CRYSTAL STRUCTURE OF THE CANCER GENOMIC DNA MUTATOR APOBEC3B | 3.5.4 3.5.4.38 |
5CQZ | HUMAN CYTOSOLIC 5'-NUCLEOTIDASE II IN COMPLEX WITH 3-(3-IMIDAZOL-1-YLPHENYL)-N-(9H-PURIN-6-YL)BENZAMIDE | 3.1.3.5 |
5CR3 | CRYSTAL STRUCTURE OF STAPHYLOCOCCAL NUCLEASE VARIANT DELTA+PHS V104E/L125E AT CRYOGENIC TEMPERATURE | 3.1.31.1 |
5CR7 | HUMAN CYTOSOLIC 5'-NUCLEOTIDASE II IN COMPLEX WITH N-(9H-PURIN-6-YL)-3-(3-PYRROL-1-YLPHENYL)BENZAMIDE | 3.1.3.5 |
5CRI | WILD-TYPE BACILLUS SUBTILIS LIPASE A WITH 0% [BMIM][CL] | 3.1.1.3 |
5CRU | CRYSTAL STRUCTURE OF THE BRO DOMAIN OF HD-PTP | 3.1.3.48 |
5CRV | CRYSTAL STRUCTURE OF THE BRO DOMAIN OF HD-PTP IN A COMPLEX WITH THE CORE REGION OF STAM2 | 3.1.3.48 |
5CRY | STRUCTURE OF IRON-SATURATED C-LOBE OF BOVINE LACTOFERRIN AT PH 6.8 INDICATES THE SOFTENING OF IRON COORDINATION | 3.4.21 |
5CS2 | CRYSTAL STRUCTURE OF PLASMODIUM FALCIPARUM DIADENOSINE TRIPHOSPHATE HYDROLASE IN COMPLEX WITH CYCLOMARIN A | 3.6.1.29 |
5CSO | STRUCTURE OF THE COMPLEX OF TYPE 1 RIBOSOME INACTIVATING PROTEIN FROM MOMORDICA BALSAMINA WITH A NUCLEOSIDE, CYTIDINE AT 1.78 A RESOLUTION | 3.2.2.22 |
5CST | STRUCTURE OF THE COMPLEX OF TYPE 1 RIBOSOME INACTIVATING PROTEIN FROM MOMORDICA BALSAMINA WITH A NUCLEOTIDE, CYTIDINE DIPHOSPHATE AT 1.78 A RESOLUTION | 3.2.2.22 |
5CT4 | WILD-TYPE BACILLUS SUBTILIS LIPASE A WITH 5% [BMIM][CL] | 3.1.1.3 |
5CT5 | WILD-TYPE BACILLUS SUBTILIS LIPASE A WITH 10% [BMIM][CL] | 3.1.1.3 |
5CT6 | WILD-TYPE BACILLUS SUBTILIS LIPASE A WITH 20% [BMIM][CL] | 3.1.1.3 |
5CT8 | G158E/K44E/R57E/Y49E BACILLUS SUBTILIS LIPASE A WITH 0% [BMIM][CL] | 3.1.1.3 |
5CT9 | G158E/K44E/R57E/Y49E BACILLUS SUBTILIS LIPASE A WITH 5% [BMIM][CL] | 3.1.1.3 |
5CTA | G158E/K44E/R57E/Y49E BACILLUS SUBTILIS LIPASE A WITH 10% [BMIM][CL] | 3.1.1.3 |
5CTM | STRUCTURE OF BPU1 BETA-LACTAMASE | 3.5.2.6 |
5CTN | STRUCTURE OF BPU1 BETA-LACTAMASE | 3.5.2.6 |
5CU5 | CRYSTAL STRUCTURE OF ERAP2 WITHOUT CATALYTIC ZN(II) ATOM | 3.4.11 |
5CUH | CRYSTAL STRUCTURE MMP-9 COMPLEXES WITH A CONSTRAINED HYDROXAMATE BASED INHIBITOR LT4 | 3.4.24.35 |
5CUQ | IDENTIFICATION AND CHARACTERIZATION OF NOVEL BROAD SPECTRUM INHIBITORS OF THE FLAVIVIRUS METHYLTRANSFERASE | 3.4.21.91 3.6.1.15 3.6.4.13 |
5CUR | G158E/K44E/R57E/Y49E BACILLUS SUBTILIS LIPASE A WITH 20% [BMIM][CL] | 3.1.1.3 |
5CUU | CRYSTAL STRUCTURE OF TRYPANOSOMA CRUZI VACUOLAR SOLUBLE PYROPHOSPHATASES IN COMPLEX WITH BISPHOSPHONATE INHIBITOR BPH-1260 | 3.6.1.1 |
5CUV | CRYSTAL STRUCTURE OF TRYPANOSOMA CRUZI VACUOLAR SOLUBLE PYROPHOSPHATASES IN APO FORM | 3.6.1.1 |
5CUX | CRYSTAL STRUCTURE OF N-TERMINAL DOMAIN TRUNCATED TRYPANOSOMA CRUZI VACUOLAR SOLUBLE PYROPHOSPHATASES IN COMPLEX WITH PPI | 3.6.1.1 |
5CUY | CRYSTAL STRUCTURE OF TRYPANOSOMA BRUCEI VACUOLAR SOLUBLE PYROPHOSPHATASES IN APO FORM | 3.6.1.1 |
5CV4 | CRYSTAL STRUCTURE OF STAPHYLOCOCCAL NUCLEASE VARIANT DELTA+PHS V23D/V66H AT CRYOGENIC TEMPERATURE | 3.1.31.1 |
5CV5 | CRYSTAL STRUCTURE OF STAPHYLOCOCCAL NUCLEASE VARIANT DELTA+PHS K64G/V66K/E67G AT CRYOGENIC TEMPERATURE | 3.1.31.1 |
5CV6 | CRYSTAL STRUCTURE OF STAPHYLOCOCCAL NUCLEASE VARIANT DELTA+PHS V66H/I92E AT CRYOGENIC TEMPERATURE | 3.1.31.1 |
5CV7 | CRYSTAL STRUCTURE OF STAPHYLOCOCCAL NUCLEASE VARIANT DELTA+PHS V66H/I92D AT CRYOGENIC TEMPERATURE | 3.1.31.1 |
5CV8 | CRYSTAL STRUCTURE OF STAPHYLOCOCCAL NUCLEASE VARIANT DELTA+PHS V23D/T62H AT CRYOGENIC TEMPERATURE | 3.1.31.1 |
5CV9 | CRYSTAL STRUCTURE OF STAPHYLOCOCCAL NUCLEASE VARIANT DELTA+PHS L36E/V66H AT CRYOGENIC TEMPERATURE | 3.1.31.1 |
5CVM | USP46~UBIQUITIN BEA COVALENT COMPLEX | 3.4.19.12 |
5CW1 | PROTEINASE K COMPLEXED WITH 4-IODOPYRAZOLE | 3.4.21.64 |
5CW3 | STRUCTURE OF CFBRCC36-CFKIAA0157 COMPLEX (ZN EDGE) | 3.4.19 |
5CW4 | STRUCTURE OF CFBRCC36-CFKIAA0157 COMPLEX (SELENIUM EDGE) | 3.4.19 |
5CW6 | STRUCTURE OF METAL DEPENDENT ENZYME DRBRCC36 | 3.4.19 |
5CWW | CRYSTAL STRUCTURE OF THE CHAETOMIUM THERMOPHILUM HETEROTRIMERIC NUP82 NTD-NUP159 TAIL-NUP145N APD COMPLEX | 3.4.21 |
5CXR | INFLUENZA ENDONUCLEASE COMPLEXED WITH 4-BROMOPYRAZOLE | 3.1 |
5CY4 | CRYSTAL STRUCTURE OF AN OLIGORIBONUCLEASE FROM ACINETOBACTER BAUMANNII | 3.1 |
5CYM | HIV-1 REVERSE TRANSCRIPTASE COMPLEXED WITH 4-IODOPYRAZOLE | 2.7.7.49 3.4.23.16 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1 |
5CYN | JC VIRUS LARGE T-ANTIGEN ORIGIN BINDING DOMAIN F258L MUTANT | 3.6.4 |
5CYQ | HIV-1 REVERSE TRANSCRIPTASE COMPLEXED WITH 4-BROMOPYRAZOLE | 2.7.7.49 3.4.23.16 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1 |
5CYS | STRUCTURE OF THE ENZYME-PRODUCT COMPLEX RESULTING FROM TDG ACTION ON A GCAC MISMATCH | 3.2.2.29 |
5CZ1 | CRYSTAL STRUCTURE OF THE CATALYTIC CORE DOMAIN OF MMTV INTEGRASE | 3.6.1.23 3.4.23 2.7.7.49 2.7.7.7 3.1.26.4 2.7.7 3.1 |
5CZ2 | CRYSTAL STRUCTURE OF A TWO-DOMAIN FRAGMENT OF MMTV INTEGRASE | 2.7.7.49 2.7.7.7 3.1.26.4 2.7.7 3.1 3.6.1.23 3.4.23 |
5CZJ | CRYSTAL STRUCTURE OF HYPD, A 1-PYRROLINE-4-HYDROXY-2-CARBOXYLATE DEAMINASE FROM SINORHIZOBIUM MELILOTI | 3.5.4.22 4.2.1.52 |
5CZK | STRUCTURE OF E. COLI BETA-GLUCURONIDASE BOUND WITH A NOVEL, POTENT INHIBITOR 1-((6,8-DIMETHYL-2-OXO-1,2-DIHYDROQUINOLIN-3-YL)METHYL)-1-(2-HYDROXYETHYL)-3-(4-HYDROXYPHENYL)THIOUREA | 3.2.1.31 |
5CZZ | CRYSTAL STRUCTURE OF STAPHYLOCOCCUS AUREUS CAS9 IN COMPLEX WITH SGRNA AND TARGET DNA (TTGAAT PAM) | 3.1 |
5D1B | CRYSTAL STRUCTURE OF G117E HDAC8 IN COMPLEX WITH TSA | 3.5.1.98 |
5D1C | CRYSTAL STRUCTURE OF D233G-Y306F HDAC8 IN COMPLEX WITH A TETRAPEPTIDE SUBSTRATE | 3.5.1.98 |
5D1D | CRYSTAL STRUCTURE OF P91L-Y306F HDAC8 IN COMPLEX WITH A TETRAPEPTIDE SUBSTRATE | 3.5.1.98 |
5D1S | ANTHRAX TOXIN LETHAL FACTOR WITH HYDROXAMIC ACID INHIBITOR | 3.4.24.83 |
5D1T | ANTHRAX TOXIN LETHAL FACTOR WITH HYDROXAMIC ACID INHIBITOR | 3.4.24.83 |
5D1U | ANTHRAX TOXIN LETHAL FACTOR WITH HYDROXAMIC ACID INHIBITOR | 3.4.24.83 |
5D3G | STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE BOUND TO A NOVEL 38-MER HAIRPIN TEMPLATE-PRIMER DNA APTAMER | 2.7.7.49 3.4.23.16 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1 |
5D3I | CRYSTAL STRUCTURE OF THE SSL3-TLR2 COMPLEX | 3.2.2.6 |
5D3O | CRYSTAL STRUCTURE OF FULL LENGTH HUMAN GLUTAMINASE C EXPRESSED IN E.COLI | 3.5.1.2 |
5D3Q | DYNAMIN 1 GTPASE-BSE FUSION DIMER COMPLEXED WITH GDP | 3.6.5.5 |
5D5A | IN MESO IN SITU SERIAL X-RAY CRYSTALLOGRAPHY STRUCTURE OF THE BETA2-ADRENERGIC RECEPTOR AT 100 K | 3.2.1.17 |
5D5B | IN MESO X-RAY CRYSTALLOGRAPHY STRUCTURE OF THE BETA2-ADRENERGIC RECEPTOR AT 100 K | 3.2.1.17 |
5D5C | IN MESO IN SITU SERIAL X-RAY CRYSTALLOGRAPHY STRUCTURE OF LYSOZYME AT 100 K | 3.2.1.17 |
5D5F | IN MESO IN SITU SERIAL X-RAY CRYSTALLOGRAPHY STRUCTURE OF LYSOZYME BY BROMINE-SAD AT 100 K | 3.2.1.17 |
5D6E | STRUCTURE OF HUMAN METHIONINE AMINOPEPTIDASE 2 WITH COVALENT SPIROEPOXYTRIAZOLE INHIBITOR (-)-31B | 3.4.11.18 |
5D6F | STRUCTURE OF HUMAN METHIONINE AMINOPEPTIDASE-2 COMPLEXED WITH SPIROEPOXYTRIAZOLE INHIBITOR (+)-31B | 3.4.11.18 |
5D7N | CRYSTAL STRUCTURE OF HUMAN SIRT3 AT AN IMPROVED RESOLUTION | 3.5.1 2.3.1.286 |
5D7O | CRYSTAL STRUCTURE OF SIRT2-ADPR AT AN IMPROVED RESOLUTION | 3.5.1 2.3.1.286 |
5D7P | CRYSTAL STRUCTURE OF HUMAN SIRT2 IN COMPLEX WITH ADPR AND EX-243 | 3.5.1 2.3.1.286 |
5D7Q | CRYSTAL STRUCTURE OF HUMAN SIRT2 IN COMPLEX WITH ADPR AND CHIC35 | 3.5.1 2.3.1.286 |
5D7U | CRYSTAL STRUCTURE OF THE C-TERMINAL DOMAIN OF MMTV INTEGRASE | 3.6.1.23 3.4.23 2.7.7.49 2.7.7.7 3.1.26.4 2.7.7 3.1 |
5D7W | CRYSTAL STRUCTURE OF SERRALYSIN | 3.4.24.40 |
5D8A | CRYSTAL STRUCTURE OF RECOMBINANT FOOT-AND-MOUTH-DISEASE VIRUS A22-H2093F EMPTY CAPSID | 2.7.7.48 3.4.22.28 3.4.22.46 3.6.1.15 |
5D9I | SV40 LARGE T ANTIGEN ORIGIN BINDING DOMAIN BOUND TO ARTIFICIAL DNA FORK | 3.6.4 |
5DAU | CRYSTAL STRUCTURE OF STAPHYLOCOCCAL NUCLEASE VARIANT DELTA+PHS V39E/V104E AT CRYOGENIC TEMPERATURE | 3.1.31.1 |
5DBJ | CRYSTAL STRUCTURE OF HALOGENASE PLTA | 3.8.1.1 |
5DC5 | CRYSTAL STRUCTURE OF D176N HDAC8 IN COMPLEX WITH M344 | 3.5.1.98 |
5DC6 | CRYSTAL STRUCTURE OF D176N-Y306F HDAC8 IN COMPLEX WITH A TETRAPEPTIDE SUBSTRATE | 3.5.1.98 |
5DC7 | CRYSTAL STRUCTURE OF D176A-Y306F HDAC8 IN COMPLEX WITH A TETRAPEPTIDE SUBSTRATE | 3.5.1.98 |
5DC8 | CRYSTAL STRUCTURE OF H142A-Y306F HDAC8 IN COMPLEX WITH A TETRAPEPTIDE SUBSTRATE | 3.5.1.98 |
5DDJ | CRYSTAL STRUCTURE OF RECOMBINANT FOOT-AND-MOUTH-DISEASE VIRUS O1M-S2093Y EMPTY CAPSID | 2.7.7.48 3.4.22.28 3.4.22.46 3.6.1.15 |
5DDZ | CRYSTAL STRUCTURE OF THE RTA-C10-P2 COMPLEX | 3.2.2.22 |
5DEH | CRYSTAL STRUCTURE OF STAPHYLOCOCCAL NUCLEASE VARIANT DELTA+PHS N100D AT CRYOGENIC TEMPERATURE | 3.1.31.1 |
5DEZ | CRYSTAL STRUCTURE OF ACMNPV CHITINASE A | 3.2.1.14 |
5DF0 | CRYSTAL STRUCTURE OF ACMNPV CHITINASE A IN COMPLEX WITH CHITOTRIO-THIAZOLINE DITHIOAMIDE | 3.2.1.14 |
5DF6 | CRYSTAL STRUCTURE OF PTPN11 TANDEM SH2 DOMAINS IN COMPLEX WITH A TXNIP PEPTIDE | 3.1.3.48 |
5DF7 | CRYSTAL STRUCTURE OF PENICILLIN-BINDING PROTEIN 3 FROM PSEUDOMONAS AERUGINOSA IN COMPLEX WITH AZLOCILLIN | 2.4.1.129 3.4.16.4 |
5DF8 | CRYSTAL STRUCTURE OF PENICILLIN-BINDING PROTEIN 3 FROM PSEUDOMONAS AERUGINOSA IN COMPLEX WITH CEFOPERAZONE | 2.4.1.129 3.4.16.4 |
5DF9 | CRYSTAL STRUCTURE OF PENICILLIN-BINDING PROTEIN 3 IN COMPLEX WITH DEACYLATED PRODUCT OF CEFOPERAZONE | 2.4.1.129 3.4.16.4 |
5DFA | 3D STRUCTURE OF THE E323A CATALYTIC MUTANT OF GAN42B, A GH42 BETA-GALACTOSIDASE FROM G. STEAROTHERMOPHILUS | 3.2.1.23 |
5DFF | HUMAN APE1 PRODUCT COMPLEX | 4.2.99.18 3.1 |
5DFH | HUMAN APE1 MISMATCH PRODUCT COMPLEX | 3.1 4.2.99.18 |
5DFI | HUMAN APE1 PHOSPHOROTHIOATE SUBSTRATE COMPLEX | 3.1 4.2.99.18 |
5DFJ | HUMAN APE1 E96Q/D210N MISMATCH SUBSTRATE COMPLEX | 4.2.99.18 3.1 |
5DG0 | HUMAN APE1 PHOSPHOROTHIOATE SUBSTRATE COMPLEX WITH MN2+ | 3.1 4.2.99.18 |
5DG6 | 2.35A RESOLUTION STRUCTURE OF NOROVIRUS 3CL PROTEASE IN COMPLEX AN OXADIAZOLE-BASED, CELL PERMEABLE MACROCYCLIC (21-MER) INHIBITOR | 3.4.22.66 3.6.1.15 2.7.7.48 |
5DGJ | 1.0A RESOLUTION STRUCTURE OF NOROVIRUS 3CL PROTEASE IN COMPLEX AN OXADIAZOLE-BASED, CELL PERMEABLE MACROCYCLIC (20-MER) INHIBITOR | 3.4.22.66 3.6.1.15 2.7.7.48 |
5DGU | CRYSTAL STRUCTURE OF HIV-1 PROTEASE INHIBITORS CONTAINING SUBSTITUTED FUSED-TETRAHYDROPYRANYL TETRAHYDROFURAN AS P2-LIGAND GRL-004-11A | 3.4.23.16 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1 |
5DGW | CRYSTAL STRUCTURE OF HIV-1 PROTEASE INHIBITOR GRL-105-11A CONTAINING SUBSTITUTED FUSED-TETRAHYDROPYRANYL TETRAHYDROFURAN AS P2-LIGAND | 3.4.23.16 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1 |
5DGX | 1.73 ANGSTROM RESOLUTION CRYSTAL STRUCTURE OF THE ABC-ATPASE DOMAIN (RESIDUES 357-609) OF LIPID A TRANSPORT PROTEIN (MSBA) FROM FRANCISELLA TULARENSIS SUBSP. TULARENSIS SCHU S4 IN COMPLEX WITH ADP | 3.6.3 7.5.2.6 |
5DH4 | PDE10 COMPLEXED WITH 5-CHLORO-N-[(2,4-DIMETHYLTHIAZOL-5-YL)METHYL]PYRAZOLO[1,5-A]PYRIMIDIN-7-AMINE | 3.1.4.17 3.1.4.35 |
5DH5 | PDE10 COMPLEXED WITH N-[(1-METHYLPYRAZOL-4-YL)METHYL]-5-[[(1S,2S)-2-(2-PYRIDYL)CYCLOPROPYL]METHOXY]PYRAZOLO[1,5-A]PYRIMIDIN-7-AMINE | 3.1.4.17 3.1.4.35 |
5DHD | CRYSTAL STRUCTURE OF CHBD2 FROM THERMOCOCCUS KODAKARENSIS KOD1 | 3.2.1.14 |
5DHE | CRYSTAL STRUCTURE OF CHBD3 FROM THERMOCOCCUS KODAKARENSIS KOD1 | 3.2.1.14 |
5DIR | MEMBRANE PROTEIN AT 2.8 ANGSTROMS | 3.4.23.36 |
5DIZ | CRYSTAL STRUCTURE OF NUCLEAR PROTEINACEOUS RNASE P 2 (PRORP2) FROM A. THALIANA | 3.1.26.5 |
5DJ5 | CRYSTAL STRUCTURE OF RICE DWARF14 IN COMPLEX WITH SYNTHETIC STRIGOLACTONE GR24 | 3.1 |
5DJF | STRUCTURE OF M. TUBERCULOSIS CYSQ, A PAP PHOSPHATASE - LIGAND-FREE STRUCTURE | 3.1.3.7 3.1.3.11 3.1.3.25 |
5DJG | STRUCTURE OF M. TUBERCULOSIS CYSQ, A PAP PHOSPHATASE WITH PAP, MG, AND LI BOUND | 3.1.3.7 3.1.3.11 3.1.3.25 |
5DJH | STRUCTURE OF M. TUBERCULOSIS CYSQ, A PAP PHOSPHATASE WITH AMP, PO4, AND 3MG BOUND | 3.1.3.7 3.1.3.11 3.1.3.25 |
5DJI | STRUCTURE OF M. TUBERCULOSIS CYSQ, A PAP PHOSPHATASE WITH AMP, PO4, AND 2MG BOUND | 3.1.3.7 3.1.3.11 3.1.3.25 |
5DJJ | STRUCTURE OF M. TUBERCULOSIS CYSQ, A PAP PHOSPHATASE WITH PO4 AND 2MG BOUND | 3.1.3.7 3.1.3.11 3.1.3.25 |
5DJK | STRUCTURE OF M. TUBERCULOSIS CYSQ, A PAP PHOSPHATASE WITH PO4 AND 2CA BOUND | 3.1.3.7 3.1.3.11 3.1.3.25 |
5DK1 | S. ERYTHRAEA TRYPSIN MIXED CATALYTIC INTERMEDIATE | 3.4.21.4 |
5DK6 | CRYSTAL STRUCTURE OF A 5'-METHYLTHIOADENOSINE/S-ADENOSYLHOMOCYSTEINE (MTA/SAH) NUCLEOSIDASE (MTAN) FROM COLWELLIA PSYCHRERYTHRAEA 34H (CPS_4743, TARGET PSI-029300) IN COMPLEX WITH ADENINE AT 2.27 A RESOLUTION | 3.2.2.9 |
5DKC | CRYSTAL STRUCTURE OF THE BROMODOMAIN OF HUMAN BRM (SMARCA2) IN COMPLEX WITH PFI-3 CHEMICAL PROBE | 3.6.4 |
5DKD | CRYSTAL STRUCTURE OF THE BROMODOMAIN OF HUMAN BRG1 (SMARCA4) IN COMPLEX WITH PFI-3 CHEMICAL PROBE | 3.6.4 |
5DKH | CRYSTAL STRUCTURE OF THE BROMODOMAIN OF HUMAN BRM (SMARCA2) IN COMPLEX WITH A HYDROXYPHENYL PROPENONE INHIBITOR 17 | 3.6.4 |
5DKM | S. ERYTHRAEA TRYPSIN MICHAELIS-MENTEN COMPLEX | 3.4.21.4 |
5DL9 | STRUCTURE OF TETRAGONAL LYSOZYME IN COMPLEX WITH IODINE SOLVED BY UWO STUDENTS | 3.2.1.17 |
5DLA | STRUCTURE OF TETRAGONAL LYSOZYME SOLVED BY UWO STUDENTS | 3.2.1.17 |
5DLH | SFX STRUCTURE OF THERMOLYSIN | 3.4.24.27 |
5DLL | AMINOPEPTIDASE N (PEPN) FROM FRANCISELLA TULARENSIS SUBSP. TULARENSIS SCHU S4 | 3.4.11.2 |
5DLO | S. AUREUS MAZF IN COMPLEX WITH SUBSTRATE ANALOGUE | 3.1 |
5DM5 | CRYSTAL STRUCTURE OF THE HEXAMERIC THIOESTERASE Y2039 FROM YERSINIA PESTIS | 3.1.2 3.1.2.20 |
5DMA | CRYSTAL STRUCTURE OF C-TERMINAL TUDOR DOMAIN IN PCRA/UVRD HELICASE | 3.6.4.12 |
5DMY | BETA-GALACTOSIDASE - CONSTRUCT 33-930 | 3.2.1.23 |
5DN4 | STRUCTURE OF THE GLYCOSIDE HYDROLASE DOMAIN FROM SALMONELLA TYPHIMURIUM FLGJ | 3.2.1 |
5DN5 | STRUCTURE OF A C-TERMINALLY TRUNCATED GLYCOSIDE HYDROLASE DOMAIN FROM SALMONELLA TYPHIMURIUM FLGJ | 3.2.1 |
5DNC | CRYSTAL STRUCTURE OF THE ASN-BOUND GUINEA PIG L-ASPARAGINASE 1 CATALYTIC DOMAIN ACTIVE SITE MUTANT T19A | 3.5.1.1 |
5DND | CRYSTAL STRUCTURE OF THE ASN-BOUND GUINEA PIG L-ASPARAGINASE 1 CATALYTIC DOMAIN ACTIVE SITE MUTANT T116A | 3.5.1.1 |
5DNE | CRYSTAL STRUCTURE OF THE ASN-BOUND GUINEA PIG L-ASPARAGINASE 1 CATALYTIC DOMAIN ACTIVE SITE MUTANT K188M | 3.5.1.1 |
5DNY | STRUCTURE OF THE ATPRS-MRE11/RAD50-DNA COMPLEX | 3.1 |
5DOR | P2 INTEGRASE CATALYTIC DOMAIN IN SPACE GROUP P21 | 2.7.7 3.1 |
5DPE | THERMOLYSIN IN COMPLEX WITH INHIBITOR. | 3.4.24.27 |
5DPF | THERMOLYSIN IN COMPLEX WITH INHIBITOR. | 3.4.24.27 |
5DPX | 1,2,4-TRIAZOLE-3-THIONE COMPOUNDS AS INHIBITORS OF L1, DI-ZINC METALLO-BETA-LACTAMASES. | 3.5.2.6 |
5DPZ | ENDOTHIAPEPSIN IN COMPLEX WITH FRAGMENT 31 | 3.4.23.22 |
5DQ1 | ENDOTHIAPEPSIN IN COMPLEX WITH FRAGMENT 34 | 3.4.23.22 |
5DQ2 | ENDOTHIAPEPSIN IN COMPLEX WITH FRAGMENT 48 | 3.4.23.22 |
5DQ4 | ENDOTHIAPEPSIN IN COMPLEX WITH FRAGMENT 66 | 3.4.23.22 |
5DQ5 | ENDOTHIAPEPSIN IN COMPLEX WITH FRAGMENT 209 | 3.4.23.22 |
5DQ6 | MUS MUSCULUS A20 OTU DOMAIN | 3.4.19.12 6.3.2 2.3.2 |
5DQC | CO-CRYSTAL OF BACE1 WITH COMPOUND 0211 | 3.4.23.46 |
5DQU | CRYSTAL STRUCTURE OF CAS-DNA-10 COMPLEX | 3.1 |
5DQX | CRYSTAL STRUCTURE OF SALMONELLA TYPHI - OMPLA WITH INHERENT BOUND COFACTOR | 3.1.1.32 3.1.1.4 |
5DR0 | ENDOTHIAPEPSIN IN COMPLEX WITH FRAGMENT 203 | 3.4.23.22 |
5DR1 | ENDOTHIAPEPSIN IN COMPLEX WITH FRAGMENT 278 | 3.4.23.22 |
5DR3 | ENDOTHIAPEPSIN IN COMPLEX WITH FRAGMENT 333 | 3.4.23.22 |
5DR4 | ENDOTHIAPEPSIN IN COMPLEX WITH FRAGMENT 231 | 3.4.23.22 |
5DR7 | ENDOTHIAPEPSIN IN COMPLEX WITH FRAGMENT 311 | 3.4.23.22 |
5DR8 | ENDOTHIAPEPSIN IN COMPLEX WITH FRAGMENT 330 | 3.4.23.22 |
5DS4 | CRYSTAL STRUCTURE THE ESCHERICHIA COLI CAS1-CAS2 COMPLEX BOUND TO PROTOSPACER DNA | 3.1 |
5DS5 | CRYSTAL STRUCTURE THE ESCHERICHIA COLI CAS1-CAS2 COMPLEX BOUND TO PROTOSPACER DNA AND MG | 3.1 |
5DS6 | CRYSTAL STRUCTURE THE ESCHERICHIA COLI CAS1-CAS2 COMPLEX BOUND TO PROTOSPACER DNA WITH SPLAYED ENDS | 3.1 |
5DTE | CRYSTAL STRUCTURE OF AN ABC TRANSPORTER PERIPLASMIC SOLUTE BINDING PROTEIN (IPR025997) FROM ACTINOBACILLUS SUCCINOGENES 130Z(ASUC_0081, TARGET EFI-511065) WITH BOUND D-ALLOSE | 3.6.3.17 |
5DTI | CRYSTAL STRUCTURE OF MOUSE ACETYLCHOLINESTERASE | 3.1.1.7 |
5DTJ | CRYSTAL STRUCTURE OF DFP-INHIBITED MOUSE ACETYLCHOLINESTERASE IN COMPLEX WITH THE REACTIVATOR SP-134 | 3.1.1.7 |
5DTO | DENGUE VIRUS FULL LENGTH NS5 COMPLEXED WITH VIRAL CAP 0-RNA AND SAH | 3.4.21.91 3.6.1.15 3.6.4.13 2.1.1.56 2.1.1.57 2.7.7.48 |
5DUD | CRYSTAL STRUCTURE OF E. COLI YBGJK | 3.5.2.9 |
5DUS | CRYSTAL STRUCTURE OF MERS-COV MACRO DOMAIN IN COMPLEX WITH ADP-RIBOSE | 3.4.19.12 3.4.22.69 3.4.22 |
5DV4 | CRYSTAL STRUCTURE OF HUMAN CNOT6L IN COMPLEX WITH NEOMYCIN | 3.1.13.4 |
5DW8 | CRYSTAL STRUCTURE OF 2'AMP BOUND SAIMPASE-II | 3.1.3.25 |
5DWA | CRYSTAL STRUCTURE OF PRE-SPECIFIC RESTRICTION ENDONUCLEASE AGEI-DNA COMPLEX | 3.1.21.4 |
5DWB | CRYSTAL STRUCTURE OF SPECIFIC RESTRICTION ENDONUCLEASE AGEI-DNA COMPLEX | 3.1.21.4 |
5DWC | CRYSTAL STRUCTURE OF RESTRICTION ENDONUCLEASE AGEI | 3.1.21.4 |
5DWD | CRYSTAL STRUCTURE OF ESTERASE PE8 | 3.1.1.1 |
5DY4 | CRYSTAL STRUCTURE OF HUMAN SIRT2 IN COMPLEX WITH A BROMINATED 2ND GENERATION SIRREAL INHIBITOR AND NAD+ | 3.5.1 2.3.1.286 |
5DY5 | CRYSTAL STRUCTURE OF HUMAN SIRT2 IN COMPLEX WITH A SIRREAL PROBE FRAGMENT | 3.5.1 2.3.1.286 |
5DYF | THE CRYSTAL STRUCTURE OF AMINOPEPTIDASE N IN COMPLEX WITH N-BENZYL-1,2-DIAMINOETHYLPHOSPHONIC ACID | 3.4.11.2 |
5DYG | STRUCTURE OF P97 N-D1 L198W MUTANT IN COMPLEX WITH ADP | 3.6.4.6 |
5DYT | CRYSTAL STRUCTURE OF HUMAN BUTYRYLCHOLINESTERASE IN COMPLEX WITH N-((1-BENZYLPIPERIDIN-3-YL)METHYL)-N-METHYLNAPHTHALENE-2-SULFONAMIDE | 3.1.1.8 |
5DYW | CRYSTAL STRUCTURE OF HUMAN BUTYRYLCHOLINESTERASE IN COMPLEX WITH N-((1-BENZYLPIPERIDIN-3-YL)METHYL)-N-(2-METHOXYETHYL)NAPHTHALENE-2-SULFONAMIDE | 3.1.1.8 |
5DYY | CRYSTAL STRUCTURE OF HUMAN BUTYRYLCHOLINESTERASE IN COMPLEX WITH N-((1-BENZYLPIPERIDIN-3-YL)METHYL)NAPHTHALENE-2-SULFONAMIDE | 3.1.1.8 |
5E09 | STRUCTURAL INSIGHT OF A TRIMODULAR HALOPHILIC CELLULASE WITH A FAMILY 46 CARBOHYDRATE-BINDING MODULE | 3.2.1.4 |
5E0C | STRUCTURAL INSIGHT OF A TRIMODULAR HALOPHILIC CELLULASE WITH A FAMILY 46 CARBOHYDRATE-BINDING MODULE | 3.2.1.4 |
5E0F | HUMAN PANCREATIC ALPHA-AMYLASE IN COMPLEX WITH MINI-MONTBRETIN A | 3.2.1.1 |
5E0O | BRUGIA MALAYI TREHALOSE-6 PHOSPHATE PHOSPHATASE IN COMPLEX WITH PEG AT THE ACTIVE SITE. | 3.1.3.12 |
5E13 | CRYSTAL STRUCTURE OF EOSINOPHIL-DERIVED NEUROTOXIN IN COMPLEX WITH THE TRIAZOLE DOUBLE-HEADED RIBONUCLEOSIDE 11C | 3.1.27.5 4.6.1.18 |
5E1F | CRYSTAL STRUCTURE OF STAPHYLOCOCCAL NUCLEASE VARIANT DELTA+PHS G20E AT CRYOGENIC TEMPERATURE | 3.1.31.1 |
5E1Q | MUTANT (D415G) GH97 ALPHA-GALACTOSIDASE IN COMPLEX WITH GAL-LAC | 3.2.1.22 |
5E27 | THE STRUCTURE OF RESUSCITATION PROMOTING FACTOR B FROM M. TUBERCULOSIS REVEALS UNEXPECTED UBIQUITIN-LIKE DOMAINS | 3 |
5E2E | CRYSTAL STRUCTURE OF BETA-LACTAMASE PRECURSOR BLAA FROM YERSINIA ENTEROCOLITICA | 3.5.2.6 |
5E2F | CRYSTAL STRUCTURE OF BETA-LACTAMASE CLASS D FROM BACILLUS SUBTILIS | 3.5.2.6 |
5E2G | CRYSTAL STRUCTURE OF D-ALANINE CARBOXYPEPTIDASE AMPC FROM BURKHOLDERIA CENOCEPACIA | 3.5.2.6 |
5E2H | CRYSTAL STRUCTURE OF D-ALANINE CARBOXYPEPTIDASE AMPC FROM MYCOBACTERIUM SMEGMATIS | 3.5.2.6 |
5E2J | CRYSTAL STRUCTURE OF SINGLE MUTANT THERMOSTABLE ENDOGLUCANASE (D468A) FROM ALICYCLOBACILLUS ACIDOCALDARIUS | 3.2.1.4 |
5E2O | FACTOR XIA IN COMPLEX WITH THE INHIBITOR 4-[(N-{(2E)-3-[5-CHLORO-2-(1H-TETRAZOL-1-YL)PHENYL]PROP-2-ENOYL}-L-PHENYLALANYL)AMINO]BENZOIC ACID | 3.4.21.27 |
5E2P | FACTOR XIA IN COMPLEX WITH THE INHIBITOR N-[(1S)-1-BENZYL-2-[2-[5-CHLORO-2-(TETRAZOL-1-YL)PHENYL]ETHYLAMINO]-2-OXO-ETHYL]-4-HYDROXY-2-OXO-1H-QUINOLINE-6-CARBOXAMIDE | 3.4.21.27 |
5E3F | CRYSTAL STRUCTURE OF STAPHYLOCOCCAL NUCLEASE VARIANT DELTA+PHS I92K AT CRYOGENIC TEMPERATURE | 3.1.31.1 |
5E3X | CRYSTAL STRUCTURE OF THERMOSTABLE CARBOXYPEPTIDASE (FISCP) FROM FERVIDOBACTERIUM ISLANDICUM AW-1 | 3.4.17.19 |
5E43 | CRYSTAL STRUCTURE OF BETA-LACTAMASE SROS_5706 FROM STREPTOSPORANGIUM ROSEUM | 3.5.2.6 |
5E50 | APLF/XRCC4 COMPLEX | 4.2.99.18 3.1 |
5E5C | CRYSTAL STRUCTURE OF DIHYDROPYRIMIDINASE FROM PSEUDOMONAS AERUGINOSA PAO1 | 3.5.2.2 |
5E5D | NATIVE STRUCTURE OF XOO1075, A PEPTIDE DEFORMYLASE FROM XANTHOMONAS ORYZAE PV. ORYZAE | 3.5.1.88 |
5E5E | X-RAY STRUCTURE OF THE ADDUCT FORMED IN THE REACTION BETWEEN RNASE A AND A NEUTRAL ORGANOMETALLIC DERIVATIVE [PT(PBI)(ME)(DMSO)], PBI=2-(2'-PYRIDIL)BENZIMIDAZOLE (COMPOUND 3) | 3.1.27.5 4.6.1.18 |
5E5F | X-RAY STRUCTURE OF THE COMPLEX BETWEEN RNASE A AND COMPOUND 4-PF6 ([(PPH3)AU(MI-PBI)PT(ME)(DMSO)][PF6]), THE HETEROBIMETALLIC DERIVATIVE OBTAINED IN THE REACTION BETWEEN THE ORGANOMETALLIC COMPOUND [PT(PBI)(ME)(DMSO)], PBI=2-(2'-PYRIDIL)BENZIMIDAZOLE (COMPOUND 3) AND THE GOLD(I) COMPOUND [AU(PH3P)][PF6] | 3.1.27.5 4.6.1.18 |
5E7I | CRYSTAL STRUCTURE OF THE ACTIVE CATALYTIC CORE OF THE HUMAN DEAD-BOX PROTEIN DDX3 | 3.6.4.13 |
5E7J | CRYSTAL STRUCTURE OF THE ACTIVE CATALYTIC CORE OF THE HUMAN DEAD-BOX PROTEIN DDX3 BOUND TO AMP | 3.6.4.13 |
5E7M | CRYSTAL STRUCTURE OF THE ACTIVE CATALYTIC CORE OF THE HUMAN DEAD-BOX PROTEIN DDX3 BOUND TO AMPPNP | 3.6.4.13 |
5E85 | ISOLATED SBD OF BIP | 3.6.4.10 |
5E86 | ISOLATED SBD OF BIP WITH LOOP34 MODIFICATION | 3.6.4.10 |
5E8F | STRUCTURE OF FULLY MODIFIED GERANYLGERANYLATED PDE6C PEPTIDE IN COMPLEX WITH PDE6D | 3.1.4.35 |
5E8M | CRYSTAL STRUCTURE OF HUMAN HEPARANASE | 3.2.1.166 |
5E95 | CRYSTAL STRUCTURE OF MB(NS1)/H-RAS COMPLEX | 3.6.5.2 |
5E97 | GLYCOSIDE HYDROLASE LIGAND STRUCTURE 1 | 3.2.1.166 |
5E98 | CRYSTAL STRUCTURE OF HUMAN HEPARANASE IN COMPLEX WITH HEPMER M04S02A | 3.2.1.166 |
5E9B | CRYSTAL STRUCTURE OF HUMAN HEPARANASE IN COMPLEX WITH HEPMER M09S05A | 3.2.1.166 |
5E9C | CRYSTAL STRUCTURE OF HUMAN HEPARANASE IN COMPLEX WITH HEPARIN TETRASACCHARIDE DP4 | 3.2.1.166 |
5E9Q | DENGUE 3 NS5 METHYLTRANSFERASE BOUND TO S-ADENOSYL METHIONINE AND MOLECULE BF174 | 3.4.21.91 3.6.1.15 3.6.4.13 2.1.1.56 2.1.1.57 2.7.7.48 |
5E9R | X-RAY STRUCTURE OF THE COMPLEX BETWEEN LYSOZYME AND THE COMPOUND FAC, CIS-[RUII(CO)3CL2(N3-MBI), MBI=N-METHYL-BENZIMIDAZOLE | 3.2.1.17 |
5EAN | CRYSTAL STRUCTURE OF DNA2 IN COMPLEX WITH A 5' OVERHANG DNA | 3.1 3.6.4.12 |
5EAW | CRYSTAL STRUCTURE OF DNA2 NUCLEASE-HELICASE | 3.1 3.6.4.12 |
5EAX | CRYSTAL STRUCTURE OF DNA2 IN COMPLEX WITH AN SSDNA | 3.1 3.6.4.12 |
5EB8 | CRYSTAL STRUCTURE OF AROMATIC MUTANT (F4W) OF AN ALKALI THERMOSTABLE GH10 XYLANASE FROM BACILLUS SP. NG-27 | 3.2.1.8 |
5EBA | CRYSTAL STRUCTURE OF AROMATIC MUTANT (Y343A) OF AN ALKALI THERMOSTABLE GH10 XYLANASE FROM BACILLUS SP. NG-27 | 3.2.1.8 |
5EBB | STRUCTURE OF HUMAN SPHINGOMYELINASE PHOSPHODIESTERASE LIKE 3A (SMPDL3A) WITH ZN2+ | 3.1.4 |
5EBC | CRYSTAL STRUCTURE OF ECCB1 OF MYCOBACTERIUM TUBERCULOSIS IN SPACEGROUP P21 (STATE III) | 3.6 |
5EBD | CRYSTAL STRUCTURE OF ECCB1 OF MYCOBACTERIUM TUBERCULOSIS IN SPACEGROUP P21 (STATE IV) | 3.6 |
5EBE | STRUCTURE OF HUMAN SPHINGOMYELINASE PHOSPHODIESTERASE LIKE 3A (SMPDL3A) WITH 5' CMP | 3.1.4 |
5EC8 | DENGUE 3 NS5 METHYLTRANSFERASE BOUND TO S-ADENOSYL METHIONINE AND COMPOUND BF175 | 3.4.21.91 3.6.1.15 3.6.4.13 2.1.1.56 2.1.1.57 2.7.7.48 |
5ECD | STRUCTURE OF THE SHIGELLA FLEXNERI VAPC MUTANT D98N CRYSTAL FORM 1 | 3.1 |
5ECT | MYCOBACTERIUM TUBERCULOSIS DUTPASE G143STOP MUTANT | 3.6.1.23 |
5ECU | THE UNLIGANDED STRUCTURE OF CALDICELLULOSIRUPTOR SACCHAROLYTICUS GH5 | 3.2.1.4 |
5ECW | STRUCTURE OF THE SHIGELLA FLEXNERI VAPC MUTANT D7A | 3.1 |
5ECY | STRUCTURE OF THE SHIGELLA FLEXNERI VAPC MUTANT D98N CRYSTAL FORM 2 | 3.1 |
5ED3 | CRYSTAL STRUCTURE OF HUMAN HINT1 COMPLEXING WITH AP5A | 3 |
5ED6 | CRYSTAL STRUCTURE OF HUMAN HINT1 H114A MUTANT COMPLEXING WITH ATP | 3 |
5EDD | CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS DUTPASE R140K, H145W MUTANT | 3.6.1.23 |
5EDK | CRYSTAL STRUCTURE OF PROTHROMBIN DELETION MUTANT RESIDUES 146-167 ( FORM II ). | 3.4.21.5 |
5EDM | CRYSTAL STRUCTURE OF PROTHROMBIN DELETION MUTANT RESIDUES 154-167 ( FORM I ) | 3.4.21.5 |
5EE0 | CRYSTAL STRUCTURE OF OSYCHF1 AT PH 6.5 | 3.6.5 |
5EE1 | CRYSTAL STRUCTURE OF OSYCHF1 AT PH 7.85 | 3.6.5 |
5EE3 | COMPLEX STRUCTURE OF OSYCHF1 WITH AMP-PNP | 3.6.5 |
5EE8 | CRYSTAL STRUCTURE OF S02030 BORONIC ACID INHIBITOR COMPLEXED TO SHV-1 BETA-LACTAMASE | 3.5.2.6 |
5EE9 | COMPLEX STRUCTURE OF OSYCHF1 WITH GMP-PNP | 3.6.5 |
5EEC | CRYSTAL STRUCTURE OF KPC-2 BETA-LACTAMASE IN COMPLEX WITH THE S02030 BORONIC ACID INHIBITOR | 3.5.2.6 |
5EFD | CRYSTAL STRUCTURE OF A SURFACE POCKET CREATING MUTANT (W6A) OF AN ALKALI THERMOSTABLE GH10 XYLANASE FROM BACILLUS SP. NG-27 | 3.2.1.8 |
5EFF | CRYSTAL STRUCTURE OF AN AROMATIC MUTANT (F4A) OF AN ALKALI THERMOSTABLE GH10 XYLANASE FROM BACILLUS SP. NG-27 | 3.2.1.8 |
5EGM | DEVELOPMENT OF A NOVEL TRICYCLIC CLASS OF POTENT AND SELECTIVE FIXA INHIBITORS | 3.4.21.22 |
5EGN | EST816 AS AN N-ACYL HOMOSERINE LACTONE DEGRADING ENZYME | 3.1.1.1 |
5EGT | CRYSTAL STRUCTURE OF STAPHYLOCOCCAL NUCLEASE VARIANT DELTA+PHS V66E AT CRYOGENIC TEMPERATURE | 3.1.31.1 |
5EH9 | INDIRECT CONTRIBUTIONS OF MUTATIONS UNDERLIE OPTIMIZATION OF NEW ENZYME FUNCTION | 3.1.1.81 |
5EHG | DENGUE 3 NS5 METHYLTRANSFERASE BOUND TO S-ADENOSYL METHIONINE AND MOLECULE BF341 | 3.4.21.91 3.6.1.15 3.6.4.13 2.1.1.56 2.1.1.57 2.7.7.48 |
5EHI | DENGUE 3 NS5 METHYLTRANSFERASE BOUND TO S-ADENOSYL METHIONINE AND MOLECULE BF287 | 3.4.21.91 3.6.1.15 3.6.4.13 2.1.1.56 2.1.1.57 2.7.7.48 |
5EHN | MACHE-SYN TZ2PA5 COMPLEX | 3.1.1.7 |
5EHQ | MACHE-ANTI TZ2PA5 COMPLEX | 3.1.1.7 |
5EHT | INDIRECT CONTRIBUTIONS OF MUTATIONS UNDERLIE OPTIMIZATION OF NEW ENZYME FUNCTION | 3.1.1.81 |
5EHX | CRYSTAL STRUCTURE OF MSF-AGED TORPEDO CALIFORNICA ACETYLCHOLINESTERASE | 3.1.1.7 |
5EHZ | MACHE-SYN TZ2PA5 COMPLEX FROM AN EQUIMOLAR MIXTURE OF THE SYN/ANTI ISOMERS | 3.1.1.7 |
5EI5 | CRYSTAL STRUCTURE OF MSF-AGED TORPEDO CALIFORNICA ACETYLCHOLINESTERASE IN COMPLEX WITH ALKYLENE-LINKED BIS-TACRINE DIMER (7 CARBON LINKER) | 3.1.1.7 |
5EIA | MACHE-ANTI TZ2PA5 COMPLEX FROM A 1:6 MIXTURE OF THE SYN/ANTI ISOMERS | 3.1.1.7 |
5EIE | MACHE-TZ2 COMPLEX | 3.1.1.7 |
5EIF | DENGUE 3 NS5 METHYLTRANSFERASE BOUND TO S-ADENOSYL METHIONINE AND FRAGMENT NB2C3 | 3.4.21.91 3.6.1.15 3.6.4.13 2.1.1.56 2.1.1.57 2.7.7.48 |
5EIH | MACHE-TZ2/PA5 COMPLEX | 3.1.1.7 |
5EIW | DENGUE 3 NS5 METHYLTRANSFERASE BOUND TO S-ADENOSYL METHIONINE AND FRAGMENT NB3C2 | 2.7.7.48 3.4.21.91 3.6.1.15 3.6.4.13 2.1.1.56 2.1.1.57 |
5EJ3 | CRYSTAL STRUCTURE OF XLNB2 | 3.2.1.8 |
5EJJ | CRYSTAL STRUCTURE OF UFSP FROM C.ELEGANS | 3.4.22 |
5EJK | CRYSTAL STRUCTURE OF THE ROUS SARCOMA VIRUS INTASOME | 3.4.23 2.7.7.49 2.7.7.7 3.1.26.4 2.7.7 3.1 |
5EKK | CRYSTAL STRUCTURE OF STAPHYLOCOCCAL NUCLEASE VARIANT DELTA+PHS V39D/L125E AT CRYOGENIC TEMPERATURE | 3.1.31.1 |
5EKL | CRYSTAL STRUCTURE OF STAPHYLOCOCCAL NUCLEASE VARIANT DELTA+PHS T62D/N100E AT CRYOGENIC TEMPERATURE | 3.1.31.1 |
5EKT | CRYSTAL STRUCTURE OF MUTANT-K146A OF PEPTIDYL-TRNA HYDROLASE FROM VIBRIO CHOLERAE AT 1.63A RESOLUTION. | 3.1.1.29 |
5EKX | DENGUE 3 NS5 METHYLTRANSFERASE BOUND TO S-ADENOSYLMETHIONINE AND FRAGMENT NB2E11 | 3.4.21.91 3.6.1.15 3.6.4.13 2.1.1.56 2.1.1.57 2.7.7.48 |
5ELX | S. CEREVISIAE DBP5 BOUND TO RNA AND MANT-ADP BEF3 | 3.6.4.13 |
5EMI | N-ACETYLMURAMOYL-L-ALANINE AMIDASE AMIC2 OF NOSTOC PUNCTIFORME | 3.5.1.28 |
5EMT | HUMAN HISTIDINE TRIAD NUCLEOTIDE BINDING PROTEIN 1 (HHINT1)-COPPER COMPLEX | 3 |
5ENM | COMPOUND 10 | 3.4.23.46 |
5EO3 | CRYSTAL STRUCTURE OF PELOTA C TERMINAL DOMAIN FROM HUMAN | 3.1 |
5EOE | CRYSTAL STRUCTURE OF EXTENDED-SPECTRUM BETA-LACTAMASE BEL-1 (ORTHORHOMBIC FORM) | 3.5.2.6 |
5EOO | CRYSTAL STRUCTURE OF EXTENDED-SPECTRUM BETA-LACTAMASE BEL-1 (MONOCLINIC FORM) | 3.5.2.6 |
5EPB | CRYSTAL STRUCTURE OF THE BROMODOMAIN OF HUMAN ATAD2 IN COMPLEX WITH COMPOUND 49 | 3.6.1.3 3.6.1 |
5EPH | CRYSTAL STRUCTURE OF EXTENDED-SPECTRUM BETA-LACTAMASE BEL-1 IN COMPLEX WITH IMIPENEM | 3.5.2.6 |
5EPP | STRUCTURAL INSIGHTS INTO THE INTERACTION OF P97 N-TERMINUS DOMAIN AND VBM MOTIF IN RHOMBOID PROTEASE, RHBDL4 | 3.6.4.6 |
5EQV | 1.45 ANGSTROM CRYSTAL STRUCTURE OF BIFUNCTIONAL 2',3'-CYCLIC NUCLEOTIDE 2'-PHOSPHODIESTERASE/3'-NUCLEOTIDASE PERIPLASMIC PRECURSOR PROTEIN FROM YERSINIA PESTIS WITH PHOSPHATE BOUND TO THE ACTIVE SITE | 3.1.4.16 |
5ER1 | A RATIONAL APPROACH TO THE DESIGN OF ANTIHYPERTENSIVES. X-RAY STUDIES OF COMPLEXES BETWEEN ASPARTIC PROTEINASES AND AMINOALCOHOL RENIN INHIBITORS | 3.4.23.6 3.4.23.22 |
5ER2 | HIGH-RESOLUTION X-RAY DIFFRACTION STUDY OF THE COMPLEX BETWEEN ENDOTHIAPEPSIN AND AN OLIGOPEPTIDE INHIBITOR. THE ANALYSIS OF THE INHIBITOR BINDING AND DESCRIPTION OF THE RIGID BODY SHIFT IN THE ENZYME | 3.4.23.6 3.4.23.22 |
5EST | CRYSTALLOGRAPHIC ANALYSIS OF THE INHIBITION OF PORCINE PANCREATIC ELASTASE BY A PEPTIDYL BORONIC ACID: STRUCTURE OF A REACTION INTERMEDIATE | 3.4.21.36 |
5ET4 | STRUCTURE OF RNASE A-K7H/R10H IN COMPLEX WITH 3'-CMP | 3.1.27.5 4.6.1.18 |
5ET8 | HUMAN MUSCLE FRUCTOSE-1,6-BISPHOSPHATASE IN ACTIVE R-STATE IN COMPLEX WITH FRUCTOSE-6-PHOSPHATE | 3.1.3.11 |
5EU7 | CRYSTAL STRUCTURE OF HIV-1 INTEGRASE CATALYTIC CORE IN COMPLEX WITH FAB | 2.7.7 3.4.23.16 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 3.1 |
5EU8 | STRUCTURE OF FIPV MAIN PROTEASE IN COMPLEX WITH DUAL INHIBITORS | 3.4.19.12 3.4.22 2.7.7.48 3.6.4.12 3.6.4.13 3.1.13 3.1 2.1.1 |
5EUA | CRYSTAL STRUCTURE OF EXTENDED-SPECTRUM BETA-LACTAMASE BEL-1 IN COMPLEX WITH MOXALACTAM | 3.5.2.6 |
5EUF | THE CRYSTAL STRUCTURE OF A PROTEASE FROM HELICOBACTER PYLORI | 3.4 |
5EUG | CRYSTALLOGRAPHIC AND ENZYMATIC STUDIES OF AN ACTIVE SITE VARIANT H187Q OF ESCHERICHIA COLI URACIL DNA GLYCOSYLASE: CRYSTAL STRUCTURES OF MUTANT H187Q AND ITS URACIL COMPLEX | 3.2.2.3 3.2.2.27 |
5EUM | 1.8 ANGSTROM CRYSTAL STRUCTURE OF ATP-BINDING COMPONENT OF FUSED LIPID TRANSPORTER SUBUNITS OF ABC SUPERFAMILY FROM HAEMOPHILUS INFLUENZAE. | 3.6.3 7.5.2.6 |
5EUT | CRYSTAL STRUCTURE OF PHOSPHATIDYL INOSITOL 4-KINASE II ALPHA IN THE APO STATE | 2.7.1.67 3.2.1.17 |
5EVI | CRYSTAL STRUCTURE OF BETA-LACTAMASE/D-ALANINE CARBOXYPEPTIDASE FROM PSEUDOMONAS SYRINGAE | 3.5.2.6 |
5EVL | CRYSTAL STRUCTURE OF BETA-LACTAMASE/D-ALANINE CARBOXYPEPTIDASE FROM CHROMOBACTERIUM VIOLACEUM | 3.5.2.6 |
5EWQ | THE CRYSTAL STRUCTURE OF AN AMIDASE FAMILY PROTEIN FROM BACILLUS ANTHRACIS STR. AMES | 3.5.1.4 |
5EYG | CRYSTAL STRUCTURE OF IMPASE/NADP PHOSPHATASE COMPLEXED WITH NADP AND CA2+ | 3.1.3.25 |
5EYH | CRYSTAL STRUCTURE OF IMPASE/NADP PHOSPHATASE COMPLEXED WITH NADP AND CA2+ AT PH 7.0 | 3.1.3.25 |
5EYI | STRUCTURE OF PRRSV APO-NSP11 AT 2.16A | 3.4.22 3.4.19.12 3.4.21 2.7.7.48 3.6.4.12 3.6.4.13 |
5EZ6 | CRYSTALLIZATION AND PRELIMINARY X-RAY CRYSTALLOGRAPHIC ANALYSIS OF A SMALL GTPASE RHOA | 3.6.5.2 |
5EZX | CRYSTAL STRUCTURE OF BACE-1 IN COMPLEX WITH {(1R,2R)-2-[(R)-2-AMINO-4-(4-DIFLUOROMETHOXY-PHENYL)-4,5-DIHYDRO-OXAZOL-4-YL]-CYCLOPROPYL}-(5-CHLORO-PYRIDIN-3-YL)-METHANONE | 3.4.23.46 |
5EZZ | CRYSTAL STRUCTURE OF BACE-1 IN COMPLEX WITH (4S)-4-[3-(5-CHLORO-3-PYRIDYL)PHENYL]-4-[4-(DIFLUOROMETHOXY)-3-METHYL-PHENYL]-5H-OXAZOL-2-AMINE | 3.4.23.46 |
5F00 | CRYSTAL STRUCTURE OF BACE-1 IN COMPLEX WITH 5-[3-[(3-CHLORO-8-QUINOLYL)AMINO]PHENYL]-5-METHYL-2,6-DIHYDRO-1,4-OXAZIN-3-AMINE | 3.4.23.46 |
5F01 | CRYSTAL STRUCTURE OF BACE-1 IN COMPLEX WITH (1SR,2SR)-2-((R)-2-AMINO-5,5-DIFLUORO-4-METHYL-5,6-DIHYDRO-4H-1,3-OXAZIN-4-YL)-N-(3-CHLOROQUINOLIN-8-YL)CYCLOPROPANECARBOXAMIDE | 3.4.23.46 |
5F02 | CATHEPSIN L IN COMPLEX WITH (2S,4R)-4-(2-CHLORO-4-METHOXY-BENZENESULFONYL)-1-[3-(5-CHLORO-PYRIDIN-2-YL)-AZETIDINE-3-CARBONYL]-PYRROLIDINE-2-CARBOXYLIC ACID (1-CYANO-CYCLOPROPYL)-AMIDE | 3.4.22.15 |
5F03 | TRYPTASE B2 IN COMPLEX WITH 5-(3-AMINOMETHYL-PHENOXYMETHYL)-3-[3-(2-CHLORO-PYRIDIN-3-YLETHYNYL)-PHENYL]-OXAZOLIDIN-2-ONE; COMPOUND WITH TRIFLUORO-ACETIC ACID | 3.4.21.59 |
5F14 | STRUCTURE OF NATIVE HEN EGG-WHITE LYSOZYME | 3.2.1.17 |
5F16 | CTA-MODIFIED HEN EGG-WHITE LYSOZYME | 3.2.1.17 |
5F17 | STRUCTURE OF EAV NSP11 K170A MUTANT AT 3.19A | 3.4.22 3.4.19.12 3.4.21 2.7.7.48 3.6.4.12 3.6.4.13 |
5F1F | CRYSTAL STRUCTURE OF A CLASS C BETA LACTAMASE | 3.5.2.6 |
5F1G | CRYSTAL STRUCTURE OF A CLASS C BETA LACTAMASE | 3.5.2.6 |
5F22 | C-TERMINAL DOMAIN OF SARS-COV NSP8 COMPLEX WITH NSP7 | 3.4.19.12 3.4.22 3.4.22.69 |
5F24 | CRYSTAL STRUCTURE OF DUAL SPECIFIC IMPASE/NADP PHOSPHATASE BOUND WITH D-INOSITOL-1-PHOSPHATE | 3.1.3.25 |
5F2D | CRYSTAL STRUCTURE OF STAPHYLOCOCCAL NUCLEASE VARIANT DELTA+PHS I92N/V99T AT CRYOGENIC TEMPERATURE | 3.1.31.1 |
5F2E | CRYSTAL STRUCTURE OF SMALL MOLECULE ARS-853 COVALENTLY BOUND TO K-RAS G12C | 3.6.5.2 |
5F36 | CRYSTAL STRUCTURE OF THE BROMODOMAIN OF HUMAN ATAD2 IN COMPLEX WITH COMPOUND A12 | 3.6.1.3 3.6.1 |
5F3A | CRYSTAL STRUCTURE OF THE BROMODOMAIN OF HUMAN ATAD2 IN COMPLEX WITH COMPOUND A14 | 3.6.1.3 3.6.1 |
5F3T | DENGUE SEROTYPE 3 RNA-DEPENDENT RNA POLYMERASE BOUND TO JF-31-MG46 | 3.4.21.91 3.6.1.15 3.6.4.13 2.1.1.56 2.1.1.57 2.7.7.48 |
5F3W | STRUCTURE OF THE ATPRS-MRE11/RAD50-DNA COMPLEX | 3.1 |
5F3Z | DENGUE SEROTYPE 3 RNA-DEPENDENT RNA POLYMERASE BOUND TO PC-79-SH52 | 3.4.21.91 3.6.1.15 3.6.4.13 2.1.1.56 2.1.1.57 2.7.7.48 |
5F41 | DENGUE SEROTYPE 3 RNA-DEPENDENT RNA POLYMERASE BOUND TO FD-83-KI26 | 3.4.21.91 3.6.1.15 3.6.4.13 2.1.1.56 2.1.1.57 2.7.7.48 |
5F5B | STRUCTURE OF E.COLI GLPG COMPLEXED WITH PEPTIDIC INHIBITOR AC-VRMA-CHO | 3.4.21.105 |
5F5D | CRYSTAL STRUCTURES AND INHIBITION KINETICS REVEAL A TWO-STATE CATALYTIC MECHANISM WITH DRUG DESIGN IMPLICATIONS FOR RHOMBOID PROTEOLYSIS | 3.4.21.105 |
5F5J | E.COLI GLPG Y205F MUTANT COMPLEXED WITH ALDEHYDE INHIBITOR IN DMPC/CHAPSO BICELLE | 3.4.21.105 |
5F5K | E.COLI GLPG Y205F MUTANT COMPLEXED WITH ALDEHYDE INHIBITOR IN DMPC/CHAPSO BICELLE | 3.4.21.105 |
5F6M | ISOTROPIC TRYPSIN MODEL FOR COMPARISON OF DIFFUSE SCATTERING | 3.4.21.4 |
5F7C | CRYSTAL STRUCTURE OF FAMILY 31 ALPHA-GLUCOSIDASE (BT_0339) FROM BACTEROIDES THETAIOTAOMICRON | 3.2.1.20 |
5F81 | ACOUSTIC INJECTORS FOR DROP-ON-DEMAND SERIAL FEMTOSECOND CRYSTALLOGRAPHY | 3.2.1.17 |
5F82 | APO GES-5 C69G MUTANT | 3.5.2.6 |
5F83 | IMIPENEM COMPLEX OF THE GES-5 C69G MUTANT | 3.5.2.6 |
5F8A | CRYSTAL STRUCTURE OF THE TERNARY ECORV-DNA-LU COMPLEX WITH UNCLEAVED DNA SUBSTRATE. LANTHANIDE BINDING TO ECORV-DNA COMPLEX INHIBITS CLEAVAGE. | 3.1.21.4 |
5F8T | THE CRYSTAL STRUCTURE OF HUMAN PLASMA KALLIKREIN IN COMPLEX WITH ITS PEPTIDE INHIBITOR PKALIN-2 | 3.4.21.34 |
5F8X | THE CRYSTAL STRUCTURE OF HUMAN PLASMA KALLIKREIN IN COMPLEX WITH ITS PEPTIDE INHIBITOR PKALIN-3 | 3.4.21.34 |
5F8Z | THE CRYSTAL STRUCTURE OF HUMAN PLASMA KALLIKREIN IN COMPLEX WITH ITS PEPTIDE INHIBITOR PKALIN-1 | 3.4.21.34 |
5F9K | DICTYOSTELIUM DISCOIDEUM DUTPASE AT 2.2 ANGSTROM | 3.6.1.23 |
5F9T | CRYSTAL STRUCTURE OF STREPTOCOCCUS PNEUMONIAE NANC, COVALENT COMPLEX WITH A FLUORINATED NEU5AC DERIVATIVE | 3.2.1.18 |
5FA7 | CTX-M-15 IN COMPLEX WITH FPI-1523 | 3.5.2.6 |
5FAH | KALLIKREIN-7 IN COMPLEX WITH COMPOUND1 | 3.4.21.117 |
5FAO | CTX-M-15 IN COMPLEX WITH FPI-1465 | 3.5.2.6 |
5FAP | CTX-M-15 IN COMPLEX WITH FPI-1602 | 3.5.2.6 |
5FAQ | OXA-48 IN COMPLEX WITH FPI-1465 | 3.5.2.6 |
5FAS | OXA-48 IN COMPLEX WITH FPI-1523 | 3.5.2.6 |
5FAT | OXA-48 IN COMPLEX WITH FPI-1602 | 3.5.2.6 |
5FB9 | S1 NUCLEASE FROM ASPERGILLUS ORYZAE WITH UNOCCUPIED ACTIVE SITE | 3.1.30.1 |
5FBA | S1 NUCLEASE FROM ASPERGILLUS ORYZAE IN COMPLEX WITH PHOSPHATE | 3.1.30.1 |
5FBB | S1 NUCLEASE FROM ASPERGILLUS ORYZAE IN COMPLEX WITH PHOSPHATE AND ADENOSINE 5'-MONOPHOSPHATE | 3.1.30.1 |
5FBC | S1 NUCLEASE FROM ASPERGILLUS ORYZAE IN COMPLEX WITH 2'-DEOXYADENOSINE-5'-THIO-MONOPHOSPHATE (5'DAMP(S)). | 3.1.30.1 |
5FBD | S1 NUCLEASE FROM ASPERGILLUS ORYZAE IN COMPLEX WITH PHOSPHATE AND 2'-DEOXYCYTIDINE | 3.1.30.1 |
5FBE | COMPLEMENT FACTOR D IN COMPLEX WITH COMPOUND2 | 3.4.21.46 |
5FBF | S1 NUCLEASE FROM ASPERGILLUS ORYZAE IN COMPLEX WITH TWO MOLECULES OF 2'-DEOXYCYTIDINE-5'-MONOPHOSPHATE | 3.1.30.1 |
5FBG | S1 NUCLEASE FROM ASPERGILLUS ORYZAE, MUTANT D65N, IN COMPLEX WITH PHOSPHATE, 2'-DEOXYCYTIDINE AND 2'-DEOXYGUANOSINE. | 3.1.30.1 |
5FBI | COMPLEMENT FACTOR D IN COMPLEX WITH COMPOUND 3B | 3.4.21.46 |
5FBJ | COMPLEX STRUCTURE OF JMJD5 AND SUBSTRATE | 1.14.11.27 1.14.11 3.4 |
5FBP | CRYSTAL STRUCTURE OF THE NEUTRAL FORM OF FRUCTOSE-1,6-BISPHOSPHATASE COMPLEXED WITH THE PRODUCT FRUCTOSE 6-PHOSPHATE AT 2.1-ANGSTROMS RESOLUTION | 3.1.3.11 |
5FC1 | MURINE SMPDL3A IN COMPLEX WITH SULFATE | 3.1.4 |
5FC5 | MURINE SMPDL3A IN COMPLEX WITH PHOSPHOCHOLINE | 3.1.4 |
5FC6 | MURINE SMPDL3A IN COMPLEX WITH ADP ANALOG AMPCP | 3.1.4 |
5FC7 | MURINE SMPDL3A IN COMPLEX WITH SULFATE (TETRAGONAL) | 3.1.4 |
5FCA | MURINE SMPDL3A IN PRESENCE OF EXCESS ZINC | 3.1.4 |
5FCB | MURINE SMPDL3A IN COMPLEX WITH AMP | 3.1.4 |
5FCF | CRYSTAL STRUCTURE OF XAA-PRO DIPEPTIDASE FROM XANTHOMONAS CAMPESTRIS, PHOSPHATE AND MN BOUND | 3.4.13.9 |
5FCH | CRYSTAL STRUCTURE OF XAA-PRO DIPEPTIDASE FROM XANTHOMONAS CAMPESTRIS, PHOSPHATE AND ZN BOUND | 3.4.13.9 |
5FCK | COMPLEMENT FACTOR D IN COMPLEX WITH COMPOUND 5 | 3.4.21.46 |
5FCR | MOUSE COMPLEMENT FACTOR D | 3.4.21.46 |
5FCW | HDAC8 COMPLEXED WITH A HYDROXAMIC ACID | 3.5.1.98 |
5FCZ | STREPTOMYCES PLICATUS N-ACETYL-BETA-HEXOSAMINIDASE IN COMPLEX WITH THIO-NAGLUCAL (TNX) | 3.2.1.52 |
5FD0 | STREPTOMYCES PLICATUS N-ACETYL-BETA-HEXOSAMINIDASE IN COMPLEX WITH NAGLUCAL | 3.2.1.52 |
5FDD | ENDONUCLEASE INHIBITOR 1 BOUND TO INFLUENZA STRAIN H1N1 POLYMERASE ACIDIC SUBUNIT N-TERMINAL REGION AT PH 7.0 | 3.1 |
5FDG | ENDONUCLEASE INHIBITOR 3 BOUND TO INFLUENZA STRAIN H1N1 POLYMERASE ACIDIC SUBUNIT N-TERMINAL REGION AT PH 7.0 | 3.1 |
5FDH | CRYSTAL STRUCTURE OF OXA-405 BETA-LACTAMASE | 3.5.2.6 |
5FDK | CRYSTAL STRUCTURE OF RECU(D88N) IN COMPLEX WITH PALINDROMIC DNA DUPLEX | 3.1.22 3.1.22.4 |
5FDL | CRYSTAL STRUCTURE OF K103N/Y181C MUTANT HIV-1 REVERSE TRANSCRIPTASE (RT) IN COMPLEX WITH IDX899 | 2.7.7.49 3.4.23.16 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1 |
5FF8 | TDG ENZYME-PRODUCT COMPLEX | 3.2.2.29 |
5FFM | YELLOW FEVER VIRUS HELICASE | 3.4.21.91 3.6.1.15 3.6.4.13 2.1.1.56 2.1.1.57 2.7.7.48 |
5FGC | THREE DIMENSIONAL STRUCTURE OF BROADLY NEUTRALIZING HUMAN ANTI - HEPATITIS C VIRUS (HCV) GLYCOPROTEIN E2 FAB FRAGMENT HC33.8 | 3.4.22 3.4.21.98 3.6.1.15 3.6.4.13 2.7.7.48 |
5FGY | STRUCTURE OF HUMAN ADENOVIRUS 2 PROTEASE WITH COFACTOR PVIC | 3.4.22.39 |
5FHT | HTRA2 PROTEASE MUTANT V226K | 3.4.21.108 |
5FHW | HEN EGG-WHITE LYSOZYME (HEWL) COMPLEXED WITH HF(IV)-SUBSTITUTED WELLS DAWSON-TYPE POLYOXOMETALATE | 3.2.1.17 |
5FIP | DISCOVERY AND CHARACTERIZATION OF A NOVEL THERMOSTABLE AND HIGHLY HALOTOLERANT GH5 CELLULASE FROM AN ICELANDIC HOT SPRING ISOLATE | 3.2.1.4 |
5FIR | CRYSTAL STRUCTURE OF C. ELEGANS XRN2 IN COMPLEX WITH THE XRN2-BINDING DOMAIN OF PAXT-1 | 3.1.13 |
5FIT | FHIT-SUBSTRATE ANALOG | 3.6.1.29 |
5FIV | STRUCTURAL STUDIES OF HIV AND FIV PROTEASES COMPLEXED WITH AN EFFICIENT INHIBITOR OF FIV PR | 3.4.23.16 3.4.23 2.7.7.49 3.1.26.13 3.1.13.2 3.6.1.23 2.7.7 3.1 |
5FIX | STRUCTURE OF D80A-FRUCTOFURANOSIDASE FROM XANTHOPHYLLOMYCES DENDRORHOUS COMPLEXED WITH SUCROSE | 3.2.1.26 |
5FJI | THREE-DIMENSIONAL STRUCTURES OF TWO HEAVILY N-GLYCOSYLATED ASPERGILLUS SP. FAMILY GH3 BETA-D-GLUCOSIDASES | 3.2.1.21 |
5FK7 | STRUCTURE OF D80A-FRUCTOFURANOSIDASE FROM XANTHOPHYLLOMYCES DENDRORHOUS COMPLEXED WITH NEOKESTOSE | 3.2.1.26 |
5FK8 | STRUCTURE OF D80A-FRUCTOFURANOSIDASE FROM XANTHOPHYLLOMYCES DENDRORHOUS COMPLEXED WITH NEO-ERLOSE | 3.2.1.26 |
5FKB | STRUCTURE OF D80A-FRUCTOFURANOSIDASE FROM XANTHOPHYLLOMYCES DENDRORHOUS COMPLEXED WITH 1-KESTOSE | 3.2.1.26 |
5FKC | STRUCTURE OF D80A-FRUCTOFURANOSIDASE FROM XANTHOPHYLLOMYCES DENDRORHOUS COMPLEXED WITH RAFFINOSE | 3.2.1.26 |
5FKQ | UNRAVELING THE FIRST STEP OF XYLOGLUCAN DEGRADATION BY THE SOIL SAPROPHYTE CELLVIBRIO JAPONICUS THROUGH THE FUNCTIONAL AND STRUCTURAL CHARACTERIZATION OF A POTENT GH74 ENDO-XYLOGLUCANASE | 3.2.1 3.2.1.151 |
5FKR | UNRAVELING THE FIRST STEP OF XYLOGLUCAN DEGRADATION BY THE SOIL SAPROPHYTE CELLVIBRIO JAPONICUS THROUGH THE FUNCTIONAL AND STRUCTURAL CHARACTERIZATION OF A POTENT GH74 ENDO-XYLOGLUCANASE | 3.2.1 3.2.1.151 |
5FKS | UNRAVELING THE FIRST STEP OF XYLOGLUCAN DEGRADATION BY THE SOIL SAPROPHYTE CELLVIBRIO JAPONICUS THROUGH THE FUNCTIONAL AND STRUCTURAL CHARACTERIZATION OF A POTENT GH74 ENDO-XYLOGLUCANASE | 3.2.1 3.2.1.151 |
5FKT | UNRAVELING THE FIRST STEP OF XYLOGLUCAN DEGRADATION BY THE SOIL SAPROPHYTE CELLVIBRIO JAPONICUS THROUGH THE FUNCTIONAL AND STRUCTURAL CHARACTERIZATION OF A POTENT GH74 ENDO-XYLOGLUCANASE | 3.2.1 3.2.1.151 |
5FKY | STRUCTURE OF A HYDROLASE BOUND WITH AN INHIBITOR | 3.2.1.169 |
5FLK | STRUCTURE OF HALOALKANE DEHALOGENASE VARIANT DHAA101 | 3.8.1.5 |
5FLW | CRYSTAL STRUCTURE OF PUTATIVE EXO-BETA-1,3-GALACTANASE FROM BIFIDOBACTERIUM BIFIDUM S17 | 3.2.1.145 |
5FM6 | DOUBLE-HETEROHEXAMERIC RINGS OF FULL-LENGTH RVB1(ADP)RVB2(APO) | 3.6.4.12 |
5FM7 | DOUBLE-HETEROHEXAMERIC RINGS OF FULL-LENGTH RVB1(ADP)RVB2(ADP) | 3.6.4.12 |
5FMB | STRUCTURE OF D80A-FRUCTOFURANOSIDASE FROM XANTHOPHYLLOMYCES DENDRORHOUS COMPLEXED WITH FRUCTOSE AND HEPES BUFFER | 3.2.1.26 |
5FMC | STRUCTURE OF D80A-FRUCTOFURANOSIDASE FROM XANTHOPHYLLOMYCES DENDRORHOUS COMPLEXED WITH FRUCTOSE AND BIS-TRIS PROPANE BUFFER | 3.2.1.26 |